|
Pennsylvania
|
| |
6311
|
| |
82-4944172
|
|
|
(State or other jurisdiction of
incorporation or organization) |
| |
(Primary Standard Industrial
Classification Code Number) |
| |
(I.R.S. Employer
Identification Number) |
|
|
Wesley R. Kelso, Esq.
Stevens & Lee, P.C. 111 North Sixth Street Reading, Pennsylvania 19603 (610) 478-2242 |
| |
James M. Connolly, Esq.
Griffin Financial Group LLC 100 Lennox Drive, Suite 200 Lawrenceville, NJ 08648 (609) 987-6677 |
|
| Large accelerated filer ☐ | | | Accelerated filer ☐ | |
| Non-accelerated filer ☐ | | | Smaller reporting company ☐ | |
| | | | Emerging growth company ☒ | |
Calculation of Registration Fee
|
| ||||||||||||||||||||||||
Title of Each Class of Securities to be Registered
|
| |
Amount to be
Registered(1) |
| |
Proposed
Maximum Offering Price Per Share(2) |
| |
Proposed
Maximum Aggregate Offering Price |
| |
Amount of
Registration Fee |
| ||||||||||||
Common Stock, par value $0.001 per share
|
| | | | 4,600,000 | | | | | $ | 10.00 | | | | | $ | 46,000,000 | | | | | $ | 5,727 | | |
|
| | |
Minimum
|
| |
Maximum
|
| ||||||
Number of shares offered
|
| | | | 3,400,000 | | | | | | 4,600,000 | | |
Gross offering proceeds
|
| | | $ | 34,000,000 | | | | | $ | 46,000,000 | | |
Estimated offering expenses
|
| | | $ | 1,000,000 | | | | | $ | 1,000,000 | | |
Commissions(1)(2) | | | | $ | 1,895,000 | | | | | $ | 2,135,000 | | |
Net proceeds
|
| | | $ | 31,105,000 | | | | | $ | 42,965,000 | | |
Net proceeds per share
|
| | | $ | 9.15 | | | | | $ | 9.32 | | |
| | | | | 1 | | | |
| | | | | 13 | | | |
| | | | | 27 | | | |
| | | | | 28 | | | |
| | | | | 30 | | | |
| | | | | 30 | | | |
| | | | | 31 | | | |
| | | | | 32 | | | |
| | | | | 33 | | | |
| | | | | 39 | | | |
| | | | | 66 | | | |
| | | | | 82 | | | |
| | | | | 103 | | | |
| | | | | 107 | | | |
| | | | | 112 | | | |
| | | | | 118 | | | |
| | | | | 119 | | | |
| | | | | 123 | | | |
| | | | | 123 | | | |
| | | | | 123 | | | |
| | | | | F-1 | | |
Plan
|
| |
Individuals
Eligible to Receive Awards |
| |
Number of
Shares |
| |
Percentage of
shares issued in the offering |
| |
Value of shares
Based on $10.00 Share Price |
| |||||||||
Shares available under the
stock-based incentive plan for restricted stock awards |
| | Selected officers | | | | | 140,000 | | | | | | 4.12% | | | | | $ | 1,400,000 | | |
Shares available under the
stock-based incentive plan for stock options |
| |
Directors and selected officers
|
| | | | 340,000 | | | | | | 10.0% | | | | |
|
(1
)
|
| |
| | |
Six Months Ended June 30,
|
| |
Years Ended December 31,
|
| ||||||||||||||||||
(dollars in thousands)
|
| |
2018
|
| |
2017
|
| |
2017
|
| |
2016
|
| ||||||||||||
Statement of Operations Data: | | | | | | | | | | | | | | | | | | | | | | | | | |
Premiums written
|
| | | $ | | | | | $ | | | | | $ | 14,133 | | | | | $ | 16,299 | | | ||
Ceded premiums
|
| | | | | | | | | | | | | | | | (2,075) | | | | | | (1,872) | | |
Insurance revenues
|
| | | | | | | | | | | | | | | $ | 12,058 | | | | | $ | 14,427 | | |
Net investment income
|
| | | | | | | | | | | | | | | | 8,523 | | | | | | 8,821 | | |
Net realized investment gains
|
| | | | | | | | | | | | | | | | 2,228 | | | | | | 1,783 | | |
Other revenues
|
| | | | | | | | | | | | | | | | 194 | | | | | | 173 | | |
Total revenues
|
| | | | | | | | | | | | | | | | 23,003 | | | | | | 25,204 | | |
Benefits and expenses | | | | | | | | | | | | | | | | | | | | | | | | | |
Policyholder benefits
|
| | | | | | | | | | | | | | | | 13,712 | | | | | | 16,069 | | |
Interest credit to policyholder balances
|
| | | | | | | | | | | | | | | | 386 | | | | | | 315 | | |
Operating costs and expenses
|
| | | | | | | | | | | | | | | | 7,889 | | | | | | 8,099 | | |
Amortization of deferred policy acquisition and sales
inducement costs |
| | | | | | | | | | | | | | | | 2,108 | | | | | | 1,876 | | |
Taxes, licenses and fees
|
| | | | | | | | | | | | | | | | 716 | | | | | | 722 | | |
Dividends to policyholders
|
| | | | | | | | | | | | | | | | 66 | | | | | | 86 | | |
Total benefits and expenses
|
| | | | | | | | | | | | | | | | 24,877 | | | | | | 27,167 | | |
Net loss before taxes
|
| | | | | | | | | | | | | | | | (1,874) | | | | | | (1,963) | | |
Tax expense
|
| | | | | | | | | | | | | | | | 34 | | | | | | 34 | | |
Net loss
|
| | | $ | | | | | | $ | | | | | | $ | (1,908) | | | | | $ | (1,997) | | |
|
| | |
June 30,
|
| |
December 31,
|
| |||||||||||||||
(dollars in thousands)
|
| |
2018
|
| |
2017
|
| |
2016
|
| ||||||||||||
Balance Sheet Data: | | | | | | | | | | | | | | | | | | |||||
Total investments, cash and cash equivalents
|
| | | $ | | | |
|
| | | $ | 208,993 | | | | | $ | 201,314 | | | |
Deferred policy acquisition costs, net
|
| | | | | | | | | | | | | 12,179 | | | | | | 11,940 | | |
Deferred sales inducement costs, net
|
| | | | | | | | | | | | | 867 | | | | | | 315 | | |
Reinsurance recoverables
|
| | | | | | | | | | | | | 3,727 | | | | | | 2,107 | | |
Accrued investment income
|
| | | | | | | | | | | | | 1,886 | | | | | | 1,832 | | |
Accounts receivable
|
| | | | | | | | | | | | | 538 | | | | | | 575 | | |
Prepaid reinsurance premiums
|
| | | | | | | | | | | | | 1,358 | | | | | | 924 | | |
Deferred tax asset, net
|
| | | | | | | | | | | | | 458 | | | | | | 664 | | |
Other assets
|
| | | | | | | | | | | | | 202 | | | | | | 254 | | |
Separate account asset
|
| | | | | | | | | | | | | 24,779 | | | | | | 21,513 | | |
Real estate, property and equipment
|
| | | | | | | | | | | | | 2,151 | | | | | | 2,297 | | |
Total Assets
|
| | | $ | | | | | | | | | $ | 257,138 | | | | | $ | 243,735 | | |
Future life policy benefits
|
| | | $ | | | | | | | | | $ | 71,927 | | | | | $ | 73,097 | | |
Policyholder account balance
|
| | | | | | | | | | | | | 109,823 | | | | | | 99,440 | | |
Future accident and health policy benefits
|
| | | | | | | | | | | | | 386 | | | | | | 351 | | |
Reserve for deposit type contracts
|
| | | | | | | | | | | | | 10,850 | | | | | | 10,529 | | |
Other policyholder funds
|
| | | | | | | | | | | | | 1,970 | | | | | | 1,889 | | |
Separate account liability
|
| | | | | | | | | | | | | 24,779 | | | | | | 21,513 | | |
Unearned revenue
|
| | | | | | | | | | | | | 1,387 | | | | | | 1,396 | | |
Deferred reinsurance settlements
|
| | | | | | | | | | | | | 2,949 | | | | | | 1,512 | | |
Other liabilities
|
| | | | | | | | | | | | | 1,710 | | | | | | 1,146 | | |
Total Liabilities
|
| | | $ | | | | | | | | | $ | 225,781 | | | | | $ | 210,873 | | |
Retained earnings
|
| | | $ | | | | | | | | | $ | 26,600 | | | | | $ | 29,313 | | |
Accumulated other comprehensive income
|
| | | | | | | | | | | | | 4,757 | | | | | | 3,549 | | |
Total Equity
|
| | | $ | | | | | | | | | $ | 31,357 | | | | | $ | 32,862 | | |
|
| | | | | | | | |
Pro Forma Capitalization
of Federal Life Group, Inc. as of December 31, 2017(2) |
| |||||||||
| | | | | | | | |
(dollars in thousands except share
and per share data) |
| |||||||||
| | |
Historical
Consolidated Capitalization of FLMHC at December 31, 2017 |
| |
Minimum
|
| |
Maximum
|
| |||||||||
Shareholders’ equity(1): | | | | | | | | | | | | | | | | | | | |
Common Stock, par value $0.01 per share; authorized 10,000,000 shares; shares to be outstanding – as shown(2)(3)
|
| | | $ | — | | | | | $ | 34 | | | | | $ | 46 | | |
Additional paid-in capital(2)(3)
|
| | | $ | — | | | | | $ | 31,071 | | | | | $ | 42,965 | | |
Retained earnings
|
| | | | 26,600 | | | | | | 26,600 | | | | | | 26,600 | | |
Accumulated other comprehensive income (loss), net of tax
|
| | | $ | 4,757 | | | | | $ | 4,757 | | | | | $ | 4,757 | | |
Total shareholders’ equity
|
| | | $ | 31,357 | | | | | $ | 62,462 | | | | | $ | 74,368 | | |
|
| | |
FLMHC
Historical Consolidated |
| |
Pro Forma
Adjustments |
| |
Federal Life
Group, Inc. Pro Forma Consolidated |
| |||||||||
Assets | | | | | | | | | | | | | | | | | | | |
Cash and investments
|
| | | $ | 208,993 | | | | | $ | 31,105 | | | | | $ | 240,098 | | |
Deferred policy acquisition costs, net
|
| | | | 12,179 | | | | | | — | | | | | | 12,179 | | |
Deferred sales inducement costs, net
|
| | | | 867 | | | | | | _ | | | | | | 867 | | |
Accrued investment income
|
| | | | 1,886 | | | | | | — | | | | | | 1,886 | | |
Accounts receivable
|
| | | | 538 | | | | | | — | | | | | | 538 | | |
Prepaid reinsurance premiums
|
| | | | 1,358 | | | | | | — | | | | | | 1,358 | | |
Real estate, property and equipment
|
| | | | 2,151 | | | | | | — | | | | | | 2,151 | | |
Reinsurance recoverables
|
| | | | 3,727 | | | | | | — | | | | | | 3,727 | | |
Separate account asset
|
| | | | 24,779 | | | | | | — | | | | | | 24,779 | | |
Deferred tax asset, net
|
| | | | 458 | | | | | | — | | | | | | 458 | | |
Other assets
|
| | | | 202 | | | | | | — | | | | | | 202 | | |
Total assets
|
| | | $ | 257,138 | | | | | $ | 31,105 | | | | | $ | 288,243 | | |
|
| | |
FLMHC
Historical Consolidated |
| |
Pro Forma
Adjustments |
| |
Federal Life
Group, Inc. Pro Forma Consolidated |
| |||||||||
Liabilities | | | | | | | | | | | | | | | | | | | |
Policyholder account balance
|
| | | $ | 109,823 | | | | | | — | | | | | $ | 109,823 | | |
Separate account liability
|
| | | | 24,779 | | | | | | — | | | | | | 24,779 | | |
Future policy benefits
|
| | | | 72,313 | | | | | | — | | | | | | 72,313 | | |
Reserve for deposit accounts
|
| | | | 10,850 | | | | | | — | | | | | | 10,850 | | |
Other policyholder funds
|
| | | | 1,970 | | | | | | — | | | | | | 1,970 | | |
Deferred reinsurance settlements
|
| | | | 2,949 | | | | | | | | | | | | 2,949 | | |
Unearned revenue
|
| | | | 1,387 | | | | | | — | | | | | | 1,387 | | |
Other liabilities
|
| | | | 1,710 | | | | | | — | | | | | | 1,710 | | |
Total liabilities
|
| | | $ | 225,781 | | | | | | — | | | | | $ | 225,781 | | |
Common stock
|
| | | | — | | | | | $ | 34(2)(3) | | | | | $ | 34 | | |
Additional paid in capital
|
| | | | — | | | | | | 31,071 | | | | | | 31,071 | | |
Retained earnings
|
| | | $ | 26,600 | | | | | | — | | | | | | 26,600 | | |
Accumulated other comprehensive income
|
| | | | 4,757 | | | | | | — | | | | | | 4,757 | | |
Total equity
|
| | | | 31,357 | | | | | | 31,105 | | | | | | 62,462 | | |
Total liabilities and equity
|
| | | $ | 257,138 | | | | | $ | 31,105 | | | | | $ | 288,243 | | |
|
|
Sale of 3,400,000 shares at $10 per share
|
| | | $ | 34,000,000 | | |
|
Conversion and offering expenses
|
| | | | 1,000,000 | | |
|
Commissions
|
| | | | 1,895,000 | | |
|
Total
|
| | | $ | 31,105,000 | | |
|
Common stock
|
| | | $ | 34,000 | | |
|
Additional paid in capital
|
| | | $ | 31,071,000 | | |
|
Total
|
| | | $ | 31,105,000 | | |
|
(dollars in thousands)
|
| |
FLMHC
Historical Consolidated |
| |
Pro Forma
Adjustments |
| |
Federal Life
Group, Inc. Pro Forma Consolidated |
| |||||||||
Revenues | | | | | | | | | | | | | | | | | | | |
Insurance revenues
|
| | | $ | 12,058 | | | | | $ | — | | | | | $ | 12,058 | | |
Net investment income
|
| | | | 8,523 | | | | | | —(1) | | | | | | 8,523 | | |
Net realized investment gains
|
| | | | 2,228 | | | | | | —(1) | | | | | | 2,228 | | |
Other revenues
|
| | | | 194 | | | | | | — | | | | | | 194 | | |
Total revenues
|
| | | $ | 23,003 | | | | | $ | — | | | | | $ | 23,003 | | |
Benefits and Expenses | | | | | | | | | | | | | | | | | | | |
Policyholder benefits
|
| | | | 13,712 | | | | | | — | | | | | | 13,712 | | |
Interest credit to policyholders
|
| | | | 386 | | | | | | — | | | | | | 386 | | |
Operating costs and expenses
|
| | | | 7,889 | | | | | | 350(2) | | | | | | 8,239 | | |
Amortization of deferred policy acquisition and sales inducement
costs |
| | | | 2,108 | | | | | | — | | | | | | 2,108 | | |
Taxes, licenses and fees
|
| | | | 716 | | | | | | — | | | | | | 716 | | |
Dividends to policyholders
|
| | | | 66 | | | | | | — | | | | | | 66 | | |
Total benefits and expenses
|
| | | | 24,877 | | | | | | 350 | | | | | | 25,227 | | |
Loss before income taxes
|
| | | | (1,874) | | | | | | (350) | | | | | | (2,224) | | |
Tax expense (benefit)
|
| | | | 34 | | | | | | —(3) | | | | | | 34 | | |
Net loss
|
| | | $ | (1,908) | | | | | $ | (350) | | | | | $ | (2,258) | | |
Earnings per share data | | | | | | | | | | | | | | | | | | | |
Basic and diluted earnings per common share
|
| | | | | | | | | | | | | | | $ | (0.66) | | |
Weighted average basic and diluted shares outstanding
|
| | | | | | | | | | | | | | | | 3,435,000(4) | | |
(dollars in thousands)
|
| |
FLMHC
Historical Consolidated |
| |
Pro Forma
Adjustments |
| |
Federal Life
Group, Inc. Pro Forma Consolidated |
| |||||||||
Revenues | | | | | | | | | | | | | | | | | | | |
Insurance revenues
|
| | | $ | | | | | $ | — | | | | | $ | | | ||
Net investment income
|
| | | | | | | | | | —(1) | | | | | | | | |
Net realized investment gains
|
| | | | | | | | | | —(1) | | | | | | | | |
Other revenues
|
| | | | | | | | | | — | | | | | | | | |
Total revenues
|
| | | | | | | | | | — | | | | | | | | |
Benefits and expenses | | | | | | | | | | | | | | | | | | | |
Policyholder benefits
|
| | | | | | | | | | — | | | | | | | | |
Interest credit to policyholders
|
| | | | | | | | | | — | | | | | | | | |
Operating costs and expenses(2)
|
| | | | | | | | |
|
(2)
|
| | | |||||
Amortization of deferred policy acquisition and sales inducement costs
|
| | | | | | | | | | — | | | | | | | | |
Taxes, licenses and fees
|
| | | | | | | | | | | | | | | | | | |
Dividends to policyholders
|
| | | | | | | | | | — | | | | | | | | |
Total benefits and expenses
|
| | | | | | | | | | | | | | | | | | |
Loss before income taxes
|
| | | | | | | | | | | | | | | | | | |
Tax expense(3)
|
| | | | | | | | |
|
(3)
|
| | | |||||
Net loss
|
| | | $ | | | | | | $ | | | | | | $ | | | |
Earnings per share data | | | | | | | | | | | | | | | | | | | |
Basic and diluted earnings per common share
|
| | | | | | | | | | | | | | | $ | (4) | | |
Weighted average basic and diluted shares outstanding
|
| | | | | | | | | | | | | | | | | | |
| | |
At or for the Year Ended December 31, 2017
|
| |||||||||||||||
| | |
3,400,000
Shares Sold at $10.00 per Share (Minimum of Range) |
| |
4,000,000
Shares Sold at $10.00 per Share (Midpoint of Range) |
| |
4,600,000
Shares Sold at $10.00 per Share (Maximum of Range) |
| |||||||||
| | |
(dollars in thousands, except share and per share data)
|
| |||||||||||||||
Pro forma offering proceeds | | | | | | | | | | | | | | | | | | | |
Gross proceeds of public offering
|
| | | $ | 34,000 | | | | | $ | 40,000 | | | | | $ | 46,000 | | |
Less offering expenses and commissions
|
| | | $ | 2,895 | | | | | $ | 3,060 | | | | | $ | 3,135 | | |
Net Proceeds
|
| | | $ | 31,105 | | | | | $ | 36,940 | | | | | $ | 42,965 | | |
Pro forma shareholders’ equity | | | | | | | | | | | | | | | | | | | |
Historical Equity
|
| | | $ | 31,357 | | | | | $ | 31,357 | | | | | $ | 31,357 | | |
Net proceeds
|
| | | $ | 31,105 | | | | | $ | 36,940 | | | | | $ | 42,965 | | |
Pro forma shareholders’ equity(1)
|
| | | $ | 62,462 | | | | | $ | 68,297 | | | | | $ | 74,322 | | |
Pro forma per share data | | | | | | | | | | | | | | | | | | | |
Total shares outstanding after the offering
|
| | | | 3,400,000 | | | | | | 4,000,000 | | | | | | 4,600,000 | | |
Pro forma book value per share
|
| | | $ | 18.37 | | | | | $ | 17.07 | | | | | $ | 16.16 | | |
Pro forma price-to-book value per share
|
| | | | 54.4% | | | | | | 58.6% | | | | | | 61.9% | | |
Pro forma net income | | | | | | | | | | | | | | | | | | | |
Historical net loss
|
| | | $ | (1,908) | | | | | $ | (1,908) | | | | | $ | (1,908) | | |
Pro forma loss
|
| | | $ | (2,258) | | | | | $ | (2,258) | | | | | $ | (2,258) | | |
Weighted average shares outstanding(2)
|
| | | | 3,435,000 | | | | | | 4,035,000 | | | | | | 4,635,000 | | |
Pro forma loss per share
|
| | | $ | (0.66) | | | | | $ | (0.56) | | | | | $ | (0.49) | | |
| | |
Expected Cash Flows
|
| |||||||||
Year
|
| |
From
Maturities |
| |
Average
Interest rate |
| ||||||
2018
|
| | | $ | 2,300,000 | | | | | | 6.73% | | |
2019
|
| | | $ | 7,500,000 | | | | | | 5.21% | | |
2020
|
| | | $ | 11,700,000 | | | | | | 4.84% | | |
| | |
(dollars in thousands)
|
| |||
Guaranteed Minimum Crediting Rates December 31, 2017
|
| |
Account Value at Minimum
Guaranteed Rate |
| |||
Policyholder account balances(1)
|
| | | | | | |
Greater than 0% to 1%
|
| | | $ | — | | |
Greater than 1% to 3%
|
| | | | 17,375 | | |
Greater than 3% to 4%
|
| | | | 42,808 | | |
Greater than 4%
|
| | | | 21,163 | | |
| | | | $ | 81,346 | | |
|
|
Fair Value of Investments as of December 31, 2017
(dollars in thousands) |
| ||||||||||||||||||
|
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
Fair Value |
| |||||||||
|
$37,448
|
| | | $ | 184,290 | | | | | $ | 2,182 | | | | | $ | 223,920 | | |
|
16.72%
|
| | | | 82.30% | | | | | | 0.98% | | | | | | 100.0% | | |
Deferred Tax Liability (in thousands) |
| |
December 31, 2017
|
| |
December 31, 2016
|
| ||||||
Total deferred tax assets
|
| | | $ | 9,139 | | | | | $ | 13,939 | | |
Total deferred tax liabilities
|
| | | | (4,668) | | | | | | (7,127) | | |
Deferred tax asset (liability) before valuation allowance
|
| | | | 4,471 | | | | | | 6,812 | | |
Valuation allowance
|
| | | | (4,013) | | | | | | (6,148) | | |
Deferred income tax liability
|
| | | $ | 458 | | | | | $ | 664 | | |
|
| | |
Six Months Ended June 30,
|
| |
Year Ended December 31,
|
| ||||||||||||||||||
| | |
2018
|
| |
2017
|
| |
2017
|
| |
2016
|
| ||||||||||||
REVENUES | | | | | | | | | | | | | | | | | | | | | | | | | |
Net insurance revenues
|
| | | $ | | | | | $ | | | | | $ | 12,058 | | | | | $ | 14,427 | | | ||
Net investment income
|
| | | | | | | | | | | | | | | | 8,523 | | | | | | 8,821 | | |
Net realized investment gains
|
| | | | | | | | | | | | | | | | 2,228 | | | | | | 1,783 | | |
Other income
|
| | | | | | | | | | | | | | | | 194 | | | | | | 173 | | |
Total revenues
|
| | | | | | | | | | | | | | | | 23,003 | | | | | | 25,204 | | |
BENEFITS AND EXPENSES | | | | | | | | | | | | | | | | | | | | | | | | | |
Policyholder benefits
|
| | | | | | | | | | | | | | | | 13,712 | | | | | | 16,069 | | |
Interest credit to policyholders
|
| | | | | | | | | | | | | | | | 386 | | | | | | 315 | | |
Operating costs and expenses
|
| | | | | | | | | | | | | | | | 7,889 | | | | | | 8,099 | | |
Amortization of deferred policy acquisition and sales inducement costs
|
| | | | | | | | | | | | | | | | 2,108 | | | | | | 1,876 | | |
Taxes, licenses and fees
|
| | | | | | | | | | | | | | | | 716 | | | | | | 722 | | |
Dividends to policyholders
|
| | | | | | | | | | | | | | | | 66 | | | | | | 86 | | |
Total benefits and expenses
|
| | | | | | | | | | | | | | | | 24,877 | | | | | | 27,167 | | |
Loss before income taxes
|
| | | | | | | | | | | | | | | | (1,874) | | | | | | (1,963) | | |
Tax expense
|
| | | | | | | | | | | | | | | | 34 | | | | | | 34 | | |
NET LOSS
|
| | | $ | | | | | | $ | | | | | | $ | (1,908) | | | | | $ | (1,997) | | |
|
| | |
Year Ended December 31,
|
| |||||||||
| | |
2017
|
| |
2016
|
| ||||||
| | |
(dollars in thousands)
|
| |||||||||
Call options: | | | | | | | | | | | | | |
Gain (loss) on option expiration
|
| | | $ | 395 | | | | | $ | 59 | | |
Change in unrealized gains (losses)
|
| | | | 94 | | | | | | — | | |
| | | | $ | 140 | | | | | $ | — | | |
| | |
Year Ended December 31,
|
| |||
| | |
2017
|
| |
2016
|
|
S&P 500 Index
|
| |
16.04 – 18.50%
|
| |
12.59 – 12.59%
|
|
Annual point-to-point strategy | | | | | | | |
Cap
|
| |
3.00 – 3.75%
|
| |
3.50 – 3.50%
|
|
Participation Rate
|
| |
30.0 – 35.0%
|
| |
30.0 – 30.0%
|
|
| | |
Year Ended December 31,
|
| |||||||||
| | |
2017
|
| |
2016
|
| ||||||
| | |
(dollars in thousands)
|
| |||||||||
Surrender charges
|
| | | $ | 69 | | | | | $ | 22 | | |
Lifetime income benefit riders (LIBR) fees
|
| | | $ | 34 | | | | | $ | 1 | | |
| | | | $ | 103 | | | | | $ | 23 | | |
Withdrawals from annuity policies subject to surrender charges
|
| | | $ | 1,091 | | | | | $ | 624 | | |
Average surrender charge collected on withdrawals subject to surrender charges
|
| | | | 6.32% | | | | | | 3.60% | | |
Fund values on policies subject to LIBR fees
|
| | | $ | 4,496 | | | | | $ | 114 | | |
Weighted average per policy LIBR fee
|
| | | | 0.75% | | | | | | 0.76% | | |
| | |
Year Ended December 31,
|
| |||||||||
| | |
2017
|
| |
2016
|
| ||||||
| | |
(dollars in thousands)
|
| |||||||||
Index credits on index policies
|
| | | $ | 145 | | | | | $ | 5 | | |
Interest credited (including interest credited on fixed allocation for fixed index annuities)
|
| | | $ | 4,209 | | | | | $ | 3,927 | | |
Lifetime income benefit riders
|
| | | | (34) | | | | | | (1) | | |
| | | | $ | 4,320 | | | | | $ | 3,931 | | |
| | |
Six Months Ended June 30,
|
| |||||||||
| | |
2018
|
| |
2017
|
| ||||||
| | |
(Dollars in thousands)
|
| |||||||||
Call options: | | | | | | | | | | | | | |
Gain (loss) on option expiration
|
| | | $ | | | | | $ | | | ||
Change in unrealized gains/losses
|
| | | $ | | | | | | $ | | | |
| | | | $ | | | | | | $ | | | |
| | |
Six Months Ended June 30,
|
| |||||||||
| | |
2018
|
| |
2017
|
| ||||||
S&P 500 Index | | | | | | | | | | | | | |
Point-to-point strategy
|
| | | | — % | | | | | | — % | | |
Monthly average strategy
|
| | | | — % | | | | | | — % | | |
Monthly point-to-point strategy
|
| | | | — % | | | | | | — % | | |
Fixed income (bond index) strategies
|
| | | | — % | | | | | | — % | | |
| | |
Six Months Ended June 30,
|
| |||||||||
| | |
2018
|
| |
2017
|
| ||||||
| | |
(Dollars in thousands)
|
| |||||||||
Surrender charges
|
| | | $ | | | | | $ | | | ||
Lifetime income benefit riders (LIBR) fees
|
| | | $ | | | | | | $ | | | |
| | | | $ | | | | | | $ | | | |
Withdrawals from annuity policies subject to surrender charges
|
| | | $ | | | | | | $ | | | |
Average surrender charge collected on withdrawals subject to surrender charges
|
| | | | % | | | | | | % | | |
Fund values on policies subject to LIBR fees
|
| | | $ | | | | | | $ | | | |
Weighted average per policy LIBR fee
|
| | | | % | | | | | | % | | |
| | |
Six Months Ended June 30,
|
| |||||||||
| | |
2018
|
| |
2017
|
| ||||||
| | |
(Dollars in thousands)
|
| |||||||||
Index credits on index policies
|
| | | | | | | | | | | | |
Interest credited (including changes in minimum guaranteed interest for fixed index annuities)
|
| | | $ | | | | | $ | | | ||
Lifetime income benefit riders
|
| | | | | | | | | | | | |
| | | | $ | | | | | | $ | | | |
|
| | |
Estimated Fair Value
|
| |||||||||||||||||||||||||||||||||
(dollars in thousands) S&P Rating |
| |
June 30, 2018
|
| |
December 31, 2017
|
| |
December 31, 2016
|
| |||||||||||||||||||||||||||
AAA
|
| | | $ | | | | | | % | | | | | $ | 7,176 | | | | | | 3.8% | | | | | $ | 9,669 | | | | | | 5.5% | | | |
AA
|
| | | | | | | | | | % | | | | | | 77,195 | | | | | | 41.0% | | | | | | 64,354 | | | | | | 36.8% | | |
A
|
| | | | | | | | | | % | | | | | | 35,668 | | | | | | 18.9% | | | | | | 36,714 | | | | | | 21.0% | | |
BBB
|
| | | | | | | | | | % | | | | | | 58,921 | | | | | | 31.3% | | | | | | 54,538 | | | | | | 31.2% | | |
Total investment grade
|
| | | | | | | | | | % | | | | | | 178,960 | | | | | | 95.0% | | | | | | 165,275 | | | | | | 94.5% | | |
BB
|
| | | | | | | | | | % | | | | | | 6,575 | | | | | | 3.5% | | | | | | 5,919 | | | | | | 3.4% | | |
| | |
Estimated Fair Value
|
| |||||||||||||||||||||||||||||||||
(dollars in thousands) S&P Rating |
| |
June 30, 2018
|
| |
December 31, 2017
|
| |
December 31, 2016
|
| |||||||||||||||||||||||||||
B
|
| | | | | | | | | | % | | | | | | 2,381 | | | | | | 1.3% | | | | | | 2,649 | | | | | | 1.5% | | |
CCC
|
| | | | | | | | | | % | | | | | | 459 | | | | | | 0.2% | | | | | | 1,030 | | | | | | 0.6% | | |
CC
|
| | | | | | | | | | % | | | | | | 0 | | | | | | 0.0% | | | | | | 0 | | | | | | 0.0% | | |
C
|
| | | | | | | | | | % | | | | | | 77 | | | | | | 0.0% | | | | | | 3 | | | | | | 0.0% | | |
D
|
| | | | | | | | | | % | | | | | | 0 | | | | | | 0.0% | | | | | | 4 | | | | | | 0.0% | | |
Total below investment grade
|
| | | | | | | | | | % | | | | | | 9,492 | | | | | | 5.0% | | | | | | 9,605 | | | | | | 5.5% | | |
Not rated
|
| | | | | | | | | | % | | | | | | 0 | | | | | | 0.0% | | | | | | 0 | | | | | | 0.0% | | |
Total
|
| | | $ | | | | | | | % | | | | | $ | 188,452 | | | | | | 100.0% | | | | | $ | 174,880 | | | | | | 100.0% | | |
|
| | |
June 30, 2018
|
| |
December 31, 2017
|
| |
December 31, 2016
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(dollars in thousands)
|
| |
Amortized
Cost |
| |
%
|
| |
Fair
Value |
| |
%
|
| |
Amortized
Cost |
| |
%
|
| |
Fair
Value |
| |
%
|
| |
Amortized
Cost |
| |
%
|
| |
Fair
Value |
| |
%
|
| ||||||||||||||||||||||||||||||||||||
Due in one year or less
|
| | | $ | | | | | | % | | | | | $ | | | | | | % | | | | | $ | 2,247 | | | | | | 1.2% | | | | | $ | 2,288 | | | | | | 1.2% | | | | | $ | 5,038 | | | | | | 3.0% | | | | | $ | 5,161 | | | | | | 3.0% | | | ||
Due after one year through five years
|
| | | $ | | | | | | | % | | | | | $ | | | | | | | % | | | | | $ | 40,926 | | | | | | 22.3% | | | | | $ | 42,809 | | | | | | 22.7% | | | | | $ | 34,101 | | | | | | 20.0% | | | | | $ | 36,605 | | | | | | 20.9% | | |
Due after five years through ten years
|
| | | $ | | | | | | | % | | | | | $ | | | | | | | % | | | | | $ | 66,739 | | | | | | 36.4% | | | | | $ | 68,151 | | | | | | 36.2% | | | | | $ | 66,029 | | | | | | 38.7% | | | | | $ | 66,648 | | | | | | 38.1% | | |
Due after ten years
|
| | | $ | | | | | | | % | | | | | $ | | | | | | | % | | | | | $ | 27,492 | | | | | | 15.0% | | | | | $ | 27,923 | | | | | | 14.8% | | | | | $ | 20,244 | | | | | | 11.9% | | | | | $ | 20,089 | | | | | | 11.5% | | |
Mortgage-backed securities
|
| | | $ | | | | | | | % | | | | | $ | | | | | | | % | | | | | $ | 46,028 | | | | | | 25.1% | | | | | $ | 47,281 | | | | | | 25.1% | | | | | $ | 45,103 | | | | | | 26.4% | | | | | $ | 46,377 | | | | | | 26.5% | | |
Total debt securities
|
| | | $ | | | | | | | 100.0% | | | | | $ | | | | | | | 100.0% | | | | | $ | 183,432 | | | | | | 100.0% | | | | | $ | 188,452 | | | | | | 100.0% | | | | | $ | 170,515 | | | | | | 100% | | | | | $ | 174,880 | | | | | | 100% | | |
|
| | |
Six Months Ended
June 30, |
| |
Year Ended
December 31, |
| ||||||||||||||||||
| | |
2018
|
| |
2017
|
| |
2017
|
| |
2016
|
| ||||||||||||
Book yield on fixed maturity securities available for sale(1)
|
| | | | % | | | | | | % | | | | | | 3.98% | | | | | | 4.35% | | |
| | |
As of June 30, 2018
|
| |||||||||||||||
(dollars in thousands)
|
| |
Ending
Balance |
| |
Year to Date
Interest Credited |
| |
Average
Crediting Rate |
| |||||||||
Annuity Contract Holder Deposits
|
| | | $ | | | | | $ | | | | | | % | | | ||
Dividends Left on Deposit
|
| | | | | | | | | | | | | | | | % | | |
Other
|
| | | | | | | | | | | | | | | | % | | |
| | | | $ | | | | | | $ | | | | | | | % | | |
|
| | |
December 31, 2017
|
| |
December 31, 2016
|
| ||||||||||||||||||||||||||||||
(dollars in thousands)
|
| |
Ending
Balance |
| |
Year to Date
Interest Credited |
| |
Average
Crediting Rate |
| |
Ending
Balance |
| |
Year to Date
Interest Credited |
| |
Average
Crediting Rate |
| ||||||||||||||||||
Annuity Contract Holder Deposits
|
| | | $ | 50,728 | | | | | $ | 1,763 | | | | | | 3.47% | | | | | $ | 52,528 | | | | | $ | 1,820 | | | | | | 3.45% | | |
Dividends Left on Deposit
|
| | | | 7,067 | | | | | | 171 | | | | | | 2.40% | | | | | | 7,405 | | | | | | 184 | | | | | | 2.47% | | |
Other
|
| | | | 570 | | | | | | 18 | | | | | | 3.50% | | | | | | 461 | | | | | | 21 | | | | | | 4.66% | | |
| | | | $ | 58,365 | | | | | $ | 1,952 | | | | | | | | | | | $ | 60,394 | | | | | $ | 2,025 | | | | | | | | |
|
Net Realized Investment Gains (Losses)
(dollars in thousands) |
| |
As of June 30,
|
| |
Years Ended
December 31, |
| ||||||||||||||||||
|
2018
|
| |
2017
|
| |
2017
|
| |
2016
|
| ||||||||||||||
Sales of Investments: | | | | | | | | | | | | | | | | | | | | | | | | | |
Fixed maturity securities, available for sale
|
| | | $ | | | | | | | | | | | | $ | 177 | | | | | $ | 130 | | |
Equity securities
|
| | | | — | | | | | | — | | | | | | 897 | | | | | | 1,073 | | |
Oil and gas interests
|
| | | | | | | | | | | | | | | | 1,060 | | | | | | 580 | | |
Real estate
|
| | | | — | | | | | | — | | | | | | 0 | | | | | | 0 | | |
Derivatives
|
| | | | | | | | | | | | | | | | 94 | | | | | | 0 | | |
Other-than-temporary impairment losses on fixed maturity securities, available for sale-net
|
| | | | ( ) | | | | | | ( ) | | | | | | 0 | | | | | | 0 | | |
Trading securities-gains and losses: | | | | | | | | | | | | | | | | | | | | | | | | | |
Fixed maturity securities
|
| | | | — | | | | | | — | | | | | | 0 | | | | | | 0 | | |
Equity securities
|
| | | | | | | | | | | | | | | | 0 | | | | | | 0 | | |
Investment expenses
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Mortgage loans impairments
|
| | | | | | | | | | | | | | | | 0 | | | | | | 0 | | |
Total net realized investment gains (losses)
|
| | | | | | | | | | | | | | | $ | 2,228 | | | | | $ | 1,783 | | |
|
Accumulated Other Comprehensive Income
(dollars in thousands) |
| |
Six Months Ended
June 30, |
| |
Years Ended
December 31, |
| ||||||||||||||||||
|
2018
|
| |
2017
|
| |
2017
|
| |
2016
|
| ||||||||||||||
Unrealized holding gains (losses) from changes in the market
value of securities, including the related impact to future policy benefit liabilities, the policyholder dividend obligation, and deferred policy acquisition cost balances |
| | | $ | | | | | $ | | | | | $ | 611 | | | | | $ | (539) | | | ||
Income tax effect
|
| | | | | | | | | | | | | | | | (208) | | | | | | 183 | | |
Cumulative effect of adoption of new accounting principle
|
| | | | | | | | | | | | | | | | 805 | | | | | | 0 | | |
Net increase in accumulated other comprehensive income
|
| | | $ | | | | | | $ | | | | | | $ | 1,208 | | | | | $ | (356) | | |
|
| | |
Six Months Ended
|
| |
Year Ended December 31,
|
| ||||||||||||||||||
Consolidated Summary of Cash Flow (in thousands) |
| |
June 30,
2018 |
| |
June 30,
2017 |
| |
2017
|
| |
2016
|
| ||||||||||||
Cash flows provided by (used for) operating activities
|
| | | $ | | | | | $ | | | | | $ | (5,779) | | | | | $ | (5,056) | | | ||
Cash flows from investing activities
|
| | | | | | | | | | | | | | | | (9,228) | | | | | | 1,653 | | |
Cash flows provided by (used for) financing activities
|
| | | | | | | | | | | | | | | | 10,703 | | | | | | 5,239 | | |
Net increase (decrease) in cash
|
| | | | | | | | | $ | | | | | | $ | (4,304) | | | | | $ | 1,836 | | |
|
Contractual Cash Obligations (dollars in thousands) |
| |
Total
|
| |
Less than
1 year |
| |
1 – 3 years
|
| |
3 – 5 years
|
| |
More than
5 years |
| |||||||||||||||
Future policy benefits and claims(1)
|
| | | $ | 159,093 | | | | | $ | 7,075 | | | | | $ | 14,145 | | | | | $ | 20,949 | | | | | $ | 116,924 | | |
Policyholder account balances(2)
|
| | | | 162,087 | | | | | | 9,086 | | | | | | 16,875 | | | | | | 21,767 | | | | | | 114,359 | | |
Other policyholder liabilities(3)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Commissions(4) | | | | | 6,023 | | | | | | 680 | | | | | | 958 | | | | | | 1,148 | | | | | | 3,237 | | |
Reinsurance liabilities and payables(5)
|
| | | | 5,162 | | | | | | 173 | | | | | | 487 | | | | | | 863 | | | | | | 3,369 | | |
Total contractual obligations
|
| | | $ | 332,365 | | | | | $ | 17,014 | | | | | $ | 32,465 | | | | | $ | 44,727 | | | | | $ | 238,159 | | |
|
| | |
Net Premium Revenue and Annuity Deposits
|
| |||||||||||||||||||||
| | |
Six Months Ended June 30,
|
| |
Years Ended December 31,
|
| ||||||||||||||||||
(dollars in thousands)
|
| |
2018
|
| |
2017
|
| |
2017
|
| |
2016
|
| ||||||||||||
Life
|
| | | $ | | | | | | $ | | | | | | $ | 12,058 | | | | | $ | 14,427 | | |
Annuity deposits
|
| | | | | | | | | | | | | | | | 12,969 | | | | | | 8,107 | | |
Total
|
| | | $ | | | | | $ | | | | | $ | 25,027 | | | | | $ | 22,534 | | | ||
|
| | |
For the Year Ended December 31,
|
| |||||||||||||||||||||||||||
| | |
2015
|
| |
2014
|
| |
2013
|
| |
2012
|
| |
2011
|
| |||||||||||||||
| | |
(Dollars in thousands)
|
| |||||||||||||||||||||||||||
Total industry sales of fixed index annuities
|
| | | $ | 53,069,850 | | | | | $ | 46,896,350 | | | | | $ | 38,646,864 | | | | | $ | 33,975,442 | | | | | $ | 32,387,045 | | |
Increase from prior year
|
| | | | 6,173,500 | | | | | | 8,249,486 | | | | | | 4,671,422 | | | | | | 1,588,397 | | | | | | 41,481 | | |
Increase from prior year
|
| | | | 13.2% | | | | | | 21.3% | | | | | | 13.7% | | | | | | 4.9% | | | | | | 0.1% | | |
| | |
Year Ended December 31,
|
| |||||||||||||||||||||||||||||||||
| | |
2017
|
| |
2016
|
| |
2015
|
| |||||||||||||||||||||||||||
Product Type
|
| |
Deposits
Collected |
| |
Deposits as
a % of Total |
| |
Deposits
Collected |
| |
Deposits as
a % of Total |
| |
Deposits
Collected |
| |
Deposits as
a % of Total |
| ||||||||||||||||||
| | |
(Dollars in thousands)
|
| |||||||||||||||||||||||||||||||||
Fixed index annuities
|
| | | $ | 11,349 | | | | | | 87% | | | | | $ | 5,788 | | | | | | 71% | | | | | $ | 250 | | | | | | 7.0% | | |
Single premium fixed rate annuities
|
| | | | 231 | | | | | | 2% | | | | | | 161 | | | | | | 2% | | | | | | 1,015 | | | | | | 31% | | |
Flexible premium fixed rate annuities
|
| | | | 716 | | | | | | 6% | | | | | | 1,428 | | | | | | 18% | | | | | | 1,650 | | | | | | 50% | | |
Single premium immediate annuities
|
| | | | 672 | | | | | | 5% | | | | | | 731 | | | | | | 9% | | | | | | 401 | | | | | | 12% | | |
| | | | $ | 12,969 | | | | | | 100% | | | | | $ | 8,107 | | | | | | 100% | | | | | $ | 3,316 | | | | | | 100% | | |
|
| | |
For the Year Ended December 31,
|
| |||||||||||||||
| | |
2017
|
| |
2016
|
| |
2015
|
| |||||||||
| | |
(dollars in thousands)
|
| |||||||||||||||
Annuity Surrender Charges:
|
| | | $ | 2,666 | | | | | $ | 1,295 | | | | | $ | 603 | | |
Average years at issue
|
| | | | 8 | | | | | | 7 | | | | | | 7 | | |
Average years remaining
|
| | | | 4 | | | | | | 2 | | | | | | 1 | | |
Average surrender charge percentage remaining
|
| | | | 4.42% | | | | | | 2.59% | | | | | | 1.32% | | |
Annuity Account Value (net of coinsurance)
|
| | | $ | 60,257 | | | | | $ | 49,931 | | | | | $ | 45,498 | | |
| | |
As of December 31, 2017
|
| |||||||||||||||||||||
| | |
2017 A.M.
Best’s Rating |
| |
Ceded Future
Policy Benefits |
| |
Claims and
Other Amounts Recoverable |
| |
Total
Reinsurance Recoverables |
| ||||||||||||
| | |
(in thousands)
|
| |||||||||||||||||||||
Reinsurer | | | | | | | | | | | | | | | | | | | | | | | | | |
Optimum Re Insurance Company
|
| | | | A- | | | | | $ | 3,275 | | | | | $ | 77 | | | | | $ | 3,352 | | |
SCOR Global Life Americas Reins Co
|
| | | | A+ | | | | | | 444 | | | | | | — | | | | | | 444 | | |
Prudential Insurance Co of America
|
| | | | A+ | | | | | | 3 | | | | | | — | | | | | | 3 | | |
Swiss Re Life & Health America Inc.
|
| | | | A+ | | | | | | 5 | | | | | | 2 | | | | | | 7 | | |
| | | | | | | | | | $ | 3,727 | | | | | $ | 79 | | | | | $ | 3,806 | | |
|
|
Fixed maturities, available for sale, at fair value
|
| | | $ | 188,452 | | |
|
Equity securities, available for sale, at fair value
|
| | | | 6,209 | | |
|
Policy loans
|
| | | | 9,852 | | |
|
Derivative instruments
|
| | | | 395 | | |
|
Total Investments
|
| | | | 204,908 | | |
|
Cash and cash equivalents
|
| | | | 4,085 | | |
|
Total Cash and Investments
|
| | | $ | 208,993 | | |
|
| | |
% of Stock owned
|
| |||||||||||||||||||||
Name
|
| |
Amount ($)
|
| |
Number of
shares |
| |
Minimum
|
| |
Adjusted
Maximum |
| ||||||||||||
Directors | | | | | | | | | | | | | | | | | | | | | | | | | |
Joseph D. Austin
|
| | | | | | | | | | | | | | | | | | | | | | | | |
William S. Austin
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Michael Austin
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Wayne R. Ebersberger
|
| | | | | | | | | | | | | | | | | | | | | | | | |
William H. Springer
|
| | | | | | | | | | | | | | | | | | | | | | | | |
James H. Stacke
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Executive Officers (who are not also directors) Anders Raaum
|
| | | | | | | | | | | | | | | | | | | | | | | | |
All Directors and Executive Officers as a Group ( persons)
|
| | | | | | | | | | | | | | | | | | | | | ||||
|
| | | | | | | | | | | |
Trailing 12 Months
|
| |
As of 12/22/2017
|
| ||||||||||||||||||
Ticker
|
| |
Company
|
| |
Total
Assets ($Mil) |
| |
Policy
Revenues ($Mil) |
| |
Total
Revenues ($Mil) |
| |
Common
Stock Price ($) |
| |
Market
Value ($Mil) |
| |||||||||||||||
| | |
Federal Life Insurance Company(1)
|
| | | $ | 258 | | | | | $ | 13 | | | | | $ | 24 | | | | | | NA | | | | | | NA | | |
AEL | | |
American Equity Investment Life Holding Company
|
| | | $ | 60,380 | | | | | $ | 230 | | | | | $ | 3,275 | | | | | $ | 32.13 | | | | | $ | 2,863 | | |
CIA | | |
Citizens, Inc.
|
| | | $ | 1,651 | | | | | $ | 199 | | | | | $ | 253 | | | | | $ | 7.48 | | | | | $ | 375 | | |
CNO | | |
CNO Financial Group, Inc.
|
| | | $ | 32,705 | | | | | $ | 2,641 | | | | | $ | 4,212 | | | | | $ | 24.87 | | | | | $ | 4,172 | | |
FFG | | |
FBL Financial Group, Inc.
|
| | | $ | 9,892 | | | | | $ | 311 | | | | | $ | 737 | | | | | $ | 71.80 | | | | | $ | 1,790 | | |
IHC | | |
Independence Holding Company
|
| | | $ | 1,039 | | | | | $ | 278 | | | | | $ | 317 | | | | | $ | 27.95 | | | | | $ | 415 | | |
KCLI | | |
Kansas City Life Insurance Company
|
| | | $ | 4,511 | | | | | $ | 292 | | | | | $ | 450 | | | | | $ | 45.10 | | | | | $ | 437 | | |
NWLI | | |
National Western Life Group, Inc.
|
| | | $ | 12,138 | | | | | $ | 181 | | | | | $ | 811 | | | | | $ | 337.03 | | | | | $ | 1,158 | | |
SNFCA | | |
Security National Financial Corporation
|
| | | $ | 1,008 | | | | | $ | 69 | | | | | $ | 288 | | | | | $ | 5.40 | | | | | $ | 82 | | |
UTGN | | |
UTG, Inc.
|
| | | $ | 405 | | | | | $ | 6 | | | | | $ | 21 | | | | | $ | 25.00 | | | | | $ | 83 | | |
| | |
Market Prices
As of 12/22/2017 |
| |
Financial Data as of
September 30, 2017 |
| |
Key Pricing Ratios as of
December 22, 2017 |
| | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Company Name
|
| |
Closing
Price ($) |
| |
Market
Value ($Mil) |
| |
Assets
($Mil) |
| |
Equity/
Assets (%) |
| |
ROAA
(%) |
| |
ROAE
(%) |
| |
Price/
Book (%) |
| |
Price/
Tangible Book (%) |
| |
Price/
TTM Earnings (x) |
| |
Price/
TTM Revenue (x) |
| | | ||||||||||||||||||||||||||||||||||
Federal Life Insurance Company | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||||||||
Maximum
|
| | | $ | 10.00 | | | | | $ | 46.00 | | | | | $ | 300 | | | | | | 26.10% | | | | | | 0.06% | | | | | | -0.22% | | | | | | 58.8% | | | | | | 58.8% | | | | | | NM | | | | | | 1.83x | | | | | ||||
Midpoint
|
| | | $ | 10.00 | | | | | $ | 40.00 | | | | | $ | 294 | | | | | | 24.69% | | | | | | 0.12% | | | | | | -0.48% | | | | | | 55.1% | | | | | | 55.1% | | | | | | NM | | | | | | 1.60x | | | | | ||||
Minimum
|
| | | $ | 10.00 | | | | | $ | 34.00 | | | | | $ | 288 | | | | | | 23.23% | | | | | | 0.18% | | | | | | -0.78% | | | | | | 50.8% | | | | | | 50.8% | | | | | | NM | | | | | | 1.37x | | | | | ||||
Peer Group | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||||
Average
|
| | | $ | 64.08 | | | | | $ | 1,264.1 | | | | | $ | 13,748 | | | | | | 17.52% | | | | | | 0.88% | | | | | | 5.65% | | | | | | 93.9% | | | | | | 97.4% | | | | | | 19.56x | | | | | | 1.52x | | | | | ||||
Median
|
| | | $ | 27.95 | | | | | $ | 436.7 | | | | | $ | 4,511 | | | | | | 14.93% | | | | | | 0.62% | | | | | | 5.38% | | | | | | 85.8% | | | | | | 85.8% | | | | | | 14.16x | | | | | | 1.31x | | | | | ||||
All Public Life Insurance Companies | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||||||||
Average
|
| | | $ | 66.40 | | | | | $ | 10,482.5 | | | | | $ | 130,630 | | | | | | 12.98% | | | | | | 0.42% | | | | | | 1.29% | | | | | | 112.3% | | | | | | 119.8% | | | | | | 17.51x | | | | | | 1.35x | | | | | ||||
Median
|
| | | $ | 51.48 | | | | | $ | 4,373.7 | | | | | $ | 45,699 | | | | | | 13.36% | | | | | | 0.59% | | | | | | 8.35% | | | | | | 98.6% | | | | | | 117.9% | | | | | | 12.81x | | | | | | 1.16x | | | | |
Name
|
| |
Age(1)
|
| |
Position
|
|
Joseph D. Austin | | |
90
|
| | Director and Executive Chairman | |
William S. Austin | | |
54
|
| | Director, President, and Chief Executive Officer | |
Anders Raaum | | |
53
|
| | Chief Financial Officer | |
Michael Austin | | |
60
|
| |
Director, Executive Vice President, and Chief of Marketing Officer
|
|
Wayne R. Ebersberger | | |
63
|
| | Director | |
William H. Springer | | |
88
|
| | Director | |
James H. Stacke | | |
79
|
| | Director | |
Name and Principal Position
|
| |
Year
|
| |
Salary
($) |
| |
Non-Equity
Incentive Plan Compensation ($) |
| |
All Other
Compensation ($)(1) |
| |
Total
($) |
| ||||||||||||
Joseph D. Austin
Chairman and Chief Executive Officer |
| |
2017
|
| | | $ | 418,140 | | | | | | — | | | | | $ | 25,333 | | | | | $ | 443,473 | | |
|
2016
|
| | | | 404,000 | | | | | | — | | | | | | 23,713 | | | | | | 427,713 | | | ||
William S. Austin
President and Chief Operating Officer |
| |
2017
|
| | | | 265,000 | | | | | | — | | | | | | 33,184 | | | | | | 298,184 | | |
|
2016
|
| | | | 254,702 | | | | | | — | | | | | | 32,897 | | | | | | 287,599 | | | ||
Anders Raaum
Chief Financial Officer |
| |
2017
|
| | | | 194,953 | | | | | | — | | | | | | 5,813 | | | | | | 200,766 | | |
|
2016
|
| | | | 190,740 | | | | | | — | | | | | | 5,722 | | | | | | 196,462 | | | ||
Michael Austin
Executive Vice President and Chief Marketing Officer |
| |
2017
|
| | | | 245,861 | | | | | | — | | | | | | 24,892 | | | | | | 270,753 | | |
|
2016
|
| | | | 238,700 | | | | | | — | | | | | | 24,914 | | | | | | 263,614 | | |
Name
|
| |
Title
|
| |
Equity Award(1)(2)
|
|
Joseph D. Austin | | | Chairman | | | Options to purchase shares and shares of restricted stock | |
William S. Austin | | | President and Chief Operating Officer | | | Options to purchase shares and shares of restricted stock | |
Anders Raaum | | | Chief Financial Officer | | | Options to purchase shares and shares of restricted stock | |
Michael Austin | | | Executive Vice President and Chief Marketing Officer | | | Options to purchase shares and shares of restricted stock | |
Wayne R. Ebersberger | | | Director | | | Options to purchase shares | |
William H. Springer | | | Director | | | Options to purchase shares | |
James H. Stacke | | | Director | | | Options to purchase shares | |
Name
|
| |
Fees Earned
or Paid in Cash |
| |
Non-Equity
Incentive Plan Compensation(1) |
| |
Total
|
| |||||||||
Wayne R. Ebersberger
|
| | | $ | 38,350 | | | | | $ | -0- | | | | | $ | 38,350 | | |
William H. Springer
|
| | | $ | 36,950 | | | | | $ | -0- | | | | | $ | 36,950 | | |
James H. Stacke
|
| | | $ | 36,950 | | | | | $ | -0- | | | | | $ | 36,950 | | |
| | |
Page
|
| |||
Audited Consolidated Financial Statements | | | | | | | |
Report of Independent Registered Public Accounting Firm
|
| | | | F-2 | | |
Consolidated Balance Sheets (As of December 31, 2017 and 2016)
|
| | | | F-3 | | |
Consolidated Statements of Operation (Years ended December 31, 2017 and 2016)
|
| | | | F-4 | | |
Consolidated Statements of Comprehensive Income (Years ended December 31, 2017 and 2016)
|
| | | | F-4 | | |
Consolidated Statements of Changes in Equity (Years ended December 31, 2017 and 2016)
|
| | | | F-5 | | |
Consolidated Statements of Cash Flows (Years ended December 31, 2017 and 2016)
|
| | | | F-6 | | |
Notes to Consolidated Financial Statements (As of December 31, 2017 and for the two years ended December 31, 2017)
|
| | | | F-7 | | |
Unaudited Condensed Consolidated Financial Statements | | | | | | | |
Condensed Consolidated Balance Sheets (As of June 30, 2018 and December 31, 2017)
|
| | | | 0 | | |
Condensed Consolidated Statements of Operations (for the six months ended June 30, 2018 and 2017)
|
| | | | 0 | | |
Condensed Consolidated Statements of Comprehensive Income (for the six months ended March 31, 2018 and 2017)
|
| | | | 0 | | |
Condensed Consolidated Statements of Changes in Equity (for the six months ended June 30, 2018 and 2017)
|
| | | | 0 | | |
Condensed Consolidated Statements of Cash Flows (for the six months ended June 30, 2018 and 2017)
|
| | | | 0 | | |
Notes to Condensed Consolidated Financial Statements
|
| | | | 0 | | |
(in thousands of dollars)
|
| |
2017
|
| |
2016
|
| ||||||
Assets | | | | | | | | | | | | | |
Investments | | | | | | | | | | | | | |
Securities available for sale, at fair value:
|
| | | | | | | | | | | | |
Fixed maturities (amortized cost; 2017, $183,432; 2016, $170,515)
|
| | | $ | 188,452 | | | | | $ | 174,880 | | |
Equity securities
|
| | | | 6,209 | | | | | | 7,927 | | |
Policy loans
|
| | | | 9,852 | | | | | | 10,059 | | |
Derivative instruments, at fair value
|
| | | | 395 | | | | | | 59 | | |
Total investments
|
| | | | 204,908 | | | | | | 192,925 | | |
Cash and cash equivalents
|
| | | | 4,085 | | | | | | 8,389 | | |
Real estate, property and equipment
|
| | | | 2,151 | | | | | | 2,297 | | |
Accrued investment income
|
| | | | 1,886 | | | | | | 1,832 | | |
Accounts receivable
|
| | | | 538 | | | | | | 575 | | |
Reinsurance recoverables
|
| | | | 3,727 | | | | | | 2,107 | | |
Prepaid reinsurance premiums
|
| | | | 1,358 | | | | | | 924 | | |
Deferred policy acquisition costs, net
|
| | | | 12,179 | | | | | | 11,940 | | |
Deferred sales inducement costs, net
|
| | | | 867 | | | | | | 315 | | |
Deferred tax asset, net
|
| | | | 458 | | | | | | 664 | | |
Other assets
|
| | | | 202 | | | | | | 254 | | |
Separate account asset
|
| | | | 24,779 | | | | | | 21,513 | | |
Total Assets
|
| | | | 257,138 | | | | | | 243,735 | | |
Liabilities | | | | | | | | | | | | | |
Policy liabilities and accruals | | | | | | | | | | | | | |
Policyholder account balance
|
| | | | 109,823 | | | | | | 99,440 | | |
Future life policy benefits
|
| | | | 71,927 | | | | | | 73,097 | | |
Future accident and health policy benefits
|
| | | | 386 | | | | | | 351 | | |
Reserve for deposit type contracts
|
| | | | 10,850 | | | | | | 10,529 | | |
Other policyholder funds
|
| | | | 1,970 | | | | | | 1,889 | | |
Unearned revenue
|
| | | | 1,387 | | | | | | 1,396 | | |
Deferred reinsurance settlements
|
| | | | 2,949 | | | | | | 1,512 | | |
Taxes payable
|
| | | | 7 | | | | | | 6 | | |
Other liabilities
|
| | | | 1,703 | | | | | | 1,140 | | |
Separate account liability
|
| | | | 24,779 | | | | | | 21,513 | | |
Total Liabilities
|
| | | | 225,781 | | | | | | 210,873 | | |
Equity | | | | | | | | | | | | | |
Retained earnings
|
| | | | 26,600 | | | | | | 29,313 | | |
Accumulated other comprehensive income
|
| | | | 4,757 | | | | | | 3,549 | | |
Total Equity
|
| | | | 31,357 | | | | | | 32,862 | | |
Total Liabilities and Equity
|
| | | $ | 257,138 | | | | | $ | 243,735 | | |
|
(in thousands of dollars)
|
| |
2017
|
| |
2016
|
| ||||||
Revenues | | | | | | | | | | | | | |
Insurance revenues
|
| | | $ | 12,058 | | | | | $ | 14,427 | | |
Net investment income
|
| | | | 8,523 | | | | | | 8,821 | | |
Net realized investment gains
|
| | | | 2,228 | | | | | | 1,783 | | |
Other revenues
|
| | | | 194 | | | | | | 173 | | |
Total Revenues
|
| | | | 23,003 | | | | | | 25,204 | | |
Benefits and expenses | | | | | | | | | | | | | |
Policyholder benefits
|
| | | | 13,712 | | | | | | 16,069 | | |
Interest credit to policyholders
|
| | | | 386 | | | | | | 315 | | |
Operating costs and expenses
|
| | | | 7,889 | | | | | | 8,099 | | |
Amortization of deferred acquisition and sales inducement costs
|
| | | | 2,108 | | | | | | 1,876 | | |
Taxes, licenses and fees
|
| | | | 716 | | | | | | 722 | | |
Dividends to policyholders
|
| | | | 66 | | | | | | 86 | | |
Total Benefits and Expenses
|
| | | | 24,877 | | | | | | 27,167 | | |
Net loss before taxes
|
| | | | (1,874) | | | | | | (1,963) | | |
Tax expense
|
| | | | 34 | | | | | | 34 | | |
Net loss
|
| | | $ | (1,908) | | | | | $ | (1,997) | | |
Other Comprehensive Income (Loss), net of tax: | | | | | | | | | | | | | |
Unrealized holding gains (losses) arising during the year (net of tax expense (benefit) of: 2017 $236; 2016 ($185))
|
| | | | 458 | | | | | | (359) | | |
Adjustment to deferred acquisition costs (net of tax expense (benefit) of: 2017 ($28); 2016 $1)
|
| | | | (55) | | | | | | 3 | | |
Other Comprehensive Income (Loss)
|
| | | | 403 | | | | | | (356) | | |
Comprehensive Loss
|
| | | $ | (1,505) | | | | | $ | (2,353) | | |
|
(in thousands of dollars)
|
| |
Accumulated Other
Comprehensive Income |
| |
Retained
Earnings |
| |
Total
|
| |||||||||
Balance, January 1, 2016
|
| | | $ | 3,905 | | | | | $ | 31,310 | | | | | $ | 35,215 | | |
Net loss
|
| | | | — | | | | | | (1,997) | | | | | | (1,997) | | |
Other Comprehensive Loss
|
| | | | (356) | | | | | | — | | | | | | (356) | | |
Balance, December 31, 2016
|
| | | $ | 3,549 | | | | | $ | 29,313 | | | | | $ | 32,862 | | |
|
(in thousands of dollars)
|
| |
Accumulated Other
Comprehensive Income |
| |
Retained
Earnings |
| |
Total
|
| |||||||||
Balance, January 1, 2017
|
| | | $ | 3,549 | | | | | $ | 29,313 | | | | | $ | 32,862 | | |
Net loss
|
| | | | — | | | | | | (1,908) | | | | | | (1,908) | | |
Other Comprehensive Income
|
| | | | 403 | | | | | | — | | | | | | 403 | | |
Cumulative effect of adoption of new accounting principle (see Note 3)
|
| | | | 805 | | | | | | (805) | | | | | | — | | |
Balance, December 31, 2017
|
| | | $ | 4,757 | | | | | $ | 26,600 | | | | | $ | 31,357 | | |
|
(in thousands of dollars)
|
| |
2017
|
| |
2016
|
| ||||||
Cash flows from operating activities: | | | | | | | | | | | | | |
Net loss
|
| | | $ | (1,908) | | | | | $ | (1,997) | | |
Adjustments to reconcile net loss to net cash used in operating activities:
|
| | | | | | | | | | | | |
Realized investment gains, net
|
| | | | (2,228) | | | | | | (1,783) | | |
Amortization on investments
|
| | | | (42) | | | | | | (180) | | |
Depreciation
|
| | | | 271 | | | | | | 263 | | |
Deferred taxes
|
| | | | (1) | | | | | | 1 | | |
Deferred insurance acquisition costs
|
| | | | (2,354) | | | | | | (2,267) | | |
Deferred sales inducement costs
|
| | | | (545) | | | | | | (246) | | |
Interest and amortization of deferred acquisition and sales inducement costs
|
| | | | 2,108 | | | | | | 1,876 | | |
Change in accrued investment income
|
| | | | (54) | | | | | | 119 | | |
Change in receivables
|
| | | | 37 | | | | | | (23) | | |
Change in reinsurance recoverable
|
| | | | (1,620) | | | | | | (1,696) | | |
Change in prepaid reinsurance premiums
|
| | | | (434) | | | | | | (821) | | |
Change in policy benefits
|
| | | | (1,053) | | | | | | 349 | | |
Change in unearned revenue
|
| | | | (8) | | | | | | 162 | | |
Change in deferred reinsurance settlements
|
| | | | 1,437 | | | | | | 1,512 | | |
Change in other assets and liabilities
|
| | | | 615 | | | | | | (325) | | |
Net cash used in operating activities
|
| | | $ | (5,779) | | | | | $ | (5,056) | | |
Cash flows from investing activities: | | | | | | | | | | | | | |
Proceeds from investments sold or matured:
|
| | | | | | | | | | | | |
Fixed maturity securities
|
| | | | 23,130 | | | | | | 26,986 | | |
Equity securities
|
| | | | 4,043 | | | | | | 3,974 | | |
Derivatives
|
| | | | 154 | | | | | | 0 | | |
Policy loans
|
| | | | 206 | | | | | | 70 | | |
Costs of investments purchased:
|
| | | | | | | | | | | | |
Fixed maturity securities
|
| | | | (35,816) | | | | | | (28,479) | | |
Equity securities
|
| | | | (327) | | | | | | (486) | | |
Derivatives
|
| | | | (255) | | | | | | (60) | | |
Real estate additions
|
| | | | (84) | | | | | | (226) | | |
Other investing activies
|
| | | | (238) | | | | | | (17) | | |
Purchase of property and equipment
|
| | | | (41) | | | | | | (109) | | |
Net cash (used in) provided by investing activities
|
| | | | (9,228) | | | | | | 1,653 | | |
Cash flows from financing activites: | | | | | | | | | | | | | |
Policyholder account balances:
|
| | | | | | | | | | | | |
Deposits
|
| | | | 19,300 | | | | | | 14,559 | | |
Withdrawals
|
| | | | (8,482) | | | | | | (9,366) | | |
Net transfers (to) from separate acounts
|
| | | | (115) | | | | | | 46 | | |
Net cash provided by financing activities
|
| | | | 10,703 | | | | | | 5,239 | | |
Net (decrease) increase in cash
|
| | | | (4,304) | | | | | | 1,836 | | |
Cash, beginning of year
|
| | | | 8,389 | | | | | | 6,553 | | |
Cash, end of year
|
| | | $ | 4,085 | | | | | $ | 8,389 | | |
|
| | |
December 31, 2017
|
| |||||||||||||||||||||
| | |
Amortized
Cost |
| |
Gross Unrealized
|
| |
Fair
Value |
| |||||||||||||||
| | |
Gains
|
| |
Losses
|
| ||||||||||||||||||
U.S. government
|
| | | $ | 4,075 | | | | | $ | 207 | | | | | $ | (120) | | | | | $ | 4,162 | | |
States, political subdivisions, other
|
| | | | 26,850 | | | | | | 876 | | | | | | (112) | | | | | | 27,614 | | |
Corporate
|
| | | | 106,479 | | | | | | 3,459 | | | | | | (543) | | | | | | 109,395 | | |
Residential mortgage-backed securities
|
| | | | 41,818 | | | | | | 1,480 | | | | | | (212) | | | | | | 43,086 | | |
Commercial mortgage-backed securities
|
| | | | 4,210 | | | | | | 26 | | | | | | (41) | | | | | | 4,195 | | |
Total fixed maturity securities
|
| | | | 183,432 | | | | | | 6,048 | | | | | | (1,028) | | | | | | 188,452 | | |
Equity securities
|
| | | | 4,443 | | | | | | 1,766 | | | | | | — | | | | | | 6,209 | | |
Total fixed maturity and equity securities
|
| | | $ | 187,875 | | | | | $ | 7,814 | | | | | $ | (1,028) | | | | | $ | 194,661 | | |
|
| | |
December 31, 2016
|
| |||||||||||||||||||||
| | |
Amortized
Cost |
| |
Gross Unrealized
|
| |
Fair
Value |
| |||||||||||||||
| | |
Gains
|
| |
Losses
|
| ||||||||||||||||||
U.S. government
|
| | | $ | 4,087 | | | | | $ | 267 | | | | | $ | (140) | | | | | $ | 4,214 | | |
States, political subdivisions, other
|
| | | | 19,627 | | | | | | 616 | | | | | | (130) | | | | | | 20,113 | | |
Corporate
|
| | | | 101,698 | | | | | | 3,452 | | | | | | (974) | | | | | | 104,176 | | |
Residential mortgage-backed securities
|
| | | | 35,282 | | | | | | 1,450 | | | | | | (314) | | | | | | 36,418 | | |
Commercial mortgage-backed securities
|
| | | | 9,821 | | | | | | 228 | | | | | | (90) | | | | | | 9,959 | | |
Total fixed maturity securities
|
| | | | 170,515 | | | | | | 6,013 | | | | | | (1,648) | | | | | | 174,880 | | |
Equity securities
|
| | | | 6,202 | | | | | | 1,745 | | | | | | (20) | | | | | | 7,927 | | |
Total fixed maturity and equity securities
|
| | | $ | 176,717 | | | | | $ | 7,758 | | | | | $ | (1,668) | | | | | $ | 182,807 | | |
|
| | |
December 31, 2017
|
| |
December 31, 2016
|
| ||||||||||||||||||
| | |
Amortized
Cost |
| |
Fair
Value |
| |
Amortized
Cost |
| |
Fair
Value |
| ||||||||||||
Due in one year or less
|
| | | $ | 2,247 | | | | | $ | 2,288 | | | | | $ | 5,038 | | | | | $ | 5,161 | | |
Due after one year through five years
|
| | | | 40,926 | | | | | | 42,809 | | | | | | 34,101 | | | | | | 36,605 | | |
Due after five years through ten years
|
| | | | 66,739 | | | | | | 68,151 | | | | | | 66,029 | | | | | | 66,648 | | |
Due after ten years
|
| | | | 27,492 | | | | | | 27,923 | | | | | | 20,244 | | | | | | 20,089 | | |
Mortgage-backed securities
|
| | | | 46,028 | | | | | | 47,281 | | | | | | 45,103 | | | | | | 46,377 | | |
Total
|
| | | $ | 183,432 | | | | | $ | 188,452 | | | | | $ | 170,515 | | | | | $ | 174,880 | | |
|
| | |
2017
|
| |||||||||||||||
| | |
Fixed
Maturities |
| |
Equity
Securities |
| |
Derivative
Instruments |
| |||||||||
Proceeds from sales or maturities
|
| | | $ | 23,130 | | | | | $ | 4,043 | | | | | $ | 154 | | |
Gross gains from sales or maturities
|
| | | | 200 | | | | | | 1,957 | | | | | | 183 | | |
Gross losses from sales or maturities
|
| | | | (23) | | | | | | — | | | | | | (89) | | |
| | |
2016
|
| |||||||||
| | |
Fixed
Maturities |
| |
Equity
Securities |
| ||||||
Proceeds from sales or maturities
|
| | | $ | 26,986 | | | | | $ | 3,974 | | |
Gross gains from sales or maturities
|
| | | | 208 | | | | | | 1,714 | | |
Gross losses from sales or maturities
|
| | | | (78) | | | | | | (61) | | |
2017
|
| |
Less than 12 months
|
| |
12 months or longer
|
| |
Total
|
| |||||||||||||||||||||||||||
Description of securities
|
| |
Fair
Value |
| |
Gross
Unrealized Loss |
| |
Fair
Value |
| |
Gross
Unrealized Loss |
| |
Fair
Value |
| |
Gross
Unrealized Loss |
| ||||||||||||||||||
U.S. government
|
| | | $ | 1,161 | | | | | $ | (31) | | | | | $ | 1,782 | | | | | $ | (89) | | | | | $ | 2,943 | | | | | $ | (120) | | |
States, political subdivisions, other
|
| | | | 8,773 | | | | | | (86) | | | | | | 714 | | | | | | (26) | | | | | | 9,487 | | | | | | (112) | | |
Corporate
|
| | | | 10,935 | | | | | | (169) | | | | | | 6,853 | | | | | | (374) | | | | | | 17,788 | | | | | | (543) | | |
Residential mortgage-backed securities
|
| | | | 11,517 | | | | | | (126) | | | | | | 2,263 | | | | | | (86) | | | | | | 13,780 | | | | | | (212) | | |
Commercial mortgage-backed securities
|
| | | | 2,039 | | | | | | (27) | | | | | | 77 | | | | | | (14) | | | | | | 2,116 | | | | | | (41) | | |
Equity securities
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Total
|
| | | $ | 34,425 | | | | | $ | (439) | | | | | $ | 11,689 | | | | | $ | (589) | | | | | $ | 46,114 | | | | | $ | (1,028) | | |
|
2016
|
| |
Less than 12 months
|
| |
12 months or longer
|
| |
Total
|
| |||||||||||||||||||||||||||
Description of securities
|
| |
Fair
Value |
| |
Gross
Unrealized Loss |
| |
Fair
Value |
| |
Gross
Unrealized Loss |
| |
Fair
Value |
| |
Gross
Unrealized Loss |
| ||||||||||||||||||
U.S. government
|
| | | $ | 2,932 | | | | | $ | (140) | | | | | $ | — | | | | | $ | — | | | | | $ | 2,932 | | | | | $ | (140) | | |
States, political subdivisions, other
|
| | | | 5,983 | | | | | | (130) | | | | | | — | | | | | | — | | | | | | 5,983 | | | | | | (130) | | |
Corporate
|
| | | | 25,055 | | | | | | (791) | | | | | | 3,239 | | | | | | (183) | | | | | | 28,294 | | | | | | (974) | | |
Residential mortgage-backed securities
|
| | | | 11,367 | | | | | | (314) | | | | | | — | | | | | | — | | | | | | 11,367 | | | | | | (314) | | |
Commercial mortgage-backed securities
|
| | | | 979 | | | | | | (25) | | | | | | 538 | | | | | | (65) | | | | | | 1,517 | | | | | | (90) | | |
Equity securities
|
| | | | 183 | | | | | | (3) | | | | | | 180 | | | | | | (17) | | | | | | 363 | | | | | | (20) | | |
Total
|
| | | $ | 46,499 | | | | | $ | (1,403) | | | | | $ | 3,957 | | | | | $ | (265) | | | | | $ | 50,456 | | | | | $ | (1,668) | | |
|
| | |
2017
|
| |
2016
|
| ||||||
Fixed maturity securities
|
| | | $ | 7,350 | | | | | $ | 7,818 | | |
Equity securities
|
| | | | 181 | | | | | | 253 | | |
Real estate
|
| | | | 149 | | | | | | 122 | | |
Cash equivalents
|
| | | | 32 | | | | | | 9 | | |
Policy loans
|
| | | | 723 | | | | | | 737 | | |
Other
|
| | | | 685 | | | | | | 470 | | |
Subtotal
|
| | | | 9,120 | | | | | | 9,409 | | |
Investment expense
|
| | | | (597) | | | | | | (588) | | |
Net investment income
|
| | | $ | 8,523 | | | | | $ | 8,821 | | |
|
| | |
December 31, 2017
|
| |||||||||||||||||||||
| | |
Fair
Value |
| |
Gross Unrealized
|
| |
Net
Unrealized Gain (Loss) |
| |||||||||||||||
| | |
Gains
|
| |
Losses
|
| ||||||||||||||||||
Fixed income securities
|
| | | $ | 188,452 | | | | | $ | 6,048 | | | | | $ | (1,028) | | | | | $ | 5,020 | | |
Equity securities
|
| | | | 6,209 | | | | | | 1,766 | | | | | | — | | | | | | 1,766 | | |
Net unrealized capital gains
|
| | | | | | | | | | | | | | | | | | | | | $ | 6,786 | | |
|
| | |
December 31, 2016
|
| |||||||||||||||||||||
| | |
Fair
Value |
| |
Gross Unrealized
|
| |
Net
Unrealized Gain (Loss) |
| |||||||||||||||
| | |
Gains
|
| |
Losses
|
| ||||||||||||||||||
Fixed income securities
|
| | | $ | 174,880 | | | | | $ | 6,013 | | | | | $ | (1,648) | | | | | $ | 4,365 | | |
Equity securities
|
| | | | 7,927 | | | | | | 1,745 | | | | | | (20) | | | | | | 1,725 | | |
Net unrealized capital gains
|
| | | | | | | | | | | | | | | | | | | | | $ | 6,090 | | |
|
| | |
Carrying\Fair
Value 12/31/2017 |
| |
Carrying\Fair
Value 12/31/2016 |
| ||||||
Financial instruments recorded as assets: | | | | | | | | | | | | | |
Fixed maturity securities
|
| | | $ | 188,452 | | | | | $ | 174,880 | | |
Equity securities
|
| | | | 6,209 | | | | | | 7,927 | | |
Policy loans
|
| | | | 9,852 | | | | | | 10,059 | | |
Derivative instruments
|
| | | | 395 | | | | | | 59 | | |
Cash and cash equivalents
|
| | | | 4,085 | | | | | | 8,389 | | |
Separate account
|
| | | | 24,779 | | | | | | 21,513 | | |
Financial instruments recorded as liabilities: | | | | | | | | | | | | | |
Policyholder account balance:
|
| | | | | | | | | | | | |
Interest sensitive life contracts
|
| | | | 41,078 | | | | | | 40,508 | | |
Annuities
|
| | | | 68,745 | | | | | | 58,932 | | |
Dividend accumulations and other(1)
|
| | | | 7,076 | | | | | | 7,413 | | |
Separate account
|
| | | | 24,779 | | | | | | 21,513 | | |
| | |
Recurring Fair Value Measurements
at December 31, 2017 Using: |
| |||||||||||||||||||||
Description
|
| |
Fair Values
|
| |
Quoted Prices
in Active Markets for Identical Assets (Level 1) |
| |
Significant
Other Obeservable Inputs (Level 2) |
| |
Significant
Unobservable Inputs (Level 3) |
| ||||||||||||
Fixed maturity securities: | | | | | | | | | | | | | | | | | | | | | | | | | |
U.S. government
|
| | | $ | 4,162 | | | | | $ | 4,162 | | | | | $ | — | | | | | $ | — | | |
States, political subdivisions, other
|
| | | | 27,614 | | | | | | — | | | | | | 27,614 | | | | | | — | | |
Corporate
|
| | | | 109,395 | | | | | | — | | | | | | 109,395 | | | | | | — | | |
Residential mortgage-backed securities
|
| | | | 43,086 | | | | | | — | | | | | | 43,086 | | | | | | — | | |
Commercial mortgage-backed securities
|
| | | | 4,195 | | | | | | — | | | | | | 4,195 | | | | | | — | | |
Total fixed maturiities
|
| | | | 188,452 | | | | | | 4,162 | | | | | | 184,290 | | | | | | — | | |
Equities
|
| | | | 6,209 | | | | | | 4,027 | | | | | | — | | | | | | 2,182 | | |
Derivative instruments
|
| | | | 395 | | | | | | 395 | | | | | | — | | | | | | — | | |
Cash equivalents(1)
|
| | | | 4,085 | | | | | | 4,085 | | | | | | — | | | | | | — | | |
Separate accounts(2)
|
| | | | 24,779 | | | | | | 24,779 | | | | | | — | | | | | | — | | |
Total
|
| | | $ | 223,920 | | | | | $ | 37,448 | | | | | $ | 184,290 | | | | | $ | 2,182 | | |
|
| | |
Recurring Fair Value Measurements
at December 31, 2016 Using: |
| |||||||||||||||||||||
Description
|
| |
Fair Values
|
| |
Quoted Prices
in Active Markets for Identical Assets (Level 1) |
| |
Significant
Other Obeservable Inputs (Level 2) |
| |
Significant
Unobservable Inputs (Level 3) |
| ||||||||||||
Fixed maturity securities: | | | | | | | | | | | | | | | | | | | | | | | | | |
U.S. government
|
| | | $ | 4,214 | | | | | $ | 4,214 | | | | | $ | — | | | | | $ | — | | |
States, political subdivisions, other
|
| | | | 20,113 | | | | | | — | | | | | | 20,113 | | | | | | — | | |
Corporate
|
| | | | 104,176 | | | | | | — | | | | | | 104,176 | | | | | | — | | |
Residential mortgage-backed securities
|
| | | | 36,418 | | | | | | — | | | | | | 36,418 | | | | | | — | | |
Commercial mortgage-backed securities
|
| | | | 9,959 | | | | | | — | | | | | | 9,959 | | | | | | — | | |
Total fixed maturiities
|
| | | | 174,880 | | | | | | 4,214 | | | | | | 170,666 | | | | | | — | | |
Equities
|
| | | | 7,927 | | | | | | 4,758 | | | | | | — | | | | | | 3,169 | | |
Derivative instruments
|
| | | | 59 | | | | | | 59 | | | | | | — | | | | | | — | | |
Cash equivalents(1)
|
| | | | 5,670 | | | | | | 5,670 | | | | | | — | | | | | | — | | |
Separate accounts(2)
|
| | | | 21,513 | | | | | | 21,513 | | | | | | — | | | | | | — | | |
Total
|
| | | $ | 210,049 | | | | | $ | 36,214 | | | | | $ | 170,666 | | | | | $ | 3,169 | | |
|
Fair value at December 31, 2017
|
| | | | | | | |
Primary Valuation
Technique(s) |
| |
Significant
Unobservable Inputs |
| |
Range
|
| |
Weighted
Average |
| ||||||||||||
|
Min
|
| |
Max
|
| ||||||||||||||||||||||||||
Rreef America REIT II
|
| | | $ | 2,150 | | | |
Discounted cash Flows
|
| | Discount Rate | | | | | 5.50% | | | | | | 9.00% | | | | | | 6.61% | | |
| | | | | | | | | | | |
Terminal capitalization rate
|
| | | | 4.00% | | | | | | 8.25% | | | | | | 5.62% | | |
Fair value at December 31, 2016
|
| | | | | | | |
Primary Valuation
Technique(s) |
| |
Significant
Unobservable Inputs |
| |
Range
|
| |
Weighted
Average |
| ||||||||||||
|
Min
|
| |
Max
|
| ||||||||||||||||||||||||||
Rreef America REIT II
|
| | | $ | 3,074 | | | |
Discounted cash Flows
|
| | Discount Rate | | | | | 5.50% | | | | | | 10.75% | | | | | | 6.71% | | |
| | | | | | | | | | | |
Terminal capitalization rate
|
| | | | 4.00% | | | | | | 9.50% | | | | | | 5.70% | | |
| | |
2017
|
| |
2016
|
| ||||||
Balance, beginning of year
|
| | | $ | 3,169 | | | | | $ | 6,006 | | |
Gains included in net income
|
| | | | 396 | | | | | | 1,131 | | |
Settlements
|
| | | | (1,000) | | | | | | (3,000) | | |
Unrealized gains (losses) in OCI
|
| | | | (383) | | | | | | (968) | | |
Balance, end of year
|
| | | $ | 2,182 | | | | | $ | 3,169 | | |
|
| | |
2017
|
| |
2016
|
| ||||||
Balance, beginning of year
|
| | | $ | 11,940 | | | | | $ | 12,288 | | |
Capitalization of commissions, sales and issue expenses
|
| | | | 2,437 | | | | | | 2,263 | | |
Accrual of interest
|
| | | | 544 | | | | | | 530 | | |
Amortization
|
| | | | (2,659) | | | | | | (2,462) | | |
Change in Shadow DAC
|
| | | | (83) | | | | | | (679) | | |
Balance end of year
|
| | | $ | 12,179 | | | | | $ | 11,940 | | |
|
| | |
2017
|
| |
2016
|
| ||||||
Balance, beginning of year
|
| | | $ | 315 | | | | | $ | 13 | | |
Capitalization of commissions and issue expenses
|
| | | | 545 | | | | | | 246 | | |
Accrual of interest
|
| | | | 18 | | | | | | — | | |
Amortization
|
| | | | (11) | | | | | | 56 | | |
Balance end of year
|
| | | $ | 867 | | | | | $ | 315 | | |
|
| | |
Unrealized
Investment Gains (losses) |
| |
Shadow DAC
|
| |
Accumulated
Other Comprehensive Income (loss) |
| |||||||||
Balance, December 31, 2015
|
| | | $ | 4,356 | | | | | $ | (451) | | | | | $ | 3,905 | | |
Available-for-sale investment gains (losses) arising during the year:
|
| | | | | | | | | | | | | | | | | | |
Fixed maturity securities net ot tax benefit of $29
|
| | | | (56) | | | | | | | | | | | | (56) | | |
Equity securities net of tax benefit of $156
|
| | | | (303) | | | | | | | | | | | | (303) | | |
Change in Shadow DAC net of tax of $1
|
| | | | | | | | | | 3 | | | | | | 3 | | |
Balance, December 31, 2016
|
| | | $ | 3,997 | | | | | $ | (448) | | | | | $ | 3,549 | | |
Available-for-sale investment gains (losses) arising during the year:
|
| | | | | | | | | | | | | | | | | | |
Fixed maturity securities net ot tax of $227
|
| | | | 440 | | | | | | | | | | | | 440 | | |
Equity securities net of tax of $9
|
| | | | 18 | | | | | | | | | | | | 18 | | |
Change in Shadow DAC net of tax benefit of $28
|
| | | | | | | | | | (55) | | | | | | (55) | | |
Cumulative effect of adoption of new accounting principle (see Note 3)
|
| | | | 904 | | | | | | (99) | | | | | | 805 | | |
Balance, December 31, 2017
|
| | | $ | 5,359 | | | | | $ | (602) | | | | | $ | 4,757 | | |
| | |
December 31, 2017
|
| |
December 31, 2016
|
| ||||||
Balance, beginning of year
|
| | | $ | 21,513 | | | | | $ | 23,335 | | |
Cost of bonds and stocks acquired
|
| | | | 299 | | | | | | 80 | | |
Unrealized valuation increase
|
| | | | 3,275 | | | | | | 91 | | |
Total gain on disposals
|
| | | | 186 | | | | | | 1,820 | | |
Deduction consideration for bonds and stocks disposed of
|
| | | | (562) | | | | | | (3,813) | | |
Other assets
|
| | | | 68 | | | | | | — | | |
Balance, end of year
|
| | | $ | 24,779 | | | | | $ | 21,513 | | |
|
| | |
2017
|
| |
2016
|
| ||||||
Traditional life contracts
|
| | | $ | 62,311 | | | | | $ | 63,141 | | |
Immediate annuities and pension plan
|
| | | | 6,774 | | | | | | 7,135 | | |
Supplemental contracts with life contingencies
|
| | | | 2,522 | | | | | | 2,500 | | |
Accident and health
|
| | | | 386 | | | | | | 351 | | |
Accident death benefits
|
| | | | 132 | | | | | | 130 | | |
Disability
|
| | | | 188 | | | | | | 191 | | |
| | | | $ | 72,313 | | | | | $ | 73,448 | | |
|
Product
|
| |
Mortality
|
| |
Interest Rate
|
| |
Estimation Method
|
|
Immediate fixed annuities | | | 1971, 1983, 2000, and 2012 annuity mortality tables |
| | Rates range from 4% to 6.5% |
| | Present value of expected future benefits based on historical experience | |
Traditional life insurance | | | Actual company experience plus loading |
| | Rates range from 2.5% to 5.75% |
| | Net level premium reserve method using the Company’s withdrawal experience |
|
Accident and health | | | Actual company experience plus loading |
| | n/a | | | Unearned premium; additional contract reserves for mortality risk |
|
| | |
2017
|
| |
2016
|
| ||||||
Interest sensitive life contracts
|
| | | $ | 41,078 | | | | | $ | 40,508 | | |
Annuities
|
| | | | 68,745 | | | | | | 58,932 | | |
| | | | $ | 109,823 | | | | | $ | 99,440 | | |
|
Product
|
| |
Interest Rate
|
| |
Withdrawal/surrender charges
|
|
Interest-sensitive life insurance | | | Rates range from 3% to 7% | | | Either a percentage of account balance or a dollar amount grading off generally over 20 years | |
Fixed annuities | | | Rates range from 0% to 8% | | | Either a declining or level charge generally over 9 years or less | |
Other investment contracts | | | Rates range from 2% to 6% | | | No explicit charge assumed | |
| | |
2017
|
| |
2016
|
| ||||||
Balance, beginning of year
|
| | | $ | 99,440 | | | | | $ | 94,691 | | |
Deposits
|
| | | | 17,994 | | | | | | 13,005 | | |
Interest credited
|
| | | | 4,353 | | | | | | 3,932 | | |
Benefits
|
| | | | (2,734) | | | | | | (2,446) | | |
Surrenders and partial withdrawals
|
| | | | (4,835) | | | | | | (5,769) | | |
COI charges
|
| | | | (2,973) | | | | | | (2,852) | | |
Contract charges
|
| | | | (1,307) | | | | | | (1,167) | | |
Net transfers from separate accounts
|
| | | | (115) | | | | | | 46 | | |
Balance, end of year
|
| | | $ | 109,823 | | | | | $ | 99,440 | | |
|
| | |
2017
|
| |
2016
|
| ||||||
Payout annuities without life contingencies
|
| | | $ | 3,774 | | | | | $ | 3,116 | | |
Dividend accumulations and other
|
| | | | 7,076 | | | | | | 7,413 | | |
| | | | $ | 10,850 | | | | | $ | 10,529 | | |
|
| | |
2017
|
| |
2016
|
| ||||||
Land
|
| | | $ | 405 | | | | | $ | 405 | | |
Building and other
|
| | | | 8,378 | | | | | | 8,294 | | |
| | | | | 8,783 | | | | | | 8,699 | | |
Accumulated depreciation
|
| | | | (6,828) | | | | | | (6,712) | | |
Real Estate, net
|
| | | $ | 1,955 | | | | | $ | 1,987 | | |
|
| | |
2017
|
| |
2016
|
| ||||||
EDP equipment
|
| | | $ | 3,955 | | | | | $ | 3,963 | | |
Furniture
|
| | | | 1,522 | | | | | | 1,501 | | |
EDP equipment & furniture cost
|
| | | | 5,477 | | | | | | 5,464 | | |
Accumulated depreciation
|
| | | | (5,281) | | | | | | (5,154) | | |
Property and Equipment, net
|
| | | $ | 196 | | | | | $ | 310 | | |
|
| | |
2017
|
| |
2016
|
| ||||||
Current
|
| | | $ | 34 | | | | | $ | 34 | | |
Deferred
|
| | | | — | | | | | | — | | |
Provision for income tax
|
| | | $ | 34 | | | | | $ | 34 | | |
|
| | |
2017
|
| |
2016
|
| ||||||
Income taxes at statutory rate
|
| | | $ | (637) | | | | | $ | (667) | | |
Dividends received deduction
|
| | | | — | | | | | | — | | |
Tax effect from change in enacted tax rate
|
| | | | 805 | | | | | | — | | |
Other
|
| | | | (134) | | | | | | 701 | | |
Income tax (benefit) expense
|
| | | $ | 34 | | | | | $ | 34 | | |
Effective tax rate
|
| | | | -1.8% | | | | | | -1.7% | | |
| | |
2017
|
| |
2016
|
| ||||||
Deferred federal tax assets: | | | | | | | | | | | | | |
Difference between financial reporting and the tax basis of: | | | | | | | | | | | | | |
Operating loss carryforward
|
| | | $ | 5,859 | | | | | $ | 9,567 | | |
Other than temporary impairments
|
| | | | 947 | | | | | | 1,545 | | |
Deferred premiums
|
| | | | 734 | | | | | | 1,465 | | |
Life policy reserves
|
| | | | 600 | | | | | | 103 | | |
Other
|
| | | | 380 | | | | | | 745 | | |
Deferred reinsurance settlements
|
| | | | 619 | | | | | | 514 | | |
Total deferred tax assets
|
| | | | 9,139 | | | | | | 13,939 | | |
Deferred federal tax liabilities: | | | | | | | | | | | | | |
Difference between financial reporting and the tax basis of: | | | | | | | | | | | | | |
Deferred acquisition costs and sales inducements
|
| | | | 2,147 | | | | | | 3,215 | | |
Net unrealized gains
|
| | | | 1,421 | | | | | | 2,064 | | |
Reinsurance recoverable
|
| | | | 766 | | | | | | 716 | | |
Amortized discount on bonds
|
| | | | 138 | | | | | | 527 | | |
Other
|
| | | | 143 | | | | | | 516 | | |
Fixed assets
|
| | | | 53 | | | | | | 89 | | |
Total deferred tax liabilities
|
| | | | 4,668 | | | | | | 7,127 | | |
Net
|
| | | | 4,471 | | | | | | 6,812 | | |
Less valuation allowance
|
| | | | (4,013) | | | | | | (6,148) | | |
Net deferred tax asset
|
| | | $ | 458 | | | | | $ | 664 | | |
|
Expiring
|
| | |||||
2018
|
| | | | 167 | | |
2019
|
| | | | 1,590 | | |
2020
|
| | | | 2,296 | | |
2021
|
| | | | 651 | | |
2022
|
| | | | 520 | | |
2023
|
| | | | 861 | | |
2024
|
| | | | 1,762 | | |
2025
|
| | | | 7,836 | | |
2026
|
| | | | 2,188 | | |
2027
|
| | | | 1,353 | | |
2028
|
| | | | 2,664 | | |
2029
|
| | | | 509 | | |
2030
|
| | | | 2,240 | | |
2031
|
| | | | 1,119 | | |
2032
|
| | | | 596 | | |
Total
|
| | | $ | 26,352 | | |
|
|
SEC Registration Fee
|
| | | $ | 5,727 | | |
|
Printing, Postage and Mailing Expenses
|
| | | $ | 225,000 | | |
|
FINRA Filing Fees
|
| | | $ | [•] | | |
|
NASDAQ Listing Fee
|
| | | $ | [•] | | |
|
Legal Fees and Expenses
|
| | | $ | 350,000 | | |
|
Accounting Fees and Expenses
|
| | | $ | 255,000 | | |
|
Valuation Expenses
|
| | | $ | 124,000 | | |
|
Transfer and Offering Agent Fees and Expenses
|
| | | $ | [•] | | |
|
Underwriters’ Expense Reimbursement
|
| | | $ | [•] | | |
|
Blue Sky Fees and Expenses
|
| | | $ | [•] | | |
|
Miscellaneous Expenses
|
| | | $ | [•] | | |
|
Total
|
| | | $ | * | | |
|
|
Exhibit
No. |
| |
Description of Exhibit
|
|
|
1.1
|
| | Agency Agreement between Federal Life Insurance Company, Federal Life Mutual Holding Company, Federal Life Group, Inc. and Griffin Financial Group LLC* | |
|
2.1
|
| | Federal Life Mutual Holding Company Plan of Conversion from Mutual Holding Company to Stock Form adopted March 8, 2018 | |
|
3.1
|
| | Form of Amended and Restated Articles of Incorporation of Federal Life Group, Inc.* | |
|
3.2
|
| | Form of Bylaws of Federal Life Group, Inc.* | |
|
4.1
|
| | Form of Stock Certificate of Federal Life Group, Inc. | |
|
4.2
|
| | Exchangeable Promissory Note issued by Federal Life Mutual Holding Company to Insurance Capital Group, LLC | |
|
5.1
|
| | Opinion of Stevens & Lee, P.C. regarding legality of stock of Federal Life Group, Inc. being issued* | |
|
8.1
|
| | Opinion of Stevens & Lee, P.C. regarding the tax treatment of the subscription rights* | |
|
10.1
|
| | Federal Life Group, Inc. 2018 Equity Incentive Plan* | |
|
10.2
|
| | Form of Non-Qualified Stock Option Award Agreement under the Federal Life Group, Inc. 2018 Equity Incentive Plan* | |
|
10.3
|
| | Form of Restricted Stock Award Agreement under the Federal Life Group, Inc. 2018 Equity Incentive Plan* | |
|
10.4
|
| | Reinsurance Agreement dated August 26, 2016 between Federal Life Insurance Company and Optimum Re Insurance Company, as amended. | |
|
10.5
|
| | Standby Stock Purchase Agreement dated as of March 9, 2018, by and among Federal Life Insurance Company, Federal Life Mutual Holding Company, Federal Life Group, Inc., and Insurance Capital Group, LLC | |
|
10.6
|
| | Executive Agreement dated March 3, 2010 between Joseph D. Austin and Federal Life Insurance Company. | |
|
10.7
|
| | Executive Agreement dated November 30, 2017 between William S. Austin and Federal Life Insurance Company. | |
|
10.8
|
| | Executive Agreement dated March 3, 2010 between Michael Austin and Federal Life Insurance Company. | |
|
21.1
|
| | Subsidiaries of Federal Life Group, Inc. | |
|
23.1
|
| | Consent of BKD, LLP | |
|
23.2
|
| | Consent of RP Financial, LC | |
|
23.3
|
| | Consent of Stevens & Lee, P.C. (contained in Exhibits 5.1 and 8.1)* | |
|
24.1
|
| | Power of Attorney (contained on signature page) | |
|
99.1
|
| | Stock Order Form and Instructions* | |
|
99.2
|
| | Question and Answer Brochure* | |
|
99.3
|
| | Letters and statements to prospective purchasers of stock in offering* | |
|
99.4
|
| | Form of Federal Life Mutual Holding Company Member Proxy Materials* | |
|
99.5
|
| | Pro Forma Valuation Appraisal Report of Federal Life Mutual Holding Company, dated as of December 22, 2017, of RP Financial, LC | |
Signature
|
| |
Title
|
| |
Date
|
|
/s/ Joseph D. Austin
Joseph D. Austin
|
| | Chairman and Chief Executive Officer (Principal Executive Officer), Director |
| |
May 24, 2018
|
|
/s/ William S. Austin
William S. Austin
|
| | President and Chief Operating Officer, Director | | |
May 24, 2018
|
|
/s/ Anders Raaum-
Anders Raaum
|
| | Chief Financial Officer (Principal Financial Officer) |
| |
May 24, 2018
|
|
/s/ Michael Austin
Michael Austin
|
| | Director | | |
May 24, 2018
|
|
/s/ Wayne R. Ebersberger
Wayne R. Ebersberger
|
| | Director | | |
May 24, 2018
|
|
/s/ William H. Springer
William H. Springer
|
| | Director | | |
May 24, 2018
|
|
/s/ James H. Stacke
James H. Stacke
|
| | Director | | |
May 24, 2018
|
|
Exhibit 2.1
PLAN OF CONVERSION
OF
FEDERAL LIFE MUTUAL HOLDING COMPANY
Under Section 59.1 of the
Illinois Insurance Code, 215 ILCS 5/59.1
As Approved on March 8, 2018
by the Board of Directors
Table of Contents
Page | |
ARTICLE 1 | |
REASONS FOR THE CONVERSION | 1 |
ARTICLE 2 | |
DEFINITIONS | 2 |
2.01 Certain Terms | 2 |
2.02 Terms Generally | 5 |
ARTICLE 3 | |
ADOPTION BY THE BOARD OF DIRECTORS | 6 |
3.01 Adoption by the Board | 6 |
ARTICLE 4 | |
APPROVAL BY THE DIRECTOR | 6 |
4.01 Application for Approval | 6 |
4.02 Director Approval | 6 |
ARTICLE 5 | |
TOTAL NUMBER OF SHARES AND PURCHASE PRICE OF COMMON STOCK | 7 |
5.01 Independent Appraiser | 7 |
5.02 Purchase Price | 7 |
5.03 Number of Shares of Common Stock to be Offered | 7 |
5.04 Number of Shares of Common Stock to be Sold | 7 |
5.05 Results of Offering | 7 |
ARTICLE 6 | |
GENERAL PROCEDURE FOR THE OFFERINGS | 9 |
6.01 Commencement of Offerings | 9 |
ARTICLE 7 | |
SUBSCRIPTION OFFERING | 9 |
7.01 Allocation of Subscription Rights | 9 |
ARTICLE 8 | |
COMMUNITY OFFERING AND PUBLIC OFFERING | 11 |
8.01 Community Offering | 11 |
8.02 Preference in Community Offering | 11 |
8.03 Delivery of Offering Materials | 11 |
8.04 Commencement of Community Offering | 11 |
8.05 Public Offering | 11 |
8.06 Alternative Offering Procedures | 12 |
ARTICLE 9 | |
STANDBY PURCHASER | 12 |
9.01 Sale of Shares to Standby Purchaser | 12 |
i
Table of Contents
Page | |
ARTICLE 10 | |
LIMITATIONS ON SUBSCRIPTIONS AND PURCHASES OF COMMON STOCK | 12 |
10.01 Maximum Number of Shares That May be Purchased | 12 |
ARTICLE 11 | |
TIMING OF THE OFFERINGS, MANNER OF PURCHASING COMMON STOCK AND ORDER FORMS | 14 |
11.01 Commencement of the Offering | 14 |
11.02 Right to Reject Orders | 14 |
11.03 Policyholders Outside the United States | 14 |
ARTICLE 12 | |
PAYMENT FOR COMMON STOCK | 15 |
12.01 Purchase Price for Shares | 15 |
12.02 Shares Nonassessable | 15 |
ARTICLE 13 | |
CONDITIONS of THE OFFERING | 15 |
13.01 Closing Conditions | 15 |
ARTICLE 14 | |
APPROVAL BY ELIGIBLE MEMBERS | 15 |
14.01 Special Meeting | 15 |
14.02 Notice of the Special Meeting | 16 |
ARTICLE 15 | |
THE CONVERSION | 16 |
15.01 Effect on FLMHC | 16 |
15.02 Effect on Existing Policies | 17 |
15.03 Closed Block of Participating Policies | 17 |
15.04 Filing of Plan of Conversion and Amended and Restated Articles | 17 |
15.05 Effectiveness of Plan of Conversion | 18 |
15.06 Tax Considerations | 18 |
ARTICLE 16 | |
POLICIES | 19 |
16.01 Policies | 19 |
16.02 Determination of Ownership | 19 |
16.03 In Force | 20 |
ARTICLE 17 | |
SUBSEQUENT POLICYHOLDERS | 20 |
17.01 Notice to Subsequent Policyholders | 20 |
17.02 Option to Rescind | 20 |
ii
Table of Contents
Page | |
ARTICLE 18 | |
OFFICERS AND BOARD OF DIRECTORS | 21 |
18.01 Directors | 21 |
18.02 Officers | 21 |
ARTICLE 19 | |
ADDITIONAL PROVISIONS | 21 |
19.01 Continuation of Corporate Existence | 21 |
19.02 Conflict of Interest | 21 |
19.03 Registration of Shares; Listing of Shares on Stock Exchange | 22 |
19.04 Restrictions on Transfer of Common Stock | 22 |
19.05 No Preemptive Rights | 22 |
19.06 Amendment or Withdrawal of Plan of Conversion | 22 |
19.07 Corrections | 23 |
19.08 Notices | 23 |
19.09 Limitation of Actions | 23 |
19.10 Costs and Expenses | 23 |
19.11 Headings | 23 |
19.12 Governing Law | 23 |
iii
PLAN OF CONVERSION
OF
FEDERAL LIFE MUTUAL HOLDING COMPANY
Under Section 59.1 of the
Illinois Insurance Code, 215 ILCS 5/59.1
This Plan of Conversion provides for the conversion of Federal Life Mutual Holding Company, a mutual holding company organized under the laws of Illinois (such entity, both before and after the Conversion, being referred to as “FLMHC”), from a mutual holding company into a stock company (the “Conversion”) and the issuance by FLMHC of newly-issued shares of common stock of FLMHC to Federal Life Group, Inc., a Pennsylvania corporation (“HoldCo”), as authorized by Section 59.1 of the Illinois Insurance Code, 215 ILCS 5/59.1 (the “Conversion Act”). In the Conversion, all Eligible Members will receive subscription rights to purchase shares of common stock of HoldCo, in exchange for the extinguishment of their Membership Interests in FLMHC. As required by Section 59.1(2) of the Illinois Insurance Code, this Plan of Conversion was originally approved and adopted by at least two-thirds of the members of the Board of Directors (the “Board”) of FLMHC, at a meeting duly called and held on March 8, 2018 (the “Adoption Date”). Capitalized terms used herein without definition have the meaning set forth in Article 2 hereof.
ARTICLE 1
REASONS FOR THE CONVERSION
The principal purpose of the Conversion is to convert FLMHC from a mutual insurance holding company into a stock holding company in order to enhance its strategic and financial flexibility and to provide the Eligible Members with the right to acquire an equity interest in HoldCo. The Board believes that the Conversion is in the best interest of FLMHC because the additional capital resulting from the Conversion should: (i) support further organic growth in life insurance premiums written and annuity deposits; (ii) provide the capital necessary to permit increased sales of life insurance and annuities by Federal Life; and (iii) enable HoldCo to attract institutional investors and engage in strategic transactions advantageous to HoldCo and its subsidiaries. The Board further believes that the transaction is fair and equitable, is consistent with the purpose and intent of Section 59.1 and will not prejudice the interests of the Members.
In its present structure as a mutual holding company, FLMHC can increase the statutory capital of Federal Life only through earnings generated by the businesses of Federal Life and its subsidiaries, the issuance of surplus notes by Federal Life, or the sale of a minority interest in Federal Life with or without the granting of subscription rights. Reliance on earnings to provide a long-term source of permanent capital, however, limits Federal Life’s ability to develop new business, issue new insurance and annuity products, and provide greater stability and protection for its policyholders. Surplus notes do not provide permanent capital and must be repaid out of the company’s earnings. The sale of a minority interest in Federal Life is unlikely to provide a meaningful amount of capital, especially in relation to the costs incurred to raise this capital.
1
ARTICLE 2
DEFINITIONS
2.01 Certain Terms. As used in this Plan of Conversion, the following terms have the meanings set forth below:
“Adoption Date” has the meaning specified in the preamble.
“Affiliate” means a Person who, directly or indirectly, through one or more intermediaries, controls or is controlled by or is under common control with the Person specified or who is acting in concert with the Person specified.
“Amended and Restated Articles of Incorporation” has the meaning specified in Section 14.01(a).
“Amended and Restated Bylaws” has the meaning specified in Section 15.04(a).
“Application” has the meaning specified in Section 4.01.
“Appraised Value” means the estimated pro forma market value of FLMHC, as determined by RP Financial, LC.
“Board” has the meaning specified in the preamble.
“Code” means the Internal Revenue Code of 1986, as amended.
“Common Stock” means the common stock of HoldCo, par value $0.01 per share.
“Community Offering” means the offering for sale by HoldCo of any shares of Common Stock not subscribed for in the Subscription Offering as set forth in Article 8 hereof, and includes any Public Offering. HoldCo may retain the assistance of a broker-dealer or syndicate of broker-dealers to assist it in connection with the sale of Common Stock in the Community Offering.
“Conversion” has the meaning specified in the preamble.
“Decision and Order” means the final and effective decision and order issued by the Director and evidencing the Director’s approval of the Application and of this Plan of Conversion.
“Department” means the Illinois Department of Insurance.
“Director” means the Director of the Illinois Department of Insurance.
“Effective Date Filing” has the meaning specified in Section 15.04.
“Effective Time” means 12:01 a.m., Illinois time, on the Plan Effective Date. This is the time that this Plan of Conversion is deemed to be effective.
2
“Eligible Member” means a Member on the Adoption Date; provided that a person insured under a group policy is not an Eligible Member unless all of the conditions in 215 ILCS 5/59.1(1)(a)(i)-(iv) are satisfied.
“Eligible Policy” means any Policy that is In Force on the Adoption Date.
“Employee” means any natural person who is a full or part-time employee of Federal Life.
“Federal Life” means Federal Life Insurance Company, an Illinois chartered stock insurance company.
“Federal Life Records” means the books, records and accounts of Federal Life.
“FLMHC Shares” means the duly authorized shares of common stock of FLMHC to be issued to HoldCo on the Plan Effective Date in accordance with this Plan of Conversion.
“Gross Proceeds” means the product of (x) the Purchase Price and (y) the number of shares for which subscriptions and orders are received in the Offering and accepted by HoldCo.
“HoldCo” means Federal Life Group, Inc., a Pennsylvania corporation that will become the sole stockholder of FLMHC, and which will issue shares of Common Stock in the Offering.
“Illinois Insurance Code” means 215 ILCS 5.
“In Force” has the meaning specified in Section 16.03(a).
“Insider” means any Officer or director of Federal Life.
“Maximum of the Valuation of Range” has the meaning specified in Section 5.01.
“Member” means a person who, according to the Federal Life Records and pursuant to its bylaws and in accordance with Article 16 hereof, is deemed to be a holder of a Membership Interest in FLMHC.
“Membership Interests” means, with respect to FLMHC, the interests of Members arising under Illinois law and the articles of incorporation and bylaws of FLMHC prior to the Conversion, including the right to vote and the right to participate in any distribution of surplus in the event that FLMHC is liquidated.
“Minimum of the Valuation of Range” has the meaning specified in Section 5.01.
“Notice of Special Meeting” has the meaning specified in Section 14.02(a).
“Offering” means the offering of shares of Common Stock pursuant to this Plan in the Subscription Offering and the Community Offering or any Public Offering.
3
“Officer” means the people elected to serve as an officer by the Board of Directors of Federal Life, FLMHC, or HoldCo.
“Order Form” means the form provided on behalf of HoldCo by which Common Stock may be ordered in the Offering.
“Owner” means, with respect to any Policy, the Person or Persons specified or determined pursuant to the provisions of Section 16.02.
“Participant” means a Person to whom Common Stock is offered in the Subscription Offering.
“Person” means an individual, partnership, firm, association, corporation, joint-stock company, limited liability company, trust, government or governmental agency, state or political subdivision of a state, public or private corporation, board, association, estate, trustee, or fiduciary, or any similar entity.
“Plan Effective Date” has the meaning specified in Section 15.05(a).
“Plan of Conversion” means this Plan of Conversion, as it may be amended from time to time in accordance with Section 19.06 or corrected in accordance with Section 19.07. Any reference to the term “Plan of Conversion” shall be deemed to incorporate by reference all of the Exhibits thereto.
“Policy” or “Policies” has the meaning specified in Section 16.01(a).
“Prospectus” means the one or more documents to be used in offering the Common Stock in the Offering and for providing information to Persons in connection with the Offering.
“Public Offering” means an underwritten firm commitment or best efforts offering to the public through one or more underwriters or registered broker-dealers
“Purchase Price” has the meaning specified in Section 5.02.
“Registration Statement” means the registration statement filed or to be filed with the SEC by HoldCo under the Securities Act with respect to the offer and sale of shares of HoldCo common stock in the Offering.
“RP Financial” means RP Financial, LC.
“SEC” means the United States Securities and Exchange Commission.
“Securities Act” means the Securities Act of 1933, as amended.
“Special Meeting” has the meaning specified in Section 14.01.
4
“Standby Purchaser” means one or more Persons that enter into a Stock Purchase Agreement to purchase stock in the Offering in an amount in excess of five percent (5%) of the number of shares issued in the Offering.
“Strategic Investors” means the Persons (which shall not exceed four (4) in number) identified in a resolution adopted by the Board and granted preference by HoldCo and FLMHC in the Community Offering.
“Stock Compensation Plan” means any executive stock incentive plan that may be established by HoldCo and under which stock options, shares of restricted stock, or restricted stock units may be granted to directors and employees of HoldCo or any of its subsidiaries.
“Stock Purchase Agreement” means any Stock Purchase Agreement entered into between HoldCo and a Standby Purchaser.
“Subscription Offering” means the offering of the Common Stock that is described in Section 7.01 hereof.
“Subscription Rights” means nontransferable rights to subscribe for Common Stock in the Subscription Offering granted to Participants as described in Section 7.01 hereof.
“Valuation Range” means the range of the estimated pro forma market value of FLMHC as converted to a stock insurance holding company as determined by RP Financial in accordance with Section 5.01 hereof.
2.02 Terms Generally. As used in this Plan of Conversion, except to the extent that the context otherwise requires:
(a) when a reference is made in this Plan of Conversion to an Article, Section or Exhibit, such reference is to an Article or Section of, or an Exhibit to, this Plan of Conversion unless otherwise indicated;
(b) the words “hereby”, “herein”, “hereof”, “hereunder” and words of similar import refer to this Plan of Conversion as a whole (including any Exhibits hereto) and not merely to the specific section, paragraph or clause in which such word appears;
(c) whenever the words “include,” “includes,” or “including” (or similar terms) are used in this Plan of Conversion, they are deemed to be followed by the words “without limitation”;
(d) the definitions contained in this Plan of Conversion are applicable to the singular as well as the plural forms of such terms; and
(e) whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms.
5
ARTICLE 3
ADOPTION BY THE BOARD OF DIRECTORS
3.01 Adoption by the Board. This Plan of Conversion has been approved and adopted by at least two-thirds of the members of the Board at a meeting duly called and held on March 8, 2018. This Plan of Conversion provides for the conversion of FLMHC into a stock insurance holding company in accordance with the requirements of Section 59.1(2) of the Illinois Insurance Code.
ARTICLE 4
APPROVAL BY THE DIRECTOR
4.01 Application for Approval. Following the adoption of this Plan of Conversion by the Board, FLMHC shall file an application (the “Application”) with the Director for approval of this Plan of Conversion in accordance with Section 59.1(3) of the Illinois Insurance Code. The Application shall include true and complete copies of the following documents:
(a) this Plan of Conversion;
(b) the independent appraisal of market value of FLMHC provided by RP Financial in accordance with Section 5.01 and required by Section 59.1(6)(f) of the Illinois Insurance Code;
(c) the form of notice of the Special Meeting, required by Section 59.1(4)(b) of the Illinois Insurance Code;
(d) the form of information statement and proxy to be solicited from Eligible Members, required by Section 59.1(4)(c)(ii) of the Illinois Insurance Code;
(e) the form of notice to persons whose Policies are issued after the Adoption Date but before the Plan Effective Date, required by Section 59.1(10)(a) of the Illinois Insurance Code;
(f) the proposed amended and restated articles of incorporation and amended and restated bylaws of FLMHC; and
(g) any other information or documentation as the Director may request.
If the Director requires modifications to this Plan of Conversion, the Board shall submit any amended Plan of Conversion to the Director for his review and approval.
4.02 Director Approval. This Plan of Conversion is subject to the approval of the Director.
6
ARTICLE 5
TOTAL NUMBER OF SHARES AND PURCHASE PRICE OF COMMON STOCK.
The number of shares of Common Stock required to be offered and sold by HoldCo in the Offering will be determined as follows:
5.01 Independent Appraiser. RP Financial has been retained by FLMHC to determine the Valuation Range. The Valuation Range will consist of a midpoint valuation, a valuation fifteen percent (15%) above the midpoint valuation (the “Maximum of the Valuation Range”) and a valuation fifteen percent (15%) below the midpoint valuation (the “Minimum of the Valuation Range”). The Valuation Range will be based upon the consolidated financial condition and results of operations of FLMHC, the consolidated pro forma book value and earnings per share of FLMHC as converted to a stock company, a comparison of FLMHC with comparable publicly-held insurance companies and insurance holding companies, and such other factors as RP Financial may deem to be relevant, including that value which RP Financial estimates to be necessary to attract a full subscription for the Common Stock. RP Financial will submit to FLMHC the Valuation Range and a related report that describes the data and methodology used to determine the Valuation Range.
5.02 Purchase Price. The Purchase Price for Common Stock in the Offering (the “Purchase Price”) will be $10.00 per share and will be uniform as to all purchasers in the Offering.
5.03 Number of Shares of Common Stock to be Offered. The maximum number of shares of Common Stock to be offered in the Offering shall be equal to the Maximum of the Valuation Range divided by the Purchase Price.
5.04 Number of Shares of Common Stock to be Sold. RP Financial will submit to FLMHC the Appraised Value as of the end of the latest calendar quarter for which financial statements of FLMHC are available prior to the initial filing of a draft Registration Statement with the SEC. If the Gross Proceeds of the Offering do not equal or exceed the Minimum of the Valuation Range, then FLMHC may cancel the Offering and terminate this Plan, establish a new Valuation Range and extend, reopen or hold a new Offering, or take such other action as it deems to be reasonably necessary.
5.05 Results of Offering.
(a) If the Gross Proceeds of the Offering equal or exceed the Minimum of the Valuation Range, the following steps will be taken:
(i) Subscription Offering Exceeds Maximum. If the number of shares to which Participants subscribe in the Subscription Offering multiplied by the Purchase Price is greater than the Maximum of the Valuation Range, then HoldCo on the Effective Date shall issue shares of Common Stock to the subscribing Participants; which shares shall be allocated among the subscribing Participants as provided in Section 7.01; provided, however, that the number of shares of Common Stock issued shall not exceed the number of shares of Common Stock offered in the Offering as provided in Section 5.03; and provided further, that no fractional shares of Common Stock shall be issued.
7
(ii) Subscription Offering Meets or Exceeds Minimum, but does not Exceed Maximum. If the number of shares of Common Stock subscribed for by Participants in the Subscription Offering multiplied by the Purchase Price is equal to or greater than the Minimum of the Valuation Range, but less than or equal to the Maximum of the Valuation Range, then HoldCo on the Effective Date shall issue shares of Common Stock to the subscribing Participants in an amount sufficient to satisfy the subscriptions of such Participants in full. To the extent that shares of Common Stock remain unsold after the subscriptions of all Participants in the Subscription Offering have been satisfied in full, HoldCo shall have the right in its absolute discretion to accept, in whole or in part, orders received from purchasers in the Community Offering, including without limitation orders from Standby Purchasers pursuant to any Stock Purchase Agreement; provided, however, that the number of shares of Common Stock issued shall not exceed the Maximum of the Valuation Range; and, provided further, that no fractional shares of Common Stock shall be issued.
(iii) Subscription Offering Does Not Meet Minimum. If the number of shares of Common Stock subscribed for by Participants in the Subscription Offering multiplied by the Purchase Price is less than the Minimum of the Valuation Range, then in such event HoldCo may accept orders received from purchasers in the Community Offering, including without limitation orders from Standby Purchasers pursuant to any Stock Purchase Agreement. If the aggregate number of shares of Common Stock subscribed for in the Subscription Offering together with the orders for shares accepted in the Community Offering multiplied by the Purchase Price is equal to or greater than the Minimum of the Valuation Range, then on the Effective Date HoldCo shall: (A) issue shares of Common Stock to subscribing Participants in an amount sufficient to satisfy the subscriptions of such Participants in full, and (B) issue to purchasers in the Community Offering whose orders have been accepted such additional number of shares of Common Stock such that the aggregate number of shares of Common Stock to be issued to subscribing Participants and to purchasers in the Community Offering multiplied by the Purchase Price shall be equal to the Minimum of the Valuation Range; provided, however, that no fractional shares of Common Stock shall be issued. HoldCo may in its absolute discretion elect to issue shares of Common Stock to purchasers in the Community Offering in excess of the number determined by reference to clause (B) of the preceding sentence; provided, however, that the number of shares of Common Stock issued shall not exceed the Maximum of the Valuation Range.
(b) Offering Does Not Meet Minimum. If the aggregate number of shares of Common Stock subscribed for in the Subscription Offering together with the orders for shares accepted in the Community Offering multiplied by the Purchase Price is less than the Minimum of the Valuation Range, then in such event HoldCo and FLMHC may (w) cancel the Offering and terminate this Plan, (x) establish a new Valuation Range, (y) extend, reopen or hold a new Offering, or (z) take such other action as they deem reasonably necessary. If a new Valuation Range is established and the Offering is extended, reopened or continued as part of a new Offering, Persons who previously submitted subscriptions or orders will be required to confirm, revise or cancel their original subscriptions or orders. If original subscriptions or orders are canceled, any related payment will be refunded (without interest).
8
If, following a reduction in the Valuation Range, the aggregate number of shares of Common Stock for which subscriptions and orders have been accepted in the Offering multiplied by the Purchase Price is equal to or greater than the Minimum of the Valuation Range (as such Valuation Range has been reduced), then HoldCo on the Effective Date shall: (i) issue shares of Common Stock to Participants in the Subscription Offering in an amount sufficient to satisfy the subscriptions of such subscribers in full, and (ii) issue to purchasers in the Community Offering whose orders have been accepted such additional number of shares of Common Stock such that the aggregate number of shares of Common Stock to be issued multiplied by the Purchase Price shall be at least equal to the Minimum of the Valuation Range (as such Valuation Range has been reduced).
(c) Allocation of Shares. In determining the allocation of shares of Common Stock to purchasers in the Offering: (i) only those orders and subscriptions accepted by FLMHC and HoldCo shall be counted; (ii) any orders and subscriptions for shares in excess of the limitations on purchases set forth in Article 10 hereof shall be accepted only up to the applicable limitation on purchases set forth in Article 10 hereof; and (iii) any order or subscription for shares of Common Stock shall only be accepted to the extent of the payment of the Purchase Price for such shares actually received prior to the termination of the Offering.
(d) Participant Eligibility. Notwithstanding anything to the contrary set forth in this Plan, FLMHC and HoldCo shall have the right in their absolute discretion and without liability to any subscriber, purchaser, underwriter, broker-dealer, or any other Person to determine which proposed Persons and which subscriptions and orders in the Offering meet the criteria provided in this Plan for eligibility to purchase Common Stock and the number of shares eligible for purchase by any Person. The determination of these matters by HoldCo and FLMHC shall be final and binding on all parties and all Persons. Except for orders submitted by any Standby Purchaser in accordance with the provisions of a Stock Purchase Agreement, FLMHC and HoldCo shall have absolute and sole discretion to accept or reject, in whole or in part, any offer to purchase that is made or received in the course of the Community Offering, irrespective of a Person’s eligibility under this Plan to participate in the Community Offering.
ARTICLE 6
GENERAL PROCEDURE FOR THE OFFERINGS.
6.01 Commencement of Offerings. As soon as practicable after the registration of the Common Stock under the Securities Act, and after the receipt of all required regulatory approvals, the Common Stock shall be first offered for sale in the Subscription Offering. It is anticipated that any shares of Common Stock remaining unsold after the Subscription Offering will be sold through a Community Offering. The purchase price per share for the Common Stock shall be a uniform price determined in accordance with Section 5.02 hereof.
ARTICLE 7
SUBSCRIPTION OFFERING.
7.01 Allocation of Subscription Rights. Rights to purchase shares of Common Stock at the Purchase Price (the “Subscription Rights”) will be distributed by HoldCo to the Participants in the following priorities:
9
(a) Eligible Members (First Priority). Each Eligible Member shall receive, without payment, nontransferable Subscription Rights to purchase up to 50,000 shares of Common Stock in the Subscription Offering; provided, however, that the maximum number of shares that may be purchased by Eligible Members in the aggregate shall be equal to the Maximum of the Valuation Range divided by the Purchase Price.
In the event of an oversubscription for shares of Common Stock pursuant to this Section 7.01(a), available shares shall be allocated among subscribing Eligible Members so as to permit each such Eligible Member, to the extent possible, to purchase a number of shares that will make his or her total allocation equal to the lesser of (i) the number of shares that he or she subscribed for or (ii) 1,000 shares. Any shares of Common Stock remaining after such initial allocation will be allocated among the subscribing Eligible Members whose subscriptions remain unsatisfied in the proportion in which (i) the aggregate number of shares as to which each such Eligible Member’s subscription remains unsatisfied bears to (ii) the aggregate number of shares as to which all such Eligible Members’ subscriptions remain unsatisfied; provided, however, that no fractional shares of Common Stock shall be issued. If, because of the magnitude of the oversubscription, shares of Common Stock cannot be allocated among subscribing Eligible Members so as to permit each such Eligible Member to purchase the lesser of 1,000 shares or the number of shares subscribed for, then shares of Common Stock will be allocated among the subscribing Eligible Members in the proportion in which: (i) the aggregate number of shares subscribed for by each such Eligible Member bears to (ii) the aggregate number of shares subscribed for by all Eligible Members; provided, however, that no fractional shares of Common Stock shall be issued.
(b) Directors and Officers of FLMHC (Second Priority). Each director and Officer of FLMHC shall receive, without payment, nontransferable Subscription Rights to purchase shares of Common Stock in the Subscription Offering; provided, however, that such Subscription Rights shall be subordinated to the Subscription Rights of the Eligible Members; and provided, further, that such Subscription Rights may be exercised only to the extent that there are shares of Common Stock that could have been purchased by Eligible Members, but which remain unsold after satisfying the subscriptions of all Eligible Members. In the event of an oversubscription among the directors and Officers, the number of shares issued to any one director or Officer shall be equal to the product of (i) the number of shares available for issuance to all directors and Officers, and (ii) a fraction, expressed as a percentage, the numerator of which is the number of shares to which the subscribing director or Officer subscribed and the denominator of which is the total number of shares subscribed by all directors and Officers. The aggregate number of shares purchased by the directors and Officers, whether purchased in the Subscription Offering in their capacity as Eligible Members, in the Community Offering, or otherwise, shall be limited as provided in Section 10.1 hereof.
A director or Officer who subscribes to purchase shares of Common Stock and who also is eligible to purchase shares of Common Stock as an Eligible Member will be deemed to purchase Common Stock first in his or her capacity as an Eligible Member.
(c) Limitations on Subscription Rights. Subscription rights granted under this Plan will be nontransferable, nonnegotiable personal rights to subscribe for and purchase shares of Common Stock at the Purchase Price. Subscription Rights under this Plan will be granted without payment, but subject to all the terms, conditions and limitations of this Plan. Any Person purchasing Common Stock hereunder will be deemed to represent and affirm to HoldCo and FLMHC that such Person is purchasing for his or her own account and not on behalf of any other Person.
10
ARTICLE 8
COMMUNITY OFFERING AND PUBLIC OFFERING.
8.01 Community Offering. If less than the total number of shares of Common Stock offered by HoldCo in connection with the Conversion are sold in the Subscription Offering, it is anticipated that remaining shares of Common Stock shall, if practicable, be sold by HoldCo in the Community Offering.
8.02 Preference in Community Offering. In the Community Offering, subject to the terms of any Stock Purchase Agreement, HoldCo may accept, in its sole and absolute discretion, orders received, in the following order of priority, from (i) Employees, (ii) any Standby Purchaser, (iii) the Federal Life 401-K plan, and (iv) Strategic Investors, before accepting orders from the general public; provided, however, that notwithstanding the foregoing, HoldCo may accept such number of orders as are necessary for HoldCo to qualify for listing on the NASDAQ Capital Market.
8.03 Delivery of Offering Materials. A Prospectus and an Order Form shall be furnished to such Persons as FLMHC and HoldCo may select in connection with the Community Offering. Except to the extent provided in any Stock Purchase Agreement with a Standby Purchaser, each order for Common Stock in the Community Offering shall be subject to the absolute right of HoldCo to accept or reject any such order in whole or in part either at the time of receipt of an order or as soon as practicable following completion of the Community Offering. In the event of an oversubscription, subject to the preferences described above, the terms of the Standby Purchase Agreement, and the right of HoldCo to accept or reject, in its sole discretion, any order received in the Community Offering, any available shares will be allocated so as to permit each purchaser whose order is accepted in the Community Offering to purchase, to the extent possible, the lesser of 1,000 shares and the number of shares subscribed for by such person. Thereafter, any shares remaining will be allocated among purchasers whose orders have been accepted but remain unsatisfied on a pro rata basis, provided no fractional shares shall be issued.
8.04 Commencement of Community Offering. HoldCo may commence the Community Offering concurrently with, at any time during, or as soon as practicable after the end of, the Subscription Offering, and the Community Offering must be completed within 45 days after the completion of the Subscription Offering, unless extended by HoldCo.
8.05 Public Offering. HoldCo may sell any shares of Common Stock remaining following the Subscription Offering and Community Offering in a Public Offering, if desired. The provisions of Section 10.01 hereof shall not be applicable to the sales to underwriters for purposes of the Public Offering, but shall be applicable to sales by the underwriters to the public. The price to be paid by the underwriters in such an offering shall be equal to the Purchase Price less an underwriting discount to be negotiated among such underwriters and HoldCo, subject to any required regulatory approval or consent.
11
8.06 Alternative Offering Procedures. If for any reason a Public Offering of shares of Common Stock not sold in the Subscription Offering and the Community Offering cannot be effected, or if the number of shares of Common Stock remaining to be sold after the Subscription Offering and Community Offering is so small that a Public Offering of those remaining shares would be impractical, HoldCo shall use its best efforts to obtain other purchases in such manner and upon such condition as may be necessary, including without limitation selling shares of Common Stock to any Standby Purchaser as described in Section 9.01 hereof.
ARTICLE 9
STANDBY PURCHASER.
9.01 Sale of Shares to Standby Purchaser. If the aggregate number of shares of Common Stock subscribed for in the Subscription Offering multiplied by the Purchase Price is less than the Maximum of the Valuation Range, then in such event HoldCo may sell shares of Common Stock to Standby Purchasers at the Purchase Price, provided that the total number of shares sold in the Offering multiplied by the Purchase Price do not exceed the Maximum of the Valuation Range. Subject to the terms of any Stock Purchase Agreement, any order submitted by Standby Purchasers in the Community Offering may be accepted by HoldCo prior to accepting any other order received in the Community Offering. The Standby Purchaser has purchased an exchangeable promissory note issued by FLMHC in the principal amount of up to $2,000,000 (the “Exchangeable Note”). The outstanding principal balance of the Exchangeable Note will be converted into shares of Common Stock at the Effective Time at a price per share equal to the Purchase Price. The shares of Common Stock issuable upon conversion of the Exchangeable Note shall be issued outside of the Offering and will have no effect on the number of shares issuable in the Offering.
ARTICLE 10
LIMITATIONS ON SUBSCRIPTIONS AND PURCHASES OF COMMON STOCK.
10.01 Maximum Number of Shares That May be Purchased. The following additional limitations and exceptions shall apply to all purchases of Common Stock in the Offering:
(a) To the extent that shares are available, no Person may purchase fewer than the lesser of (i) 50 shares of Common Stock or (ii) shares of Common Stock having an aggregate purchase price of $500.00 in the Offering.
(b) Except for an Officer or director, no employee may purchase more than 50,000 shares of Common Stock in the Offering.
(c) No Strategic Investor may purchase more than 50,000 shares of Common Stock in the Offering.
12
(d) In addition to the other restrictions and limitations set forth herein, except for purchases by a director or Officer, the maximum amount of Common Stock which any Person together with any Affiliate may, directly or indirectly, subscribe for or purchase in the Offering (including without limitation the Subscription Offering and/or Community Offering), shall not exceed 50,000 shares, except that any Standby Purchaser may purchase such number of shares of Common Stock as provided in Section 9.01; and provided further, that any purchase in excess of five percent (5%) of the total shares of Common Stock sold in the Offering must be approved by the Director as otherwise provided under the Illinois Insurance Code. The limit set forth in this section shall not be construed to increase any other purchase limit provided herein. Purchases of shares of Common Stock in the Offering by any Person other than any Standby Purchaser shall not exceed five percent (5%) of the total shares of Common Stock sold in the Offering irrespective of the different capacities in which such person may have received Subscription Rights or other rights or options to place orders for shares of Common Stock under this Plan. The aggregate number of shares purchased in the Offering by the Strategic Investors, employees, the Federal Life 401-K Plan, and the directors and Officers as a group may not exceed 700,000 shares.
(e) For purposes of the foregoing limitations and the determination of Subscription Rights, (i) directors, Officers, and Employees shall not be deemed to be Affiliates or a group acting in concert solely as a result of their capacities as such, (ii) shares of Common Stock purchased by any plan participant in any tax-qualified retirement account using personal funds or funds held in any tax-qualified retirement account (including, for avoidance of doubt, the Federal Life 401-K Plan) pursuant to the exercise of Subscription Rights granted to such plan participant in his individual capacity as an Eligible Member or as a director or Officer and/or purchases by such plan participant in the Community Offering in such plan participant’s capacity as an employee, director or Officer shall not be deemed to be purchases by the tax-qualified retirement account for purposes of calculating the maximum amount of Common Stock that the tax-qualified retirement account may purchase, but shall count towards the individual limitations on purchases set forth in this Plan, and (iii) no Person shall be deemed to be an Affiliate of any Standby Purchaser.
(f) HoldCo may increase or decrease any of the purchase limitations set forth herein at any time; provided that in no event shall the maximum purchase limitation applicable to Eligible Members be less than the maximum purchase limitation percentage applicable to any other class of subscribers or purchasers in the Offering other than the directors and Officers and any Standby Purchaser. In the event that either an individual or aggregate purchase limitation is increased after commencement of the Offering, any Person who ordered the maximum number of shares of Common Stock shall be permitted to purchase an additional number of shares such that such Person may subscribe for or order the then maximum number of shares permitted to be subscribed for or ordered by such Person, subject to the rights and preferences of any person who has priority rights to purchase shares of Common Stock in the Offering. In the event that either an individual or the aggregate purchase limitation is decreased after commencement of the Offering, the orders of any Person who subscribed for or submitted an order for the maximum number of shares of Common Stock shall be decreased by the minimum amount necessary so that such Person shall be in compliance with the then maximum number of shares permitted to be subscribed for or ordered by such Person.
13
(g) Each Person who purchases Common Stock in the Offering shall be deemed to confirm that such purchase does not conflict with the purchase limitations under this Plan or otherwise imposed by law. FLMHC shall have the right to take any action as it may, in its sole discretion, deem necessary, appropriate or advisable in order to monitor and enforce the terms, conditions, limitations and restrictions contained in this Section and elsewhere in this Plan and the terms, conditions and representations contained in the Order Form, including, but not limited to, the absolute right of FLMHC and HoldCo to reject, limit or revoke acceptance of any order and to delay, terminate or refuse to consummate any sale of Common Stock that they believe might violate, or is designed to, or is any part of a plan to, evade or circumvent such terms, conditions, limitations, restrictions and representations. Any such action shall be final, conclusive and binding on all Persons, and HoldCo and FLMHC shall be free from any liability to any Person on account of any such action.
ARTICLE 11
TIMING OF THE OFFERINGS, MANNER OF
PURCHASING COMMON STOCK AND ORDER FORMS.
11.01 Commencement of the Offering. The exact timing of the commencement of the Offering shall be determined by HoldCo in consultation with any financial advisory or investment banking firm retained by it in connection with the Offering. HoldCo may consider a number of factors in determining the exact timing of the commencement of the Offering, including, but not limited to, its pro forma current and projected future earnings, local and national economic conditions and the prevailing market for stocks in general and stocks of insurance companies in particular. HoldCo shall have the right to withdraw, terminate, suspend, delay, revoke or modify the Offering at any time and from time to time, as it in its sole discretion may determine, without liability to any Person, subject to any necessary regulatory approval or concurrence.
11.02 Right to Reject Orders. Subject to the terms of any Stock Purchase Agreement, FLMHC and HoldCo shall have the absolute right, in their sole discretion and without liability to any Person, to reject any Order Form, including, but not limited to, any Order Form that is (i) improperly completed or executed, (ii) not timely received, (iii) not accompanied by the proper payment, or (iv) submitted by a Person whose representations FLMHC or HoldCo believes to be false or who it otherwise believes, either alone, or acting in concert with others, is violating, evading or circumventing, or intends to violate, evade or circumvent, the terms and conditions of this Plan. HoldCo and FLMHC may, but will not be required to, waive any irregularity on any Order Form or may require the submission of corrected Order Forms or the remittance of full payment for shares of Common Stock by such date as FLMHC and HoldCo may specify. The interpretation of FLMHC and HoldCo of the terms and conditions of the Order Forms shall be final and conclusive. Once HoldCo receives an Order Form, the order shall be deemed placed and will be irrevocable; provided, however, that no Order Form shall be accepted until the Prospectus has been filed with the SEC and mailed or otherwise made available to the Persons entitled to Subscription Rights in the Offering, and any Order Form received prior to that time shall be rejected and no sale of Common Stock shall be made in respect thereof.
11.03 Policyholders Outside the United States. HoldCo shall make reasonable efforts to comply with the securities laws of all jurisdictions in the United States in which Persons entitled to subscribe reside. However, HoldCo has no obligation to offer or sell shares to any Person under the Plan if such Person resides in a foreign country or in a jurisdiction of the United States with respect to which (i) there are few Persons otherwise eligible to subscribe for shares under this Plan who reside in such jurisdiction, (ii) the granting of Subscription Rights or the offer or sale of shares of Common Stock to such Persons would require HoldCo or its directors, Officers or employees, under the laws of such jurisdiction, to register as a broker or dealer, salesman or selling agent or to register or otherwise qualify the Common Stock for sale in such jurisdiction, or HoldCo would be required to qualify as a foreign corporation or file a consent to service of process in such jurisdiction, or (iii) such registration or qualification in the judgment of HoldCo would be impracticable or unduly burdensome for reasons of cost or otherwise.
14
ARTICLE 12
PAYMENT FOR COMMON STOCK.
12.01 Purchase Price for Shares. Payment for shares of Common Stock ordered by Persons in the Offering shall be equal to the Purchase Price per share multiplied by the number of shares that are being ordered. Payment for shares subscribed for or ordered in the Subscription Offering or the Community Offering shall be made by bank draft, check, or money order at the time the Order Form is delivered to HoldCo, or in HoldCo’s sole and absolute discretion by delivery of a wire transfer of immediately available funds. Payment for all shares of Common Stock subscribed for must be received in full and collected by HoldCo or by any subscription agent engaged by HoldCo. All subscription payments will be deposited by HoldCo in an escrow account at a bank designated by HoldCo and FLMHC and any wire transfers will be delivered directly to such escrow account. Payment for shares ordered by a Standby Purchaser or through a broker-dealer or underwriter in the Community Offering or any Public Offering may be made by delivery of a wire transfer of immediately available funds to such escrow account.
12.02 Shares Nonassessable. Each share of Common Stock issued in the Offering shall be nonassessable upon payment in full of the Purchase Price.
ARTICLE 13
CONDITIONS of THE OFFERING
13.01 Closing Conditions. Consummation of the Offering is subject to (i) the receipt of all required federal and state approvals for the issuance of Common Stock in the Offering, (ii) approval of the Plan by the members of FLMHC as provided in Section 59.1(4)(c)(i) of the Conversion Act, and (iii) the sale in the Offering (including any shares sold to a Standby Purchaser) of such minimum number of shares of Common Stock within the Valuation Range as may be determined by the Board of Directors of FLMHC.
ARTICLE 14
APPROVAL BY ELIGIBLE MEMBERS
14.01 Special Meeting.
(a) After the approval of the Application by the Director, FLMHC shall hold a special meeting of Eligible Members to vote on this Plan of Conversion (the “Special Meeting”). At the Special Meeting, each Eligible Member shall be entitled to vote on a single proposal (the “Proposal”) to (i) adopt and approve this Plan of Conversion and the other transactions contemplated by this Plan of Conversion, and (ii) amend and restate the articles of incorporation of FLMHC to read in the form attached as Exhibit A (the “Amended and Restated Articles of Incorporation”). The number of votes that each Eligible Member is entitled to cast at the Special Meeting shall be governed by the Bylaws of FLMHC.
15
(b) Adoption of this Plan of Conversion and the Amended and Restated Articles of Incorporation, pursuant to Section 59.1(4)(c)(i) of the Illinois Insurance Code, is subject to the approval of at least two-thirds of the votes cast by Eligible Members in person or by proxy at the Special Meeting.
14.02 Notice of the Special Meeting.
(a) FLMHC shall mail notice of the Special Meeting in a form satisfactory to the Department (the “Notice of Special Meeting”). The Notice of Special Meeting shall be mailed within forty-five (45) days following the Director’s approval of this Plan of Conversion. Such notice shall inform each Eligible Member of such Eligible Member’s right to vote upon the Proposal and the place, the day, and the hour of the Special Meeting. Such notice and other materials set forth in Sections 14.02(b) shall be mailed by first class or priority mail or an equivalent of first class or priority mail, to the last-known address of each Eligible Member as it appears on the Federal Life Records, at least thirty (30) days prior to the date of the Special Meeting, and shall be in a form satisfactory to the Director.
Beginning on the date that the first Notice of Special Meeting is mailed pursuant to Section 14.02(a) and continuing until the Plan Effective Date, FLMHC shall also make available at its statutory home office located at 3750 Deerfield Road, Riverwoods, Illinois, 60015, during regular business hours, copies of the Notice of Special Meeting, this Plan of Conversion and its Exhibits, each in its entirety, for inspection by Eligible Members.
(b) The Notice of the Special Meeting shall be accompanied by information relevant to the Special Meeting, including a copy or summary of this Plan of Conversion, a form of proxy allowing the Eligible Members to vote for or against the Plan of Conversion, a policyholder information statement regarding this Plan of Conversion, and such other explanatory information that the Director approves or requires, all of which shall be in a form satisfactory to the Director. With the prior approval of the Director, FLMHC may also send supplemental information relating to this Plan of Conversion to Eligible Members either before or after the date of the Special Meeting.
ARTICLE 15
THE CONVERSION
15.01 Effect on FLMHC. On the Plan Effective Date, FLMHC shall be converted from a mutual insurance holding company into a stock insurance holding company in accordance with Section 59.1 and the closing of the Offering shall occur in accordance with this Plan of Conversion. Under the terms of this Plan of Conversion, HoldCo will acquire all of the FLMHC Shares. HoldCo thereupon will become the sole shareholder of FLMHC and will have all the rights, privileges, immunities and powers and will be subject to all of the duties and liabilities to the extent provided by law of a shareholder of a corporation organized under the laws of the State of Illinois.
16
15.02 Effect on Existing Policies.
(a) Any Policy In Force on the Plan Effective Date will remain In Force under the terms of such Policy, except that the following rights, to the extent they existed in FLMHC, shall be extinguished on the Plan Effective Date:
(i) any voting rights of the policyholder provided under or as a result of the Policy;
(ii) any right to share in the surplus of FLMHC, except as provided in Section 15.02(b).
(b) Except as otherwise provided in Section 15.02(c), an Owner of a participating Policy In Force on the Plan Effective Date will continue to have a right to receive policyholder dividends as provided in the participating Policy, if any, consistent with Federal Life’s dividend principles and policies practice prior to the Plan Effective Date. Nothing in this Plan shall be construed to guarantee the future payment of any policy dividend for any Policy, whether issued by Federal Life prior to the Plan Effective Date or after the Plan Effective Date. Policy dividends may increase or decrease. The declaration and crediting of future policy dividends, if any, shall remain within the sole discretion of the Board of Directors of Federal Life, except as provided by law. Federal Life may modify the dividend principles and policy in effect on June 1, 2015, with the approval of the Director.
(c) Except for life insurance policies, guaranteed renewable accident and health policies and non-cancellable accident and health policies, after the Plan Effective Date Federal Life may issue the Owner a nonparticipating Policy as a substitute for the participating Policy upon the renewal date of any Policy.
15.03 Closed Block of Participating Policies. Federal Life believes that the size of the block of Policies in Force on the Adoption Date that are participating policies and eligible to receive dividends is insignificant and that the reserve supporting such policies is adequate to continue to support Federal Life’s obligations under such Policies. Accordingly, subject to the Director’s approval of this Plan, Federal Life does not intend to establish a closed block for such policies.
15.04 Filing of Plan of Conversion and Amended and Restated Articles. As soon as practicable following (i) the receipt of the Decision and Order, (ii) the Director’s determination that all conditions to such approval contained in the Decision and Order have been satisfied, except for those conditions required by the Decision and Order to be satisfied after the Plan Effective Date and with respect to which the Director has received commitments, acceptable to the Director, from FLMHC and/or HoldCo to satisfy after the Plan Effective Date, (iii) the adoption of this Plan of Conversion and the Amended and Restated Articles of Incorporation by the Eligible Members as provided in this Plan of Conversion, and (iv) the satisfaction or waiver of all of the conditions contained in this Plan of Conversion, FLMHC shall file with the Director (A) the minutes of the Special Meeting, (B) a certificate of the Secretary of FLMHC setting forth the results of the vote on the Plan of Conversion and the Amended and Restated Articles of Incorporation and certifying as to whether or not it was approved by not less than two-thirds of the votes cast by the Eligible Members voting in person or by proxy at the Special Meeting, and (C) the Amended and Restated Articles of Incorporation and the Amended and Restated Bylaws of FLMHC (the filing described in clauses (A), (B) and (C) above, the “Effective Date Filing”).
17
15.05 Effectiveness of Plan of Conversion.
(a) The “Plan Effective Date” of the Plan of Conversion shall be the date and time as of which all of the following steps have been completed: (i) the Plan of Conversion has been approved by the Director, (ii) the Eligible Members have approved the Plan of Conversion by the requisite vote, (iii) the Amended and Restated Articles of Incorporation have been duly adopted, (iv) the Effective Date Filing shall have been made by FLMHC, and (v) the Articles of Incorporation of HoldCo have been filed with the Illinois Secretary of State. Subsequent to the Plan Effective Date, the bylaws of FLMHC shall be substantially in the form attached hereto as Exhibit B (the “Amended and Restated Bylaws”). This Plan of Conversion shall be deemed to have become effective at the Effective Time.
(b) At the Effective Time:
(i) FLMHC shall by operation of Section 59.1 of the Illinois Insurance Code become a stock insurance holding company;
(ii) the Amended and Restated Articles of Incorporation and the Amended and Restated Bylaws shall without further action become effective; and
(iii) all of the Membership Interests shall be extinguished.
(c) On the Plan Effective Date:
(i) FLMHC shall issue all of the authorized FLMHC Shares to HoldCo, representing all of the issued and outstanding common stock of FLMHC; and
(ii) HoldCo shall issue shares of Common Stock to Persons whose subscriptions and orders were accepted in the Offering.
15.06 Tax Considerations. This Plan of Conversion shall not become effective and the Conversion shall not occur unless, on or prior to the Plan Effective Date, FLMHC shall have received a favorable opinion of Stevens & Lee, P.C., special counsel to FLMHC, or other nationally-recognized independent tax counsel to FLMHC, dated as of the Plan Effective Date, addressed to the Board and in form and substance satisfactory to FLMHC, which, notwithstanding any qualifications expressed therein, is substantially to the effect that FLMHC will not recognize any gain or loss for U.S. federal income tax purposes as a result of the Conversion.
18
ARTICLE 16
POLICIES
16.01 Policies.
(a) For the purposes of this Plan of Conversion, the term “Policy” means each insurance policy and annuity contract that has been issued or will be issued or assumed through assumption reinsurance, if any, by Federal Life.
(b) The following policies and contracts shall be deemed not to be Policies for purposes of this Plan of Conversion:
(i) any reinsurance assumed by Federal Life as a reinsurer on an indemnity basis (but assumption certificates may constitute Policies if they otherwise fall within the definition of Policies as provided in Section 16.01(a));
(ii) all administrative services agreements; and
(iii) any policy or contract issued by Federal Life and ceded to another insurance company through assumption reinsurance.
16.02 Determination of Ownership. Unless otherwise stated herein, the Owner of any Policy as of any date shall be determined on the basis of the Federal Life Records as of such date in accordance with the following provisions:
(a) the Owner shall be the owner of the Policy as shown on the Federal Life Records;
(b) an additional insured under a Policy shall not be an Owner of the Policy and shall not be a Member;
(c) except as otherwise set forth in this Section 16.02, the identity of the Owner of a Policy shall be determined without giving effect to any interest of any other Person in such Policy;
(d) in any situation not expressly covered by the foregoing provisions of this Section 16.02, the owner of the Policy, as reflected on the Federal Life Records, and as determined in good faith by FLMHC, shall conclusively be presumed to be the Owner of such Policy for purposes of this Section 16.02, and except for administrative errors, FLMHC shall not be required to examine or consider any other facts or circumstances;
(e) the mailing address of an Owner as of any date for purposes of this Plan of Conversion shall be the Owner’s last known address as shown on the Federal Life Records as of such date;
(f) in no event may there be more than one Owner of a Policy, although more than one Person may constitute a single Owner. If a Person owns a Policy with one or more other Persons, they will constitute a single Owner with respect to the Policy; and
19
(g) any dispute as to the identity of the Owner of a Policy or the right to vote shall be resolved in accordance with the foregoing and such other procedures as FLMHC may determine. Any determinations made by FLMHC shall be conclusive as between FLMHC and any Owner of a Policy or any other Person with an interest therein but shall not preclude any actions among such Persons.
16.03 In Force.
(a) A Policy shall be deemed to be in force (“In Force”) as of any date if, as shown in the Federal Life Records:
(i) the Policy has been issued or coverage has been bound by Federal Life or assumed by Federal Life through assumption reinsurance as of such date; and
(ii) such Policy has not expired, cancelled, non-renewed or otherwise terminated, provided that a Policy shall be deemed to be In Force after lapse for nonpayment of premiums until expiration of any applicable grace period (or similar period however designated in such Policy) during which the Policy is in full force for its basic benefits.
(b) The date of expiration, cancellation or termination of a Policy shall be as shown on the Federal Life Records.
(c) A Policy shall not be deemed to be In Force as of a given date if the Policy is returned to Federal Life and all premiums are refunded within thirty (30) days of such date.
(d) Any dispute as to whether a Policy is In Force shall be resolved in accordance with the foregoing.
ARTICLE 17
SUBSEQUENT POLICYHOLDERS
17.01 Notice to Subsequent Policyholders. Upon the issuance of a Policy that becomes effective after the Adoption Date and before the Plan Effective Date (excluding renewals of Policies In Force on the Adoption Date), Federal Life shall send to the Owner of such Policy (a “Subsequent Policyholder”) a written notice regarding this Plan of Conversion in accordance with 215 ILCS 5/59.1(10). Such notice shall specify such Subsequent Policyholder’s right to rescind such Policy as provided in Section 17.02 within forty-five (45) days after the Plan Effective Date and shall be accompanied by a copy or summary of this Plan of Conversion. The form of such notice shall be filed with and approved by the Director.
17.02 Option to Rescind. Each Subsequent Policyholder shall be entitled to rescind his Policy and receive a full refund of any amounts paid for the Policy within ten (10) days after the receipt by Federal Life of the notice of rescission by such Subsequent Policyholder. No Subsequent Policyholder, the estate of such Subsequent Policyholder, or any beneficiary under such policy that has made or filed a claim under a Policy will be entitled to rescission or refund of any premiums paid for such policy. If a Subsequent Policyholder rescinds its Policy pursuant to the right described in this Section 17.02, such Subsequent Policyholder, the estate of such Subsequent Policyholder, or any beneficiary under such policy will have no insurance coverage under such Policy and may not make or file a claim under such Policy.
20
ARTICLE 18
OFFICERS AND BOARD OF DIRECTORS
18.01 Directors. Each of the members of FLMHC’s Board immediately prior to the Effective Time shall remain as a director of FLMHC as of the Effective Time, and thereafter, HoldCo, as the sole shareholder of FLMHC, shall have the right to elect the directors of FLMHC.
18.02 Officers. The officers of FLMHC immediately prior to the Effective Time shall serve as officers of FLMHC after the Effective Time until new officers are duly elected pursuant to the Amended and Restated Articles of Incorporation and the Amended and Restated Bylaws.
ARTICLE 19
ADDITIONAL PROVISIONS
19.01 Continuation of Corporate Existence. Upon the conversion of FLMHC to a stock insurance holding company in accordance with the terms of this Plan of Conversion and the provisions of Section 59.1(11):
(a) the corporate existence of FLMHC as a mutual insurance holding company shall be continued in FLMHC’s corporate existence as a stock insurance holding company;
(b) all the rights, franchises and interests of FLMHC as a mutual insurance holding company in and to every type of property, real, personal and mixed, and things in action thereunto belonging, shall be deemed transferred to and vested in FLMHC as a stock insurance holding company without any deed or transfer;
(c) FLMHC (as converted to a stock insurance holding company) shall be deemed to have assumed all the obligations and liabilities of FLMHC (as the former mutual insurance holding company);
(d) Except to the extent any surplus note or other convertible instrument is converted to shares of HoldCo common stock in accordance with its terms, all outstanding surplus notes, guaranty fund interests or other surplus debentures issued by Federal Life prior to the Effective Time shall remain in full force and effect following the Conversion.
19.02 Conflict of Interest. No director, officer, agent or employee of FLMHC, or any of its subsidiaries or affiliates or any other person shall receive any fee, commission or other valuable consideration whatsoever, other than his or her usual regular salary and compensation, for in any manner aiding, promoting or assisting in the transactions contemplated by this Plan of Conversion; provided, that FLMHC may pay reasonable fees and compensation to attorneys, accountants and actuaries for services performed in the independent practice of their professions, even if such attorney, accountant or actuary is also a director or agent of FLMHC or any of its subsidiaries.
21
19.03 Registration of Shares; Listing of Shares on Stock Exchange.
HoldCo shall register the Common Stock pursuant to the Securities Exchange Act of 1934, as amended. HoldCo shall use its best efforts to (i) encourage and assist a market maker to establish and maintain a market for that class of stock and (ii) list that class of stock on a national or regional securities exchange or to have quotations for that class of stock disseminated on The Nasdaq Stock Market.
19.04 Restrictions on Transfer of Common Stock.
(a) All shares of the Common Stock which are purchased in the Offering by Persons other than directors and officers of FLMHC shall be transferable without restriction. Shares of Common Stock purchased by directors and officers of FLMHC in the Offering shall be subject to the restriction that such shares shall not be sold for a period of one year following the date of purchase. The shares of Common Stock issued by HoldCo to officers and directors of FLMHC shall bear the following legend giving appropriate notice of such one year restriction:
The shares represented by this Certificate may not be sold by the registered holder hereof for a period of one year from the date of the issuance printed hereon. This restrictive legend shall be deemed null and void after one year from the date of this Certificate.
(b) In addition, HoldCo shall give appropriate instructions to the transfer agent for its Common Stock with respect to the applicable restrictions relating to the transfer of restricted stock. Any shares issued at a later date as a stock dividend, stock split or otherwise with respect to any such restricted stock shall be subject to the same holding period restrictions as may then be applicable to such restricted stock.
(c) The foregoing restriction on transfer shall be in addition to any restrictions on transfer that may be imposed by federal and state securities laws.
19.05 No Preemptive Rights. No Member or other Person shall have any preemptive right to acquire FLMHC shares in connection with this Plan of Conversion.
19.06 Amendment or Withdrawal of Plan of Conversion.
(a) At any time prior to the Plan Effective Date, FLMHC may, by resolution of not less than two-thirds of the Board, amend or withdraw this Plan of Conversion (including the Exhibits hereto). Any amendment shall require the written consent of the Director. No amendment may change the Plan of Conversion after its approval by the Eligible Members in a manner that the Director determines is material unless the Plan of Conversion, as amended, is submitted for reconsideration by the Eligible Members of FLMHC pursuant to the provisions of Sections 14.01 and 14.02. No amendment may change the Adoption Date of the Plan of Conversion.
(b) After the Plan Effective Date, the Amended and Restated Articles of Incorporation adopted pursuant to this Plan of Conversion may be amended pursuant to the provisions of such articles of incorporation, the Illinois Insurance Code and the statutory provisions generally applicable to the amendment of the articles of incorporation of insurance holding companies, or such other statutory provisions as may be applicable at the time of the amendment.
22
19.07 Corrections. Prior to the Plan Effective Date, FLMHC, with the prior consent of the Director, may make such modifications as are appropriate to correct errors, cure ambiguities, clarify existing items or make additions to correct manifest omissions in this Plan of Conversion or any exhibits hereto.
19.08 Notices. If FLMHC complies substantially and in good faith with the notice requirements of Section 59.1 of the Illinois Insurance Code with respect to the giving of any required notice to Members, the failure of FLMHC to give any Member any required notice does not impair the validity of any action taken under Section 59.1 of the Illinois Insurance Code.
19.09 Limitation of Actions. Any action or proceeding challenging the validity of or arising out of acts taken or proposed to be taken pursuant to Section 59.1 of the Illinois Insurance Code shall be commenced within 30 days after the Plan Effective Date. No Person shall have any rights or claims against FLMHC or its Board based upon the withdrawal or termination of this Plan of Conversion.
19.10 Costs and Expenses. All the costs and expenses related to the Plan of Conversion, including the costs of outside advisors and consultants of the regulatory agencies, shall be borne, directly or indirectly, by FLMHC or its subsidiaries.
19.11 Headings. Article and Section headings contained in this Plan of Conversion are for convenience only and shall not be considered in construing or interpreting any of the provisions hereof.
19.12 Governing Law. The Plan of Conversion shall be governed by and construed in accordance with the laws of the State of Illinois, without regard to such State’s principles of conflicts of law.
19.13 Limitation on Acquisition of Shares of Common Stock. In accordance with Section 59.1(6)(i) of the Conversion Act, no person or group of persons acting in concert may acquire more than 5% of the outstanding shares of Common Stock, through a public offering or subscription rights, for a period of five (5) years after the Effective Time without the prior approval of the Director.
[Remainder of this page intentionally left blank]
23
IN WITNESS WHEREOF, FLMHC by authority of its Board, has caused this Plan of Conversion to be duly executed as of the day and year first above written.
Federal Life Mutual Holding Company | ||
By: | /s/ William S. Austin | |
Name: William S. Austin | ||
Title: President |
24
Exhibit 4.1
CUSIP NO. ___________ | |
COMMON STOCK | COMMON STOCK |
CERTIFICATE NO. | SHARES |
FEDERAL LIFE GROUP, INC.
ORGANIZED UNDER THE LAWS OF THE COMMONWEALTH OF PENNSYLVANIA
[SPECIMEN]
is the owner of:
FULLY PAID AND NONASSESSABLE SHARES OF COMMON STOCK,
$0.01 PAR VALUE, OF FEDERAL LIFE GROUP, INC.
a Pennsylvania corporation.
The shares represented by this certificate are transferable only on the stock transfer books of Federal Life Group, Inc. (the “Company”) by the holder of record hereof, or by such holder’s duly authorized attorney or legal representative, upon the surrender of this certificate properly endorsed. This certificate and the shares represented hereby are issued and shall be held subject to all the provisions contained in the Company’s official corporate papers filed with the Department of State of the Commonwealth of Pennsylvania (copies of which are on file with the Transfer Agent), to all of the provisions the holder by acceptance hereof assents.
This certificate is not valid unless countersigned and registered by the Transfer Agent and Registrar.
IN WITNESS WHEREOF, FEDERAL LIFE GROUP, INC. has caused this certificate to be executed by the signatures of its duly authorized officers and has caused its corporate seal to be hereunto affixed.
Dated: | [SEAL] |
Treasurer | President and Chief Executive Officer |
FEDERAL LIFE GROUP, INC.
Preferred stock may be issued from time to time as a class without series or, if so determined by the board of directors of the Company, either in whole or in part, in one or more series. The board of directors of the Company has the authority to fix and determine, by resolution, the voting powers, full or limited, or no voting power, and such designations, preferences and relative, participating, optional, or other special rights, if any, and the qualifications, limitations, or restrictions thereof, if any, including specifically, but not limited to, the dividend rights, conversion rights, redemption rights and liquidation preferences, if any, of any wholly unissued series of preferred stock (or the entire class of preferred stock if none of such shares have been issued), the number of shares constituting any such series and the terms and conditions of the issue thereof. The Company will furnish to any shareholder upon request and without charge a full description of each class of stock and any series thereof.
The shares represented by this certificate may not be cumulatively voted in the election of directors of the Company.
The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable laws or regulations:
TEN COM | - | as tenants in common | UNIF GIFTS MIN ACT - | __________ custodian __________ |
TEN ENT | - | as tenants by the entireties | (Cust) (Minor) | |
JT TEN | - | as joint tenants with right of | ||
survivorship and not as tenants | under Uniform Gifts to Minors Act | |||
in common | ||||
(State) |
Additional abbreviations may also be used though not in the above list.
FOR VALUE RECEIVED, __________ hereby sell, assign and transfer unto
PLEASE INSERT SOCIAL SECURITY OR
OTHER IDENTIFICATION NUMBER OF ASSIGNEE
[ ]
Please print or typewrite name and address including postal zip code of assignee. |
__________________________________________________ shares of the common stock represented by this certificate and do hereby irrevocably constitute and appoint _____________________________________________________________, attorney, to transfer the said stock on the books of the within-named corporation with full power of substitution in the premises.
DATED ______________________ | |
NOTICE: The signature to this assignment must correspond with the name as written upon the face of the certificate in every particular without alteration or enlargement or any change whatever. | |
SIGNATURE GUARANTEED: | |
THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION, (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM), PURSUANT TO S.E.C. RULE 17Ad-15 |
Exhibit 4.2
Exchangeable PROMISSORY NOTE
Up to $2,000,000 | June 29, 2018 |
For value received Federal Life Mutual Holding Company, an Illinois corporation (the “Company”), promises to pay to Insurance Capital Group LLC or its assigns (“Holder”) the principal sum of up to TWO MILLION DOLLARS $2,000,000 (the “Maximum Amount”) together with accrued and unpaid interest thereon, each due and payable on the date and in the manner set forth below.
This exchangeable promissory note (the “Note”) is issued in connection with that certain Standby Stock Purchase Agreement (as may be amended, the “Purchase Agreement”) dated as of the date hereof, among the Company, Federal Life Group, Inc. (“ListCo”), Federal Life Insurance Company (“Federal Life”) and Holder. Capitalized terms used herein without definition shall have the meanings given to such terms in the Purchase Agreement.
1. Advances. Advances under this Note (each, an “Advance” and, collectively, the “Advances”) shall be made within five (5) Business Days of the receipt by Holder of a written request from the Company, which request shall include the amount of the requested Advance and wire details of the Company’s bank account into which such Advance shall be paid. The Company may not request an Advance, and Holder shall have no obligation to fund an Advance (a) until Holder has received evidence satisfactory to it (in its sole and absolute discretion) of the proper filing of the Registration Statement, (b) if an Event of Default shall have occurred and be continuing, or (c) if the amount requested, when added to the aggregate amount of all prior Advances, would exceed the Maximum Amount. Nothing herein shall entitle the Company to re-borrow any Advances previously repaid.
2. Payments Generally. All payments of interest and principal shall be in lawful money of the United States of America. All payments shall be applied first to accrued interest, and thereafter to principal.
(a) Payments of Interest. Unless this Note has been previously exchanged in accordance with the terms of Section 4 below (or as otherwise agreed by the Company and Holder), commencing September 30, 2018 and continuing until all amounts due under the Note are paid in full, the Company shall make interest payments in arrears at the rate described in Section 3 hereof on the last day of each calendar quarter.
(b) Payments of Principal. Unless this Note has been previously exchanged in accordance with the terms of Section 4 below (or as otherwise agreed by the Company and Holder), the Company shall repay the outstanding Advances, together with any accrued and unpaid interest on the earlier to occur of (i) the date that is two (2) years following the date hereof, (ii) the date of the issuance of Shares in connection with the Community Offering, in which case the outstanding Advances shall be exchanged for Shares in the manner described in Section 4 on such date and (iii) the date on which payment of this Note is accelerated pursuant to Section 7 hereof (the “Maturity Date”).
(c) Prepayments. The Advances may not be prepaid prior to the date of the issuance of Shares in connection with the Community Offering.
3. Interest Rate. Interest shall accrue on the amount of the outstanding Advances during each calendar quarter following the date of this Note at a rate for such quarter equal to (a) from the date of this Note to the date that is twelve months (or, if the Outside Date is extended pursuant to Section 16(a)(iv) of the Purchase Agreement, eighteen months) following the date of this Note, three and three-quarters percent (3.75%) per annum and (b) thereafter, or anytime after the occurrence and during the continuation of an Event of Default (defined below), ten percent (10%) per annum. Interest shall be calculated on the basis of a 365-day year for the actual number of days elapsed.
4. Assumption and Exchange. Upon the occurrence of the Conversion and the issuance of Shares in connection with the Community Offering, Listco shall automatically assume and be liable for the obligations of the Company hereunder and the outstanding Advances shall be exchanged and deemed to be repaid in full upon the issuance to Holder of a number of Shares equal to aggregate amount of the outstanding Advances divided by the Subscription Price.
5. Expenses. In the event of any default hereunder, the Company shall pay all reasonable attorneys’ fees and court costs incurred by Holder in enforcing and collecting this Note.
6. Covenants. Until all of the obligations to pay principal and interest under this note shall have been satisfied (whether by payment or by exchange in accordance with Section 4), the Company shall not (a) incur or permit to exist any Indebtedness other than the Indebtedness under this Note, permit Listco to incur or permit to exist any Indebtedness other than the Indebtedness under this Note, or permit Federal Life to incur or permit to exist any Indebtedness other than Indebtedness that Federal Life is permitted to incur under the Purchase Agreement (notwithstanding the termination of the Purchase Agreement), (b) declare or pay any dividends or other distributions to its shareholders, (c) sell or dispose of any of its assets or cause or permit Federal Life to, directly or indirectly, sell or dispose of any of its assets outside of the ordinary course of Federal Life’s business, or (d) without the prior written consent of Holder, make any investments or acquisitions of assets or cause or permit Federal Life to make any investments or acquisitions of assets outside of the ordinary course of its business.
7. Default. If there shall be any Event of Default hereunder, at the option and upon the declaration of Holder and upon written notice to the Company (which election and notice shall not be required in the case of an Event of Default under Section 7(c) or Section 7(d)), this Note shall accelerate and all principal and unpaid accrued interest shall become due and payable. For the purposes of this Note, an “Event of Default” shall mean the occurrence of any one or more of the following:
(a) The Company fails to pay timely any of the principal amount due under this Note on the date the same becomes due and payable or any accrued interest or other amounts due under this Note on the date the same becomes due and payable;
(b) The Company, ListCo or Federal Life shall default in its performance of any covenant under the Purchase Agreement or the Note;
(c) The Company files any petition or action for relief under any bankruptcy, reorganization, insolvency or moratorium law or any other law for the relief of, or relating to, debtors, now or hereafter in effect, or makes any assignment for the benefit of creditors or takes any corporate action in furtherance of any of the foregoing;
(d) An involuntary petition is filed against the Company (unless such petition is dismissed or discharged within 60 days under any bankruptcy statute now or hereafter in effect, or a custodian, receiver, trustee, assignee for the benefit of creditors (or other similar official) is appointed to take possession, custody or control of any property of the Company); or
8. Waiver. The Company hereby waives: (a) all presentments, demands for performance, notices of nonperformance (except to the extent required by the provisions of this Note), protests, notices of protest and notices of dishonor; (b) any requirement of diligence or promptness on the part of Holder in the enforcement of its rights hereunder; (c) any and all notices of every kind and description which may be required to be given by any statute or rule of law; and (d) any defense (other than indefeasible payment in full) which it may now or hereafter have with respect to its liability hereunder.
2 |
9. Governing Law. This Note shall be governed by and construed under the laws of the State of New York, without giving effect to conflicts of laws principles which would lead to the application of the laws of any other jurisdiction.
10. Modification; Waiver. Any term of this Note may be amended or waived with the written consent of the Company and Holder.
11. Assignment. This Note may be transferred only (i) upon its surrender to the Company for registration of transfer, duly endorsed, or accompanied by a duly executed written instrument of transfer in form reasonably satisfactory to the Company and (ii) unless the Purchase Agreement has been terminated in accordance with the terms thereof, in connection with an assignment of Holder’s rights under the Purchase Agreement in accordance with Section 19 thereof. Thereupon, this Note shall be reissued to, and registered in the name of, the transferee, or a new Note for like principal amount and interest shall be issued to, and registered in the name of, the transferee. Interest and principal shall be paid solely to the registered holder of this Note. Such payment shall constitute full discharge of the Company’s obligation to pay such interest and principal.
[Signature Page Follows]
3 |
IN WITNESS WHEREOF, the Company and ListCo have caused this Note to be duly executed and delivered as of the date first above written.
FEDERAL LIFE MUTUAL HOLDING COMPANY | ||
By: | ||
William S. Austin | ||
President | ||
FEDERAL LIFE GROUP, INC. | ||
By: | ||
William S. Austin | ||
President |
[Signature Page to Exchangeable Promissory Note]
Exhibit 10.4
AMENDMENT NUMBER ONE
to
REINSURANCE AGREEMENT
NUMBER 308-16AY12
between
FEDERAL LIFE INSURANCE COMPANY
3750 West Deerfield Road
Riverwoods, Illinois 60015
(hereinafter referred to as “THE COMPANY”)
and
OPTIMUM RE INSURANCE COMPANY
1345 River Bend Drive, Suite 100,
Dallas, TX 75247
(hereinafter referred to as “OPTIMUM RE”)
Respecting reinsurance of a closed in-force block of Universal Life policies reinsured on YRT basis from October 1, 2017
1. Effective October 1, 2017, this Agreement shall be amended as follows:
A. Article 1.1, Scope of Reinsurance Ceded and Accepted, shall be amended and replaced by the following to reflect the addition of a closed in-force block of Universal Life policies:
1.1 Scope of Reinsurance Ceded and Accepted
Effective July 1, 2016, OPTIMUM IRE hereby agrees to assume 100% of the amount in excess of THE COMPANY’s retention, net of the existing amount of reinsurance, on THE COMPANY’s closed in-force block of Level Term policies as per the attached in-force listing specified in Schedule E. It is understood that no additional policies are to be added to this block past the effective date of this Agreement without OPTIMUM RE’s prior written approval.
Effective October 1, 2017, OPTIMUM RE hereby agrees to assume 100% of the amount in excess of THE COMPANY’s retention, net of the existing amount of reinsurance, on THE COMPANY’s closed in-force block of Universal Life policies as per the attached in-force listing specified in Schedule H. It is understood that no additional policies are to be added to this block past the effective date of this Agreement without OPTIMUM RE’s prior written approval.
The maximum reinsurance amount per life that will be ceded to OPTIMUM RE is as described in Schedule A.
B. Article 3.2, Net Amount at Risk Basis, shall be amended and replaced by the following to reflect a change in A.2 due to the administration of the closed in-force block of Universal Life policies.
3.2 Net Amount at Risk Basis
When the reinsurer does not participate in the surrender values on a policy, as in reinsurance based on YRT or cost of insurance rates, the reinsurance amount at risk shall be based on the death benefit less a fund which represents the savings element in the policies.
The overriding principle involved is that OPTIMUM RE and THE COMPANY will each continue to insure their original proportionate share of the net amount at risk.
1 |
Net Amounts at Risk mill be defined as follows:
A. Insurance With Cash Values
1. Scheduled Face Amount and Cash Value
Amounts at risk will be projected for 10 year intervals (or until there is a scheduled change in face amount if less than 10 years). Cash, values will be used to represent the fund at the end of an interval, and amounts at risk for each intervening year will be interpolated on a straight line basis.
2. Variable Face Amount or Variable Cash Value
The amount at risk applicable to each policy year will be the projected amount at risk at the beginning of that policy year. Amounts at risk will be recalculated when THE COMPANY periodically provides updated cash values. Upon recalculation, the amount at risk will remain level until THE COMPANY provides the subsequent updated cash values. The amount at risk on which reinsurance premiums were paid will be the basis for the reinsurance claim liability.
B. Insurance Without Cash Values
This category should include policies where the cash values never exceed 10% of the face amount.
1. Scheduled Face Amount
The amount at risk applicable to each policy year will be the face amount applicable at the beginning of the policy year.
2. Variable Face Amount
The amount at risk applicable to each policy year will be the face amount projected to be applicable at the beginning of that policy year. Face amounts will be projected for five year intervals. Where actual face amounts diverge from the originally projected face amounts by more than 10%, THE COMPANY may re-establish the projected schedule at the next policy anniversary for future face amounts. If the schedule is not amended, the existing established schedule will be used for determining premium and claims liabilities.
2 |
C. Article 4. 2, Standard, Risks, shall be amended and replaced by the following to reflect the addition of a closed in-force block of Universal Life policies:
4.2 Standard Risks
TERM BLOCK
For policies issued prior to 2009, reinsurance premiums for standard risks are calculated based on the issue age and duration for that policy by applying the appropriate percentage as specified in Schedule B to the age nearest birthday mortality tables specified in Schedule C, exclusive of policy fees.
For policies issued in 2009 and afterwards, reinsurance premiums for standard risks are calculated based on the issue age and duration for that policy by applying the appropriate percentage as specified in Schedule B to the age last birthday mortality tables specified in Schedule D, exclusive of policy fees.
UNIVERSAL LIFE BLOCK
For policies issued on forms I-385, L-7620, and, L-7929, reinsurance premiums for standard risks are calculated based on the issue age and duration for that policy by applying the appropriate percentage as specified in Schedule B to the age nearest birthday mortality tables specified in Schedule F, exclusive of policy fees.
For policies issued on form L-8031, reinsurance premiums for standard risks are calculated based on the issue age and duration for that policy by applying the appropriate percentage as specified in Schedule B to the age last birthday mortality tables specified in Schedule G, exclusive of policy fees.
TERM AND UNIVERSAL LIFE BLOCKS
For the period from the effective date of the reinsurance coverage under this Agreement up to the next policy anniversary date, THE COMPANY shall pay a pro-rated reinsurance premium to OPTIMUM RE. Following the initial reinsurance premium, all reinsurance premiums shall be as described above and in Article 7.
D. Article 8.8, Recapture, shall be renumbered to Article 8.9, and a new Article 8.8, Reduced Paid Up and Extended Term, shall be included as shown below:
8 .8 Reduced Paid Up and Extended Term
If a Reduced Paid Up or Extended Term option is selected by the policyholder, OPTIMUM RE will continue to reinsure its proportionate share of the policy.
3 |
For policies where OPTIMUM RE does not participate in surrender value accumulation, reinsurance premiums will be calculated on a point-in-scale basis using the same YRT rates that applied to the policy and the calculation of the Net Amount at Risk according to Article 3.
8 9 Recapture
Recapture will not be permitted under this Agreement unless explicitly approved by OPTIMUM RE, except as stated in Article 3.3.
E. Schedule B shall be amended and replaced with the attached.
F. Schedules F, G, and H shall be included as attached.
4 |
2. Signatures
The terms and conditions of this Agreement are not changed in any way except as stated herein.
IN WITNESS of the above, this Amendment is signed in duplicate on the dates indicated.
FOR: FEDERAL LIFE INSURANCE COMPANY |
BY: | /s/ Paul R. Murphy | DATE: | 01-10-2018 | |
NAME: | Paul R. Murphy | |||
TITLE: | Actuary |
BY: | /s/ Dorothy M. Latuzek | DATE: | 01-10-2018 | |
NAME: | Dorothy M. Latuzek | |||
TITLE: | Director of Underwriting |
FOR: OPTIMUM RE INSURANCE COMPANY
BY: | /s/ Sebastien Blondeau | DATE: | 12-20-2017 | |
NAME: | Sebastien Blondeau | |||
TITLE: | President & COO | |||
BY: | /s/ Serge Goulet | DATE: | 12-20-2017 | |
NAME: | Serge Goulet | |||
TITLE: | Managing Director |
5 |
SCHEDULE B
EFFECTIVE JULY 1, 2016
REINSURANCE PREMIUM PERCENTAGES FOR THE
CLOSED IN-FORCE BLOCK OF LEVEL TERM POLICIES
PREMIUM PERCENTAGES APPLIED TO THE APPLICABLE MORTALITY
TABLES SPECIFIED IN SCHEDULE C AND SCHEDULE D
3-CLASS TERM PRODUCTS
RISK CLASS | LEVEL TERM PERIOD | POST LEVEL TERM PERIOD | ||||||
MALE PREFERRED NONTOBACCO | 43 | % | 62 | % | ||||
MALE RESIDUAL NONTOBACCO | 52 | % | 82 | % | ||||
MALE STANDARD TOBACCO | 109 | % | 169 | % | ||||
FEMALE PREFERRED NONTOBACCO | 47 | % | 68 | % | ||||
FEMALE RESIDUAL NONTOBACCO | 63 | % | 99 | % | ||||
FEMALE STANDARD TOBACCO | 140 | % | 217 | % |
2-CLASS & AGGREGATE TERM PRODUCTS,
ART ONLY | ALL OTHER TERM PLANS | |||||||||||
RISK CLASS | ALL DURATIONS | LEVEL TERM PERIOD | POST LEVEL TERM PERIOD | |||||||||
MALE STANDARD NONTOBACCO | 52 | % | 52 | % | 82 | % | ||||||
MALE STANDARD TOBACCO | 109 | % | 109 | % | 169 | % | ||||||
MALE AGGREGATE | 63 | % | 63 | % | 98 | % | ||||||
FEMALE STANDARD NONTOBACCO | 63 | % | 63 | % | 99 | % | ||||||
FEMALE STANDARD TOBACCO | 140 | % | 140 | % | 217 | % | ||||||
FEMALE AGGREGATE | 81 | % | 81 | % | 125 | % |
*AFTER APPLYING THE ABOVE PERCENTAGES TO THE MORTALITY TABLES SPECIFIED, MULTIPLY THESE BY THE NET AMOUNT AT RISK PER THOUSAND AND ROUND THE RESULTING REINSURANCE PREMIUMS TO TWO DECIMAL PLACES (I.E., NEAREST CENT).
6 |
SCHEDULE B (Continued)
EFFECTIVE JULY 1, 2016
REINSURANCE PREMIUM PERCENTAGES FOR THE
CLOSED IN-FORCE BLOCK OF LEVEL TERM POLICIES
PREMIUM PERCENTAGES APPLIED TO THE APPLICABLE MORTALITY
TABLES SPECIFIED IN SCHEDULES F AND G
RISK CLASS | ALL DURATIONS | |||
ALL CLASSES | 115 | % |
*AFTER APPLYING THE ABOVE PERCENTAGES TO THE MORTALITY TABLES SPECIFIED, MULTIPLY THESE BY THE NET AMOUNT AT RISK PER THOUSAND AND ROUND THE RESULTING REINSURANCE PREMIUMS TO TWO DECIMAL PLACES (I.E., NEAREST CENT). FOR UNIVERSAL LIFE POLICIES, THE NET AMOUNT AT RISK SHALL BE DEFINED AS THE FACE AMOUNT MINUS THE CASH VALUE.
7 |
SCHEDULE F
SOA 2008 VBT, AGE NEAREST BIRTHDAY,
SELECT & ULTIMATE, SMOKER AND
GENDER DISTINCT MORTALITY TABLES
PART 1 - MALE RATES
8 |
REINSURANCE AGREEMENT
NUMBER: 308-16AY12
Between
FEDERAL LIFE INSURANCE COMPANY (MUTUAL)
3750 West Deerfield Road
Riverwoods, Illinois 60015
(hereinafter referred to as “THE COMPANY”)
And
OPTIMUM RE INSURANCE COMPANY
1345 River Bend Drive, Suite 100
Dallas, TX 75247
(hereinafter referred to as “OPTIMUM RE”)
Respecting reinsurance of a closed in-force block of Level Term policies reinsured on an Automatic YRT basis from July 1, 2016.
TABLE OF CONTENTS
Page | |
ARTICLE 1 REINSURANCE CEDED AND ACCEPTED | 3 |
1.1. Scope of Reinsurance Ceded and Accepted | 3 |
1.2. Currency | 3 |
ARTICLE 2 LIABILITY | 4 |
ARTICLE 3 REINSURANCE AMOUNT AT RISK | 5 |
3.1. Face Amount Basis | 5 |
3.2. Net Amount at Risk Basis | 5 |
3.3. Minimum Reinsured Risk Amount | 6 |
ARTICLE 4 REINSURANCE PREMIUMS | 7 |
4.1. Life Premiums | 7 |
4.2. Standard Risks | 7 |
4.3. Substandard Risks | 7 |
ARTICLE 5 ALLOWANCES | 9 |
5.1. Allowances | 9 |
5.2. Premium Taxes | 9 |
ARTICLE 6 GENERAL PROCEDURES | 10 |
6.1. Inspection of Records | 10 |
6.2. Errors and Omissions | 10 |
6.3. Reserves | 10 |
6.4. Reporting | 10 |
6.5. Confidentiality | 11 |
ARTICLE 7 ACCOUNTING AND BILLING | 12 |
7.1. Reinsurance Premiums | 12 |
7.2. Individual Cession Billing | 12 |
7.3. Late Payment | 12 |
ARTICLE 8 CHANGES AND ADJUSTMENTS | 13 |
8.1. Change Information | 13 |
8.2. Reductions | 13 |
8.3. Reinstatements | 13 |
8.4. Conversions | 13 |
8.5. Terminations | 13 |
i |
8.6. Cash Values | 14 |
8.7. Policy loans and Dividends | 14 |
8.8. Recapture | 14 |
ARTICLE 9 CLAIMS | 15 |
9.1. Claims Liability | 15 |
9.2. Notice | 15 |
9.3. Authorization for Payment | 15 |
9.4. Adjusted Amounts | 15 |
9.5. Payment | 15 |
9.6. Contest | 15 |
9.7. Punitive Damages | 16 |
ARTICLE 10 ARBITRATION | 17 |
10.1. Principle | 17 |
10.2. Arbitrators | 17 |
10.3. Matters In Dispute | 17 |
10.4. Procedures | 17 |
10.5. Decision | 17 |
10.6. Applicable Laws | 17 |
ARTICLE 11 INSOLVENCY | 18 |
11.1. Payment of Claims | 18 |
11.2. Notice to OPTIMUM RE | 18 |
11.3. Expenses | 18 |
11.4. Right to Offset | 18 |
ARTICLE 12 DEFERRED ACQUISITION COST TAX | 19 |
ARTICLE 13 EXECUTION | 20 |
13.1. Duration | 20 |
13.2. Parties to the Agreement | 20 |
13.3. Written Agreement | 20 |
13.4. Change of Control/Assignment | 20 |
13.5. Compliance | 21 |
13.6. Signatures | 21 |
ii |
SCHEDULES
SCHEDULE A: | RETENTION AND REINSURANCE LIMITS |
SCHEDULE B: | REINSURANCE PREMIUM PERCENTAGES FOR THE CLOSED IN-FORCE BLOCK OF LEVEL TERM POLICIES |
SCHEDULE C: | US 75-80, BASIC SELECT & ULTIMATE, AGGREGATE AGE NEAREST BIRTHDAY, GENDER DISTINCT MORTALITY TABLES |
PART 1 - |
MALE RATES
| |
PART 2 - | FEMALE RATES |
SCHEDULE D: | US 75-80, BASIC SELECT & ULTIMATE, AGGREGATE AGE LAST BIRTHDAY, GENDER DISTINCT MORTALITY TABLES |
PART 1 - |
MALE RATES
| |
PART 2 - | FEMALE RATES |
SCHEDULE E: | IN-FORCE LIST OF LEVEL TERM POLICIES |
iii |
By this Agreement, FEDERAL LIFE INSURANCE COMPANY (MUTUAL), a corporation organized under the laws of the State of Illinois, hereinafter referred to as “THE COMPANY”, and OPTIMUM RE INSURANCE COMPANY, a corporation organized under the laws of the State of Texas, hereinafter referred to as “OPTIMUM RE”, mutually agree to reinsure on the following terms and conditions.
1 |
DEFINITION OF TERMS USED IN THIS AGREEMENT
Compensatory Damages | Shall mean the amounts awarded to compensate for the actual damages sustained, and not awarded as a penalty, nor fixed in amount by statute. | |
Insolvency | Shall mean the legal incapacity of a company to operate as declared by a court of competent jurisdiction. | |
Policy | Shall mean the contract(s) of insurance issued by THE COMPANY in respect of which reinsurance is applied for and/or placed in whole or in part. | |
Punitive Damages | Shall mean the damages awarded as a penalty, the amount of which is not governed, nor fixed by statute. | |
Reinsurance Cession | Shall mean the insurance transferred to OPTIMUM RE by THE COMPANY on a policy. | |
Statutory Penalties | Shall mean the amounts which are awarded as a penalty, but fixed in amount by statute. |
2 |
ARTICLE
1
REINSURANCE CEDED AND ACCEPTED
1.1. Scope of Reinsurance Ceded and Accepted
OPTIMUM RE hereby agrees to assume 100% of the amount in excess of THE COMPANY’s retention, net of the existing amount of reinsurance, on THE COMPANY’s closed in-force block of Level Term policies as per the attached in-force listing specified in Schedule E. It is understood that no additional policies are to be added to this block past the effective date of this Agreement without OPTIMUM RE’s prior written approval.
The maximum reinsurance amount per life that will be ceded to OPTIMUM RE is as described in Schedule A.
1.2. Currency
Reinsurance will be in U.S. dollars. Any other currency requires specific agreement between THE COMPANY and OPTIMUM RE.
3 |
ARTICLE
2
LIABILITY
OPTIMUM RE accepts liability for its share of the risks on eligible lives for deaths occurring on or after the effective date of the Agreement.
The liability of OPTIMUM RE on any policy shall commence on the effective date of this Agreement and end simultaneously with that of THE COMPANY.
4 |
ARTICLE
3
REINSURANCE AMOUNT AT RISK
3.1. Face Amount Basis
When the reinsurer is participating in the accumulation of surrender values on a policy, or when there are no surrender values on a policy, the reinsurance amount shall be based on the face amount of the policy.
The overriding principle involved is that OPTIMUM RE and THE COMPANY will each continue to insure their original proportionate share of the initial face amount.
3.2. Net Amount at Risk Basis
When the reinsurer does not participate in the surrender values on a policy, as in reinsurance based on YRT or cost of insurance rates, the reinsurance amount at risk shall be based on the death benefit less a fund which represents the savings element in the policies.
The overriding principle involved is that OPTIMUM RE and THE COMPANY will each continue to insure their original proportionate share of the net amount at risk.
Net Amounts at Risk will be defined as follows:
A. Insurance With Cash Values
1. Scheduled Face Amount and Cash Value
Amounts at risk will be projected for 10 year intervals (or until there is a scheduled change in face amount if less than 10 years). Cash values will be used to represent the fund at the end of an interval, and amounts at risk for each intervening year will be interpolated on a straight line basis.
2. Variable Face Amount or Variable Cash Value
The amount at risk applicable to each policy year will be the projected amount at risk at the beginning of that policy year. Amounts at risk will be projected for five year intervals. Where an actual amount at risk diverges from an originally projected amount at risk by more than 10%, THE COMPANY may re-establish the projected Schedule at the next policy anniversary for future amounts at risk. If the Schedule is not amended, the existing established Schedule will be used for determining premium and claims liabilities.
B. Insurance Without Cash Values
This category should include policies where the cash values never exceed 10% of the face amount.
5 |
1. Scheduled Face Amount
The amount at risk applicable to each policy year will be the face amount applicable at the beginning of the policy year.
2. Variable Face Amount
The amount at risk applicable to each policy year will be the face amount projected to be applicable at the beginning of that policy year. Face amounts will be projected for five year intervals. Where actual face amounts diverge from the originally projected face amounts by more than 10%, THE COMPANY may re-establish the projected Schedule at the next policy anniversary for future face amounts. If the Schedule is not amended, the existing established Schedule will be used for determining premium and claims liabilities.
3.3. Minimum Reinsured Risk Amount
The minimum reinsured risk amount shall be $1,000. In the event that the reinsured risk amount reduces below the minimum, THE COMPANY will automatically recapture the risk on that policy anniversary.
6 |
ARTICLE
4
REINSURANCE PREMIUMS
4.1. Life Premiums
Until further notice, the reinsurance premiums shall be at the rates described in Articles 4.2 and 4.3.
Although OPTIMUM RE anticipates that the reinsurance premium rates in Schedule B shall apply indefinitely, it guarantees only that the reinsurance premium rates applicable to the business reinsured hereunder will not exceed the YRT net premiums at the applicable statutory minimum valuation select and ultimate mortality table and statutory maximum interest rate.
In the event THE COMPANY increases its premiums or cost-of-insurance charges on any block of policies, OPTIMUM RE reserves the right to review and modify its reinsurance premium rates. Any such increase in the reinsurance premium rates shall be in proportion to THE COMPANY’s increase in premiums or cost-of-insurance charges.
The increase in the reinsurance premium rates shall become effective on the policy anniversary dates beginning no sooner than 30 days after OPTIMUM RE has given its written notice to THE COMPANY of its intent to increase the reinsurance premium rates and no sooner than the COMPANY’s increase in its premiums or cost-of-insurance charges.
4.2. Standard Risks
For policies issued prior to 2009, reinsurance premiums for standard risks are calculated based on the issue age and attained duration for that policy by applying the appropriate percentage as specified in Schedule B to the age nearest mortality tables specified in Schedule C, exclusive of policy fees.
For policies issued in 2Q09 and afterwards, reinsurance premiums for standard risks are calculated based on the issue age and attained duration for that policy by applying the appropriate percentage as specified in Schedule B to the age last mortality tables specified in Schedule D, exclusive of policy fees.
For the period from the effective date of this Agreement up to the next policy anniversary date, THE COMPANY shall pay a pro-rated reinsurance premium to OPTIMUM RE. Following the initial reinsurance premium, all reinsurance premiums shall be as described above and in Article 7.
4.3. Substandard Risks
Substandard reinsurance premiums shall be paid on policies which have been underwritten as a substandard risk. The substandard extra premium rate per $1,000 for one table (25% mortality) is 25% of the standard rate. The extra premium for additional tables is the corresponding multiple of the extra premium rate for one table.
7 |
When a flat extra premium is charged by THE COMPANY, a flat extra reinsurance premium is paid at the same rate and for the same period.
8 |
ARTICLE
5
ALLOWANCES
5.1. Allowances
There are no allowances payable on the standard and substandard life premiums based on the YRT rates in Schedule B.
Allowances on Flat Extra Premiums
On permanent (6 years or more) flat extra premiums:
1st year | : | 75 | % | |||
Renewals | : | 10 | % |
On temporary (5 years of less) flat extra premiums:
All years | : | 10 | % |
5.2. Premium Taxes
OPTIMUM RE shall not reimburse THE COMPANY for state premium tax or any other tax levied on THE COMPANY.
9 |
ARTICLE
6
GENERAL PROCEDURES
6.1. Inspection of Records
OPTIMUM RE shall have the right to inspect, make copies of, or reproduce, at any reasonable time, at the office of THE COMPANY, all books and documents relating to reinsurance under this Agreement.
6.2. Errors and Omissions
It is expressly understood and agreed that if failure to comply with any terms of this Agreement is shown to be unintentional and the result of administrative errors or omissions on the part of either THE COMPANY or OPTIMUM RE, both THE COMPANY and OPTIMUM RE shall be restored to the position they would have occupied had no such error or omission occurred.
This provision shall apply only to oversights, misunderstandings or clerical errors relating to the administration of reinsurance covered by this Agreement and not to the administration of the insurance provided by THE COMPANY to its insured. Any negligent or deliberate acts or omissions by THE COMPANY regarding the insurance provided are the responsibility of THE COMPANY and its liability insurer, if any, but not that of OPTIMUM RE.
Furthermore, the deviating party will undertake to identify, through a prudent review of its records all other errors and omissions of the same or similar category and correct them within a mutually negotiated time frame.
If seven (7) years have elapsed since the error or oversight occurred, there will not be rectification as above, unless both OPTIMUM RE and THE COMPANY agree to such rectification.
6.3. Reserves
OPTIMUM RE will establish appropriate reserves in accordance with the Standard Valuation Law in effect in Texas, on the portion of policies reinsured, and in force, as reported to OPTIMUM RE under this Agreement.
6.4. Reporting
THE COMPANY shall promptly report all transactions to OPTIMUM RE. In particular, but not limited to, changes and terminations.
Should THE COMPANY encounter, or expect to encounter, delays in reporting its business; it shall promptly:
1. | Notify OPTIMUM RE of the situation; and |
10 |
2. | Present OPTIMUM RE with a plan of action to correct the situation, including a time frame to solve the problem. |
OPTIMUM RE, upon receipt of the above, may request that THE COMPANY:
1. | Make modifications to the plan; |
2. | Pay estimated premiums for the duration of the reporting problem; and/or |
3. | Report larger individual exposures manually, until the situation is resolved. |
In any case where the above is not met, or if the plan is not accepted by both OPTIMUM RE and THE COMPANY, or when the plan is not adhered to, OPTIMUM RE reserves the right to deny liability on claims or limit refunds of reinsurance premiums.
6.5. Confidentiality
THE COMPANY and OPTIMUM RE agree that Customer and Proprietary Information will be treated as confidential. Customer Information includes, but is not limited to, medical, financial, and other personal information about proposed, current, and former policy owners, insureds, applicants, and beneficiaries of policies issued by THE COMPANY. Proprietary Information includes, but is not limited to, business plans, mortality and lapse studies, underwriting manuals and guidelines, applications and contract forms. Furthermore, the specific terms and conditions of this Agreement, cannot be disclosed to any other party for competitive use, unless prior written approval is obtained.
Customer and Proprietary Information will not include information that:
a. | is or becomes available to the general public through no fault of the party receiving the Customer or Proprietary Information (the “Recipient”); |
b. | is independently developed by the Recipient; |
c. | is acquired by the Recipient from a third party not covered by a confidentiality agreement; or |
d. | is disclosed under a court order, law or regulation. |
The parties will not disclose such information to any other parties unless agreed to in writing, except as necessary for retrocession purposes, as requested by external auditors, as required by court order, or as required or allowed by law or regulation.
THE COMPANY acknowledges that OPTIMUM RE can aggregate data with other companies reinsured with OPTIMUM RE as long as the data cannot be identified as belonging to THE COMPANY.
11 |
ARTICLE
7
ACCOUNTING AND BILLING
7.1. Reinsurance Premiums
For the period from the effective date of this Agreement up to the next policy anniversary date, the reinsurance premiums are due at the effective date of this Agreement. Following the initial payment of reinsurance premiums, reinsurance premiums are due on the policy anniversary date and payable to OPTIMUM RE on an annual basis regardless of how premiums are paid to THE COMPANY.
7.2. Individual Cession Billing
OPTIMUM RE will submit every month to THE COMPANY a listing of changes and terminations, and a statement of amounts payable.
The net balance is due to OPTIMUM RE within 30 days of receiving the statement. If a balance is due to THE COMPANY, OPTIMUM RE will remit its payment with the statement.
7.3. Late Payment
Any overdue balance bears interest from the end of a 30-day period following receipt of the monthly billing.
The interest for the period from 30 to 60 days will be the then current annual prime interest rate of the JP Morgan Chase Bank, Dallas, Texas calculated on a monthly basis.
For each additional month, after 60 days that a balance remains unpaid, interest will be calculated using the above annual rate plus 2%.
The payment of reinsurance premiums shall be a condition precedent to the liability of OPTIMUM RE under this Agreement. If any premium remains unpaid for more than 60 days after the due date, OPTIMUM RE may send to THE COMPANY a formal demand for immediate payment. If THE COMPANY does not comply with this demand within 30 days, then OPTIMUM RE may cancel any unpaid reinsurance cessions for nonpayment of premium; however, any unpaid premiums to the time of cancellation would be due with interest.
THE COMPANY will not force cancellation under the provisions of this Article solely to circumvent the provisions regarding recapture in Article 8.8., or to transfer the reinsured policies to another reinsurer.
12 |
ARTICLE
8
CHANGES AND ADJUSTMENTS
8.1. Change Information
THE COMPANY will keep OPTIMUM RE informed of any changes or adjustments affecting a reinsured case. If a change affects either the reinsurance premiums or allowances, or amount at risk, THE COMPANY will provide OPTIMUM RE with the necessary information to complete a modified Reinsurance Cession Form.
8.2. Reductions
If a policy is changed in any way that results in a reduction in the amount of insurance on any policy, the amount of reinsurance on that policy will be reduced proportionately.
If a Life has multiple policies and one or more are terminated or reduced, the reinsurance on remaining policies for that same Life that are reinsured under this Agreement will not be reduced to allow THE COMPANY to fill its retention.
If more than one reinsurer has a cession on that policy, each reinsurer’s cession will be reduced proportionately.
8.3. Reinstatements
If a policy reinsured with OPTIMUM RE lapses and is subsequently reinstated under THE COMPANY’s regular rules, the reinsurance will automatically be reinstated for the same amount, upon receipt by OPTIMUM RE of written notice of the reinstatement. All other reinstatement requests shall be submitted to OPTIMUM RE for its approval before THE COMPANY can reinstate such policy.
THE COMPANY shall pay all reinsurance premiums in arrears for the same period THE COMPANY received premiums in arrears under its policy, including interest, if any.
8.4. Conversions
When a conversion right is contractually available under the original plan, provided the conversion occurs before age 65, OPTIMUM RE shall continue to reinsure its share of the policy. The reinsurance premiums shall be calculated on a point-in-scale basis using the same reinsurance factor specified in Schedule B, at the time of the policy conversion, for the conversion plan. The calculation of the Net Amount at Risk shall be as described in Article 3.
8.5. Terminations
At termination of a policy, other than death, all premiums and allowances, excluding cession fees, are adjusted pro rata for the period of coverage.
In the event of termination by death, there will be no adjustment of premiums.
13 |
8.6. Cash Values
OPTIMUM RE will not participate in the payment of cash values.
8.7. Policy loans and Dividends
OPTIMUM RE will not participate in policy loans or dividends.
8.8. Recapture
Recapture will not be permitted under this Agreement unless explicitly approved by OPTIMUM RE, except as stated in Article 3.3.
14 |
ARTICLE
9
CLAIMS
9.1. Claims Liability
OPTIMUM RE will be liable to THE COMPANY for the benefits reinsured hereunder to the same extent as THE COMPANY is liable to the insured for such benefits, and all reinsurance will be subject to the terms and conditions of the policy under which THE COMPANY is liable. OPTIMUM RE will also be liable for its proportionate share of interest on payment of the claim at the usual interest rate allowed by THE COMPANY.
9.2. Notice
THE COMPANY will give OPTIMUM RE prompt notice of any claim. Copies of notification, claim papers and proofs will be furnished to OPTIMUM RE within ten (10) working days of having been received by THE COMPANY.
9.3. Authorization for Payment
On all claims, THE COMPANY must obtain the approval of OPTIMUM RE prior to acknowledgment of its liability to the claimant.
9.4. Adjusted Amounts
In the event the amount of insurance provided by a policy reinsured hereunder is increased or reduced because of a misstatement of age or sex established after the death of the insured, OPTIMUM RE will share in the increase or reduction in the proportion that the liability of OPTIMUM RE bore to the total liability under the policy immediately prior to such increase or reduction.
9.5. Payment
On death claims, OPTIMUM RE will pay its share in a lump sum to THE COMPANY without regard to the form of claim settlement. OPTIMUM RE is not responsible for usual claim expenses that THE COMPANY incurs in claim settlement such as compensation of employees and routine investigative expenses.
9.6. Contest
THE COMPANY will advise OPTIMUM RE of its intention to contest, compromise or litigate a claim or rescind a contract involving reinsurance. If after reviewing the complete file OPTIMUM RE agrees in writing with THE COMPANY’s intention, then OPTIMUM RE agrees to pay a share of the expenses incurred by THE COMPANY in contesting or investigating a claim on a reinsured policy or in rescinding a reinsured policy, in proportion to the respective liabilities of OPTIMUM RE and THE COMPANY. Compensation of officers and employees of THE COMPANY is not deemed a claim expense.
15 |
If OPTIMUM RE declines to be a party to a claim contest, OPTIMUM RE will discharge any and all liability by payment of its full share of the claim to THE COMPANY according to the terms and conditions of this Agreement.
9.7. Punitive Damages
OPTIMUM RE will not participate in punitive, compensatory or statutory damages or penalties which are awarded against THE COMPANY as a result of an act, omission or course of conduct committed solely by THE COMPANY in connection with the insurance reinsured under this Agreement.
16 |
ARTICLE
10
ARBITRATION
10.1. Principle
The parties express their formal intention to resolve any differences arising from the interpretation or execution of this Agreement in accordance with equity and usage rather than according to strict legal rules. Any difference that cannot be resolved by the parties shall be submitted to arbitration by written notice sent by one party to the other. The location for arbitration shall be Dallas, Texas.
10.2. Arbitrators
There shall be three disinterested arbitrators who shall be officers or retired officers of life insurance or reinsurance companies other than the parties to the Agreement or their subsidiaries. The arbitrators shall be disinterested parties and cannot be jurists, present or former employees of one of the parties or their affiliate or therefore related to the management of one of the parties or their affiliates. Each of the parties shall appoint one of the arbitrators and these two arbitrators shall select the third. In the event that either party should fail to choose an arbitrator within thirty days after the other party has given notice of its arbitrator appointment, that party may choose two arbitrators who shall in turn choose a third arbitrator before entering arbitration.
Any arbitrator who does not perform their duties or resigns will be replaced by the party who originally selected that arbitrator.
10.3. Matters In Dispute
The parties will state together or separately the subjects in dispute and submit them in writing to the arbitrators along with the necessary documents.
10.4. Procedures
The arbitrators must themselves establish the procedure to be followed: they are exempt from any judicial formality or rule. They can adjudicate and are empowered to act as mediators. They shall decide how the arbitration costs are apportioned.
10.5. Decision
The award rendered by the majority, must be in writing, give the reasons for the decision and be signed by each arbitrator. The parties agree to abide by the decision rendered and to consider the award as final and binding on both parties.
10.6. Applicable Laws
Should there be improprieties in the arbitration process or if one of the parties objects to the implementation of the arbitration process, the laws of the State of Texas shall then apply.
17 |
ARTICLE
11
INSOLVENCY
11.1. Payment of Claims
In the event of insolvency of THE COMPANY, all claims under this Agreement will be paid by OPTIMUM RE directly to THE COMPANY, its liquidator, receiver or statutory successor. OPTIMUM RE’s share of claims will be paid without diminution because of the insolvency of THE COMPANY, provided that all reinsurance premiums have been duly paid and subject to Article 11.4.
OPTIMUM RE shall be liable only for the claims actually paid by THE COMPANY to the insured or its beneficiary on amounts reinsured and shall not be or become liable for any amounts or reserves to be held by THE COMPANY on policies reinsured under this Agreement.
11.2. Notice to OPTIMUM RE
In the event of the insolvency of THE COMPANY, the liquidator, receiver, or statutory successor of THE COMPANY will give written notice of a pending claim against THE COMPANY on any policy reinsured, within a reasonable time after the claim is filed in the insolvency proceedings. While the claim is pending, OPTIMUM RE may investigate and interpose, at its own expense, in the proceedings where the claim is to be adjudicated, any defenses which it may deem available to THE COMPANY or its liquidator, receiver, or statutory successor.
11.3. Expenses
The expenses incurred by OPTIMUM RE will be charged, subject to court approval, against THE COMPANY as expenses of liquidation to the extent of a proportionate share of the benefit which accrues to THE COMPANY as a result of the defenses undertaken by OPTIMUM RE. Where two or more reinsurers are involved and a majority in interest elects to defend a claim, the expenses will be apportioned in accordance with the terms of the reinsurance agreements as if the expenses had been incurred by THE COMPANY.
11.4. Right to Offset
In the event of the insolvency of either OPTIMUM RE or THE COMPANY, any amounts owed by OPTIMUM RE to THE COMPANY and by THE COMPANY to OPTIMUM RE with respect to this and all other Reinsurance Agreements between OPTIMUM RE and THE COMPANY, shall be offset against each other with the balance to be paid by the appropriate party.
18 |
ARTICLE
12
DEFERRED ACQUISITION COST TAX
THE COMPANY and OPTIMUM RE mutually agree to the following pursuant to Section 1.848-2(g)(8) of the Income Tax Regulations issued December 29, 1992 of the Internal Revenue Code of 1986.
1. | The Party with net positive consideration for the Agreement(s) for each taxable year shall compute specified policy acquisition expenses without regard to the general deductions limitation of Section 848(c)(1). |
2. | THE COMPANY and OPTIMUM RE agree to exchange information pertaining to the amount of net consideration as determined for all reinsurance agreements in force between them to ensure consistency or as may otherwise be required by the Internal Revenue Service. |
3. | THE COMPANY will submit a Schedule to OPTIMUM RE by June 1st of its calculation of the net consideration for the preceding calendar year. This calculation shall be accompanied by a statement signed by an officer of THE COMPANY stating that THE COMPANY will report such net consideration in its tax return for the preceding calendar year. |
4. | OPTIMUM RE shall advise THE COMPANY if it disagrees with the amounts provided and OPTIMUM RE and THE COMPANY agree to amicably resolve any difference. The amounts provided by THE COMPANY shall be presumed correct if it does not receive a response from OPTIMUM RE at the latest 30 days after receipt by OPTIMUM RE of these amounts or by May 30th of the current year. |
19 |
ARTICLE
13
EXECUTION
13.1. Duration
This Agreement will be effective on July 1, 2016. Reinsurance for these policies shall remain in-force until termination of the original policy with THE COMPANY or as provided elsewhere within this Agreement.
13.2. Parties to the Agreement
This is an agreement solely between THE COMPANY and OPTIMUM RE. There will be no legal relationship between OPTIMUM RE and any person having an interest of any kind in any of THE COMPANY’s insurance, or between OPTIMUM RE and any other reinsurer, or between OPTIMUM RE and any other third party.
13.3. Written Agreement
A. Entirety
This Agreement shall constitute the entire agreement between THE COMPANY and OPTIMUM RE with respect to the business reinsured hereunder. There are no understandings between THE COMPANY and OPTIMUM RE other than as expressed in this Agreement.
B. Amendments
Any change or modification to the Agreement shall be null and void unless made by amendment to the Agreement and signed by both parties.
C. Waiver
A waiver of any provision(s) of this Agreement shall constitute a waiver only with respect to the particular circumstance for which it is given and not a waiver for any future circumstances.
D. Severability
If any section or provision of this Agreement is determined to be invalid or unenforceable, such determination will not impact or affect the validity or the enforceability of the remaining sections or provisions of this Agreement.
13.4. Change of Control/Assignment
Neither THE COMPANY nor its liquidator, receiver, or statutory successor will, without the prior written consent of OPTIMUM RE, sell, assign, transfer, or otherwise dispose of this Agreement, or any interest in this Agreement, by voluntary or involuntary act.
20 |
13.5. Compliance
THE COMPANY represents that to the best of its knowledge and belief it is, and shall use its best efforts to continue to be, in substantial compliance in all material respects with all laws, regulations, and judicial and administrative orders applicable to the business reinsured under this Agreement, including but not limited to, privacy laws and the maintenance of an effective anti-money laundering policy, (collectively, the “Law”). Neither THE COMPANY nor OPTIMUM RE shall be required to take any action under this Agreement that would result in it being in violation of the Law, which shall include requirements enforced by the U.S. Treasury Department Office of Foreign Assets Control and Terrorist Financing Act. THE COMPANY and OPTIMUM RE acknowledge and agree that a claim under this Agreement is not payable if payment would cause OPTIMUM RE to be in violation of the Law. Should either party discover a reinsurance payment has been made in violation of the Law, it shall notify the other party and the parties shall cooperate in order to take all necessary corrective actions.
13.6. Signatures
IN WITNESS of the above, this Agreement is signed in duplicate on the dates indicated.
FOR: FEDERAL LIFE INSURANCE COMPANY |
BY: | DATE: | |||
NAME: | ||||
TITLE: |
BY: | DATE: | |||
NAME: | ||||
TITLE: |
FOR: OPTIMUM RE INSURANCE COMPANY
BY: | /s/ Sebastien Blondeau | DATE: | 8-26-2016 | |
NAME: | Sebastien Blondeau | |||
TITLE: | President & COO | |||
BY: | /s/ Serge Goulet | DATE: | 8-26-2016 | |
NAME: | Serge Goulet | |||
TITLE: | Managing Director |
21 |
SCHEDULE
A
RETENTION AND REINSURANCE LIMITS
FEDERAL LIFE INSURANCE COMPANY (MUTUAL)
LIFE | ||
THE COMPANY’S Retention Limit per Life | 20% retained on all ceded amounts. | |
Maximum Reinsurance Amount per Life | $208,000 | |
Minimum Cession | $5,000 |
22 |
SCHEDULE
B
REINSURANCE PREMIUM PERCENTAGES FOR THE CLOSED IN-FORCE BLOCK OF LEVEL TERM POLICIES
PREMIUM PERCENTAGES APPLIED TO THE APPLICABLE
MORTALITY
TABLES SPECIFIED IN SCHEDULE C AND SCHEDULE D
3-CLASS TERM PRODUCTS
RISK CLASS | LEVEL TERM PERIOD | POST LEVEL TERM PERIOD | ||||||
MALE PREFERRED NONTOBACCO | 43 | % | 62 | % | ||||
MALE RESIDUAL NONTOBACCO | 52 | % | 82 | % | ||||
MALE STANDARD TOBACCO | 109 | % | 169 | % | ||||
FEMALE PREFERRED NONTOBACCO | 47 | % | 68 | % | ||||
FEMALE RESIDUAL NONTOBACCO | 63 | % | 99 | % | ||||
FEMALE STANDARD TOBACCO | 140 | % | 217 | % |
*AFTER APPLYING THE ABOVE PERCENTAGES TO THE MORTALITY TABLES SPECIFIED IN SCHEDULE C OR SCHEDULE D, MULTIPLY THESE BY THE NET AMOUNT AT RISK PER THOUSAND AND ROUND THE RESULTING REINSURANCE PREMIUMS TO TWO DECIMAL PLACES (I.E., NEAREST CENT).
2-CLASS & AGGREGATE TERM PRODUCTS
ART ONLY | ALL OTHER TERM PLANS | |||||||||||
RISK CLASS | ALL DURATIONS | LEVEL TERM PERIOD | POST LEVEL TERM PERIOD | |||||||||
MALE STANDARD NONTOBACCO | 52 | % | 52 | % | 82 | % | ||||||
MALE STANDARD TOBACCO | 109 | % | 109 | % | 169 | % | ||||||
MALE AGGREGATE | 63 | % | 63 | % | 98 | % | ||||||
FEMALE STANDARD NONTOBACCO | 63 | % | 63 | % | 99 | % | ||||||
FEMALE STANDARD TOBACCO | 140 | % | 140 | % | 217 | % | ||||||
FEMALE AGGREGATE | 81 | % | 81 | % | 125 | % |
*AFTER APPLYING THE ABOVE PERCENTAGES TO THE MORTALITY TABLES SPECIFIED IN SCHEDULE C OR SCHEDULE D, MULTIPLY THESE BY THE NET AMOUNT AT RISK PER THOUSAND AND ROUND THE RESULTING REINSURANCE PREMIUMS TO TWO DECIMAL PLACES (I.E., NEAREST CENT).
23 |
SCHEDULE
C
US 75-80, BASIC SELECT & ULTIMATE, AGGREGATE AGE NEAREST BIRTHDAY, GENDER DISTINCT MORTALITY TABLES
PART 1 | - | MALE RATES |
24 |
Extended Basic US 1975-80 Select and Ultimate Automatic YRT Rates
Male Aggregate | Age Nearest Birthday |
Policy Year | Att. | |||||||||||||||||||||||||||||||||
Age | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16+ | Age | |||||||||||||||||
0 | 1.23 | 0.74 | 0.48 | 0.43 | 0.38 | 0.34 | 0.33 | 0.29 | 0.27 | 0.27 | 0.25 | 0.28 | 0.31 | 0.38 | 0.54 | 0.68 | 15 | |||||||||||||||||
1 | 0.49 | 0.47 | 0.42 | 0.36 | 0.28 | 0.23 | 0.22 | 0.22 | 0.24 | 0.24 | 0.27 | 0.30 | 0.38 | 0.54 | 0.68 | 1.01 | 16 | |||||||||||||||||
2 | 0.35 | 0.37 | 0.33 | 0.28 | 0.23 | 0.22 | 0.21 | 0.24 | 0.24 | 0.27 | 0.30 | 0.37 | 0.54 | 0.68 | 1.01 | 1.14 | 17 | |||||||||||||||||
3 | 0.35 | 0.29 | 0.25 | 0.23 | 0.22 | 0.20 | 0.22 | 0.24 | 0.27 | 0.30 | 0.37 | 0.53 | 0.68 | 1.01 | 1.14 | 1.22 | 18 | |||||||||||||||||
4 | 0.29 | 0.25 | 0.23 | 0.22 | 0.20 | 0.22 | 0.24 | 0.27 | 0.30 | 0.36 | 0.52 | 0.66 | 0.99 | 1.11 | 1.22 | 1.31 | 19 | |||||||||||||||||
5 | 0.25 | 0.23 | 0.22 | 0.20 | 0.22 | 0.24 | 0.27 | 0.30 | 0.36 | 0.50 | 0.66 | 0.96 | 1.09 | 1.16 | 1.31 | 1.37 | 20 | |||||||||||||||||
6 | 0.23 | 0.22 | 0.20 | 0.22 | 0.24 | 0.27 | 0.30 | 0.36 | 0.50 | 0.66 | 0.94 | 1.07 | 1.14 | 1.21 | 1.37 | 1.40 | 21 | |||||||||||||||||
7 | 0.19 | 0.20 | 0.22 | 0.24 | 0.27 | 0.30 | 0.35 | 0.50 | 0.66 | 0.87 | 1.05 | 1.13 | 1.19 | 1.23 | 1.40 | 1.41 | 22 | |||||||||||||||||
8 | 0.18 | 0.21 | 0.21 | 0.27 | 0.29 | 0.35 | 0.50 | 0.66 | 0.87 | 1.05 | 1.13 | 1.19 | 1.23 | 1.30 | 1.39 | 1.40 | 23 | |||||||||||||||||
9 | 0.19 | 0.20 | 0.24 | 0.29 | 0.35 | 0.50 | 0.66 | 0.87 | 1.05 | 1.13 | 1.19 | 1.23 | 1.30 | 1.35 | 1.36 | 1.38 | 24 | |||||||||||||||||
10 | 0.18 | 0.22 | 0.27 | 0.35 | 0.50 | 0.66 | 0.87 | 1.05 | 1.13 | 1.19 | 1.23 | 1.30 | 1.35 | 1.36 | 1.32 | 1.34 | 25 | |||||||||||||||||
11 | 0.20 | 0.25 | 0.34 | 0.50 | 0.66 | 0.87 | 1.05 | 1.13 | 1.19 | 1.23 | 1.30 | 1.35 | 1.36 | 1.30 | 1.27 | 1.29 | 26 | |||||||||||||||||
12 | 0.23 | 0.32 | 0.50 | 0.66 | 0.87 | 1.05 | 1.13 | 1.19 | 1.23 | 1.30 | 1.35 | 1.36 | 1.30 | 1.2.5 | 1.20 | 1.24 | 27 | |||||||||||||||||
13 | 0.30 | 0.46 | 0.63 | 0.87 | 1.05 | 1.12 | 1.19 | 1.22 | 1.24 | 1.28 | 1.31 | 1.30 | 1.25 | 1.20 | 1.16 | 1.20 | 28 | |||||||||||||||||
14 | 0.44 | 0.59 | 0.87 | 1.05 | 1.12 | 1.17 | 1.22 | 1.23 | 1.23 | 1.24 | 1.26 | 1.25 | 1.19 | 1.16 | 1.13 | 1.17 | 29 | |||||||||||||||||
15 | 0.58 | 0.87 | 1.05 | 1.12 | 1.17 | 1.21 | 1.23 | 1.22 | 1.20 | 1.20 | 1.19 | 1.18 | 1.13 | 1.12 | 1.11 | 1.14 | 30 | |||||||||||||||||
16 | 0.87 | 1.05 | 1.12 | 1.17 | 1.21 | 1.20 | 1.21 | 1.19 | 1.16 | 1.14 | 1.12 | 1.12 | 1.09 | 1.09 | 1.09 | 1.12 | 31 | |||||||||||||||||
17 | 1.05 | 1.12 | 1.17 | 1.21 | 1.20 | 1.18 | 1.18 | 1.15 | 1.11 | 1.07 | 1.05 | 1.06 | 1.05 | 1.06 | 1.08 | 1.11 | 32 | |||||||||||||||||
18 | 1.03 | 1.10 | 1.13 | 1.15 | 1.14 | 1.11 | 1.11 | 1.07 | 1.04 | 1.01 | 1.00 | 1.02 | 1.01 | 1.03 | 1.07 | 1.12 | 33 | |||||||||||||||||
19 | 1.00 | 1.05 | 1.06 | 1.07 | 1.05 | 1.04 | 1.02 | 0.98 | 0.96 | 0.95 | 0.97 | 0.97 | 0.98 | 1.01 | 1.07 | 1.14 | 34 | |||||||||||||||||
20 | 0.93 | 0.97 | 0.97 | 0.97 | 0.97 | 0.95 | 0.93 | 0.90 | 0.90 | 0.91 | 0.93 | 0.94 | 0.96 | 1.01 | 1.08 | 1.17 | 35 | |||||||||||||||||
21 | 0.84 | 0.87 | 0.87 | 0.87 | 0.87 | 0.86 | 0.85 | 0.83 | 0.85 | 0.86 | 0.90 | 0.92 | 0.96 | 1.02 | 1.11 | 1.22 | 36 | |||||||||||||||||
22 | 0.73 | 0.76 | 0.76 | 0.76 | 0.77 | 0.77 | 0.77 | 0.77 | 0.80 | 0.83 | 0.88 | 0.91 | 0.96 | 1.04 | 1.15 | 1.28 | 37 | |||||||||||||||||
23 | 0.73 | 0.76 | 0.75 | 0.75 | 0.75 | 0.76 | 0.77 | 0.77 | 0.80 | 0.84 | 0.90 | 0.94 | 1.00 | 1.10 | 1.21 | 1.36 | 38 | |||||||||||||||||
24 | 0.73 | 0.74 | 0.73 | 0.73 | 0.74 | 0.76 | 0.77 | 0.78 | 0.82 | 0.87 | 0.93 | 0.97 | 1.05 | 1.17 | 1.29 | 1.45 | 39 | |||||||||||||||||
25 | 0.72 | 0.72 | 0.72 | 0.72 | 0.74 | 0.76 | 0.77 | 0.79 | 0.84 | 0.90 | 0.96 | 1.03 | 1.12 | 1.25 | 1.38 | 1.56 | 40 | |||||||||||||||||
26 | 0.70 | 0.70 | 0.71 | 0.72 | 0.73 | 0.76 | 0.78 | 0.82 | 0.88 | 0.95 | 1.02 | 1.09 | 1.20 | 1.35 | 1.49 | 1.70 | 41 | |||||||||||||||||
27 | 0.68 | 0.68 | 0.70 | 0.71 | 0.73 | 0.77 | 0.81 | 0.86 | 0.92 | 1.01 | 1.08 | 1.17 | 1.30 | 1.47 | 1.63 | 1.87 | 42 | |||||||||||||||||
28 | 0.66 | 0.68 | 0.71 | 0.73 | 0.76 | 0.81 | 0.86 | 0.92 | 1.00 | 1.08 | 1.17 | 1.28 | 1.42 | 1.61 | 1.81 | 2.07 | 43 | |||||||||||||||||
29 | 0.65 | 0.68 | 0.73 | 0.76 | 0.81 | 0.86 | 0.92 | 1.00 | 1.08 | 1.17 | 1.28 | 1.42 | 1.58 | 1.81 | 2.03 | 2.31 | 44 | |||||||||||||||||
30 | 0.64 | 0.68 | 0.76 | 0.81 | 0.86 | 0.92 | 1.00 | 1.08 | 1.17 | 1.28 | 1.42 | 1.58 | 1.81 | 2.03 | 2.26 | 2.58 | 45 | |||||||||||||||||
31 | 0.63 | 0.69 | 0.79 | 0.86 | 0.92 | 1.00 | 1.08 | 1.17 | 1.28 | 1.42 | 1.58 | 1.81 | 2.03 | 2.26 | 2.53 | 2.89 | 46 | |||||||||||||||||
32 | 0.63 | 0.71 | 0.84 | 0.92 | 1.00 | 1.08 | 1.17 | 1.28 | 1.40 | 1.58 | 1.81 | 2.03 | 2.26 | 2.53 | 2.83 | 3.24 | 47 | |||||||||||||||||
33 | 0.63 | 0.72 | 0.88 | 0.98 | 1.08 | 1.17 | 1.28 | 1.40 | 1.58 | 1.78 | 2.01 | 2.25 | 2.53 | 2.83 | 3.17 | 3.61 | 48 | |||||||||||||||||
34 | 0.63 | 0.73 | 0.93 | 1.05 | 1.17 | 1.28 | 1.40 | 1.58 | 1.78 | 2.01 | 2.24 | 2.53 | 2.81 | 3.16 | 3.54 | 4.02 | 49 |
C-1-1 |
Extended Basic US 1975-80 Select and Ultimate Automatic YRT Rates
Male Aggregate | Age Nearest Birthday |
Policy Year | Att. | |||||||||||||||||||||||||||||||||
Age | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16+ | Age | |||||||||||||||||
35 | 0.63 | 0.76 | 0.99 | 1.14 | 1.28 | 1.40 | 1.58 | 1.78 | 2.01 | 2.24 | 2.53 | 2.80 | 3.13 | 3.52 | 3.94 | 4.45 | 50 | |||||||||||||||||
36 | 0.65 | 0.79 | 1.06 | 1.25 | 1.40 | 1.58 | 1.78 | 2.01 | 2.24 | 2.53 | 2.80 | 3.10 | 3.48 | 3.91 | 4.36 | 4.92 | 51 | |||||||||||||||||
37 | 0.67 | 0.84 | 1.15 | 1.37 | 1.58 | 1.78 | 2.01 | 2.24 | 2.53 | 2.80 | 3.08 | 3.43 | 3.86 | 4.32 | 4.82 | 5.44 | 52 | |||||||||||||||||
38 | 0.70 | 0.89 | 1.23 | 1.47 | 1.70 | 1.91 | 2.16 | 2.41 | 2.72 | 3.04 | 3.35 | 3.76 | 4.25 | 4.28 | 5.33 | 6.00 | 53 | |||||||||||||||||
39 | 0.74 | 0.95 | 1.33 | 1.59 | 1.83 | 2.07 | 2.33 | 2.60 | 2.93 | 3.27 | 3.64 | 4.10 | 4.67 | 5.28 | 5.88 | 6.61 | 54 | |||||||||||||||||
40 | 0.79 | 1.02 | 1.45 | 1.73 | 2.00 | 2.23 | 2.51 | 2.79 | 3.13 | 3.51 | 3.94 | 4.47 | 5.13 | 5.82 | 6.48 | 7.27 | 55 | |||||||||||||||||
41 | 0.85 | 1.11 | 1.59 | 1.90 | 2.17 | 2.42 | 2.70 | 2.98 | 3.33 | 3.75 | 4.24 | 4.86 | 5.62 | 6.41 | 7.12 | 8.01 | 56 | |||||||||||||||||
42 | 0.92 | 1.22 | 1.76 | 2.09 | 2.37 | 2.62 | 2.89 | 3.18 | 3.52 | 3.99 | 4.57 | 5.28 | 6.15 | 7.05 | 7.85 | 8.82 | 57 | |||||||||||||||||
43 | 0.99 | 1.37 | 1.92 | 2.30 | 2.61 | 2.88 | 3.18 | 3.47 | 3.83 | 4.33 | 4.96 | 5.71 | 6.63 | 7.61 | 8.50 | 9.73 | 58 | |||||||||||||||||
44 | 1.08 | 1.53 | 2.11 | 2.52 | 2.86 | 3.17 | 3.47 | 3.79 | 4.17 | 4.70 | 5.37 | 6.16 | 7.16 | 8.20 | 9.22 | 10.75 | 59 | |||||||||||||||||
45 | 1.17 | 1.72 | 2.31 | 2.75 | 3.13 | 3.47 | 3.79 | 4.14 | 4.56 | 5.08 | 5.80 | 6.66 | 7.73 | 8.85 | 10.02 | 11.89 | 60 | |||||||||||||||||
46 | 1.28 | 1.94 | 2.51 | 3.00 | 3.40 | 3.78 | 4.14 | 4.56 | 4.91 | 5.48 | 6.28 | 7.19 | 8.35 | 9.56 | 10.89 | 13.17 | 61 | |||||||||||||||||
47 | 1.39 | 2.17 | 2.73 | 3.25 | 3.69 | 4.13 | 4.56 | 4.89 | 5.31 | 5.93 | 6.79 | 7.78 | 9.03 | 10.34 | 11.85 | 14.57 | 62 | |||||||||||||||||
48 | 1.49 | 2.27 | 2.84 | 3.40 | 3.90 | 4.38 | 4.87 | 5.28 | 5.80 | 6.49 | 7.53 | 8.64 | 9.94 | 11.30 | 12.79 | 16.07 | 63 | |||||||||||||||||
49 | 1.60 | 2.35 | 2.95 | 3.54 | 4.09 | 4.62 | 5.18 | 5.70 | 6.33 | 7.12 | 8.36 | 9.60 | 10.96 | 12.32 | 13.75 | 17.71 | 64 | |||||||||||||||||
50 | 1.70 | 2.42 | 3.04 | 3.66 | 4.29 | 4.87 | 5.51 | 6.15 | 6.93 | 7.83 | 9.30 | 10.69 | 12.06 | 13.40 | 14.77 | 19.50 | 65 | |||||||||||||||||
51 | 1.80 | 2.48 | 3.12 | 3.77 | 4.47 | 5.12 | 5.86 | 6.65 | 7.59 | 8.61 | 10.35 | 11.89 | 13.24 | 14.56 | 15.83 | 21.47 | 66 | |||||||||||||||||
52 | 1.90 | 2.52 | 3.17 | 3.85 | 4.65 | 5.38 | 6.23 | 7.20 | 8.32 | 9.48 | 11.51 | 13.18 | 14.52 | 15.80 | 16.96 | 23.65 | 67 | |||||||||||||||||
53 | 2.06 | 2.75 | 3.46 | 4.23 | 5.08 | 5.90 | 6.84 | 7.89 | 9.11 | 10.43 | 12.63 | 14.52 | 15.80 | 16.96 | 19.16 | 26.05 | 68 | |||||||||||||||||
54 | 2.23 | 2.99 | 3.78 | 4.64 | 5.57 | 6.47 | 7.52 | 8.66 | 9.96 | 11.44 | 13.85 | 15.80 | 16.96 | 19.16 | 21.62 | 28.69 | 69 | |||||||||||||||||
55 | 2.41 | 3.27 | 4.12 | 5.10 | 6.11 | 7.11 | 8.27 | 9.50 | 10.86 | 12.54 | 15.17 | 16.96 | 19.16 | 21.62 | 24.39 | 31.57 | 70 | |||||||||||||||||
56 | 2.61 | 3.56 | 4.51 | 5.61 | 6.71 | 7.83 | 9.09 | 10.38 | 11.83 | 13.73 | 16.62 | 19.16 | 21.62 | 24.39 | 27.47 | 34.68 | 71 | |||||||||||||||||
57 | 2.82 | 3.89 | 4.94 | 6.18 | 7.38 | 8.60 | 9.96 | 11.33 | 12.87 | 15.03 | 18.21 | 21.36 | 24.39 | 27.15 | 30.87 | 38.00 | 72 | |||||||||||||||||
58 | 2.96 | 4.13 | 5.44 | 6.74 | 8.10 | 9.20 | 10.59 | 12.05 | 13.66 | 15.94 | 19.22 | 22.43 | 25.64 | 28.58 | 32.76 | 41.60 | 73 | |||||||||||||||||
59 | 3.10 | 4.37 | 6.00 | 7.34 | 8.87 | 9.82 | 11.23 | 12.79 | 14.47 | 16.88 | 20.25 | 23.49 | 26.85 | 29.94 | 34.70 | 45.54 | 74 | |||||||||||||||||
60 | 3.23 | 4.63 | 6.61 | 7.97 | 9.71 | 10.46 | 11.89 | 13.57 | 15.32 | 17.85 | 21.28 | 24.48 | 27.97 | 31.28 | 36.71 | 49.90 | 75 | |||||||||||||||||
61 | 3.37 | 4.89 | 7.26 | 8.64 | 10.46 | 11.59 | 12.58 | 14.38 | 16.18 | 18.82 | 22.26 | 25.39 | 29.04 | 32.61 | 38.82 | 54.71 | 76 | |||||||||||||||||
62 | 3.50 | 5.14 | 7.97 | 9.36 | 11.59 | 11.83 | 13.29 | 15.21 | 17.05 | 19.77 | 23.18 | 26.21 | 30.06 | 33.93 | 41.03 | 60.03 | 77 | |||||||||||||||||
63 | 3.89 | 5.77 | 8.74 | 10.48 | 11.83 | 13.29 | 15.21 | 17.05 | 20.11 | 22.42 | 25.79 | 28.87 | 33.14 | 37.75 | 44.66 | 65.85 | 78 | |||||||||||||||||
64 | 4.32 | 6.47 | 9.57 | 11.73 | 13.29 | 15.21 | 17.05 | 20.11 | 22.42 | 25.79 | 28.69 | 32.93 | 36.55 | 42.02 | 48.60 | 72.18 | 79 | |||||||||||||||||
65 | 4.80 | 7.26 | 10.50 | 13.13 | 15.21 | 17.05 | 20.11 | 22.42 | 25.79 | 28.69 | 32.93 | 35.12 | 40.34 | 46.75 | 52.83 | 79.02 | 80 | |||||||||||||||||
66 | 5.32 | 8.14 | 11.51 | 14.69 | 17.05 | 20.11 | 22.42 | 25.79 | 28.69 | 32.93 | 34.69 | 38.78 | 44.51 | 51.97 | 57.68 | 86.36 | 81 | |||||||||||||||||
67 | 5.91 | 9.12 | 12.62 | 16.42 | 20.11 | 22.42 | 25.79 | 28.69 | 32.93 | 34.47 | 38.42 | 42.80 | 49.08 | 57.68 | 62.18 | 94.12 | 82 | |||||||||||||||||
68 | 6.51 | 10.04 | 13.89 | 18.04 | 22.04 | 24.54 | 28.23 | 31.44 | 34.47 | 37.82 | 42.14 | 46.91 | 53.73 | 62.18 | 67.77 | 102.35 | 83 | |||||||||||||||||
69 | 7.17 | 11.05 | 15.25 | 19.76 | 24.12 | 26.87 | 30.94 | 34.47 | 37.82 | 41.49 | 46.20 | 51.36 | 58.72 | 67.77 | 73.69 | 111.41 | 84 |
C-1-2 |
Extended Basic US 1975-80 Select and Ultimate Automatic YRT Rates
Male Aggregate | Age Nearest Birthday |
Policy Year | Att. | |||||||||||||||||||||||||||||||||
Age | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16+ | Age | |||||||||||||||||
70 | 7.89 | 12.14 | 16.72 | 21.64 | 26.41 | 29.44 | 33.92 | 37.82 | 41.49 | 45.48 | 50.57 | 56.13 | 64.00 | 73.69 | 80.22 | 121.31 | 85 | |||||||||||||||||
71 | 9.53 | 14.60 | 19.60 | 24.97 | 29.44 | 34.32 | 41.78 | 48.80 | 57.45 | 65.58 | 74.61 | 84.52 | 95.47 | 107.84 | 121.31 | 132.05 | 86 | |||||||||||||||||
72 | 11.40 | 16.64 | 22.87 | 28.77 | 34.15 | 39.89 | 48.34 | 56.16 | 65.58 | 74.61 | 84.52 | 95.39 | 107.67 | 121.31 | 132.05 | 143.63 | 87 | |||||||||||||||||
73 | 13.52 | 19.13 | 26.61 | 33.20 | 39.52 | 46.21 | 55.72 | 64.40 | 74.61 | 84.52 | 95.39 | 107.62 | 121.31 | 132.05 | 143.63 | 156.05 | 88 | |||||||||||||||||
74 | 15.94 | 22.46 | 30.70 | 38.25 | 45.60 | 53.35 | 64.01 | 73.58 | 84.52 | 95.39 | 107.62 | 121.31 | 132.05 | 143.63 | 156.05 | 169.12 | 89 | |||||||||||||||||
75 | 18.71 | 26.26 | 35.35 | 43.95 | 52.45 | 61.35 | 73.23 | 83.67 | 95.39 | 107.62 | 121.31 | 132.05 | 143.63 | 156.05 | 169.12 | 182.61 | 90 | |||||||||||||||||
76 | 21.88 | 30.62 | 40.61 | 50.35 | 60.12 | 70.26 | 83.39 | 94.78 | 107.62 | 121.31 | 132.05 | 143.63 | 156.05 | 169.12 | 182.61 | 196.52 | 91 | |||||||||||||||||
77 | 25.51 | 34.90 | 46.52 | 57.51 | 68.66 | 80.09 | 94.57 | 107.29 | 121.31 | 132.05 | 143.63 | 156.05 | 169.12 | 182.61 | 196.52 | 210.85 | 92 | |||||||||||||||||
78 | 29.63 | 40.42 | 53.12 | 65.47 | 78.04 | 90.90 | 107.18 | 121.31 | 132.05 | 143.63 | 156.05 | 169.12 | 182.61 | 196.52 | 210.85 | 225.60 | 93 | |||||||||||||||||
79 | 34.65 | 46.62 | 60.45 | 74.20 | 88.36 | 103.10 | 121.31 | 132.05 | 143.63 | 156.05 | 169.12 | 182.61 | 196.52 | 210.85 | 225.60 | 240.77 | 94 | |||||||||||||||||
80 | 40.30 | 53.54 | 68.50 | 83.78 | 99.99 | 116.79 | 132.05 | 143.63 | 156.05 | 169.12 | 182.61 | 196.52 | 210.85 | 225.60 | 240.77 | 256.36 | 95 | |||||||||||||||||
81 | 46.63 | 61.18 | 77.33 | 94.56 | 113.02 | 132.05 | 143.63 | 156.05 | 169.12 | 182.61 | 196.52 | 210.85 | 225.60 | 240.77 | 256.36 | 272.37 | 96 | |||||||||||||||||
82 | 53.65 | 69.60 | 87.27 | 106.64 | 127.54 | 143.63 | 156.05 | 169.12 | 182.61 | 196.52 | 210.85 | 225.60 | 240.77 | 256.36 | 272.37 | 288.80 | 97 | |||||||||||||||||
83 | 61.41 | 79.10 | 98.40 | 120.07 | 143.63 | 156.05 | 169.12 | 182.61 | 196.52 | 210.85 | 225.60 | 240.77 | 256.36 | 272.37 | 288.80 | 305.65 | 98 | |||||||||||||||||
84 | 72.42 | 89.77 | 110.78 | 134.94 | 156.05 | 169.12 | 182.61 | 196.52 | 210.85 | 225.60 | 240.77 | 256.36 | 272.37 | 288.80 | 305.65 | 322.92 | 99 | |||||||||||||||||
85 | 84.92 | 104.82 | 124.48 | 151.33 | 169.12 | 182.61 | 196.52 | 210.85 | 225.60 | 240.77 | 256.36 | 272.37 | 288.80 | 305.65 | 322.92 | 340.61 | 100 |
C-1-3 |
SCHEDULE C
US 75-80, BASIC SELECT & ULTIMATE, AGGREGATE AGE NEAREST BIRTHDAY, GENDER DISTINCT MORTALITY TABLES
PART 2 | - | FEMALE RATES |
Extended Basic US 1975-80 Select and Ultimate Automatic YRT Rates
Female Aggregate | Age Nearest Birthday |
Policy Year | Att. | |||||||||||||||||||||||||||||||||
Age | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16+ | Age | |||||||||||||||||
0 | 0.93 | 0.34 | 0.30 | 0.27 | 0.24 | 0.22 | 0.20 | 0.18 | 0.18 | 0.18 | 0.19 | 02.1 | 0.24 | 0.27 | 0.32 | 0.36 | 15 | |||||||||||||||||
1 | 0.34 | 0.30 | 0.27 | 0.24 | 0.22 | 0.20 | 0.18 | 0.18 | 0.18 | 0.19 | 0.21 | 02.4 | 0.27 | 0.32 | 0.36 | 0.40 | 16 | |||||||||||||||||
2 | 0.28 | 0.27 | 0.24 | 0.22 | 0.20 | 0.18 | 0.18 | 0.18 | 0.19 | 0.21 | 0.24 | 0.27 | 0.32 | 0.36 | 0.40 | 0.44 | 17 | |||||||||||||||||
3 | 0.24 | 0.24 | 0.22 | 0.20 | 0.18 | 0.18 | 0.18 | 0.19 | 0.21 | 0.24 | 0.27 | 0.32 | 0.36 | 0.40 | 0.44 | 0.47 | 18 | |||||||||||||||||
4 | 0.22 | 0.22 | 0.20 | 0.18 | 0.18 | 0.18 | 0.19 | 0.21 | 0.24 | 0.27 | 0.32 | 0.36 | 0.40 | 0.44 | 0.47 | 0.49 | 19 | |||||||||||||||||
5 | 0.20 | 0.20 | 0.18 | 0.18 | 0.18 | 0.19 | 0.21 | 0.24 | 0.27 | 0.32 | 0.36 | 0.40 | 0.44 | 0.47 | 0.49 | 0.51 | 20 | |||||||||||||||||
6 | 0.19 | 0.18 | 0.18 | 0.18 | 0.19 | 0.21 | 0.24 | 0.27 | 0.32 | 0.36 | 0.40 | 0.44 | 0.47 | 0.49 | 0.51 | 0.52 | 21 | |||||||||||||||||
7 | 0.17 | 0.18 | 0.18 | 0.19 | 0.21 | 0.24 | 0.27 | 0.32 | 0.36 | 0.40 | 0.44 | 0.47 | 0.49 | 0.51 | 0.52 | 0.53 | 22 | |||||||||||||||||
8 | 0.16 | 0.18 | 0.19 | 0.21 | 0.24 | 0.27 | 0.32 | 0.36 | 0.40 | 0.44 | 0.47 | 0.49 | 0.51 | 0.52 | 0.53 | 0.53 | 23 | |||||||||||||||||
9 | 0.16 | 0.19 | 0.21 | 0.24 | 0.27 | 0.32 | 0.36 | 0.40 | 0.44 | 0.47 | 0.49 | 0.51 | 0.52 | 0.53 | 0.53 | 0.53 | 24 | |||||||||||||||||
10 | 0.16 | 0.21 | 0.24 | 0.27 | 0.32 | 0.36 | 0.40 | 0.44 | 0.47 | 0.49 | 0.51 | 0.52 | 0.53 | 0.53 | 0.53 | 0.53 | 25 | |||||||||||||||||
11 | 0.17 | 0.24 | 0.27 | 0.32 | 0.36 | 0.40 | 0.44 | 0.47 | 0.49 | 0.51 | 0.52 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 26 | |||||||||||||||||
12 | 0.18 | 0.27 | 0.32 | 0.36 | 0.40 | 0.44 | 0.47 | 0.49 | 0.51 | 0.52 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 27 | |||||||||||||||||
13 | 0.21 | 0.31 | 0.35 | 0.38 | 0.42 | 0.45 | 0.47 | 0.49 | 0.52 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 28 | |||||||||||||||||
14 | 0.25 | 0.33 | 0.37 | 0.40 | 0.43 | 0.45 | 0.47 | 0.48 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.54 | 29 | |||||||||||||||||
15 | 0.28 | 0.35 | 0.39 | 0.41 | 0.43 | 0.45 | 0.46 | 0.48 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.54 | 0.55 | 30 | |||||||||||||||||
16 | 0.32 | 0.37 | 0.39 | 0.41 | 0.42 | 0.43 | 0.45 | 0.46 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.54 | 0.55 | 0.58 | 31 | |||||||||||||||||
17 | 0.36 | 0.37 | 0.39 | 0.40 | 0.41 | 0.42 | 0.43 | 0.44 | 0.53 | 0.53 | 0.53 | 0.53 | 0.54 | 0.55 | 0.58 | 0.61 | 32 | |||||||||||||||||
18 | 0.36 | 0.37 | 0.39 | 0.40 | 0.41 | 0.42 | 0.43 | 0.44 | 0.51 | 0.52 | 0.53 | 0.54 | 0.55 | 0.58 | 0.61 | 0.65 | 33 | |||||||||||||||||
19 | 0.36 | 0.37 | 0.39 | 0.40 | 0.41 | 0.42 | 0.43 | 0.44 | 0.50 | 0.50 | 0.54 | 0.55 | 0.58 | 0.61 | 0.65 | 0.70 | 34 | |||||||||||||||||
20 | 0.35 | 0.36 | 0.38 | 0.39 | 0.41 | 0.41 | 0.43 | 0.44 | 0.48 | 0.50 | 0.55 | 0.58 | 0.61 | 0.65 | 0.70 | 0.77 | 35 | |||||||||||||||||
21 | 0.34 | 0.36 | 0.37 | 0.39 | 0.40 | 0.41 | 0.43 | 0.44 | 0.47 | 0.49 | 0.58 | 0.61 | 0.65 | 0.70 | 0.77 | 0.84 | 36 | |||||||||||||||||
22 | 0.32 | 0.34 | 0.36 | 0.38 | 0.40 | 0.41 | 0.43 | 0.45 | 0.46 | 0.50 | 0.61 | 0.65 | 0.70 | 0.77 | 0.84 | 0.93 | 37 | |||||||||||||||||
23 | 0.32 | 0.34 | 0.37 | 0.39 | 0.41 | 0.42 | 0.45 | 0.46 | 0.50 | 0.55 | 0.65 | 0.70 | 0.77 | 0.84 | 0.93 | 1.03 | 38 | |||||||||||||||||
24 | 0.31 | 0.34 | 0.38 | 0.40 | 0.42 | 0.45 | 0.46 | 0.50 | 0.55 | 0.59 | 0.70 | 0.77 | 0.84 | 0.93 | 1.03 | 1.15 | 39 | |||||||||||||||||
25 | 0.31 | 0.35 | 0.39 | 0.41 | 0.44 | 0.46 | 0.50 | 0.55 | 0.59 | 0.63 | 0.77 | 0.84 | 0.93 | 1.03 | 1.15 | 1.29 | 40 | |||||||||||||||||
26 | 0.30 | 0.35 | 0.39 | 0.43 | 0.46 | 0.30 | 0.55 | 0.59 | 0.63 | 0.69 | 0.84 | 0.93 | 1.03 | 1.15 | 1.29 | 1.45 | 41 | |||||||||||||||||
27 | 0.30 | 0.35 | 0.41 | 0.45 | 0.50 | 0.55 | 0.59 | 0.63 | 0.66 | 0.76 | 0.93 | 1.03 | 1.15 | 1.29 | 1.45 | 1.62 | 42 | |||||||||||||||||
28 | 0.31 | 0.36 | 0.42 | 0.48 | 0.53 | 0.59 | 0.63 | 0.66 | 0.76 | 0.86 | 1.03 | 1.15 | 1.29 | 1.45 | 1.62 | 1.79 | 43 | |||||||||||||||||
29 | 0.32 | 0.37 | 0.44 | 0.51 | 0.57 | 0.63 | 0.66 | 0.76 | 0.86 | 0.97 | 1.15 | 1.29 | 1.45 | 1.62 | 1.79 | 1.96 | 44 | |||||||||||||||||
30 | 0.33 | 0.39 | 0.47 | 0.54 | 0.62 | 0.66 | 0.76 | 0.86 | 0.97 | 1.08 | 1.29 | 1.45 | 1.62 | 1.79 | 1.96 | 2.14 | 45 | |||||||||||||||||
31 | 0.35 | 0.41 | 0.50 | 0.59 | 0.66 | 0.76 | 0.86 | 0.97 | 1.08 | 1.19 | 1.45 | 1.62 | 1.79 | 1.96 | 2.14 | 2.33 | 46 | |||||||||||||||||
32 | 0.38 | 0.44 | 0.54 | 0.65 | 0.76 | 0.86 | 0.97 | 1.08 | 1.19 | 1.31 | 1.62 | 1.79 | 1.96 | 2.14 | 2.33 | 2.52 | 47 | |||||||||||||||||
33 | 0.39 | 0.46 | 0.57 | 0.69 | 0.82 | 0.93 | 1.07 | 1.19 | 1.31 | 1.48 | 1.77 | 1.94 | 2.12 | 2.33 | 2.52 | 2.72 | 48 | |||||||||||||||||
34 | 0.41 | 0.49 | 0.60 | 0.74 | 0.88 | 1.02 | 1.18 | 1.31 | 1.48 | 1.64 | 1.92 | 2.10 | 2.30 | 2.51 | 2.72 | 2.93 | 49 |
C-2-1 |
Extended Basic US 1975-80 Select and Ultimate Automatic YRT Rates
Female Aggregate | Age Nearest Birthday |
Policy Year | Att. | |||||||||||||||||||||||||||||||||
Age | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16+ | Age | |||||||||||||||||
35 | 0.43 | 0.51 | 0.63 | 0.79 | 0.95 | 1.12 | 1.30 | 1.48 | 1.64 | 1.81 | 2.07 | 2.27 | 2.46 | 2.71 | 2.92 | 3.17 | 50 | |||||||||||||||||
36 | 0.45 | 0.54 | 0.67 | 0.85 | 1.04 | 1.23 | 1.43 | 1.63 | 1.81 | 2.00 | 2.23 | 2.43 | 2.64 | 2.92 | 3.16 | 3.43 | 51 | |||||||||||||||||
37 | 0.48 | 0.58 | 0.71 | 0.92 | 1.13 | 1.35 | 1.56 | 1.77 | 1.98 | 2.19 | 2.39 | 2.60 | 2.82 | 3.15 | 3.42 | 3.71 | 52 | |||||||||||||||||
38 | 0.51 | 0.64 | 0.80 | 1.04 | 1.26 | 1.49 | 1.70 | 1.92 | 2.14 | 2.35 | 2.56 | 2.78 | 3.02 | 3.38 | 3.66 | 4.04 | 53 | |||||||||||||||||
39 | 0.55 | 0.72 | 0.89 | 1.16 | 1.39 | 1.63 | 1.85 | 2.08 | 2.30 | 2.52 | 2.74 | 2.98 | 3.23 | 3.62 | 3.94 | 4.40 | 54 | |||||||||||||||||
40 | 0.60 | 0.80 | 1.00 | 1.28 | 1.52 | 1.78 | 2.01 | 2.24 | 2.46 | 2.69 | 2.94 | 3.19 | 3.46 | 3.91 | 4.25 | 4.80 | 55 | |||||||||||||||||
41 | 0.65 | 0.89 | 1.10 | 1.41 | 1.66 | 1.94 | 2.17 | 2.41 | 2.63 | 2.89 | 3.15 | 3.42 | 3.72 | 4.23 | 4.58 | 5.23 | 56 | |||||||||||||||||
42 | 0.70 | 0.98 | 1.20 | 1.54 | 1.80 | 2.10 | 2.33 | 2.58 | 2.83 | 3.10 | 3.38 | 3.69 | 4.01 | 4.57 | 4.94 | 5.70 | 57 | |||||||||||||||||
43 | 0.76 | 1.05 | 1.29 | 1.63 | 1.90 | 2.20 | 2.45 | 2.74 | 3.01 | 3.31 | 3.64 | 3.98 | 4.34 | 4.94 | 5.37 | 6.22 | 58 | |||||||||||||||||
44 | 0.81 | 1.12 | 1.39 | 1.71 | 2.00 | 2.30 | 2.59 | 2.90 | 3.21 | 3.55 | 3.92 | 4.30 | 4.69 | 5.37 | 5.85 | 6.78 | 59 | |||||||||||||||||
45 | 0.86 | 1.19 | 1.48 | 1.79 | 2.10 | 2.42 | 2.73 | 3.07 | 3.43 | 3.82 | 4.23 | 4.64 | 5.07 | 5.83 | 6.36 | 7.37 | 60 | |||||||||||||||||
46 | 0.91 | 1.26 | 1.58 | 1.86 | 2.22 | 2.53 | 2.88 | 3.28 | 3.67 | 4.11 | 4.55 | 5.01 | 5.49 | 6.32 | 6.89 | 8.00 | 61 | |||||||||||||||||
47 | 0.96 | 1.33 | 1.68 | 1.95 | 2.34 | 2.65 | 3.06 | 3.49 | 3.94 | 4.41 | 4.90 | 5.41 | 5.94 | 6.84 | 7.46 | 8.67 | 62 | |||||||||||||||||
48 | 1.00 | 1.39 | 1.76 | 2.04 | 2.45 | 2.82 | 3.27 | 3.76 | 4.20 | 4.70 | 5.23 | 5.77 | 6.31 | 7.25 | 7.88 | 9.38 | 63 | |||||||||||||||||
49 | 1.05 | 1.46 | 1.83 | 2.13 | 2.58 | 3.00 | 3.50 | 4.04 | 4.48 | 5.02 | 5.57 | 6.13 | 6.70 | 7.67 | 8.30 | 10.15 | 64 | |||||||||||||||||
50 | 1.10 | 1.53 | 1.91 | 2.24 | 2.72 | 3.20 | 3.74 | 4.35 | 4.78 | 5.34 | 5.92 | 6.50 | 7.09 | 8.09 | 8.75 | 10.99 | 65 | |||||||||||||||||
51 | 1.15 | 1.60 | 2.01 | 2.35 | 2.86 | 3.40 | 4.00 | 4.68 | 5.09 | 5.67 | 6.28 | 6.88 | 7.49 | 8.53 | 9.21 | 11.91 | 66 | |||||||||||||||||
52 | 1.20 | 1.68 | 2.10 | 2.47 | 3.01 | 3.61 | 4.28 | 5.03 | 5.40 | 6.01 | 6.64 | 7.27 | 7.91 | 9.00 | 9.70 | 12.92 | 67 | |||||||||||||||||
53 | 1.26 | 1.76 | 2.22 | 2.65 | 3.23 | 3.87 | 4.57 | 5.34 | 5.77 | 6.41 | 7.05 | 7.75 | 8.47 | 9.68 | 10.50 | 14.03 | 68 | |||||||||||||||||
54 | 1.32 | 1.85 | 2.35 | 2.84 | 3.47 | 4.15 | 4.87 | 5.65 | 6.15 | 6.81 | 7.49 | 8.26 | 9.07 | 10.43 | 11.37 | 15.25 | 69 | |||||||||||||||||
55 | 1.38 | 1.93 | 2.48 | 3.05 | 3.72 | 4.43 | 5.18 | 5.97 | 6.55 | 7.25 | 7.96 | 8.81 | 9.72 | 11.24 | 12.33 | 16.63 | 70 | |||||||||||||||||
56 | 1.45 | 2.02 | 2.62 | 3.27 | 3.97 | 4.72 | 5.50 | 6.29 | 6.97 | 7.71 | 8.46 | 9.40 | 10.43 | 12.13 | 13.41 | 18.21 | 71 | |||||||||||||||||
57 | 1.51 | 2.11 | 2.76 | 3.49 | 4.24 | 5.02 | 5.82 | 6.62 | 7.42 | 8.21 | 9.00 | 10.04 | 11.20 | 13.13 | 14.65 | 20.04 | 72 | |||||||||||||||||
58 | 1.63 | 2.29 | 2.99 | 3.76 | 4.54 | 5.34 | 6.18 | 7.03 | 7.88 | 8.71 | 9.76 | 10.86 | 12.11 | 14.18 | 15.84 | 22.17 | 73 | |||||||||||||||||
59 | 1.75 | 2.48 | 3.24 | 4.04 | 4.85 | 5.69 | 6.57 | 7.46 | 8.36 | 9.25 | 10.60 | 11.79 | 13.14 | 15.40 | 17.21 | 24.65 | 74 | |||||||||||||||||
60 | 1.88 | 2.68 | 3.50 | 4.34 | 5.18 | 6.06 | 6.98 | 7.93 | 8.89 | 9.83 | 11.55 | 12.85 | 14.33 | 16.80 | 18.78 | 27.53 | 75 | |||||||||||||||||
61 | 2.01 | 2.90 | 3.77 | 4.66 | 5.54 | 6.45 | 7.42 | 8.43 | 9.45 | 10.47 | 12.64 | 14.08 | 15.70 | 18.42 | 20.59 | 30.86 | 76 | |||||||||||||||||
62 | 2.15 | 3.12 | 4.07 | 5.01 | 5.93 | 6.88 | 7.90 | 8.97 | 10.07 | 11.19 | 13.90 | 15.50 | 17.30 | 20.28 | 22.64 | 34.96 | 77 | |||||||||||||||||
63 | 2.27 | 3.27 | 4.26 | 5.24 | 6.21 | 7.22 | 8.30 | 9.49 | 10.75 | 12.11 | 15.04 | 16.80 | 18.79 | 22.08 | 24.73 | 39.07 | 78 | |||||||||||||||||
64 | 2.40 | 3.43 | 4.46 | 5.48 | 6.50 | 7.57 | 8.75 | 10.07 | 11.53 | 13.17 | 16.34 | 18.28 | 20.47 | 20.49 | 27.05 | 44.00 | 79 | |||||||||||||||||
65 | 2.59 | 3.59 | 4.66 | 5.73 | 6.80 | 7.95 | 9.24 | 10.72 | 12.43 | 14.38 | 17.83 | 19.94 | 22.34 | 26.30 | 29.55 | 49.48 | 80 | |||||||||||||||||
66 | 2.67 | 3.76 | 4.88 | 5.99 | 7.12 | 8.37 | 9.80 | 11.47 | 13.45 | 15.78 | 19.51 | 21.81 | 24.41 | 28.69 | 32.20 | 55.51 | 81 | |||||||||||||||||
67 | 2.82 | 3.94 | 5.10 | 6.27 | 7.48 | 8.85 | 10.43 | 12.32 | 14.61 | 17.37 | 21.40 | 23.87 | 26.64 | 31.21 | 34.98 | 62.09 | 82 | |||||||||||||||||
68 | 3.06 | 4.28 | 5.56 | 6.87 | 8.23 | 9.79 | 11.60 | 13.76 | 16.38 | 19.53 | 23.87 | 26.64 | 29.96 | 34.98 | 39.13 | 69.22 | 83 | |||||||||||||||||
69 | 3.33 | 4.67 | 6.09 | 7.56 | 9.11 | 10.89 | 12.95 | 15.42 | 18A1 | 21.99 | 26.64 | 29.96 | 33.61 | 39.13 | 43.62 | 76.90 | 84 |
C-2-2 |
Extended Basic US 1975-80 Select and Ultimate Automatic YRT Rates
Female Aggregate | Age Nearest Birthday |
Policy Year | Att. | |||||||||||||||||||||||||||||||||
Age | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16+ | Age | |||||||||||||||||
70 | 3.63 | 5.11 | 6.70 | 8.36 | 10.13 | 12.16 | 14.52 | 17.34 | 20.73 | 24.77 | 29.96 | 33.61 | 37.59 | 43.62 | 48.46 | 85.18 | 85 | |||||||||||||||||
71 | 5.01 | 7.70 | 10.44 | 13.52 | 16.24 | 19.36 | 24.15 | 28.95 | 35.02 | 41.07 | 47.96 | 55.76 | 64.57 | 74.44 | 85.13 | 93.91 | 86 | |||||||||||||||||
72 | 6.01 | 8.87 | 12.38 | 15.87 | 19.26 | 23.05 | 28.68 | 34.23 | 41.07 | 47.96 | 55.76 | 64.51 | 74.32 | 85.13 | 93.91 | 103.24 | 87 | |||||||||||||||||
73 | 7.20 | 10.35 | 14.68 | 18.73 | 22.84 | 27.42 | 33.97 | 40.33 | 47.96 | 55.76 | 64.51 | 74.28 | 85.13 | 93.91 | 103.24 | 113.12 | 88 | |||||||||||||||||
74 | 8.63 | 12.39 | 17.32 | 22.10 | 27.06 | 32.52 | 40.08 | 47.30 | 55.76 | 64.51 | 74.28 | 85.13 | 93.91 | 103.24 | 113.12 | 123.55 | 89 | |||||||||||||||||
75 | 10.32 | 14.81 | 20.43 | 26.07 | 31.97 | 38.41 | 47.07 | 55.20 | 64.51 | 74.28 | 85.13 | 93.91 | 103.24 | 113.12 | 123.55 | 134.53 | 90 | |||||||||||||||||
76 | 12.34 | 17.69 | 24.09 | 30.69 | 37.65 | 45.16 | 55.01 | 64.10 | 74.28 | 85.13 | 93.91 | 103.24 | 113.12 | 123.55 | 134.53 | 146.06 | 91 | |||||||||||||||||
77 | 14.74 | 20.71 | 28.36 | 36.01 | 44.13 | 52.83 | 63.96 | 74.06 | 85.13 | 93.91 | 103.24 | 113.12 | 123.55 | 134.53 | 146.06 | 158.14 | 92 | |||||||||||||||||
78 | 17.58 | 24.64 | 33.26 | 42.08 | 51.48 | 61.48 | 73.98 | 85.13 | 93.91 | 103.24 | 113.12 | 123.55 | 134.53 | 146.06 | 158.14 | 170.77 | 93 | |||||||||||||||||
79 | 21.12 | 29.19 | 38.86 | 48.95 | 59.76 | 71.17 | 85.13 | 93.91 | 103.24 | 113.12 | 123.55 | 134.53 | 146.06 | 158.14 | 170.77 | 183.95 | 94 | |||||||||||||||||
80 | 25.23 | 32.42 | 45.19 | 56.66 | 69.02 | 81.96 | 93.91 | 103.24 | 113.12 | 123.55 | 134.53 | 146.06 | 158.14 | 170.77 | 183.95 | 197.68 | 95 | |||||||||||||||||
81 | 29.98 | 40.36 | 52.30 | 65.27 | 79.31 | 93.91 | 103.24 | 113.12 | 123.55 | 134.53 | 146.06 | 158.14 | 170.77 | 183.95 | 197.68 | 211.96 | 96 | |||||||||||||||||
82 | 35.39 | 47.07 | 60.24 | 74.83 | 90.70 | 103.24 | 113.12 | 123.55 | 134.53 | 146.06 | 158.14 | 170.77 | 183.95 | 197.68 | 211.96 | 226.79 | 97 | |||||||||||||||||
83 | 41.53 | 54.60 | 69.05 | 85.39 | 103.24 | 113.12 | 123.55 | 134.53 | 146.06 | 158.14 | 170.77 | 183.95 | 197.68 | 211.96 | 226.79 | 242.17 | 98 | |||||||||||||||||
84 | 49.99 | 63.00 | 78.78 | 97.00 | 113.12 | 123.55 | 134.53 | 146.06 | 158.14 | 170.77 | 183.95 | 197.68 | 211.96 | 226.79 | 242.17 | 258.10 | 99 | |||||||||||||||||
85 | 59.59 | 74.19 | 89.47 | 109.70 | 123.55 | 134.53 | 146.06 | 158.14 | 170.77 | 183.95 | 197.68 | 211.96 | 226.79 | 242.17 | 258.10 | 274.58 | 100 |
C-2-3 |
SCHEDULE
D
US 75-80, BASIC SELECT & ULTIMATE, AGGREGATE AGE LAST BIRTHDAY, GENDER DISTINCT MORTALITY TABLES
PART 1 | - | MALE RATES |
Extended Basic US 1975-80 Select and Ultimate Automatic YRT Rates
Male Aggregate | Age Last Birthday |
Policy Year | Att. | |||||||||||||||||||||||||||||||||
Age | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16+ | Age | |||||||||||||||||
0 | 1.12 | 0.70 | 0.47 | 0.37 | 0.32 | 0.31 | 0.28 | 0.27 | 0.27 | 0.28 | 0.33 | 0.38 | 0.46 | 0.66 | 0.85 | 0.85 | 15 | |||||||||||||||||
1 | 0.46 | 0.43 | 0.38 | 0.27 | 0.23 | 0.23 | 0.23 | 0.25 | 0.28 | 0.33 | 0.38 | 0.46 | 0.66 | 0.80 | 1.08 | 1.08 | 16 | |||||||||||||||||
2 | 0.34 | 0.35 | 0.31 | 0.23 | 0.23 | 0.23 | 0.25 | 0.28 | 0.33 | 0.38 | 0.46 | 0.62 | 0.80 | 1.04 | 1.18 | 1.18 | 17 | |||||||||||||||||
3 | 0.33 | 0.28 | 0.25 | 0.23 | 0.21 | 0.25 | 0.28 | 0.33 | 0.38 | 0.46 | 0.61 | 0.74 | 1.04 | 1.17 | 1.27 | 1.27 | 18 | |||||||||||||||||
4 | 0.28 | 0.24 | 0.23 | 0.21 | 0.25 | 0.28 | 0.33 | 0.38 | 0.44 | 0.61 | 0.74 | 0.95 | 1.11 | 1.26 | 1.34 | 1.34 | 19 | |||||||||||||||||
5 | 0.23 | 0.23 | 0.23 | 0.25 | 0.28 | 0.33 | 0.38 | 0.43 | 0.61 | 0.74 | 0.95 | 1.08 | 1.17 | 1.32 | 1.39 | 1.39 | 20 | |||||||||||||||||
6 | 0.22 | 0.22 | 0.21 | 0.28 | 0.33 | 0.38 | 0.43 | 0.58 | 0.74 | 0.95 | 1.08 | 1.15 | 1.21 | 1.36 | 1.41 | 1.41 | 21 | |||||||||||||||||
7 | 0.19 | 0.21 | 0.25 | 0.33 | 0.38 | 0.43 | 0.57 | 0.72 | 0.91 | 1.08 | 1.15 | 1.20 | 1.23 | 1.38 | 1.41 | 1.41 | 22 | |||||||||||||||||
8 | 0.19 | 0.21 | 0.26 | 0.37 | 0.43 | 0.57 | 0.72 | 0.91 | 1.06 | 1.15 | 1.20 | 1.23 | 1.28 | 1.37 | 1.39 | 1.39 | 23 | |||||||||||||||||
9 | 0.20 | 0.23 | 0.30 | 0.43 | 0.57 | 0.72 | 0.91 | 1.06 | 1.14 | 1.20 | 1.23 | 1.28 | 1.32 | 1.34 | 1.36 | 1.36 | 24 | |||||||||||||||||
10 | 0.21 | 0.27 | 0.34 | 0.57 | 0.72 | 0.91 | 1.06 | 1.14 | 1.19 | 1.23 | 1.28 | 1.32 | 1.33 | 1.30 | 1.32 | 1.32 | 25 | |||||||||||||||||
11 | 0.26 | 0.32 | 0.40 | 0.72 | 0.91 | 1.06 | 1.14 | 1.19 | 1.23 | 1.28 | 1.32 | 1.33 | 1.28 | 1.25 | 1.27 | 1.27 | 26 | |||||||||||||||||
12 | 0.31 | 0.40 | 0.57 | 0.90 | 1.06 | 1.14 | 1.19 | 1.22 | 1.28 | 1.32 | 1.33 | 1.28 | 1.23 | 1.19 | 1.22 | 1.22 | 27 | |||||||||||||||||
13 | 0.38 | 0.57 | 0.72 | 1.02 | 1.12 | 1.18 | 1.21 | 1.22 | 1.26 | 1.28 | 1.28 | 1.23 | 1.18 | 1.15 | 1.19 | 1.19 | 28 | |||||||||||||||||
14 | 0.55 | 0.72 | 0.90 | 1.08 | 1.16 | 1.20 | 1.21 | 1.20 | 1.22 | 1.22 | 1.22 | 1.17 | 1.14 | 1.13 | 1.16 | 1.16 | 29 | |||||||||||||||||
15 | 0.72 | 0.90 | 1.02 | 1.13 | 1.17 | 1.20 | 1.19 | 1.17 | 1.17 | 1.16 | 1.16 | 1.12 | 1.11 | 1.11 | 1.13 | 1.13 | 30 | |||||||||||||||||
16 | 0.90 | 1.02 | 1.08 | 1.17 | 1.17 | 1.18 | 1.15 | 1.13 | 1.11 | 1.10 | 1.09 | 1.08 | 1.09 | 1.09 | 1.12 | 1.12 | 31 | |||||||||||||||||
17 | 1.02 | 1.08 | 1.13 | 1.16 | 1.14 | 1.14 | 1.11 | 1.08 | 1.05 | 1.03 | 1.05 | 1.04 | 1.06 | 1.09 | 1.12 | 1.12 | 32 | |||||||||||||||||
18 | 1.01 | 1.06 | 1.09 | 1.10 | 1.07 | 1.07 | 1.04 | 1.01 | 0.99 | 0.99 | 1.01 | 1.00 | 1.04 | 1.09 | 1.13 | 1.13 | 33 | |||||||||||||||||
19 | 0.97 | 1.01 | 1.02 | 1.02 | 1.00 | 0.99 | 0.96 | 0.95 | 0.95 | 0.96 | 0.97 | 0.98 | 1.03 | 1.09 | 1.16 | 1.16 | 34 | |||||||||||||||||
20 | 0.91 | 0.94 | 0.94 | 0.94 | 0.93 | 0.91 | 0.89 | 0.90 | 0.91 | 0.93 | 0.95 | 0.98 | 1.03 | 1.12 | 1.20 | 1.20 | 35 | |||||||||||||||||
21 | 0.83 | 0.85 | 0.85 | 0.86 | 0.85 | 0.83 | 0.86 | 0.86 | 0.87 | 0.91 | 0.94 | 0.97 | 1.05 | 1.16 | 1.25 | 1.25 | 36 | |||||||||||||||||
22 | 0.73 | 0.75 | 0.75 | 0.77 | 0.77 | 0.77 | 0.78 | 0.81 | 0.85 | 0.90 | 0.94 | 0.99 | 1.08 | 1.20 | 1.32 | 1.32 | 37 | |||||||||||||||||
23 | 0.73 | 0.74 | 0.74 | 0.76 | 0.77 | 0.77 | 0.78 | 0.82 | 0.87 | 0.92 | 0.98 | 1.04 | 1.14 | 1.27 | 1.41 | 1.41 | 38 | |||||||||||||||||
24 | 0.73 | 0.73 | 0.73 | 0.76 | 0.77 | 0.78 | 0.80 | 0.84 | 0.90 | 0.96 | 1.03 | 1.10 | 1.22 | 1.36 | 1.51 | 1.51 | 39 | |||||||||||||||||
25 | 0.71 | 0.71 | 0.72 | 0.75 | 0.77 | 0.80 | 0.82 | 0.87 | 0.95 | 1.01 | 1.09 | 1.18 | 1.33 | 1.47 | 1.63 | 1.63 | 40 | |||||||||||||||||
26 | 0.70 | 0.69 | 0.71 | 0.75 | 0.78 | 0.82 | 0.85 | 0.92 | 1.00 | 1.07 | 1.16 | 1.29 | 1.44 | 1.59 | 1.79 | 1.79 | 41 | |||||||||||||||||
27 | 0.68 | 0.68 | 0.71 | 0.76 | 0.80 | 0.85 | 0.90 | 0.97 | 1.07 | 1.15 | 1.26 | 1.40 | 1.58 | 1.75 | 1.97 | 1.97 | 42 | |||||||||||||||||
28 | 0.66 | 0.68 | 0.72 | 0.80 | 0.84 | 0.90 | 0.97 | 1.06 | 1.15 | 1.26 | 1.38 | 1.53 | 1.74 | 1.94 | 2.19 | 2.19 | 43 | |||||||||||||||||
29 | 0.65 | 0.68 | 0.75 | 0.84 | 0.90 | 0.97 | 1.06 | 1.15 | 1.26 | 1.38 | 1.52 | 1.70 | 1.94 | 2.17 | 2.45 | 2.45 | 44 | |||||||||||||||||
30 | 0.63 | 0.68 | 0.78 | 0.90 | 0.97 | 1.06 | 1.15 | 1.25 | 1.38 | 1.52 | 1.70 | 1.94 | 2.17 | 2.42 | 2.74 | 2.74 | 45 | |||||||||||||||||
31 | 0.63 | 0.70 | 0.82 | 0.97 | 1.06 | 1.15 | 1.25 | 1.38 | 1.52 | 1.70 | 1.94 | 2.17 | 2.42 | 2.71 | 3.07 | 3.07 | 46 | |||||||||||||||||
32 | 0.63 | 0.72 | 0.87 | 1.06 | 1.15 | 1.25 | 1.38 | 1.51 | 1.70 | 1.94 | 2.17 | 2.42 | 2.71 | 3.03 | 3.43 | 3.43 | 47 | |||||||||||||||||
33 | 0.63 | 0.74 | 0.91 | 1.14 | 1.25 | 1.36 | 1.50 | 1.67 | 1.87 | 2.14 | 2.41 | 2.69 | 3.03 | 3.39 | 3.82 | 3.82 | 48 | |||||||||||||||||
34 | 0.64 | 0.76 | 0.96 | 1.24 | 1.36 | 1.49 | 1.66 | 1.86 | 2.10 | 2.37 | 2.67 | 3.00 | 3.38 | 3.77 | 4.24 | 4.24 | 49 |
D-1-1 |
Extended Basic US 1975-80 Select and Ultimate Automatic YRT Rates
Male Aggregate | Age Last Birthday |
Policy Year | Att. | |||||||||||||||||||||||||||||||||
Age | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16+ | Age | |||||||||||||||||
35 | 0.65 | 0.79 | 1.03 | 1.20 | 1.35 | 1.49 | 1.66 | 1.86 | 2.10 | 2.33 | 2.63 | 2.96 | 3.34 | 3.75 | 4.19 | 4.69 | 50 | |||||||||||||||||
36 | 0.67 | 0.83 | 1.12 | 1.31 | 1.49 | 1.66 | 1.86 | 2.10 | 2.33 | 2.63 | 2.92 | 3.28 | 3.70 | 4.16 | 4.63 | 5.18 | 51 | |||||||||||||||||
37 | 0.70 | 0.88 | 1.21 | 1.44 | 1.66 | 1.86 | 2.10 | 2.33 | 2.63 | 2.92 | 3.23 | 3.62 | 4.09 | 4.59 | 5.12 | 5.72 | 52 | |||||||||||||||||
38 | 0.74 | 0.94 | 1.29 | 1.55 | 1.78 | 2.01 | 2.27 | 2.52 | 2.84 | 3.16 | 3.52 | 3.96 | 4.49 | 5.06 | 5.64 | 6.31 | 53 | |||||||||||||||||
39 | 0.78 | 1.00 | 1.40 | 1.68 | 1.93 | 2.18 | 2.45 | 2.72 | 3.06 | 3.41 | 3.82 | 4.31 | 4.92 | 5.37 | 6.22 | 6.94 | 54 | |||||||||||||||||
40 | 0.83 | 1.09 | 1.53 | 1.83 | 2.11 | 2.36 | 2.65 | 2.93 | 3.27 | 3.67 | 4.12 | 4.69 | 5.39 | 6.13 | 6.82 | 7.64 | 55 | |||||||||||||||||
41 | 0.89 | 1.20 | 1.68 | 2.01 | 2.29 | 2.56 | 2.86 | 3.14 | 3.49 | 3.92 | 4.45 | 5.09 | 5.90 | 6.72 | 7.50 | 8.42 | 56 | |||||||||||||||||
42 | 0.97 | 1.32 | 1.86 | 2.21 | 2.50 | 2.77 | 3.06 | 3.35 | 3.70 | 4.18 | 4.79 | 5.53 | 6.44 | 7.38 | 8.25 | 9.28 | 57 | |||||||||||||||||
43 | 1.05 | 1.46 | 2.02 | 2.41 | 2.74 | 3.04 | 3.35 | 3.66 | 4.03 | 4.55 | 5.21 | 5.99 | 6.96 | 7.97 | 8.93 | 10.24 | 58 | |||||||||||||||||
44 | 1.14 | 1.62 | 2.20 | 2.63 | 2.98 | 3.32 | 3.66 | 3.98 | 4.39 | 4.94 | 5.66 | 6.30 | 7.54 | 8.60 | 9.67 | 11.32 | 59 | |||||||||||||||||
45 | 1.23 | 1.81 | 2.39 | 2.85 | 3.24 | 3.61 | 3.98 | 4.34 | 4.77 | 5.35 | 6.15 | 7.06 | 8.16 | 9.30 | 10.49 | 12..53 | 60 | |||||||||||||||||
46 | 1.33 | 2.00 | 2.58 | 3.08 | 3.51 | 3.92 | 4.34 | 4.73 | 5.17 | 5.80 | 6.68 | 7.66 | 8.83 | 10.06 | 11.39 | 13.87 | 61 | |||||||||||||||||
47 | 1.44 | 2.21 | 2.77 | 3.31 | 3.79 | 4.26 | 4.73 | 5.12 | 5.61 | 6.29 | 7.26 | 8.32 | 9.58 | 10.89 | 12.36 | 15.32 | 62 | |||||||||||||||||
48 | 1.55 | 2.32 | 2.90 | 3.48 | 4.02 | 4.53 | 5.06 | 5.54 | 6.13 | 6.89 | 8.04 | 9.23 | 10.57 | 11.94 | 13.41 | 16.89 | 63 | |||||||||||||||||
49 | 1.66 | 2.42 | 3.03 | 3.64 | 4.24 | 4.81 | 5.41 | 5.99 | 6.69 | 7.55 | 8.91 | 10.26 | 11.67 | 13.06 | 14.53 | 18.61 | 64 | |||||||||||||||||
50 | 1.77 | 2.51 | 3.15 | 3.80 | 4.46 | 5.09 | 5.78 | 6.48 | 7.31 | 8.30 | 9.90 | 11.41 | 12.85 | 14.25 | 15.72 | 20.49 | 65 | |||||||||||||||||
51 | 1.88 | 2.59 | 3.26 | 3.94 | 4.69 | 5.39 | 6.18 | 7.02 | 8.01 | 9.13 | 10.99 | 12.65 | 14.12 | 15.54 | 16.98 | 22.56 | 66 | |||||||||||||||||
52 | 1.99 | 2.66 | 3.35 | 4.08 | 4.92 | 5.70 | 6.60 | 7.61 | 8.78 | 10.04 | 12.18 | 14.00 | 15.51 | 16.94 | 18.35 | 24.85 | 67 | |||||||||||||||||
53 | 2.15 | 2.89 | 3.66 | 4.47 | 5.38 | 6.22 | 7.22 | 8.32 | 9.57 | 10.98 | 13.29 | 15.31 | 16.94 | 18.35 | 20.53 | 27.37 | 68 | |||||||||||||||||
54 | 2.31 | 3.13 | 4.00 | 4.90 | 5.89 | 6.81 | 7.90 | 9.09 | 10.42 | 11.98 | 14.48 | 16.73 | 18.35 | 20.53 | 22.96 | 30.13 | 69 | |||||||||||||||||
55 | 2.49 | 3.40 | 4.37 | 5.37 | 6.47 | 7.46 | 8.65 | 9.91 | 11.31 | 13.06 | 15.77 | 18.29 | 20.53 | 22.85 | 25.67 | 33.13 | 70 | |||||||||||||||||
56 | 2.68 | 3.70 | 4.78 | 5.91 | 7.10 | 8.16 | 9.44 | 10.78 | 12.26 | 14.23 | 17.18 | 19.99 | 22.70 | 25.23 | 28.65 | 36.34 | 71 | |||||||||||||||||
57 | 2.89 | 4.02 | 5.24 | 6.50 | 7.80 | 8.92 | 10.29 | 11.72 | 13.29 | 15.50 | 18.71 | 21.85 | 24.96 | 27.83 | 31.89 | 39.80 | 72 | |||||||||||||||||
58 | 3.05 | 4.30 | 5.78 | 7.12 | 8.58 | 9.62 | 11.05 | 12.58 | 14.24 | 16.56 | 19.88 | 23.10 | 26.39 | 29.47 | 33.93 | 43.57 | 73 | |||||||||||||||||
59 | 3.22 | 4.60 | 6.37 | 7.78 | 9.42 | 10.36 | 11.84 | 13.48 | 15.26 | 17.68 | 21.09 | 24.35 | 27.80 | 31.11 | 36.05 | 47.72 | 74 | |||||||||||||||||
60 | 3.40 | 4.91 | 7.01 | 8.49 | 10.34 | 11.15 | 12.69 | 14.45 | 16.34 | 18.85 | 22.31 | 25.55 | 29.18 | 32.79 | 38.29 | 52.31 | 75 | |||||||||||||||||
61 | 3.57 | 5.22 | 7.69 | 9.25 | 11.15 | 12.44 | 13.59 | 15.48 | 17.47 | 20.04 | 23.51 | 26.72 | 30.56 | 34.52 | 40.66 | 57.37 | 76 | |||||||||||||||||
62 | 3.74 | 5.54 | 8.44 | 10.07 | 12.44 | 12.89 | 14.54 | 16.56 | 18.64 | 21.24 | 24.70 | 27.87 | 31.96 | 36.31 | 43.15 | 62.94 | 77 | |||||||||||||||||
63 | 4.15 | 6.18 | 9.21 | 11.19 | 12.89 | 14.50 | 16.42 | 18.63 | 21.03 | 23.56 | 27.15 | 30.60 | 35.16 | 40.29 | 47.22 | 69.02 | 78 | |||||||||||||||||
64 | 4.59 | 6.88 | 10.04 | 12.43 | 14.50 | 16.29 | 18.52 | 20.91 | 23.56 | 26.17 | 29.85 | 33.67 | 38.70 | 44.72 | 51.64 | 75.60 | 79 | |||||||||||||||||
65 | 5.08 | 7.66 | 10.96 | 13.82 | 16.29 | 18.27 | 20.82 | 23.41 | 26.17 | 29.29 | 33.67 | 36.95 | 42.60 | 49.60 | 56.42 | 82.69 | 80 | |||||||||||||||||
66 | 5.63 | 8.53 | 11.96 | 15.34 | 18.27 | 20.62 | 23.35 | 26.17 | 29.29 | 33.67 | 36.18 | 40.63 | 46.88 | 54.95 | 61.55 | 90.24 | 81 | |||||||||||||||||
67 | 6.23 | 9.50 | 13.04 | 17.02 | 20.62 | 22.82 | 26.17 | 29.29 | 33.67 | 35.69 | 39.85 | 44.66 | 51.53 | 60.78 | 66.99 | 98.24 | 82 | |||||||||||||||||
68 | 6.86 | 10.46 | 14.34 | 18.67 | 22.58 | 24.98 | 28.66 | 32.11 | 35.69 | 39.16 | 43.70 | 48.92 | 56.36 | 66.33 | 72.93 | 106.88 | 83 | |||||||||||||||||
69 | 7.55 | 11.50 | 15.73 | 20.45 | 24.72 | 27.36 | 31.42 | 35.21 | 39.16 | 42.94 | 47.87 | 53.51 | 61.51 | 72.21 | 79.34 | 116.36 | 84 |
D-1-2 |
Extended Basic US 1975-80 Select and Ultimate Automatic YRT Rates
Male Aggregate | Age Last Birthday |
Policy Year | Att. | |||||||||||||||||||||||||||||||||
Age | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16+ | Age | |||||||||||||||||
70 | 8.31 | 12.61 | 17.23 | 22.38 | 27.08 | 29.99 | 34.46 | 38.63 | 42.94 | 47.03 | 52.35 | 58.39 | 66.96 | 78.56 | 86.38 | 126.68 | 85 | |||||||||||||||||
71 | 10.47 | 15.62 | 21.23 | 26.87 | 31.79 | 37.10 | 45.06 | 52.48 | 61.52 | 70.10 | 79.36 | 89.95 | 101.57 | 114.38 | 126.68 | 137.84 | 86 | |||||||||||||||||
72 | 12.46 | 17.88 | 24.74 | 30.99 | 36.83 | 43.05 | 52.03 | 60.28 | 70.10 | 79.56 | 89.95 | 101.50 | 114.49 | 126.68 | 137.84 | 149.84 | 87 | |||||||||||||||||
73 | 14.73 | 20.79 | 28.66 | 35.72 | 42.56 | 49.78 | 59.87 | 68.99 | 79.56 | 89.95 | 101.50 | 114.47 | 126.68 | 137.84 | 149.84 | 162.59 | 88 | |||||||||||||||||
74 | 17.32 | 24.36 | 33.02 | 41.10 | 49.03 | 57.35 | 68.62 | 78.63 | 89.95 | 101.50 | 114.47 | 126.68 | 137.84 | 149.84 | 162.59 | 175.87 | 89 | |||||||||||||||||
75 | 20.30 | 28.44 | 37.98 | 47.15 | 56.29 | 65.81 | 78.31 | 89.23 | 101.50 | 114.47 | 126.68 | 137.84 | 149.84 | 162.59 | 175.87 | 18937 | 90 | |||||||||||||||||
76 | 23.70 | 32.76 | 43.56 | 53.93 | 64.39 | 75.18 | 88.98 | 101.03 | 114.47 | 126.68 | 137.84 | 149.84 | 162.59 | 175.87 | 189.57 | 203.69 | 91 | |||||||||||||||||
77 | 27.57 | 37.66 | 49.82 | 61.49 | 73.35 | 85.50 | 100.87 | 114.30 | 126.68 | 137.84 | 149.84 | 16239 | 175.87 | 189.57 | 203.69 | 218.23 | 92 | |||||||||||||||||
78 | 32.14 | 43.52 | 56.79 | 69.83 | 83.20 | 97.00 | 114.24 | 126.68 | 137.84 | 149.84 | 162.59 | 175.87 | 189.57 | 203.69 | 218.23 | 233.19 | 93 | |||||||||||||||||
79 | 37.47 | 50.08 | 64.48 | 78.99 | 94.18 | 109.95 | 126.68 | 137.84 | 149.84 | 162.59 | 175.87 | 189.57 | 203.69 | 218.23 | 233.19 | 248.57 | 94 | |||||||||||||||||
80 | 43.47 | 57.36 | 72.91 | 89.17 | 106.51 | 124.42 | 137.84 | 149.84 | 162.59 | 175.87 | 189.57 | 203.69 | 218.23 | 233.19 | 248.57 | 264.37 | 95 | |||||||||||||||||
81 | 50.14 | 65.39 | 82.30 | 100.60 | 120.28 | 137.84 | 149:84 | 16239 | 175.87 | 189.57 | 203.69 | 218.23 | 233.19 | 248.57 | 264.37 | 280.59 | 96 | |||||||||||||||||
82 | 57.53 | 74.35 | 92.83 | 113.35 | 135.58 | 149.84 | 162.59 | 175.87 | 189.57 | 203.69 | 218.23 | 233.19 | 248.57 | 264.37 | 280.59 | 297.23 | 97 | |||||||||||||||||
83 | 66.91 | 84.44 | 104.59 | 127.51 | 149.84 | 162.59 | 175.87 | 189.57 | 203.69 | 218.23 | 233.19 | 248.57 | 264.37 | 280.39 | 297.23 | 314.29 | 98 | |||||||||||||||||
84 | 78.67 | 97.04 | 117.63 | 143.14 | 162.59 | 175.87 | 189.57 | 203.69 | 218.23 | 233.19 | 248.57 | 264.37 | 280.59 | 297.23 | 314.29 | 331.77 | 99 | |||||||||||||||||
85 | 91.98 | 111.05 | 132.03 | 160.23 | 175.87 | 189.57 | 203.69 | 218.23 | 233.19 | 248.57 | 264.37 | 280.59 | 297.23 | 314.29 | 331.77 | 349.67 | 100 |
D-1-3 |
SCHEDULE D
US 75-80, BASIC SELECT & ULTIMATE,
AGGREGATE AGE LAST BIRTHDAY,
GENDER DISTINCT MORTALITY TABLES
PART 2 | - | FEMALE RATES |
Extended Basic US 1975-80 Select and Ultimate Automatic YRT Rates
Female Aggregate | Age Nearest Birthday |
Policy Year | Att. | |||||||||||||||||||||||||||||||||
Age | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16+ | Age | |||||||||||||||||
0 | 0.84 | 0.33 | 0.30 | 0.27 | 0.24 | 0.22 | 0.20 | 0.18 | 0.19 | 0.19 | 0.21 | 0.23 | 0.26 | 0.29 | 0.34 | 0.38 | 15 | |||||||||||||||||
1 | 0.32 | 0.29 | 0.26 | 0.23 | 0.22 | 0.20 | 0.18 | 0.19 | 0.19 | 0.21 | 0.23 | 0.26 | 0.29 | 0.34 | 0.38 | 0.42 | 16 | |||||||||||||||||
2 | 0.27 | 0.26 | 0.23 | 0.22 | 0.20 | 0.18 | 0.19 | 0.19 | 0.21 | 0.23 | 0.26 | 0.29 | 0.34 | 0.38 | 0.42 | 0.46 | 17 | |||||||||||||||||
3 | 0.23 | 0.23 | 0.22 | 0.20 | 0.18 | 0.19 | 0.19 | 0.21 | 0.23 | 0.26 | 0.29 | 0.34 | 0.38 | 0.41 | 0.45 | 0.48 | 18 | |||||||||||||||||
4 | 0.21 | 0.21 | 0.20 | 0.18 | 0.19 | 0.19 | 0.21 | 0.23 | 0.26 | 0.29 | 0.34 | 0.38 | 0.41 | 0.45 | 0.48 | 0.50 | 19 | |||||||||||||||||
5 | 0.20 | 0.20 | 0.18 | 0.19 | 0.19 | 0.21 | 0.23 | 0.26 | 0.29 | 0.34 | 0.38 | 0.41 | 0.45 | 0.48 | 0.49 | 0.52 | 20 | |||||||||||||||||
6 | 0.18 | 0.18 | 0.19 | 0.19 | 0.21 | 0.23 | 0.26 | 0.29 | 0.34 | 0.38 | 0.41 | 0.45 | 0.48 | 0.49 | 0.51 | 0.53 | 21 | |||||||||||||||||
7 | 0.17 | 0.19 | 0.19 | 0.21 | 0.23 | 0.26 | 0.29 | 0.34 | 0.38 | 0.41 | 0.45 | 0.48 | 0.49 | 0.51 | 0.52 | 0.53 | 22 | |||||||||||||||||
8 | 0.17 | 0.19 | 0.21 | 0.23 | 0.26 | 0.29 | 0.34 | 0.38 | 0.41 | 0.45 | 0.47 | 0.49 | 0.51 | 0.52 | 0.53 | 0.53 | 23 | |||||||||||||||||
9 | 0.17 | 0.21 | 0.23 | 0.25 | 0.28 | 0.33 | 0.38 | 0.41 | 0.45 | 0.47 | 0.49 | 0.51 | 0.52 | 0.53 | 0.53 | 0.53 | 24 | |||||||||||||||||
10 | 0.18 | 0.23 | 0.25 | 0.28 | 0.33 | 0.37 | 0.41 | 0.45 | 0.47 | 0.49 | 0.51 | 0.52 | 0.53 | 0.53 | 0.53 | 0.53 | 25 | |||||||||||||||||
11 | 0.18 | 0.25 | 0.28 | 0.33 | 0.37 | 0.41 | 0.45 | 0.47 | 0.49 | 0.51 | 0.52 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 26 | |||||||||||||||||
12 | 0.20 | 0.28 | 0.33 | 0.36 | 0.40 | 0.44 | 0.47 | 0.49 | 0.51 | 0.52 | 0.53 | 0.53 | 0.53 | 0.53 | 0.54 | 0.53 | 27 | |||||||||||||||||
13 | 0.22 | 0.32 | 0.35 | 0.38 | 0.42 | 0.44 | 0.47 | 0.49 | 0.52 | 0.52 | 0.53 | 0.53 | 0.53 | 0.53 | 0.54 | 0.54 | 28 | |||||||||||||||||
14 | 0.26 | 0.34 | 0.38 | 0.40 | 0.42 | 0.45 | 0.47 | 0.49 | 0.52 | 0.52 | 0.53 | 0.53 | 0.53 | 0.54 | 0.54 | 0.55 | 29 | |||||||||||||||||
15 | 0.30 | 0.36 | 0.39 | 0.40 | 0.42 | 0.45 | 0.47 | 0.47 | 0.52 | 0.53 | 0.53 | 0.53 | 0.34 | 0.54 | 0.56 | 0.57 | 30 | |||||||||||||||||
16 | 0.33 | 0.37 | 0.39 | 0.40 | 0.42 | 0.44 | 0.45 | 0.46 | 0.32 | 0.53 | 0.53 | 0.54 | 0.54 | 0.56 | 0.57 | 0.60 | 31 | |||||||||||||||||
17 | 0.36 | 0.37 | 0.39 | 0.40 | 0.41 | 0.42 | 0.43 | 0.44 | 0.52 | 0.53 | 0.54 | 0.54 | 0.56 | 0.57 | 0.61 | 0.63 | 32 | |||||||||||||||||
18 | 0.36 | 0.37 | 0.40 | 0.40 | 0.41 | 0.42 | 0.43 | 0.44 | 0.51 | 0.52 | 0.54 | 0.55 | 0.57 | 0.60 | 0.64 | 0.68 | 33 | |||||||||||||||||
19 | 0.36 | 0.37 | 0.40 | 0.40 | 0.41 | 0.42 | 0.43 | 0.45 | 0.49 | 0.51 | 0.55 | 0.57 | 0.60 | 0.64 | 0.69 | 0.74 | 34 | |||||||||||||||||
20 | 0.35 | 0.37 | 0.39 | 0.40 | 0.41 | 0.42 | 0.44 | 0.45 | 0.48 | 0.51 | 0.57 | 0.60 | 0.64 | 0.69 | 0.75 | 0.81 | 35 | |||||||||||||||||
21 | 0.34 | 0.35 | 0.38 | 0.39 | 0.41 | 0.42 | 0.44 | 0.46 | 0.48 | 0.52 | 0.60 | 0.64 | 0.69 | 0.75 | 0.82 | 0.89 | 36 | |||||||||||||||||
22 | 0.32 | 0.34 | 0.37 | 0.39 | 0.41 | 0.42 | 0.45 | 0.47 | 0.48 | 0.53 | 0.64 | 0.69 | 0.75 | 0.82 | 0.90 | 0.98 | 37 | |||||||||||||||||
23 | 0.32 | 0.34 | 0.38 | 0.40 | 0.42 | 0.44 | 0.47 | 0.48 | 0.53 | 0.58 | 0.69 | 0.75 | 0.82 | 0.90 | 1.00 | 1.09 | 38 | |||||||||||||||||
24 | 0.32 | 0.35 | 0.38 | 0.41 | 0.44 | 0.46 | 0.48 | 0.53 | 0.58 | 0.63 | 0.75 | 0.82 | 0.90 | 1.00 | 1.11 | 1.22 | 39 | |||||||||||||||||
25 | 0.31 | 0.35 | 0.39 | 0.43 | 0.46 | 0.48 | 0.53 | 0.58 | 0.63 | 0.68 | 0.82 | 0.90 | 1.00 | 1.11 | 1.23 | 1.37 | 40 | |||||||||||||||||
26 | 0.31 | 0.35 | 0.41 | 0.44 | 0.48 | 0.53 | 0.58 | 0.63 | 0.68 | 0.74 | 0.90 | 1.00 | 1.11 | 1.23 | 1.38 | 1.34 | 41 | |||||||||||||||||
27 | 0.31 | 0.36 | 0.42 | 0.47 | 0.53 | 0.58 | 0.63 | 0.68 | 0.71 | 0.82 | 1.00 | 1.11 | 1.23 | 1.38 | 1.54 | 1.71 | 42 | |||||||||||||||||
28 | 0.32 | 0.37 | 0.43 | 0.50 | 0.56 | 0.63 | 0.68 | 0.71 | 0.80 | 0.91 | 1.11 | 1.23 | 1.38 | 1.34 | 1.71 | 1.88 | 43 | |||||||||||||||||
29 | 0.33 | 0.38 | 0.46 | 0.52 | 0.60 | 0.68 | 0.71 | 0.80 | 0.91 | 1.03 | 1.23 | 1.38 | 1.54 | 1.71 | 1.88 | 2.05 | 44 | |||||||||||||||||
30 | 0.35 | 0.40 | 0.48 | 0.57 | 0.66 | 0.71 | 0.80 | 0.91 | 1.03 | 1.15 | 1.38 | 1.54 | 1.71 | 1.88 | 2.05 | 2.24 | 45 | |||||||||||||||||
31 | 0.37 | 0.42 | 0.52 | 0.62 | 0.71 | 0.80 | 0.91 | 1.03 | 1.15 | 1.27 | 1.54 | 1.71 | 1.88 | 2.05 | 2.24 | 2.43 | 46 | |||||||||||||||||
32 | 0.39 | 0.45 | 0.56 | 0.68 | 0.80 | 0.91 | 1.03 | 1.15 | 1.27 | 1.40 | 1.70 | 1.87 | 2.05 | 2.24 | 2.44 | 2.62 | 47 | |||||||||||||||||
33 | 0.41 | 0.48 | 0.59 | 0.73 | 0.86 | 0.99 | 1.14 | 1.27 | 1.40 | 1.56 | 1.85 | 2.02 | 2.22 | 2.43 | 2.62 | 2.83 | 48 | |||||||||||||||||
34 | 0.43 | 0.51 | 0.63 | 0.77 | 0.93 | 1.09 | 1.25 | 1.40 | 1.56 | 1.73 | 2.00 | 2.19 | 2.39 | 2.62 | 2.83 | 3.05 | 49 |
D-2-1 |
Extended Basic US 1975-80 Select and Ultimate Automatic YRT Rates
Female Aggregate | Age Nearest Birthday |
Policy Year | Att. | |||||||||||||||||||||||||||||||||
Age | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16+ | Age | |||||||||||||||||
35 | 0.45 | 0.54 | 0.66 | 0.83 | 1.01 | 1.20 | 1.39 | 1.56 | 1.73 | 1.90 | 2.17 | 2.36 | 2.36 | 2.82 | 3.05 | 3.30 | 50 | |||||||||||||||||
36 | 0.47 | 0.58 | 0.71 | 0.90 | 1.10 | 1.32 | 1.52 | 1.71 | 1.90 | 2.09 | 2.33 | 2.53 | 2.75 | 3.04 | 3.30 | 3.57 | 5I | |||||||||||||||||
37 | 0.50 | 0.62 | 0.76 | 0.98 | 1.20 | 1.43 | 1.64 | 1.85 | 2.07 | 2.28 | 2.49 | 2.71 | 2.94 | 3.29 | 3.57 | 3.88 | 52 | |||||||||||||||||
38 | 0.54 | 0.69 | 0:85 | 1.10 | 1.33 | 1.57 | 1.78 | 2.01 | 2.23 | 2.44 | 2.67 | 2.89 | 3.15 | 3.53 | 3.84 | 4.22 | 53 | |||||||||||||||||
39 | 0.58 | 0.76 | 0.95 | 1.22 | 1.45 | 1.70 | 1.93 | 2.17 | 2.39 | 2.62 | 2.85 | 3.10 | 3.37 | 3.80 | 4.13 | 4.60 | 54 | |||||||||||||||||
40 | 0.63 | 0.85 | 1.05 | 1.33 | 1.58 | 1.86 | 2.08 | 2.32 | 2.56 | 2.80 | 3.06 | 3.33 | 3.62 | 4.10 | 4.46 | 5.02 | 55 | |||||||||||||||||
41 | 0.68 | 0.94 | 1.15 | 1.45 | 1.71 | 2.01 | 2.23 | 2.49 | 2.74 | 3.01 | 3.28 | 3.58 | 3.90 | 4.44 | 4.81 | 5.47 | 56 | |||||||||||||||||
42 | 0.73 | 1.02 | 1.25 | 1.58 | 1.85 | 2.16 | 2.40 | 2.67 | 2.94 | 3.23 | 3.53 | 3.86 | 4.20 | 4.80 | 5.19 | 5.96 | 57 | |||||||||||||||||
43 | 0.78 | 1.09 | 1.35 | 1.67 | 1.95 | 2.27 | 2.53 | 2.83 | 1.13 | 3.46 | 3.79 | 4.16 | 4.54 | 5.19 | 5.62 | 6.50 | 58 | |||||||||||||||||
44 | 0.83 | 1.16 | 1.44 | 1.74 | 2.26 | 2.37 | 2.67 | 3.01 | 3.34 | 3.70 | 4.08 | 4.49 | 4.89 | 5.61 | 6.09 | 7.08 | 59 | |||||||||||||||||
45 | 0.89 | 1.23 | 1.53 | 1.83 | 2.16 | 2.49 | 2.83 | 3.20 | 3.57 | 3.97 | 4.39 | 4.83 | 5.28 | 6.07 | 6.60 | 7.69 | 60 | |||||||||||||||||
46 | 0.93 | 1.30 | 1.62 | 1.91 | 2.28 | 2.61 | 3.00 | 3.41 | 3.82 | 4.26 | 4.72 | 5.20 | 5.70 | 6.55 | 7.12 | 8.34 | 61 | |||||||||||||||||
47 | 0.98 | 1.37 | 1.72 | 2.00 | 2.41 | 2.75 | 3.18 | 3.64 | 4.09 | 4.57 | 5.07 | 5.60 | 6.14 | 7.06 | 7.68 | 9.03 | 62 | |||||||||||||||||
48 | 1.03 | 1.43 | 1.80 | 2.10 | 2.54 | 2.92 | 3.40 | 3.91 | 4.36 | 4.87 | 5.41 | 5.97 | 6.53 | 7.50 | 8.14 | 9.77 | 63 | |||||||||||||||||
49 | 1.07 | 1.50 | 1.88 | 2.21 | 2.68 | 3.11 | 3.64 | 4.20 | 4.65 | 5.20 | 5.77 | 6.35 | 6.94 | 7.94 | 8.61 | 10.57 | 64 | |||||||||||||||||
50 | 1.12 | 1.56 | 1.97 | 2.32 | 2.82 | 3.32 | 3.89 | 4.51 | 4.96 | 5.54 | 6.13 | 6.74 | 7.36 | 8.41 | 9.10 | 11.45 | 65 | |||||||||||||||||
51 | 1.17 | 1.64 | 2.07 | 2.44 | 2.98 | 3.53 | 4.15 | 4.84 | 5.28 | 5.88 | 6.50 | 7.14 | 7.79 | 8.89 | 9.63 | 12.42 | 66 | |||||||||||||||||
52 | 1.23 | 1.72 | 2.17 | 2.57 | 3.13 | 3.75 | 4.43 | 5.19 | 5.60 | 6.23 | 6.88 | 7.55 | 8.24 | 9.41 | 10.20 | 13.48 | 67 | |||||||||||||||||
53 | 1.29 | 1.81 | 2.30 | 2.76 | 3.36 | 4.02 | 4.73 | 5.51 | 5.98 | 6.63 | 7.33 | 8.06 | 8.84 | 10.14 | 11.03 | 14.64 | 68 | |||||||||||||||||
54 | 1.36 | 1.91 | 2.44 | 2.96 | 3.61 | 4.31 | 5.04 | 5.83 | 6.37 | 7.06 | 7.81 | 8.62 | 9.49 | 10.93 | 11.94 | 15.94 | 69 | |||||||||||||||||
55 | 1.43 | 2.01 | 2.58 | 3.18 | 3.87 | 4.60 | 5.36 | 6.16 | 6.78 | 7.50 | 8.33 | 9.23 | 10.20 | 11.80 | 12.96 | 17.42 | 70 | |||||||||||||||||
56 | 1.50 | 2.11 | 2.74 | 3.41 | 4.13 | 4.90 | 5.69 | 6.51 | 7.22 | 7.99 | 8.89 | 9.88 | 10.96 | 12.76 | 14.12 | 19.13 | 71 | |||||||||||||||||
57 | 1.57 | 2.21 | 2.89 | 3.64 | 4.41 | 5.21 | 6.03 | 6.86 | 7.69 | 8.51 | 9.49 | 10.59 | 11.81 | 13.85 | 15.45 | 21.11 | 72 | |||||||||||||||||
58 | 1.69 | 2.39 | 3.12 | 3.91 | 4.71 | 5.54 | 6.40 | 7.28 | 8.17 | 9.05 | 10.28 | 11.45 | 12.76 | 14.97 | 16.71 | 23.41 | 73 | |||||||||||||||||
59 | 1.82 | 2.58 | 3.36 | 4.19 | 5.02 | 5.88 | 6.79 | 7.74 | 8.69 | 9.63 | 11.16 | 12.42 | 13.25 | 16.25 | 18.16 | 26.09 | 74 | |||||||||||||||||
60 | 1.94 | 2.77 | 3.61 | 4.48 | 5.35 | 6.25 | 7.21 | 8.22 | 9.24 | 10.27 | 12.16 | 13.55 | 15.11 | 17.72 | 19.83 | 29.20 | 75 | |||||||||||||||||
61 | 2.08 | 2.98 | 3.28 | 4.80 | 5.70 | 6.65 | 7.67 | 8.74 | 9.84 | 10.99 | 13.31 | 14.84 | 16.55 | 19.42 | 21.73 | 32.78 | 76 | |||||||||||||||||
62 | 2.22 | 3.20 | 4.17 | 5.14 | 6.09 | 7.08 | 8.15 | 9.31 | 10.52 | 11.81 | 14.65 | 16.34 | 18.23 | 21.37 | 23.87 | 36.88 | 77 | |||||||||||||||||
63 | 2.36 | 3.38 | 4.40 | 5.42 | 6.42 | 7.47 | 8.61 | 9.88 | 14.24 | 12.74 | 15.86 | 17.73 | 19.83 | 23.30 | 26.11 | 41.54 | 78 | |||||||||||||||||
64 | 2.51 | 3.58 | 4.65 | 5.72 | 6.77 | 7.89 | 9.12 | 10.52 | 12.06 | 13.80 | 17.25 | 19.31 | 21.63 | 25.45 | 28.57 | 46.74 | 79 | |||||||||||||||||
65 | 2.67 | 3.79 | 4.91 | 6.03 | 7.15 | 8.35 | 9.70 | 1124 | 13.00 | 15.01 | 18.83 | 21.08 | 23.62 | 27.79 | 31.21 | 52.50 | 80 | |||||||||||||||||
66 | 2.84 | 4.01 | 5.19 | 6.37 | 7.57 | 8.88 | 10.36 | 12.07 | 14.06 | 16.40 | 20.61 | 23.04 | 25.79 | 30.30 | 34.00 | 58.80 | 81 | |||||||||||||||||
67 | 3.03 | 4.24 | 5.49 | 6.75 | 8.04 | 9.48 | 11.10 | 13.00 | 15.26 | 17.95 | 22.58 | 25.19 | 28.11 | 32.93 | 36.89 | 65.66 | 82 | |||||||||||||||||
68 | 3.29 | 4.62 | 6.00 | 7.41 | 8.87 | 10.51 | 12.37 | 14.55 | 17.13 | 20.20 | 25.19 | 28.11 | 31.57 | 36.88 | 41.19 | 73.06 | 83 | |||||||||||||||||
69 | 3.58 | 5.05 | 6.59 | 8.18 | 9.84 | 11.72 | 13.85 | 16.33 | 19.27 | 22.75 | 28.11 | 31.57 | 35.36 | 41.18 | 45.84 | 81.02 | 84 |
D-2-2 |
Extended Basic US 1975-80 Select and Ultimate Automatic YRT Rates
Female Aggregate | Age Nearest Birthday |
Policy Year | Att. | |||||||||||||||||||||||||||||||||
Age | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16+ | Age | |||||||||||||||||
70 | 3.92 | 5.54 | 7.27 | 9.07 | 10.97 | 13.11 | 15.54 | 18.38 | 21.71 | 25.59 | 31.57 | 35.36 | 39.49 | 45.83 | 50.83 | 89.52 | 85 | |||||||||||||||||
71 | 5.51 | 8.28 | 11.4I | 14.70 | 17.75 | 21.20 | 26.41 | 31.59 | 38.04 | 44.51 | 51.86 | 60.13 | 69.44 | 79.78 | 89.52 | 98.58 | 86 | |||||||||||||||||
72 | 6.61 | 9.61 | 13.53 | 17.30 | 21.05 | 25.24 | 31.32 | 37.28 | 44.51 | 51.86 | 60.13 | 69.40 | 79.72 | 89.52 | 98.58 | 108.18 | 87 | |||||||||||||||||
73 | 7.92 | 11.37 | 16.00 | 20.42 | 24.95 | 29.97 | 37.02 | 43.81 | 51.86 | 60.13 | 69.40 | 79.71 | 89.52 | 98.58 | 108.18 | 118.34 | 88 | |||||||||||||||||
74 | 9.47 | 13.60 | 18.87 | 24.09 | 29.51 | 35.47 | 43.58 | 51.25 | 60.13 | 69.40 | 79.71 | 89.52 | 98.58 | 108.18 | 118.34 | 129.04 | 89 | |||||||||||||||||
75 | 11.33 | 16.25 | 22.26 | 28.38 | 34.81 | 41.79 | 51.04 | 59.65 | 69.40 | 79.71 | 89.52 | 98.58 | 108.18 | 118.34 | 129.04 | 140.30 | 90 | |||||||||||||||||
76 | 13.54 | 19.20 | 26.22 | 33.35 | 40.89 | 49.00 | 59.49 | 69.08 | 79.71 | 89.52 | 98.58 | 108.18 | 118.34 | 129.04 | 140.30 | 152.10 | 91 | |||||||||||||||||
77 | 16.16 | 22.67 | 30.81 | 39.05 | 47.81 | 57.16 | 68.97 | 79.59 | 89.52 | 98.58 | 108.18 | 118.34 | 129.04 | 140.30 | 152.10 | 164.46 | 92 | |||||||||||||||||
78 | 1935 | 26.92 | 36.06 | 45.51 | 55.62 | 66.32 | 79.55 | 89.52 | 98.58 | 108.18 | 11834 | 129.04 | 14030 | 152.10 | 164.46 | 17736 | 93 | |||||||||||||||||
79 | 23.18 | 31.80 | 42.02 | 52.80 | 64.39 | 76.56 | 89.52 | 98.58 | 108.18 | 118.34 | 129.04 | 140.30 | 152.10 | 164.46 | 177.36 | 190.82 | 94 | |||||||||||||||||
80 | 27.61 | 37.39 | 48.74 | 60.97 | 74.17 | 87.93 | 98.58 | 108.18 | 118.34 | 129.04 | 140.30 | 152.10 | 164.46 | 177.36 | 190.82 | 204.82 | 95 | |||||||||||||||||
81 | 32.68 | 43.71 | 56.27 | 70.05 | 85.01 | 98.58 | 108.18 | 118.34 | 129.04 | 140.30 | 152.10 | 164.46 | 177.36 | 190.82 | 20412 | 219.38 | 96 | |||||||||||||||||
82 | 38.46 | 50.83 | 64.64 | 80.11 | 96.97 | 108.18 | 118.34 | 129.04 | 140.30 | 152.10 | 164.46 | 177.36 | 190.82 | 204.82 | 219.38 | 234.48 | 97 | |||||||||||||||||
83 | 45.76 | 58.80 | 73.91. | 91.19 | 108.18 | 11834 | 129.04 | 140.30 | 152.10 | 164.46 | 177.36 | 190.82 | 204.82 | 219.38 | 234.48 | 250.14 | 98 | |||||||||||||||||
84 | 54.79 | 68.59 | 84.13 | 103.35 | 118.34 | 129.04 | 140.30 | 152.10 | 164.46 | 177.36 | 190.82 | 204.82 | 219.38 | 234.48 | 250.14 | 266.34 | 99 | |||||||||||||||||
85 | 65.01 | 79.42 | 95.33 | 116.62 | 129.04 | 140.30 | 152.10 | 164.46 | 177.36 | 190.82 | 204.82 | 219.38 | 234.48 | 250.14 | 26634 | 283.10 | 100 |
D-2-3 |
SCHEDULE E
IN-FORCE LIST OF LEVEL TERM POLICIES
Exhibit 10.5
STANDBY STOCK PURCHASE AGREEMENT
This STANDBY STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of March 8, 2018, is entered into by and among Federal Life Group, Inc., a Pennsylvania corporation (the “Company”), Federal Life Insurance Company, an Illinois insurance company (“Federal Life”), Federal Life Mutual Holding Company, an Illinois corporation (“FLMHC”), and Insurance Capital Group, LLC (the “Standby Purchaser”).
WITNESSETH:
WHEREAS, the Board of Directors of FLMHC has adopted a Plan of Conversion (the “Plan of Conversion”) pursuant to which FLMHC will convert from a mutual holding company to a stock holding company in accordance with Illinois law (the “Conversion”); and
WHEREAS, in accordance with the Plan of Conversion, FLMHC proposes, as soon as practicable after the Registration Statement, as defined herein, becomes effective, to distribute to Eligible Members, as defined herein, non-transferable rights (the “Rights”) to subscribe for and purchase shares of Common Stock of the Company (the “Shares”) at a subscription price (the “Subscription Price”) of $10.00 per share (such offering, the “Subscription Offering”); and
WHEREAS, contemporaneously with the Subscription Offering, the Company will offer the Shares to a limited group of persons at the Subscription Price (the “Community Offering”); and
WHEREAS, the Standby Purchaser is purchasing from FLMHC a promissory note of FLMHC in the form of Exhibit A hereto in the principal amount of up to $2,000,000 that will be exchanged for Common Stock of the Company upon the effective date of the Conversion at a price per share equal to the Subscription Price (the “Exchangeable Note”); and
WHEREAS, the Company has requested the Standby Purchaser to agree to purchase from the Company in the Community Offering any shares remaining after completion of the Subscription Offering and any orders accepted in the Community Offering by persons other than the Standby Purchaser, and the Standby Purchaser is willing to purchase Shares in the Community Offering on the terms and conditions provided herein.
NOW THEREFORE, in consideration of the foregoing and the mutual covenants herein contained, and intending to be legally bound, the parties hereto hereby agree as follows:
Section 1. Certain Other Definitions. The following terms used herein shall have the meanings set forth below:
“90-Day Limit” shall have the meaning given to such term in Section 9(c)(i) hereof.
“Adjusted Stockholders’ Equity” shall mean stockholders’ equity as determined in accordance with GAAP (excluding the fixed income component of accumulated other comprehensive income).
1 |
“Affiliate” shall have the meaning set forth in Rule 12b-2 under the Exchange Act and shall include Persons who become Affiliates of any Person subsequent to the date hereof. In the case of the Standby Purchaser, its “Affiliates” shall include entities which are controlled by a principal of the Standby Purchaser.
“Agreement” shall have the meaning given to such term in the preamble hereof.
“ASE Event” shall mean, that, in any fiscal quarter, the Company’s consolidated GAAP financial statements for such fiscal quarter includes an Adjusted Stockholders’ Equity that is less than 85% of the Company’s Adjusted Stockholders’ Equity as of the Closing (as shown in the Company’s consolidated GAAP financial statements for the most recent fiscal quarter as of Closing).
“Associate” shall have the meaning set forth in Rule 12b-2 under the Exchange Act and shall include Persons who become Associates of any Person subsequent to the date hereof.
“Bankruptcy and Equity Exception” shall have the meaning given to such term in Section 3(b) hereof.
“Board” shall mean the board of directors of the Company.
“Burdensome Condition” shall have the meaning given to such term in Section 6(c) hereof.
“Business Day” shall mean any day that is not a Saturday, a Sunday or a day on which banks are required or permitted to be closed in the Commonwealth of Pennsylvania.
“Change of Control” shall mean any transaction or series of transactions (as a result of a tender offer, merger, consolidation or otherwise) that results in, or that is in connection with (a) any Third Party Purchaser or “group” (within the meaning of Section 13(d)(3) of the Exchange Act) of Third Party Purchasers acquiring beneficial ownership, directly or indirectly, of a majority of the then issued and outstanding Common Stock or (b) the sale, lease, exchange, conveyance, transfer, or other disposition (for cash, shares of stock, securities or other consideration) of all or substantially all of the property and assets of the Company and its Subsidiaries, on a consolidated basis, to any Third Party Purchaser or “group” (within the meaning of Section 13(d)(3) of the Exchange Act) of Third Party Purchasers (including any liquidation, dissolution, or winding up of the affairs of the Company, or any other distribution made in connection therewith).
“Closing” shall mean the closing of the purchase described in Section 2 hereof, which shall be held at 10:00 a.m. Eastern Time on the Closing Date at the offices of Stevens & Lee, 620 Freedom Business Center, King of Prussia, Pennsylvania 19406, or such other time and place as may be agreed to by the parties hereto.
“Closing Date” shall mean the date on which the closing of the sale of the Shares pursuant to the Offerings takes place.
2 |
“Commission” shall mean the United States Securities and Exchange Commission, or any successor agency thereto.
“Common Stock” shall mean the common stock of the Company, par value $0.01 per share.
“Common Stock Equivalent” shall mean any convertible debt instrument, option, warrant or other right to acquire Common Stock and shall include the number of shares of Common Stock that may be acquired upon exercise or conversion of such Common Stock Equivalent.
“Company” shall have the meaning given to such term in the preamble hereof.
“Company Contracts” shall have the meaning given to such term in Section 3(f) hereof.
“Company Offer Notice” shall have the meaning given to such term in Section 13(a) hereof.
“Conversion Plan Approval” shall mean the approval of the Plan of Conversion by the Department and the requisite vote of the Voting Members.
“Department” shall mean the Illinois Insurance Department.
“Designated Securities” shall have the meaning given to such term in Section 11(b) hereof.
“Drag-along Notice” shall have the meaning given to such term in Section 14(b) hereof.
“Drag-along Sale” shall have the meaning given to such term in Section 14(a) hereof.
“Drag-along Stockholder” shall have the meaning given to such term in Section 14(a) hereof.
“Dragging Stockholder” shall have the meaning given to such term in Section 14(a) hereof.
“Eligible Members” shall mean the members of FLMHC eligible to purchase Shares in the Subscription Offering.
“Equity Securities” shall include (i) with respect to the Company, (a) any Common Stock, (b) any security convertible into or exercisable or exchangeable for, with or without consideration, shares of Common Stock (including any option to purchase such a convertible security), (c) any security carrying any warrant or right to subscribe to or purchase any shares of Common Stock, and (d) any such warrant or right and (ii) with respect to any Subsidiary of the Company, (a) any equity ownership interests, (b) any security convertible into or exercisable or exchangeable for, with or without consideration, equity ownership interests (including any option to purchase such a convertible security), (c) any security carrying any warrant or right to subscribe to or purchase any shares of equity ownership interests, and (d) any such warrant or right.
3 |
“Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated by the Commission thereunder.
“Federal Life” shall have the meaning given to such term in the recitals hereof.
“FLMHC” shall have the meaning given to such term in the recitals hereof.
“Financial Statements” shall have the meaning given to such term in Section 3(g) hereof.
“First Offer Termination Event” shall mean the earliest to occur of (a) the fifth (5th) anniversary of the Closing Date, (b) the first date upon which the Standby Purchaser no longer beneficially owns shares of the Common Stock representing more than five percent (5%) of the issued and outstanding shares of the Common Stock, or (c) the occurrence of a Standstill Termination Event.
“GAAP” shall mean accounting principles generally accepted in the United States of America, consistently applied by the Company with prior practice.
“Griffin” shall mean Griffin Financial Group, LLC.
“Governmental Entity” shall mean any federal or state court, administrative agency or commission or other governmental authority or instrumentality, other than the Department.
“Gross Up Right” shall have the meaning given to such term in Section 11(a) hereof.
“Including” shall mean including, without limitation.
“Indebtedness” means, with respect to any Person, (a) all obligations for borrowed money, (b) any other obligations owed by such Person under any credit agreement or facility, or evidenced by any note, bond, debenture or other debt security or instrument made or issued by such Person, (c) all obligations for the deferred purchase price of property or services with respect to which such Person is liable, contingently or otherwise, as obligor or otherwise, (d) all capitalized lease obligations, synthetic lease obligations and sale leaseback obligations, whether secured or unsecured, (e) all obligations under interest rate cap, swap, collar or similar transactions or currency or commodity hedging transactions (valued at the termination value thereof), (f) all obligations under conditional sale or other title retention agreements relating to any purchased property, (g) all letters of credit or performance bonds issued for the account of such Person, (h) all guarantees of such Person with respect to any of the foregoing of any other Person, (i) all interest, premium and prepayment penalties due and payable in respect of any of the foregoing and (j) all indebtedness referred to in clauses (a) through (i) above secured by (or for which the holder of such indebtedness has an existing right, contingent or otherwise, to be secured by) any encumbrance upon or in property (including accounts and contract rights) owned by such Person, even though such Person may not have assumed or become liable for the payment of such indebtedness, and including in clauses (a) through (i) above any accrued and unpaid interest or penalties thereon.
4 |
“Law” shall have the meaning given to such term in Section 6(d) hereof.
“Liability” means any liability, debt, expense, claim, demand, loss, commitment, damage, deficiency, obligation or actions of any kind, character or description, whether asserted or not asserted, disputed or undisputed, known or unknown, joint or several, fixed or unfixed, liquidated or unliquidated, secured or unsecured, accrued or unaccrued, matured or unmatured, absolute, contingent, determined, determinable or otherwise, whenever or however arising (including, whether arising out of any contract or tort based on negligence or strict liability) and whether or not the same would be required by SAP to be reflected in financial statements or disclosed in the notes thereto, including all costs and expenses related thereto.
“Liens” means all pledges, liens (statutory or other), encumbrances, charges, claims, community property interests, conditions, deeds of trust, equitable interests, options, hypothecations, mortgages, easements, encroachments, burdens, rights of others, rights of way, rights of first refusal, rights of first offer, title defects, title retention agreements, leases, subleases, licenses, occupancy agreements, covenants, voting trust agreements, interests, negotiations or refusals, security interests of any kind, proxies or restrictions of any kind, including any restriction on use, voting, transfer, receipt of income or exercise of any other attribute of ownership or any applicable insurance Laws.
“Material Action” shall mean (a) incurring Indebtedness or any other material Liability or contracting for the extension or ability to incur Indebtedness (even if not yet incurred), (b) modifying or amending Company Contracts, (c) adopting of a plan of complete or partial liquidation, rehabilitation or entering into any merger agreement, (d) creating or acquiring of Subsidiaries, (e) undertaking or committing to make any capital expenditures, (f) mortgaging, pledging or otherwise encumbering or subjecting to a Lien any material assets or properties, tangible or intangible, other than Permitted Liens, (g) defaulting under any Indebtedness, or cancelling or compromising any Indebtedness or waiving any material rights with respect thereto without receiving a realizable benefit of similar or greater value, (h) paying or prepaying any Liability, or discharging or satisfying any Lien, or settling any Liability, claim, dispute, proceeding, suit or appeal, pending or threatened against it or any of its assets or properties, other than short-term liabilities which have been paid prior to the contractual due date therefor in the ordinary course of business, (i) effecting any employee profit-sharing, stock option, stock purchase, pension, bonus, incentive, retirement, medical reimbursement, life insurance, deferred compensation, severance or termination agreements, (j) entering into any new line of business, introduced any new products or services or changed in any material respect existing products or services, except as may be required by applicable Law, (k) abandoning, modifying, failing to renew, waiving, terminating or letting lapse any Permits or failing to timely file with any Governmental Entity all required annual and quarterly statutory financial statements and other insurance regulatory reports, statements, documents, registrations, filings or submissions or (l) entering into any agreement or commitment, whether in writing or otherwise, to do any of the forgoing.
5 |
“Material Adverse Effect” shall mean (a) a material adverse effect on the financial condition, or on the earnings, operations, assets, business or prospects of the Company, Federal Life and their respective subsidiaries taken as a whole, or (b) the failure of either Joseph D. Austin or William S. Austin to serve as Chief Executive Officer of the Company; provided, however, that in determining whether a Material Adverse Effect has occurred under clause (a), there shall be excluded any effect to the extent resulting from (i) actions or omissions of the Company or Federal Life expressly required or contemplated by the terms of this Agreement, (ii) changes after the date hereof in general economic conditions in the United States, including financial market volatility or downturn, (iii) changes after the date hereof affecting generally the life insurance business in the United States, (iv) acts of war, sabotage or terrorism, military actions or the escalation thereof, or outbreak of hostilities, (v) any changes after the date hereof in applicable laws or accounting rules or principles, including changes in GAAP, or (vi) the announcement or pendency of the transactions contemplated by this Agreement; provided further, however, that any circumstance, event, change, development or effect referred to in clauses (ii), (iii), (iv) and (v) shall be taken into account in determining whether a Material Adverse Effect has occurred or would reasonably be expected to occur to the extent that such circumstance, event, change, development or effect has a disproportionate effect on the Company and Federal Life compared to other participants in the industries or markets in which the Company and Federal Life operate.
“Maximum of the Valuation Range” has the meaning given to such term in the Plan of Conversion.
“Minimum of the Valuation Range” has the meaning given to such term in the Plan of Conversion.
“Non-public information” shall have the meaning given to such term in Section 6(d) hereof.
“Offer Period” shall have the meaning given to such term in Section 11(b) hereof.
“Offered Shares” shall have the meaning given to such term in Section 9(d) hereof.
“Offerings” shall mean, collectively, the Subscription Offering and the Community Offering.
“Offering Expiration Date” shall mean the date on which the Offerings expire.
“Organizational Documents” of a Person means, as applicable, the declaration and charter, certificate of incorporation, articles of incorporation, certificate of designation, bylaws, certificate of formation, operating agreement or any similar organizational or governing document or instrument of a Person.
“Permits” shall have the meaning given to such term in Section 3(f) hereof.
6 |
“Permitted Liens” means (a) Liens for taxes that are not yet due and payable or are not delinquent and are being contested in good faith by appropriate proceedings for which adequate reserves are maintained, or (b) mechanics’, materialmens’, carriers’, workmens’, repairmens’, contractors’ and warehousemens’ Liens imposed by applicable Law, arising or incurred in the ordinary course of business.
“Person” shall mean individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization and a Governmental Entity.
“Plan of Conversion” shall mean the plan of conversion adopted by FLMHC in connection with its conversion from a mutual insurance holding company to a stock insurance holding company pursuant to Section 59.1 of the Illinois Insurance Code, 215 ILCS 5/59.1.
“Potential Sale Notice” shall have the meaning given to such term in Section 13(a) hereof.
“Proposed Transferee” shall have the meaning given to such term in Section 15(a).
“Prospectus” shall mean the final Prospectus included in the Registration Statement for use in connection with the Offerings.
“Public Sale Notice” shall have the meaning given to such term in Section 9(d) hereof.
“Purchased Shares” shall have the meaning given to such term in Section 2(b) hereof.
“Qualifying Offer” shall have the meaning given to such term in Section 13(c) hereof.
“Registration Statement” shall mean the Company’s Registration Statement on Form S-1 or such other appropriate form under the Securities Act, pursuant to which the shares of Common Stock to be issued in the Offerings will be registered pursuant to the Securities Act.
“Rights” shall have the meaning given to such term in the recitals hereof.
“ROFO Termination Date” shall mean (a) if the Standstill Period terminates as scheduled on the fifth (5th) anniversary of the Closing Date, the date that is two (2) years following the end of the Standstill Period and (b) if the Standstill Period terminates for any other reason, the date of the occurrence of a Standstill Termination Event.
“Sale Notice” has the meaning given to such term in Section 15(b) hereof.
“SAP” shall mean the accounting practices prescribed or permitted by the Department.
“Securities Act” shall mean the Securities Act of 1933, as amended, and the rules and regulations promulgated by the Commission thereunder.
“Selling Stockholder” shall have the meaning given to such term in Section 15(a) hereof.
“Senior Management Shareholders” shall mean the Executive Chairman, the Chief Executive Officer, the President, the Chief Financial Officer and any Executive Vice President.
7 |
“Shares” shall have the meaning given to such term in the recitals hereof.
“Standby Purchaser” shall have the meaning given to such term in the preamble hereof.
“Standstill Period” means the period commencing on the Closing Date and ending on the occurrence of a Standstill Termination Event.
“Standstill Termination Event” shall mean the earliest to occur of (a) the fifth (5th) anniversary of the Closing Date, (b) the failure of either Joseph D. Austin or William S. Austin to serve as Chief Executive Officer of the Company unless a new Chief Executive Officer acceptable to the Standby Purchaser is appointed by the Board within a reasonable time thereafter, or (c) the occurrence of an ASE Event.
“Statutory Financial Statements” shall have the meaning given to such term in Section 3(h) hereof.
“Stockholder” shall mean any Person who is a record holder of Common Stock or any Common Stock Equivalent.
“Strategic Direction” shall have the meaning given to such term in Section 13(d) hereof.
“Strategic Investor” shall have the meaning given to such term in the Plan of Conversion.
“Subscription Agent” shall have the meaning given to such term in Section 6(a)(vi) hereof.
“Subscription Offering” shall have the meaning given to such term in the recitals hereof.
“Subscription Price” shall have the meaning given to such term in the recitals hereof.
“Subsidiary” means, with respect to any Person, any corporation, limited liability company, general or limited partnership, limited liability partnership, joint venture, association or other Person that is a business entity, trust or estate of which (a) if a corporation, a majority of the total voting power of shares of stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a combination thereof or (b) if a limited liability company, partnership, association or other business entity (other than a corporation), a majority of the partnership or other similar ownership interests thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more Subsidiaries of that Person or a combination thereof and for this purpose, a Person or Persons own a majority ownership interest in such a business entity (other than a corporation) if such Person or Persons shall be allocated a majority of such business entity’s gains or losses or shall be or control any managing director or general partner of such business entity (other than a corporation). The term “Subsidiary” shall include all Subsidiaries of such Subsidiary.
“Tag-along Notice” shall have the meaning given to such term in Section 15(c) hereof.
8 |
“Tag-along Period” shall have the meaning given to such term in Section 15(c) hereof.
“Tag-along Sale” shall have the meaning given to such term in Section 15(a) hereof.
“Tag-along Stockholder” shall have the meaning given to such term in Section 15(a) hereof.
“Third Party Purchaser” shall mean any Person who, immediately prior to the contemplated transaction does not directly or indirectly own or have the right to acquire any outstanding Common Stock.
“Transfer” shall have the meaning given to such term in Section 9(a) hereof.
“Unsubscribed Shares” shall mean the number of Shares not purchased in connection with the Subscription Offering.
“Voting Members” shall mean the members of FLMHC eligible to vote to adopt and approve the Plan of Conversion.
“VWAP Price” shall mean the average of daily volume weighted average price of the Common Stock on the NASDAQ Stock Market for the 20 trading days immediately preceding the date of the Public Sale Notice.
Section 2. Standby Purchase Commitment.
(a) On the date of the filing of the Registration Statement, the Standby Purchaser shall purchase from FLMHC at a price of up to $2,000,000, and FLMHC shall issue to the Standby Purchaser, the Exchangeable Note, and FLMHC shall deliver to the Standby Purchaser the original Exchangeable Note executed by FLMHC. The Standby Purchaser shall pay the purchase price for the Exchangeable Note to FLMHC by a wire transfer of immediately available funds as and when Advances (as defined in the Exchangeable Note) are requested in accordance with the terms thereof, to an account designated by FLMHC.
(b) Subject to the terms, conditions and limitations of this Agreement and to the availability of Shares after purchases made in the Subscription Offering, the Standby Purchaser agrees to purchase from the Company in the Community Offering, at the Subscription Price, the greater of (i) such number of Shares as shall result in the sale of Shares in the Offering equal to the number of Shares at the Minimum of the Valuation Range, or (ii) at least the lesser of: (A) 2,800,000 Shares (including any Shares issued as a result of the exchange of the Exchangeable Note), or (B) such number of Shares, that when added to (x) any Shares for which subscriptions have been accepted in the Subscription Offering, plus (y) any Shares for which orders have been accepted in the Community Offering from other than the Standby Purchaser, shall equal the number of Shares at the Maximum of the Valuation Range in the Offering. With the consent of the Company, the Standby Purchaser may purchase such additional Shares above the maximum number of Shares offered in the Offering as shall result in the Standby Investor owning 2,800,000 Shares (the number of Shares purchased by the Standby Purchaser are referred to herein as the “Purchased Shares”).
9 |
(c) Payment of the purchase price for the Purchased Shares shall be made by the Standby Purchaser, on the Closing Date, against delivery of certificates or a book entry statement evidencing the Purchased Shares, in United States dollars by means of a wire transfer of immediately available funds to the escrow account for the Offerings.
Section 3. Representations and Warranties of the Company. The Company, Federal Life, and FLMHC represent and warrant as of the date hereof and as of the Closing Date (except for the representations and warranties that are as of a specific date, which shall be made as of such date) to the Standby Purchaser as follows:
(a) The Company is a corporation duly organized, validly existing and in good standing under the laws of the Commonwealth of Pennsylvania and has all requisite corporate power and authority to carry on its business as now conducted and as proposed to be conducted. Federal Life is a stock insurance company duly organized, validly existing and in good standing under the laws of the State of Illinois and has all requisite corporate power and authority to carry on its business as now conducted and as proposed to be conducted. FLMHC is a corporation duly organized, validly existing and in good standing under the laws of the State of Illinois and has all requisite corporate power and authority to carry on its business as now conducted and as proposed to be conducted. The copies of the Organizational Documents of the Company, FLMHC, and Federal Life that have been provided to the Standby Purchaser are complete and correct and in full force and effect. The Company has no joint venture or similar arrangement, no subsidiaries, no significant assets or liabilities, and it is not engaged in any business.
(b) This Agreement has been duly and validly authorized, executed and delivered by each of the Company, Federal Life and FLMHC and constitutes a binding obligation of each of the Company, Federal Life, and FLMHC enforceable against each of them in accordance with its terms, subject to (i) the application of bankruptcy, receivership, conservatorship, reorganization, insolvency and similar laws affecting creditors’ rights generally and (ii) equitable principles being applied at the discretion of a court before which any proceeding may be brought (clauses (i) and (ii) collectively, the “Bankruptcy and Equity Exception”).
(c) The authorized capital of the Company consists of (i) 10,000,000 shares of Common Stock, none of which shares were issued and outstanding as of the date of this Agreement, and (ii) 1,000,000 shares of preferred stock, none of which preferred stock has been issued, as of the date hereof. Except for equity awards to be granted to management upon completion of the Offerings as described in the Registration Statement, there are no options, warrants, subscriptions, calls, rights, convertible securities or other agreements or commitments obligating the Company to issue, transfer, sell, redeem, repurchase or otherwise acquire any shares of its capital stock. The authorized capital stock of Federal Life consists of 25,000,000 shares of common stock, of which 2,500,000 shares are issued and outstanding. FLMHC owns all of the outstanding shares of capital stock of Federal Life. As of the date of this Agreement there are no authorized shares of capital stock of FLMHC. At the Closing Date, all of the authorized capital stock of FLMHC will be issued to and will be owned by the Company. There are no options, warrants, subscriptions, calls, rights, convertible securities or other agreements or commitments obligating either Federal Life or FLMHC to issue, transfer, sell, redeem, repurchase or otherwise acquire any shares of its capital stock.
10 |
(d) At the time the Registration Statement becomes effective, the Registration Statement will comply in all material respects with the requirements of the Securities Act and will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. The Prospectus, at the time the Registration Statement becomes effective and at the Closing Date, will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading; provided, however, that the representations and warranties in this subsection shall not apply to statements in or omissions from the Registration Statement or the Prospectus made in reliance upon and in conformity with the information furnished to the Company in writing by the Standby Purchaser for use in the Registration Statement or in the Prospectus.
(e) All of the Shares, including the Purchased Shares, will have been duly authorized for issuance prior to the Closing (assuming the Conversion Plan Approval has been obtained), and, when issued and distributed as set forth in the Prospectus, will be validly issued, fully paid and non-assessable; and none of the Shares will have been issued in violation of the preemptive rights of any security holders of the Company arising as a matter of law or under or pursuant to the Company’s Articles of Incorporation, the Company’s bylaws, or any agreement or instrument to which the Company is a party or by which it is bound.
(f) Neither the execution, delivery or performance of this Agreement or the Plan of Conversion by the Company, FLMHC or Federal Life, nor the consummation by the Company, Federal Life or FLMHC of the transactions contemplated hereby or thereby, will: (i) conflict with or result in any breach of any provisions of the Organizational Documents of the Company, FLMHC or Federal Life; (ii) result in a violation or breach of, or constitute (with or without due notice or lapse of time or both) a default (or give rise to any right of termination, cancellation, vesting, payment, exercise, acceleration, suspension or revocation) under, any of the terms, conditions or provisions of any note, bond, mortgage, deed of trust, security interest, indenture, license, contract, agreement, plan or other instrument or obligation to which the Company, FLMHC or Federal Life is a party or by which it or any of their properties or assets may be bound (collectively, the “Company Contracts”); (iii) violate any order, writ, injunction, decree, statute, rule or regulation applicable to the Company, FLMHC, Federal Life or any of their properties or assets; (iv) result in the creation or imposition of any Lien on any asset of the Company, FLMHC or Federal Life; or (v) cause the suspension or revocation of any permit, license, governmental authorization, consent or approval necessary for the Company, FLMHC or Federal Life to conduct its business as currently conducted (collectively, the “Permits”), except in the case of clauses (ii), (iii), (iv) and (v) for violations, breaches, defaults, terminations, cancellations, accelerations, creations, impositions, suspensions or revocations which would not individually or in the aggregate have or be reasonably likely to result in a Material Adverse Effect. Except for the Conversion Plan Approval, no vote of any member or holder of any other interest in FLMHC or Federal Life (equity or otherwise), is required to consummate the transactions contemplated by this Agreement or the Plan of Conversion.
11 |
(g) Federal Life has delivered to the Standby Purchaser complete and correct copies of the Financial Statements. The Financial Statements have been derived from the accounting books and records of FLMHC and Federal Life and have been prepared on a basis consistent with GAAP, subject, in the case of interim unaudited Financial Statements, only to normal recurring year-end adjustments. The Financial Statements present fairly in all material respects the consolidated financial position of FLMHC and Federal Life as at the respective dates thereof, and the consolidated statements of income, cash flow and equity included in the Financial Statements present fairly in all material respects the consolidated results of operations, cash flows and consolidated equity of FLMHC and Federal Life, as applicable, for the respective periods indicated. The term “Financial Statements” means the unaudited consolidated financial statements of FLMHC and Federal Life as at and for the nine-month period ended September 30, 2017 and the audited consolidated financial statements of FLMHC and Federal Life as at and for the year ended December 31, 2016, including in each case a consolidated balance sheet and consolidated statements of income, cash flow and equity, as previously made available to the Standby Purchaser.
(h) The annual statements of Federal Life for the years ended December 31, 2017, December 31, 2016 and December 31, 2015 and the quarterly statements of Federal Life for the quarters ended March 31, June 30, and September 30, 2017 as filed with the Department (collectively, together with all exhibits and schedules thereto, the “Statutory Financial Statements”) have been prepared in accordance with SAP, and such accounting practices have been applied on a consistent basis throughout the periods involved, except to the extent permitted by the Department and as expressly set forth in the notes, exhibits or schedules thereto, and the Statutory Financial Statements present fairly in all material respects the financial position and the results of operations for Federal Life as of the dates and for the periods therein in accordance with such accounting practices. Federal Life has made available to the Standby Purchaser true and complete copies of all examination reports of the Department and any insurance regulatory agencies since January 1, 2014, relating to Federal Life. Federal Life has delivered to the Standby Purchaser true and complete copies of the Statutory Financial Statements.
(i) As of the date of this Agreement, since December 31, 2017 , there has been no event or condition that, individually or in the aggregate, has had (or is reasonably likely to result in) a Material Adverse Effect, and Federal Life and FLMHC have in all material respects conducted their respective businesses in the ordinary course consistent with past practice. Except (x) for actions taken in the ordinary course of business (including the settlement of undisputed claims) and (y) for such actions as are necessary for the completion of the Offerings and the transactions contemplated by this Agreement and the Plan of Conversion, since December 31, 2017, none of the Company, Federal Life or FLMHC has taken any Material Action that resulted, or could reasonably result, in the payment of an amount, or the incurrence of a liability of, more than $100,000.
(j) Except for insurance claims litigation arising in the ordinary course of business for which adequate reserves have been established, there is no suit, action, proceeding or investigation (whether at law or equity, before or by any Government Entity or before any arbitrator) pending or, to the knowledge of Federal Life, FLMHC or the Company, threatened against or affecting any of them, the outcome of which would individually or in the aggregate have or be reasonably likely to result in a Material Adverse Effect, nor is there any judgment, decree, injunction, rule or order of any Government Entity or arbitrator outstanding against Federal Life, FLMHC or the Company that would individually or in the aggregate have or be reasonably likely to result in a Material Adverse Effect.
12 |
(k) The aggregate reserves of Federal Life as recorded in the Financial Statements and Statutory Financial Statements have been determined in accordance with generally accepted actuarial principles consistently applied or the requirements of the State of Illinois (except as permitted by the State of Illinois and as set forth therein). The insurance reserving practices and policies of Federal Life have not changed, in any material respect, since December 31, 2017, and the results of the application of such practices and policies are reflected in the Financial Statements and Statutory Financial Statements. All reserves of Federal Life set forth in the Financial Statements and Statutory Financial Statements are fairly stated in accordance with sound actuarial principles and meet the requirements of the insurance laws of the State of Illinois, except where the failure to so state such reserves or meet such requirements would not have or be reasonably likely to result in a Material Adverse Effect.
Section 4. Representations and Warranties of the Standby Purchaser. The Standby Purchaser represents and warrants as of the date hereof and as of the Closing Date (except for the representations and warranties that are as of a specific date, which shall be made as of such date) to the Company as follows:
(a) The Standby Purchaser is duly organized, validly existing and in good standing under the laws of the jurisdiction in which it is organized and has the requisite organizational power and authority to enter into and perform its obligations under this Agreement and to consummate the transactions contemplated hereby. Assuming the correctness of the representations and warranties made by the Company in Section 3 hereof, the execution and delivery of this Agreement by the Standby Purchaser and performance by the Standby Purchaser of the transactions contemplated hereby have been duly authorized by all necessary limited liability company action on the part of the Standby Purchaser, and no further consent or authorization in connection therewith is required by the Standby Purchaser, its board of directors or its members. This Agreement has been duly executed by the Standby Purchaser, and when delivered by the Standby Purchaser in accordance with the terms of this Agreement and thereof, will constitute the legal, valid and binding obligations of the Standby Purchaser, enforceable against it in accordance with its respective terms, subject to the Bankruptcy and Equity Exception.
(b) The Standby Purchaser was contacted by the Company or Griffin with respect to a potential investment in the Shares. The Standby Purchaser understands that the Standby Purchaser is acquiring the Purchased Shares in the ordinary course of its business directly from the Company (and not from Griffin), as principal for its own account, with no present intention of dividing its participation with others or reselling or otherwise distributing the same in violation of the Securities Act or any applicable state securities laws. The Standby Purchaser does not presently have any agreement or understanding, directly or indirectly, with any Person to: (i) distribute any of the Purchased Shares; (ii) hold or to dispose of the Purchased Shares; or (iii) acquire any Shares from any other Person other than from the Company pursuant to this Agreement. Notwithstanding the foregoing, except as otherwise set forth in this Agreement, by making the representations herein, the Standby Purchaser does not agree to hold any of the Purchased Shares for any minimum or other specific term.
13 |
(c) The Standby Purchaser is an “accredited investor” as that term is defined in Rule 501(a) of Regulation D. The Standby Purchaser is not a registered broker-dealer under Section 15 of the Exchange Act, or an unregistered broker-dealer engaged in the business of being a broker-dealer. The Standby Purchaser is an experienced institutional investor, is knowledgeable regarding the life insurance industry, and has experience in investing in life insurance companies and life insurance holding companies.
(d) The Standby Purchaser is not purchasing the Purchased Shares as a result of any advertisement, article, notice or other communication regarding the Purchased Shares published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or any other general advertisement. The Standby Purchaser did not learn about Federal Life or the Offerings as a result of the Registration Statement.
(e) The Standby Purchaser understands that the Purchased Shares Shares are being offered and sold to it in reliance on specific exemptions from the registration requirements of United States federal and state securities laws and regulations.
Section 5. Deliveries at Closing.
(a) At the Closing, the Company shall deliver to the Standby Purchaser the following:
(i) a certificate or certificates or a book entry statement representing the number of shares of Common Stock issued to the Standby Purchaser pursuant to Section 2 hereof; and
(ii) a certificate of an officer of the Company certifying on its behalf to the effect that the conditions set forth in Sections 8(a) and 8(c) have been satisfied on and as of the Closing Date.
(b) At the Closing, the Standby Purchaser shall deliver to the Company the following:
(i) payment of the Subscription Price of the Shares purchased by the Standby Purchaser, as set forth in Section 2(b) hereof; and
(ii) a certificate of the Standby Purchaser certifying to the effect that the conditions set forth in Sections 8(b) and 8(c) have been satisfied on and as of the Closing Date.
Section 6. Covenants.
(a) The Company, Federal Life and FLMHC, as applicable, agree as follows between the date hereof and the Closing Date:
(i) to as soon as reasonably practical file with the Commission the Registration Statement;
14 |
(ii) to use reasonable best efforts to cause the Registration Statement and any amendments thereto to become effective as promptly as practical;
(iii) to use reasonable best efforts to effectuate the Offerings;
(iv) as soon as reasonably practical after the Company is advised or obtains knowledge thereof, to advise the Standby Purchaser with a confirmation in writing, of (A) the time when the Registration Statement or any amendment thereto has been filed or declared effective or the Prospectus or any amendment or supplement thereto has been filed, (B) the issuance by the Commission of any stop order, or of the initiation or threatening of any proceeding suspending the effectiveness of the Registration Statement or any amendment thereto or any order preventing or suspending the use of any preliminary prospectus or the Prospectus or any amendment or supplement thereto, (C) the issuance by any state securities commission of any notice of any proceedings for the suspension of the qualification of the Shares for offering or sale in any jurisdiction or of the initiation, or the threatening, of any proceeding for that purpose, (D) the receipt of any comments from the Commission, and (E) any request by the Commission for any amendment to the Registration Statement or any amendment or supplement to the Prospectus or for additional information. The Company will use its reasonable best efforts to prevent the issuance of any such order or the imposition of any such suspension and, if any such order is issued or suspension is imposed, to obtain the withdrawal thereof as promptly as practical;
(v) to operate the business of Federal Life, the Company and FLMHC in the ordinary course of business consistent with past practice;
(vi) to notify, or to cause the subscription agent for the Subscription Offering (the “Subscription Agent”) to notify, the Standby Purchaser on each Friday during the exercise period of the Rights, or more frequently if reasonably requested by the Standby Purchaser, of the aggregate number of Shares known by the Company or the Subscription Agent to have been subscribed for or ordered in the Subscription Offering as of the close of business on the preceding Business Day or the most recent practical time before such request, as the case may be;
(vii) not to issue any shares of capital stock of the Company, or options, warrants, purchase rights, subscription rights, conversion rights, exchange rights, securities convertible into or exchangeable for capital stock of the Company, or other agreements or rights to purchase or otherwise acquire capital stock of the Company, except for the Exchangeable Note, shares of Common Stock issuable in the Offerings, and equity awards to management as described in the Registration Statement;
(viii) not to authorize any stock split, stock dividend, stock combination or similar transaction affecting the number of issued and outstanding shares of Common Stock or shares of the Company’s preferred stock;
15 |
(ix) except for dividends payable to FLMHC or Federal Life, not to declare or pay any dividends or repurchase any shares of Common Stock or shares of the Company’s preferred stock;
(x) except for the Exchangeable Note, not to incur any Indebtedness other than (A) trade payables or other similar Indebtedness incurred in the ordinary course of business consistent with past practice and (B) other Indebtedness not in excess of $1,000,000 in the aggregate;
(xi) to discuss the orders received in the Community Offering (other than, for avoidance of doubt, any orders from the Standby Purchaser) with the Standby Purchaser and only accept such orders and in such amounts as are agreed to by both the Standby Purchaser, on the one hand, and the Company and FLMHC, on the other hand;
(xii) to not, without the prior written consent of the Standby Purchaser exercise the Company’s right to increase or decrease the purchase limitations set forth in the Plan of Conversion pursuant to Section 10.01(f) thereof;
(xiii) to not exercise the Company’s or FLMHC’s right under Section 11.02 of the Plan of Conversion to reject order for Shares placed by the Standby Purchaser in accordance with the terms of this Agreement and the Plan of Conversion; and
(xiv) to not enter into any other Standby Purchase Agreement (as defined in the Plan of Conversion) with any other Standby Purchaser (as defined in the Plan of Conversion).
(b) The Standby Purchaser agrees as follows between the date hereof and the Closing Date:
(i) it shall be a condition precedent to the obligations of the Company to complete the registration or qualification pursuant to Section 6(a) hereof that the Standby Purchaser shall timely furnish to the Company in writing such information regarding itself as shall be reasonably requested by the Company and as shall be required to effect such registration or qualification and shall timely execute such documents in connection with such registration as the Company may reasonably request; and
(ii) to cooperate with the Company as reasonably requested by the Company in connection with the preparation and filing of the Registration Statement and the qualification of the Shares offered for sale in the Offerings under applicable “blue sky” laws hereunder.
16 |
(c) Each of the Standby Purchaser and the Company will cooperate with the other and use commercially reasonable efforts to promptly prepare all necessary documentation, to effect all necessary filings and to obtain all necessary permits, consents, waivers, approvals and authorizations of the Commission, the Department and any other third parties or Governmental Entities, necessary or desirable to consummate the purchase of the Shares by the Standby Purchaser contemplated by this Agreement. The Standby Purchaser and the Company will furnish each other and each other’s counsel with all information concerning themselves, their subsidiaries, directors, officers and shareholders and such other matters as may be necessary or advisable in connection with any application, petition or any other statement or application made by or on behalf of the Standby Purchaser or the Company to the Department or any Governmental Entity in connection with the purchase of the Shares by the Standby Purchaser contemplated by this Agreement. The Standby Purchaser shall notify the Company promptly of the receipt of any comments of the Department or any Governmental Entity with respect to such filings. Notwithstanding anything to the contrary contained herein, between the date of this Agreement and the Closing Date, the Standby Purchaser shall not be obligated to take or refrain from taking or to agree to it or its Affiliates taking or refraining from any action or to suffer to exist any condition, limitation, restriction or requirement that, individually or in the aggregate with any other actions, conditions, limitations, restrictions or requirements, would or would reasonably be likely to result in a Burdensome Condition, and the Standby Purchaser shall not be required to seek review by a court, administrative or regulatory authority, agency, commission, board, tribunal or similar adjudicative body of any determination of any insurance regulatory authority, including in their capacity as a rehabilitator, conservator, liquidator or similar capacity. As used herein, “Burdensome Condition” means any condition that would: (A) have a material negative effect on the business or the Permits, assets, liabilities, properties, operations, results of operations or condition (financial or otherwise) of the Standby Purchaser, its Affiliates or the Company; (B) impose any material requirement relating to the contribution of capital, keep-well or capital maintenance arrangements or maintaining risk-based capital level or any material restrictions on dividends or distributions or the ability of the Company to operate its business, in each case, excluding any changes in applicable Law or the effects of any actions, conditions, limitations, restrictions or requirements that are customary for the applicable Governmental Entity to impose in transactions of the type of transaction contemplated hereby; or (C) impose any requirement to modify this Agreement, the Plan of Conversion or other agreement entered or to be entered into in connection herewith or therewith in any manner that materially changes the rights, liabilities or obligations of the parties hereto or thereto.
17 |
(d) After the Closing, if and for so long as the Standby Purchaser beneficially owns more than five percent (5.0%) of the issued and outstanding shares of the Common Stock, the Company shall provide the Standby Purchaser with reasonable opportunities upon reasonable notice and during regular business hours to discuss with the senior management of the Company at least on a quarterly basis, the business and operations of the Company, with at least one of those meetings each year to be held, if requested by the Standby Purchaser, in-person at the Company’s offices or such other mutually agreeable location. The Standby Purchaser hereby acknowledges that it is aware, and it agrees that it will advise its representatives, agents, advisors, Affiliates and Associates who are informed as to the matters which are the subject of this provision (collectively, its “Representatives”), that the United States securities laws prohibit any Person who has received material, non-public information concerning the Company or the matters which are the subject of this provision from purchasing or selling securities of the Company or from communicating such information to any other Person. The Standby Purchaser agrees, and shall instruct its Representatives, to (i) keep such non-public information provided by the Company strictly confidential, (ii) use the same degree of care to protect such non-public information as each would use to protect its own non-public information of a similar nature, but in no event with less than reasonable care, and (iii) not disclose the non-public information in any manner whatsoever to any Person, except with the specific prior written consent of the Company. As used in this Section 6(d), “non-public information” shall not include information which (a) is or becomes public knowledge other than as a result of a breach of the obligations of the Standby Purchaser or its Representatives; (b) was known to the Standby Purchaser prior to the date of this Agreement, except as provided to the Standby Purchaser pursuant to a confidentiality agreement with Federal Life; (c) becomes available without restriction from a third party not known by the Standby Purchaser to be under any confidentiality obligation to the Company with respect thereto; or (d) is developed by the Standby Purchaser or its Representatives without use of the Company’s non-public information. In the event that the Standby Purchaser or any of its Representatives are requested or required by law, regulation, deposition, interrogatory, request for documents, subpoena, civil investigative demand, administrative regulatory requirement, order, decree or the rules of any applicable stock exchange or similar legal process (collectively, “Law”) to disclose any of the foregoing non-public information, the Standby Purchaser shall (or will direct its Representatives to) provide the Company with prompt prior written notice of such requirement to the extent permissible under applicable Law and reasonably practicable under the circumstances in order to enable the Company to (A) seek, at its own cost, an appropriate protective order or other remedy or (B) waive compliance, in whole or in part, with the terms of this Agreement; and the Standby Purchaser or such Representative shall consult and reasonably cooperate with the Company, at the Company’s expense and upon its written request, with respect to taking steps to resist or narrow the scope of such request or requirement. If, in the absence of a protective order, the Standby Purchaser or such Representative are nonetheless, on the advice of counsel of such Standby Purchaser or such Representative, as applicable, required by applicable Law to disclose the foregoing non-public information, the Standby Purchaser or such Representative shall (I) furnish only that portion of the foregoing non-public information that, based upon advice of legal counsel, is legally required, (II) give advance notice to the Company of the information to be disclosed as far in advance as is legally permissible and practical, and (III) exercise commercially reasonable efforts, at the Company’s expense and upon its written request, to obtain reliable assurance that confidential treatment will be accorded such non-public information. Notwithstanding anything to the contrary herein, without satisfying the other obligations of this paragraph, Standby Purchaser and its Representative may disclose such non-public information to the extent such disclosure is requested or required in connection with routine audits or examinations by, or blanket document requests from, a Governmental Entity that does not specifically target the other parties, this Agreement or the transactions contemplated hereby.
(e) The Company shall at all times reserve and hold available sufficient number of shares of Common Stock to satisfy its obligations under this Agreement.
(f) After the Closing, if and for so long as the Standby Purchaser beneficially owns more than five percent (5.0%) of the issued and outstanding shares of the Common Stock and a Standstill Termination Event has not occurred, the Company and Federal Life shall nominate election to the Board of Directors of the Company and Federal Life either (i) Matthew T. Popoli and Jay Novik or either of them, to the extent that the Standby Purchaser notifies the Company that such individuals are to be elected to the Board or (ii) if either Mr. Popoli or Mr. Novick are not selected by the Standby Purchaser, such individuals who are mutually and reasonably acceptable to the Company and the Standby Purchaser.
18 |
(g) As soon as eligible to register Shares for resale on a Form S-3 registration statement, or, if earlier, upon the occurrence of a Standstill Termination Event, the Company shall register the Purchased Shares and the Common Stock held by the Senior Management Shareholders for resale under the Securities Act in accordance with the provisions of Exhibit B attached hereto, at which time the legend described in Section 9(b) hereof shall be removed from the Purchased Shares and the Common Stock held by the Senior Management Shareholders and the restrictions set forth in Section 9(b) hereof shall be of no further force or effect.
Section 7. Public Statements. Neither the Company nor the Standby Purchaser shall issue any public announcement, statement or other disclosure with respect to this Agreement or the transactions contemplated hereby without the prior consent of the other party hereto, which consent shall not be unreasonably withheld or delayed, except if such public announcement, statement or other disclosure is required by applicable law or applicable stock market rules, in which case the disclosing party shall consult in advance with respect to such disclosure with the other parties to the extent reasonably practicable.
Section 8. Conditions to Closing.
(a) The obligations of the Standby Purchaser to consummate the transactions contemplated hereunder are subject to the fulfillment, prior to or on the Closing Date, of the following conditions:
(i) the representations and warranties of the Company, FLMHC, and Federal Life in Section 3 shall be true and correct in all respects as of the date hereof and at and as of the Closing Date as if made on such date, except where the failure to be true and correct (without regard to any materiality or Material Adverse Effect qualifications contained therein), would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect (and except that (1) representations and warranties made as of a specified date shall be true and correct as of such date and (2) the representations and warranties of the Company set forth in Sections 3(a), 3(b), 3(c), 3(e), 3(f)(i) and 3(i) shall be true and correct in all respects);
(ii) the Company, FLMHC, and Federal Life shall have performed in all material respects all of their respective obligations under this Agreement required to be performed on or prior to the Closing Date;
(iii) as of the Closing Date, none of the following events shall have occurred and be continuing: (A) trading in the Common Stock shall have been suspended by the Commission or trading in securities generally on The New York Stock Exchange or The Nasdaq Stock Market shall have been suspended or limited or minimum prices shall have been established on either such exchange, (B) a banking moratorium shall have been declared either by U.S. federal or New York State authorities, or (C) there shall have occurred any material outbreak or material escalation of hostilities, declaration by the United States of a national emergency or war or other calamity or crisis which has a material adverse effect on the U.S. financial markets;
19 |
(iv) the gross proceeds from the Offerings, including the purchase of the Purchased Shares by the Standby Purchaser, is equal to at least the Minimum of the Valuation Range;
(v) since the date of this Agreement, a Material Adverse Effect shall not have occurred and no change or other event shall have occurred that would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect; and
(vi) Senior Management Shareholders shall have agreed to be bound by transfer restrictions on Shares of Common Stock of the Company held by such Persons which are no less restrictive than the restrictions set forth in Section 9 hereof, and to be bound by tag along rights no less restrictive than those set forth in Section 15 hereof, in each case, pursuant to an agreement in form and substance satisfactory to Standby Purchaser; provided, however, that the Senior Management Shareholders shall be permitted to make transfers (x) for estate planning purposes, (y) of shares that in the aggregate are less than 50% of the number of shares owned by Senior Management Shareholders immediately after the Closing Date, or (z) to pay the exercise price upon the exercise of any stock options held by one of the Senior Management Shareholders.
(b) The obligations of the Company to consummate the transactions contemplated hereunder are subject to the fulfillment, prior to or on the Closing Date, of the following conditions:
(i) The representations and warranties of the Standby Purchaser in Section 4 shall be true and correct in all material respects as of the date hereof and at and as of the Closing Date as if made as of such date (except for representations and warranties made as of a specified date, which shall be true and correct in all material respects as of such specified date); and
(ii) the Standby Purchaser shall have performed in all material respects all of its obligations under this Agreement required to be performed on or prior to the Closing Date.
(c) The obligations of each of the Company and the Standby Purchaser to consummate the transactions contemplated hereunder in connection with the Offerings are subject to the fulfillment, prior to or on the Closing Date, of the following conditions:
(i) no judgment, injunction, decree or other legal restraint shall be outstanding, nor shall any action, suit, claim, investigation or other legal proceeding be pending that would reasonably be expected to prohibit, or have the effect of rendering unachievable, the consummation of the Offerings or the transactions contemplated by this Agreement;
(ii) the Registration Statement shall have been filed with the Commission and declared effective; no stop order suspending the effectiveness of the Registration Statement or any part thereof shall have been issued and no proceeding for that purpose shall have been initiated or threatened by the Commission; and any request of the Commission for inclusion of additional information in the Registration Statement or otherwise shall have been complied with;
20 |
(iii) at least two-thirds of the votes cast by the Voting Members voting at the meeting of the Voting Members called for such purpose shall have voted to adopt and approve the Plan of Conversion and the transactions contemplated thereunder;
(iv) all consents and approvals of the Department and any other regulatory body or agency necessary to consummate the transactions contemplated by this Agreement shall have been obtained and all notice and waiting periods required by law to pass after receipt of such approvals or consents shall have passed; and
(v) the Shares shall have been authorized for listing on the Nasdaq Capital Market.
Section 9. Restrictions on Transfer.
(a) Except as set forth in Section 9(c), the Standby Purchaser shall not, and shall ensure that its Affiliates do not, directly or indirectly, purchase, sell, transfer, assign, lend, convey, gift, mortgage, pledge, encumber, hypothecate or otherwise dispose of, directly or indirectly (“Transfer”), any shares of Common Stock. Any purported Transfers of shares of Common Stock in violation of this Section 9 shall be null and void and no right, title or interest in or to such shares shall be Transferred to the purported transferee, buyer, donee, assignee or encumbrance holder. The Company will not give, and will not permit the Company’s transfer agent to give, any effect to such purported Transfer in its stock records.
(b) The Standby Purchaser understands and agrees that the Purchased Shares will bear a legend substantially similar to the legend set forth below in addition to any other legend that may be required by applicable law or by any agreement between the Company and the Standby Purchaser. The legend shall be removed to permit Transfers made in accordance with Sections 9(c)(i), 9(c)(ii) and 9(c)(iii) unless prohibited by the Securities Act. Alternatively, upon receipt of certifications from the Standby Purchaser reasonably satisfactory to the Company’s counsel, the Company shall cause the legend to be removed in accordance with, and pursuant to, Rule 144 promulgated under the Securities Act and any other applicable federal and state securities laws.
THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR REGISTERED AND/OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE TRANSFERRED EXCEPT (A) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND REGISTRATION AND/OR QUALIFICATION UNDER APPLICABLE STATE SECURITIES LAWS, (B) IN A TRANSACTION WHICH IS EXEMPT FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND REGISTRATION AND/OR QUALIFICATION UNDER APPLICABLE STATE SECURITIES LAWS PROVIDED THAT AT THE ISSUER’S REQUEST, THE TRANSFEROR THEREOF SHALL HAVE DELIVERED TO THE ISSUER AN OPINION OF COUNSEL (WHICH OPINION SHALL BE IN FORM, SUBSTANCE AND SCOPE REASONABLY SATISFACTORY TO THE ISSUER) TO THE EFFECT THAT SUCH SECURITIES MAY BE SOLD OR TRANSFERRED PURSUANT TO AN EXEMPTION FROM SUCH REGISTRATION, OR (C) SUCH SECURITIES MAY BE SOLD PURSUANT TO RULE 144 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.
21 |
(c) The provisions of Section 9(a) hereof shall not apply to any of the following Transfers by the Standby Purchaser of any shares of Common Stock:
(i) beginning on the third anniversary of the Closing Date, by offering or selling to Persons (other than to Persons party hereto or pursuant to clause (iii) below) shares of Common Stock pursuant to Section 9(d) hereof not more than six and one-quarter percent (6-1/4%) of the number equal to the Purchased Shares every ninety (90) days (the “90-Day Limit”);
(ii) pursuant to a tender or exchange offer to an acquiror seeking to acquire 100% of the Common Stock of the Company that has been approved by the Board prior to such sale;
(iii) to one or more members or Affiliates of the Standby Purchaser, provided that such member or Affiliate executes a written agreement in a form reasonably satisfactory to the Company to be bound by the terms and conditions hereof; and
(iv) occurring after the occurrence of a Standstill Termination Event.
(d) If and for so long as the Standby Purchaser beneficially owns any shares of the Common Stock and a First Offer Termination Event has not occurred, the Standby Purchaser shall provide the Company with not less than fifteen (15) Business Days prior written notice (the “Public Sale Notice”) on each occasion before offering to sell to Persons (other than to Persons party hereto or pursuant to Section 9(c)(ii) or 9(c)(iii) above) any shares of Common Stock that it is permitted to sell under the Securities Act (the “Offered Shares”). The Company shall have a right to notify the Standby Purchaser of the Company’s intent to purchase on or before the expiration of such fifteen (15) Business Days, all or any portion of such Offered Shares at a price per share equal to the greater of (i) the VWAP Price, or (ii) 95% times the Company’s then book value as calculated in accordance with GAAP (determined without regard to its accumulated other comprehensive income) for the most recent quarter preceding the date of the Public Sale Notice by at least forty-five (45) days.
If the Company fails (A) to exercise the foregoing right with respect to such Offered Shares within fifteen (15) Business Days after receipt of the Public Sale Notice and (B) to complete the purchase of such Offered Shares within ten (10) Business Days after receipt of all required regulatory approvals, the Standby Purchaser may sell such Offered Shares in the market in accordance with Section 9(c)(i) hereof.
Any repurchase by the Company pursuant to this Section 9(d) is subject to the prior approval of the Department, to the extent required under applicable Illinois law governing mutual-to-stock conversions or distributions by Federal Life. In the event that the Company exercises its right to purchase the Shares pursuant to this Section 9(d), (i) the Company shall use commercially reasonable efforts to obtain all required regulatory approvals of the purchase of the Shares as soon as practical and (ii) closing upon the purchase of the Shares will occur within ten (10) Business Days after all required regulatory approvals have been received.
22 |
(e) If, at any time while the Common Stock is listed on any public exchange, the per share price of the Common Stock exceeds 250% of the per share price as of Closing, the Company shall, at the written request of the Standby Purchaser, register the Offered Shares for resale under the Securities Act in accordance with the provisions of Exhibit B attached hereto, following which registration the restrictions of Section 9(a) through Section 9(d) shall terminate and be of no further force or effect.
(f) If the Standby Purchaser sells more than 5% of the outstanding shares of Common Stock to any Person prior to the occurrence of a Standstill Termination Event,, then such Person must enter into a standstill agreement reasonably acceptable to the Company containing provisions similar to those in Section 9(f), Section 10 and Section 12(a) of this Agreement.
Section 10. Post-Closing Standstill Provision. If and for so long as the Standby Purchaser beneficially owns more than five percent (5.0%) of the issued and outstanding shares of the Common Stock and a Standstill Termination Event has not occurred, the Standby Purchaser agrees that, without the prior written consent of the Board as specifically expressed in a resolution adopted by a majority of the entire membership of the Board (other than a designee of the Standby Purchaser), neither the Standby Purchaser, nor any of its Affiliates or Associates nor any Person acting at their direction or on their behalf, will, directly or indirectly:
(a) with respect to the Company or Common Stock, make, engage or in any way participate in, directly or indirectly, any “solicitation” (as such term is used in the proxy rules of the Commission) of proxies or consents (whether or not relating to the election or removal of directors); seek to advise, encourage or influence any Person with respect to the voting of any Common Stock (other than Affiliates or Associates); initiate, propose or otherwise “solicit” (as such term is used in the proxy rules of the Commission) shareholders of the Company for the approval of shareholder proposals whether made pursuant to Rule 14a-8 or Rule 14a-4 under the Exchange Act, or otherwise, or cause or encourage or attempt to cause or encourage any other Person to initiate any such shareholder proposal; otherwise communicate with the Company’s shareholders or others pursuant to Rule 14a-1(l)(2)(iv) under the Exchange Act; or participate in, or take any action pursuant to, any “shareholder access” proposal which may be adopted by the Commission, whether in accordance with previously proposed Rule 14a-11 or otherwise;
(b) take any action to cause the Company or any of its subsidiaries to be merged with or into or otherwise acquired (including any purchase of all of the stock or substantially all of the assets of the Company or any of its subsidiaries or any loss portfolio transfer involving any subsidiary of the Company) by Prosperity Life Insurance Company or any other insurance company or affiliate of an insurance company owned or controlled by the Standby Purchaser or any affiliate of the Standby Purchaser.
23 |
(c) seek, propose, or make any statement with respect to any merger, consolidation, business combination, tender or exchange offer, sale or purchase of assets, sale or purchase of securities, dissolution, liquidation, restructuring, recapitalization or similar transactions of or involving the Company or any of its Affiliates or Associates;
(d) except as otherwise permitted by this Agreement, acquire, offer or propose to acquire, or agree to acquire (except by way of stock dividends, stock splits, reverse stock splits or other distributions or offerings made available to holders of any shares of Common Stock generally), directly or indirectly, whether by purchase, tender or exchange offer, through the acquisition of control of another Person, by joining a partnership, limited partnership, syndicate or other “group” (within the meaning of Section 13(d)(3) of the Exchange Act) or otherwise, any shares of Common Stock, Equity Securities, or any loans, debt securities, or assets of the Company or any of its subsidiaries, or rights or options to acquire interests in any of the loans, debt securities, equity securities or assets of the Company or any of its subsidiaries;
(e) form, join or in any way participate in a “group” (within the meaning of Section 13(d)(3) of the Exchange Act) with respect to any shares of Common Stock;
(f) deposit any shares of Common Stock in any voting trust or subject any shares of Common Stock to any arrangement or agreement with respect to the voting of any shares of Common Stock;
(g) act alone or in concert with others to control or seek to control, or influence or seek to influence, the management, the Board or policies of the Company;
(h) make any demand or request for any shareholder list, or any related material, or for the books and records of the Company or its Affiliates;
(i) seek, alone or in concert with others, election or appointment to or representation on, or nominate or propose the nomination of any candidate to, the Board, or seek the removal of any member of the Board, in a manner inconsistent with this Agreement;
(j) have any discussions or communications, or enter into any arrangements, understanding or agreements (whether written or oral) with, or knowingly instigate, advise, finance, assist or encourage, any other Person in connection with any of the foregoing (including by granting any waiver to any legal, financial, public relations, proxy solicitation or other firm that represented or was engaged by the Standby Purchaser, its Affiliates, Associates or any of their legal counsel with respect to the Company, which waiver would permit any such firm to represent any Person in connection with matters relating to the Company), or make any investment in or enter into any arrangement with any other Person that engages, or offers or proposes to engage, in any of the foregoing;
(k) make or disclose any statement regarding any intent, purpose, plan or proposal with respect to the Board, the Company, its management, policies or affairs or any of its securities or assets or this Agreement that is inconsistent with the provisions of this Agreement, including any intent, purpose, plan or proposal that is conditioned on, or would require waiver, amendment, nullification or invalidation of, any provision of this Agreement or take any action that could require the Company to make any public disclosure relating to any such intent, purpose, plan, proposal or condition; or
24 |
(l) otherwise take, or solicit, cause or encourage others to take, any action inconsistent with any of the foregoing; provided, however, that the act of requesting that the Board consider any of the foregoing acts or actions taken in preparation of a privatization of the Company shall not constitute a breach of this Section 10.
Section 11. Post-Closing Pre-Emptive Rights.
(a) Subject to applicable securities laws, other than the Offerings, following the Closing Date, the Standby Purchaser shall have the right to purchase (its “Gross Up Right”) its pro rata share of all Equity Securities that the Company or any Subsidiary of the Company may, from time to time, propose to sell and issue after the date of this Agreement, other than the Equity Securities excluded by Sections 11(d) and 11(e) hereof. The Standby Purchaser’s pro rata share is equal to the ratio of (i) the total number of outstanding shares of the Common Stock that the Standby Purchaser is deemed to be a holder of immediately prior to the issuance of such Equity Securities to (ii) the total number of shares of the outstanding Common Stock (including all shares of the Common Stock issued or issuable upon conversion of any securities convertible into the Common Stock or upon the exercise of any outstanding warrants or options) immediately prior to the issuance of the Equity Securities.
(b) If the Company or a Subsidiary of the Company proposes to issue any Equity Securities, the Company shall give the Standby Purchaser written notice of its intention, describing the Equity Securities and the price and the terms and conditions upon which the Company or such Subsidiary proposes to issue the same. The Standby Purchaser shall have twenty (20) days from the receipt of such notice (the “Offer Period”) to notify the Company in writing that it intends to exercise its Gross Up Right and as to the amount of Equity Securities the Standby Purchaser intends to purchase, up to the maximum calculated in accordance with Section 11(a) hereof (the “Designated Securities”); provided, however, that if providing the Standby Purchaser twenty (20) days’ notice to respond is not practicable, the Company may provide an earlier deadline for the Standby Purchaser to respond to such notice by giving the Standby Purchaser the maximum number of days to respond as is practicable but in any event no fewer than five (5) days’ notice. Such notice from the Standby Purchaser shall constitute a non-binding indication of interest of the Standby Purchaser to purchase the amount of Designated Securities specified by the Standby Purchaser (or a proportionately lesser amount if the amount of Equity Securities to be offered if such offering of Equity Securities is subsequently reduced) at the price (or range of prices) and other terms set forth in the Company’s notice to it. The failure to respond during the Offer Period constitutes a waiver of its Gross Up Right in respect of such offering. The Standby Purchaser shall execute a binding agreement to purchase any such Equity Securities within thirty (30) days after expiration of the Offer Period, and any Equity Securities that the Standby Purchaser indicated it would purchase but that are not covered by a binding purchase agreement at such time may be sold to other Persons, unless the failure to execute such an agreement is attributable to actions of the Company or a Subsidiary of the Company, in which case the Company or such Subsidiary shall have the right to sell the Equity Securities to other Persons if the Standby Purchaser shall not have executed such an agreement within the later of (i) five (5) Business Days after the reason for such delay has been resolved or (ii) thirty (30) days after expiration of the Offer Period. Notwithstanding the foregoing, neither the Company nor such Subsidiary shall be required to offer or sell such Equity Securities to the Standby Purchaser if it would cause the Company or such Subsidiary to be in violation of applicable federal securities or insurance regulatory laws by virtue of such offer or sale.
25 |
(c) The Company or such Subsidiary shall have 90 days after expiration of the Offer Period to sell any Equity Securities in respect of which the Standby Purchaser’s Gross Up Rights were not exercised, at a price and upon general terms and conditions not materially more favorable to the purchasers thereof than specified in the Company’s notice to the Standby Purchaser pursuant to Section 11(b) hereof. If the Company or such Subsidiary has not sold such Equity Securities within such 90-day period, neither the Company nor such Subsidiary shall thereafter issue or sell any Equity Securities without first offering such Equity Securities to the Standby Purchaser in the manner provided above.
(d) The Gross Up Rights provided by this Section 11 shall not apply to, and shall terminate upon the earlier of (a) the first date upon which the Standby Purchaser no longer beneficially owns shares of the Common Stock representing more than five percent (5%) of the issued and outstanding shares of the Common Stock immediately prior to an issuance contemplated under Section 11(a) hereof, (b) the date of any breach by the Standby Purchaser of any material obligation under this Agreement that remains uncured after thirty (30) days’ notice thereof, or (c) the end of the Standstill Period.
(e) The provisions in this Section 11 shall not apply to any issuance of Equity Securities by the Company (i) to employees, consultants, officers or directors of the Company or any of its subsidiaries for the primary purpose of soliciting or retaining their employment or services or in a transaction or pursuant to management or employee agreements, incentive programs or stock purchase or equity compensation plans approved by the Board (including any such programs or plans in existence on the date hereof), (ii) to a third party as consideration in connection with (but not in connection with raising capital to fund) (A) a strategic business combination or other merger, acquisition or disposition transaction, partnership, joint venture, strategic alliance or investment by the Company or similar non-capital raising transaction approved by the Board, or (B) an investment by the Company or its subsidiaries approved by the Board in any party which is not prior to such transaction an Affiliate of the Company (whether by merger, consolidation, sale or exchange of stock, sale of assets or securities, or otherwise), (iii) as part of any offering registered under the Securities Act; provided, that the Standby Purchaser shall not be precluded by the Company, its underwriter(s) or its agent(s) in connection with such offering from purchasing in such offering, and the Company shall use commercially reasonable efforts to cause its underwriter(s) or agent(s) engaged in connection with such offering to allocate shares, on the same terms and conditions offered to the public, a sufficient number of Designated Securities, so as to maintain the Standby Purchaser’s pro rata share of all Equity Securities, (iv) upon the exercise, conversion or exchange of options, warrants or similar rights or other convertible securities, (v) the issuance of Equity Securities by a Subsidiary of the Company to the Company or one of its direct or indirect Subsidiaries and (vi) in connection with any stock split, stock dividend paid on a proportionate basis to all holders of the affected class of capital stock or recapitalization approved by the Board.
26 |
Section 12. Post-Closing Voting. If and for so long as the Standby Purchaser beneficially owns more than five percent (5.0%) of the shares of the Common Stock outstanding and a Standstill Termination Event has not occurred:
(a) subject to the final proviso of this paragraph, the Standby Purchaser shall vote and cause to be voted all shares of Common Stock beneficially owned by the Standby Purchaser (i) for persons nominated and recommended by the Board for election as directors of the Board and against any Person nominated for election as a director by any other Person and (ii) as directed or recommended by the Board with respect to any proposal presented at any meeting of the Company’s shareholders, including, but not limited to (A) the entire slate of directors recommended for election by the Board to the shareholders of the Company at any meeting of the Company’s shareholders at which any directors are elected, (B) any shareholder proposal submitted for a vote at any meeting of the Company’s shareholders, and (C) any proposal submitted by the Company for a vote at any meeting of the Company’s shareholders relating (x) to the appointment of the Company’s accountants or (y) an equity compensation plan of the Company and/or any material revisions thereto; provided, however, that the Standby Purchaser shall not be bound to vote in accordance with the foregoing provisions if the Company is in violation of a material obligation of this Agreement that remains uncured after fifteen (15) days’ notice thereof or if such proposal (1) would have a disproportionate effect on the Standby Purchaser compared to all of the other holders of the Common Stock as a group, (2) (other than the matters specified in clause (i)) requires approval of a related party transaction between the Company and one or more of its Affiliates other than as set forth in clauses (i), (ii)(A) and (ii)(C)(y), or (3) would result in nominees of the Standby Purchaser being removed from the Board.
(b) Notwithstanding the foregoing, so long as the Standby Purchaser owns 25% or more of the outstanding shares of Common Stock, without the affirmative vote or written approval of the Standby Purchaser, none of the Company, Federal Life, or FLMHC shall cause or permit, take or decide, or agree or commit to take any of the actions set forth on Exhibit C, and the Standby Purchaser shall have the right to vote its shares (or provide or withhold its written approval) with respect to such actions in its sole and absolute discretion.
Section 13. Exit Provisions.
(a) If, at any time prior to the ROFO Termination Date, the Standby Purchaser provides a written notice to the Company that the Standby Purchaser and those of its Affiliates who own Common Stock desire to sell the Common Stock held by such Persons (a “Potential Sale Notice”) the Company or its designee may, by written notice to the Standby Purchaser (a “Company Offer Notice”) delivered by the date that is the earlier of (i) the date that is six (6) months following the date of the Potential Sale Notice and (ii) the ROFO Termination Date, make a Qualifying Offer to purchase all, but not less than all, of the Common Stock held by the Standby Purchaser and its Affiliates. If the Standby Purchaser or such Affiliate accepts the Qualifying Offer contained in the Company Offer Notice, the Standby Purchaser shall notify the Company of such acceptance within ten (10) Business Days of receipt of such Company Offer Notice, and the closing of the sale of the Offered Shares to the Company or such designee shall occur on the later to occur of (x) thirty (30) days of such election and (y) ten (10) Business Days after any required regulatory approvals for such sale are received.
27 |
(b) If either (i) the Company confirms in writing that the Company will not provide a Company Offer Notice, (ii) the Company does not deliver a Company Offer Notice to the Standby Purchaser in the manner set forth in Section 13(a), (iii) the Company delivers a Company Offer Notice to the Standby Purchaser and fails to close on the purchase described in such Company Offer Notice for reasons other than the default by the Standby Purchaser or its Affiliates, or (iv) the Standby Purchaser or its applicable Affiliate does not accept the offer contained in the Company Offer Notice, then the Standby Purchaser and its Affiliates may (A) sell all or any portion of the Common Stock held by the Standby Purchaser or its Affiliates to a third party (subject to applicable Law) or (B) require the Company to register such Common Stock for resale under the Securities Act in accordance with the provisions of Exhibit B attached hereto; provided, that until the ROFO Termination Date, if the Company has delivered a Company Offer Notice to the Standby Purchaser, any such sale must be for a price that is not less than the price contained in the Company Offer Notice.
(c) For the purposes of this Section 13, a “Qualifying Offer” shall mean an offer for all but not less than all of the Common Stock owned by the Standby Purchaser and its Affiliates which (i) provides payment of the purchase price at closing in immediately available funds, (ii) is not subject to any contingency except receipt by the buyer of all required regulatory approvals, and (iii) is accompanied by commitment letters or other evidence, in each case, in form and substance reasonably acceptable to the Standby Purchaser, that the proposed buyer for such Common Stock will have the funds available to purchase such Common Stock in accordance with the terms set forth in the applicable Company Offer Notice.
(d) If (x) the Standby Purchaser disagrees with any material corporate action taken or proposed to be taken by the Company or Federal Life or (y) the Company or Federal Life fails to take any material corporate action proposed by the Standby Purchaser (either, a “Strategic Direction”) and the Standby Purchaser gives written notice thereof to the Company, the Company shall have ninety (90) days to rescind or terminate such Strategic Direction that is proposed to be taken, if such action is capable of being terminated or rescinded or, upon a failure to take action proposed by the Standby Purchaser, to take the action which is the subject of such Strategic Direction within one year after receipt of such written notice from the Standby Purchaser. If the Company fails to rescind or terminate such Strategic Direction or take the action which is the subject of such Strategic Direction within the applicable time period, upon receipt by the Company of written notice from the Standby Purchaser, then within six (6) months after receipt by the Company of such written notice from the Standby Purchaser, the Company shall either:
(i) Purchase or cause another Person to offer to purchase all of the Shares using the price set forth in Section 9(d) hereof; or
28 |
(ii) if such Shares have not been registered previously, register the Shares owned by the Standby Purchaser for resale under the Securities Act in accordance with the provisions of Exhibit B attached hereto, following which registration the restrictions of Section 9(a) through Section 9(d) shall terminate and be of no further force or effect.
In the event that the Company exercises its right to purchase the Shares pursuant to Section 13(d)(i) above, (i) the Company or its applicable designee shall use commercially reasonable efforts to obtain all required regulatory approvals of the purchase of the Shares as soon as practical and (ii) closing upon the purchase the Shares will occur within ten (10) Business Days after all required regulatory approvals have been received.
(e) On the occurrence of an ASE Event, (i) the Company shall, promptly upon the request of the Standby Purchaser, remove any restrictive legend on the shares of Common Stock owned by the Standby Purchaser, (ii) the restrictions on transfer in Section 9 hereof (other than the provisions of Section 9(f) hereof) shall terminate and be of no further force or effect, and (iii) the Standby Purchaser shall be permitted to sell such shares at any time and from time to time without any notice to the Company.
Section 14. Drag Along Rights.
(a) After the occurrence of a Standstill Termination Event, if a Stockholder who holds no less than 51% of the outstanding Common Stock of the Company (a “Dragging Stockholder”), receives a bona fide offer from a non-affiliated Third Party Purchaser to consummate, in one transaction, or a series of related transactions, a Change of Control (a “Drag-along Sale”), the Dragging Stockholder shall have the right to require that each other Stockholder (each, a “Drag-along Stockholder”) participate in such Transfer in the manner set forth in this Section 14, provided, however, that no Drag-along Stockholder shall be required to participate in the Drag-along Sale if the consideration for the Drag-along Sale is other than cash or registered securities listed on an established U.S. securities exchange or traded on the NASDAQ Stock Market. Notwithstanding anything to the contrary in this Agreement, each Drag-along Stockholder shall vote in favor of the transaction and take all actions to waive any dissenters, appraisal or other similar rights.
(b) The Dragging Stockholder shall exercise its rights pursuant to this Section 14 by delivering a written notice (the “Drag-along Notice”) to the Company and each Drag-along Stockholder no later than 20 Business Days prior to execution of an agreement to effect a Drag-along Sale. The Drag-along Notice shall make reference to the Dragging Stockholder’s rights and obligations hereunder and shall describe in reasonable detail:
(i) the number of shares of Common Stock to be sold by the Dragging Stockholder, if the Drag-along Sale is structured as a Transfer of Common Stock;
(ii) the identity of the Third Party Purchaser;
(iii) the proposed date, time and location of the closing of the Drag-along Sale;
29 |
(iv) the per share purchase price and the other material terms and conditions of the Transfer, including a description of any non-cash consideration in sufficient detail to permit the valuation thereof; and
(v) a copy of any form of agreement proposed to be executed in connection therewith.
(c) If the Drag-along Sale is structured as a Transfer of Common Stock, then, subject to Section 14(d), the Dragging Stockholder and each Drag-along Stockholder shall Transfer the number of shares equal to the product of (x) the aggregate number of shares of Common Stock the Third Party Purchaser proposes to buy as stated in the Drag-along Notice and (y) a fraction (A) the numerator of which is equal to the number of shares of Common Stock and Common Stock Equivalents then held by such Dragging Stockholder or Drag-along Stockholder, as the case may be, and (B) the denominator of which is equal to the number of shares of Common Stock and Common Stock Equivalents then held by all of the Stockholders (including, for the avoidance of doubt, the Dragging Stockholder).
(d) The consideration to be received by a Drag-along Stockholder shall be the same form and amount of consideration per share of Common Stock to be received by the Dragging Stockholder (or, if the Dragging Stockholder is given an option as to the form and amount of consideration to be received, the same option shall be given) and the terms and conditions of such Transfer shall, except as otherwise provided in the immediately succeeding sentence, be the same as those upon which the Dragging Stockholder Transfers its Common Stock. Each Drag-along Stockholder shall make or provide the same representations, warranties, covenants, and agreements as the Dragging Stockholder makes or provides in connection with the Drag-along Sale (except that in the case of representations, warranties, covenants, and agreements pertaining specifically to the Dragging Stockholder, the Drag-along Stockholder shall make the comparable representations, warranties, covenants, and agreements pertaining specifically to itself); provided, that all representations, warranties, covenants and indemnities shall be made by the Dragging Stockholder and each Drag-along Stockholder severally and not jointly and further provided that no Drag-along Stockholder shall be required to provide any indemnification to the Third Party Purchaser other than in respect of actions taken or defaults caused by such Drag-along Stockholder.
(e) The fees and expenses of the Dragging Stockholder incurred in connection with a Drag-along Sale shall be paid by the Dragging Stockholder to the extent not paid or reimbursed by the Company or the Third Party Purchaser.
(f) Each Drag-along Stockholder shall take all actions as may be reasonably necessary to consummate the Drag-along Sale, including entering into agreements and delivering certificates and instruments, in each case consistent with the agreements being entered into and the certificates being delivered by the Dragging Stockholder.
30 |
(g) The Dragging Stockholder shall have 120 days following the date of the Drag-along Notice in which to consummate the Drag-along Sale, on the terms set forth in the Drag-along Notice (which such 120 day period may be extended for a reasonable time not to exceed 180 days to the extent reasonably necessary to obtain any Government Approvals). If at the end of such period, the Dragging Stockholder has not completed the Drag-along Sale, the Dragging Stockholder may not then effect a transaction subject to this Section 14 without again fully complying with the provisions of this Section 14.
Section 15. Tag Along Rights.
(a) After the occurrence a Standstill Termination Event, except for transfers effected on an Exchange, if a Senior Management Shareholder or a Stockholder who holds no less than 51% of the outstanding Common Stock of the Company (the “Selling Stockholder”) proposes to Transfer any shares of its Common Stock to a Third Party Purchaser (the “Proposed Transferee”) and the Selling Stockholder cannot or has not elected to exercise its drag-along rights set forth in Section 14, each other Stockholder (each, a “Tag-along Stockholder”) shall be permitted to participate in such Transfer (a “Tag-along Sale”) on the terms and conditions set forth in this Section 15.
(b) Prior to the consummation of any such Transfer of Common Stock described in Section 15(a), the Selling Stockholder shall deliver to the Company and each other Stockholder a written notice (a “Sale Notice”) of the proposed Tag-along Sale subject to this Section 15 no later than 10 Business Days prior to the execution of an agreement for a Tag-along Sale. The Sale Notice shall make reference to the Tag-along Stockholders’ rights hereunder and shall describe in reasonable detail:
(i) the aggregate number of shares of Common Stock the Proposed Transferee has offered to purchase.
(ii) the identity of the Proposed Transferee;
(iii) the proposed date, time and location of the closing of the Tag-along Sale;
(iv) the per share purchase price and the other material terms and conditions of the Transfer, including a description of any non-cash consideration in sufficient detail to permit the valuation thereof; and
(v) a copy of any form of agreement proposed to be executed in connection therewith.
(c) Each Tag-along Stockholder shall exercise its right to participate in a Transfer of Common Stock by the Selling Stockholder subject to this Section 15 by delivering to the Selling Stockholder a written notice (a “Tag-along Notice”) stating its election to do so and specifying the number of shares of Common Stock to be Transferred by it no later than five Business Days after receipt of the Sale Notice (the “Tag-along Period”). The offer of each Tag-along Stockholder set forth in a Tag-along Notice shall be irrevocable, and, to the extent such offer is accepted, such Tag-along Stockholder shall be bound and obligated to Transfer in the proposed Transfer on the terms and conditions set forth in this Section 15. The Selling Stockholder and each Tag-along Stockholder shall have the right to Transfer in a Transfer subject to this Section 15 the number of shares of Common Stock equal to the product of (x) the aggregate number of shares of Common Stock the Proposed Transferee proposes to buy as stated in the Sale Notice and (y) a fraction (A) the numerator of which is equal to the number of shares of Common Stock and Common Stock Equivalents then held by the Selling Stockholder or such Tag-along Stockholder, as the case may be, and (B) the denominator of which is equal to the number of shares of Common Stock and Common Stock Equivalents then held by all of the Stockholders (including, for the avoidance of doubt, the Selling Stockholder).
31 |
(d) Each Tag-along Stockholder who does not deliver a Tag-along Notice in compliance with Section 15(c) above shall be deemed to have waived all of such Tag-along Stockholder’s rights to participate in such Transfer, and the Selling Stockholder shall (subject to the rights of any participating Tag-along Stockholder) thereafter be free to Transfer to the Proposed Transferee its shares of Common Stock at a per share price that is no greater than the per share price set forth in the Sale Notice and on terms and conditions which are not materially more favorable to the Selling Stockholder than those set forth in the Sale Notice without any further obligation to the non-accepting Tag-along Stockholders.
(e) Each Tag-along Stockholder participating in a Transfer pursuant to this Section 15 shall receive the same consideration per share as the Selling Stockholder after deduction of such Tag-along Stockholder’s proportionate share of the related expenses in accordance with Section 15(g) below.
(f) Each Tag-along Stockholder shall make or provide the same representations, warranties, covenants, and agreements as the Selling Stockholder makes or provides in connection with the Tag-along Sale (except that in the case of representations, warranties, covenants, and agreements pertaining specifically to the Selling Stockholder, the Tag-along Stockholder shall make the comparable representations, warranties, covenants, indemnities and agreements pertaining specifically to itself); provided, that all representations, warranties, and covenants shall be made by the Selling Stockholder and each Tag-along Stockholder severally and not jointly and provided further that no Tag-along Stockholder shall have any indemnification obligation to the Proposed Transferee other than in respect of actions taken or defaults caused by such Tag-along Stockholder.
(g) The Selling Stockholder and each Tag-along Stockholder shall be responsible for its own expenses.
(h) Each Tag-along Stockholder shall take all actions as may be reasonably necessary to consummate the Tag-along Sale, including entering into agreements and delivering certificates and instruments, in each case consistent with the agreements being entered into and the certificates being delivered by the Selling Stockholder.
(i) The Selling Stockholder shall have 120 Business Days following the expiration of the Tag-along Period in which to Transfer the shares of Common Stock described in the Sale Notice, on the terms set forth in the Sale Notice (which such 120 Business Day period may be extended for a reasonable time not to exceed 180 Business days to the extent reasonably necessary to obtain any Government Approvals). If at the end of such 120 Business day period, the Selling Stockholder has not completed such Transfer, the Selling Stockholder may not then effect a Transfer of Common Stock subject to this Section 15 without again fully complying with the provisions of this Section 15.
32 |
(j) If the Selling Stockholder Transfers to the Proposed Transferee any of its shares of Common Stock in breach of this Section 15, then each Tag-along Stockholder shall have the right to Transfer to the Selling Stockholder, and the Selling Stockholder undertakes to purchase from each Tag-along Stockholder, the number of shares of Common Stock that such Tag-along Stockholder would have had the right to Transfer to the Proposed Transferee pursuant to this Section 15, for a per share amount and form of consideration and upon the terms and conditions on which the Proposed Transferee bought such Common Stock from the Selling Stockholder, and without indemnity being granted by any Tag-along Stockholder to the Selling Stockholder; provided, that, nothing contained in this Section 15 shall preclude any Stockholder from seeking alternative remedies against such Selling Stockholder as a result of its breach of this Section 15. The Selling Stockholder shall also reimburse each Tag-along Stockholder for any and all reasonable and documented out-of-pocket fees and expenses, including reasonable legal fees and expenses, incurred pursuant to the exercise or the attempted exercise of the Tag-along Stockholder’s rights.
Section 16. Termination.
(a) This Agreement may be terminated at any time prior to the Closing Date:
(i) by the Company on one hand or the Standby Purchaser on the other hand by written notice to the other party hereto, if there is a material breach of this Agreement by the other party that is not cured within fifteen (15) days after receipt of written notice of such breach by such breaching party;
(ii) if, by action of FLMHC’s board of directors, FLMHC shall have decided to abandon the Plan of Conversion;
(iii) if the Plan of Conversion shall have been proposed for approval and adoption at a meeting of the Voting Members and shall have failed to receive approval at such meeting or any adjournment thereof or if the Department shall have stated in writing that it does not approve or intend to approve the Plan of Conversion;
(iv) the Closing has not occurred by December 31, 2018 (the “Outside Date”), provided that the party seeking to terminate this Agreement pursuant to this clause (iv) shall not have failed to perform the covenants, agreements and conditions to be performed by it which has been the primary cause of, or resulted in, the failure of the Closing to occur by the Outside Date, and further provided that if any approvals necessary to proceed with or complete the Conversion or the Offerings have not been received by December 1, 2018, either the Company or the Standby Purchaser may extend the Outside Date for up to six months by giving written notice thereof to the other party, so long as, in the case of an extension sought by the Company, each of the Company, FLMHC and Federal Life shall have performed the covenants, agreements and conditions to be performed by it; or
33 |
(v) if any Governmental Entity shall have issued an order, decree or ruling or taken any other action permanently restraining, enjoining or otherwise prohibiting the transactions contemplated by this Agreement and such order, decree, ruling or other action shall have become final and nonappealable or if the removal or reversal of such order, decree, ruling or other action should constitute a Burdensome Condition.
(b) In the event of termination of this Agreement pursuant to Section 16(a), written notice thereof shall as promptly as practicable be given to the other parties to this Agreement and this Agreement shall terminate and the transactions contemplated hereby shall be abandoned, without further action by any of the parties hereto. If this Agreement is terminated pursuant to Section 16(a):
(i) there shall be no liability or obligation on the part of the parties hereto or their respective officers and directors, and all obligations of the parties hereto shall terminate, except for (A) the obligations of the parties pursuant to this Section 17(b), and the provisions of Sections 17 through 23 and Section 25, and (B) any liabilities for any breach by the parties of the terms and conditions of this Agreement prior to such termination; and
(ii) all filings, applications and other submissions made pursuant to the transactions contemplated by this Agreement shall, to the extent practicable, be withdrawn from any Governmental Entity to which made.
Section 17. Survival. The representations and warranties of the Company and the Standby Purchaser contained in this Agreement or in any certificate delivered hereunder shall survive the Closing hereunder.
Section 18. Notices. All notices, communications and deliveries required or permitted by this Agreement shall be made in writing signed by the party making the same, shall specify the Section of this Agreement pursuant to which it is given or being made and shall be deemed given or made (i) on the date delivered if delivered by hand, (ii) on the third (3rd) Business Day after it is mailed if mailed by United States registered or certified mail (return receipt requested) (with postage and other fees prepaid), or (iii) on the day after it is delivered, prepaid, to an overnight express delivery service promising next business day delivery that confirms to the sender delivery to the recipient on such day, as follows:
(a) If to the Company, at: |
Federal Life Insurance Company 3750 Deerfield Road Riverwoods, Illinois 60015 Attention: William Austin, President |
(b) If to the Standby Purchaser, at: |
Insurance Capital Group, LLC 767 5th Avenue New York, New York 10153 Attention: Matthew T. Popoli |
34 |
or to such other representative or at such other address of a party as such party hereto may furnish to the other parties in writing in accordance with this Section 18. If notice is given pursuant to this Section 18 of any assignment to a permitted successor or assign of a party hereto, the notice shall be given as set forth above to such successor or permitted assign of such party.
Section 19. Assignment. This Agreement will be binding upon, and will inure to the benefit of and be enforceable by, the parties hereto and their respective successors and assigns. No party to this Agreement may assign this Agreement or any of its rights or obligations under this Agreement without the prior written consent of the other party hereto; provided that the Standby Purchaser may assign its rights and obligations hereunder to an Affiliate of the Standby Purchaser (excluding Prosperity Life Insurance Group or any subsidiary thereof) if the Standby Purchaser gives written notice of such assignment to the Company within five (5) Business Days thereof and the Standby Purchaser guarantees performance by such Affiliate of the Standby Purchaser’s obligations under this Agreement.
Section 20. Entire Agreement. This Agreement embodies the entire agreement and understanding between the parties hereto in respect of the subject matter contained herein. There are no restrictions, promises, warranties, or undertakings, other than those set forth or referred to herein, with respect to the transactions contemplated by this Agreement. This Agreement supersedes all prior agreements and understandings between the parties with respect to the subject matter of this Agreement.
Section 21. Governing Law; Venue. This Agreement shall be governed by and construed in accordance with the laws of the Commonwealth of Pennsylvania (other than its rules of conflict of laws to the extent the application of the laws of another jurisdiction would be required thereby). The state courts of the County of Philadelphia, Pennsylvania and the United States District Court for the Eastern District of Philadelphia shall have the exclusive jurisdiction over any and all claims, lawsuits and litigation relating to or arising out of this Agreement, the subject matter hereof or the transactions contemplated hereby. Each party hereto hereby irrevocably (a) submits to the personal jurisdiction of such courts over such party in connection with any litigation, proceeding or other legal action arising out of or in connection with this Agreement, and (b) waives to the fullest extent permitted by law any objection to the venue of any such litigation, proceeding or action which is brought in any such court.
Section 22. Severability. If any provision of this Agreement or the application thereof to any Person or circumstances is determined by a court of competent jurisdiction to be invalid, void or unenforceable, the remaining provisions hereof, or the application of such provision to Persons or circumstances other than those as to which it has been held invalid or unenforceable, shall remain in full force and effect and shall in no way be affected, impaired or invalidated thereby, so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner adverse to any party. Upon such determination, the parties shall negotiate in good faith in an effort to agree upon a suitable and equitable substitute provision to effect the original intent of the parties.
35 |
Section 23. Extension or Modification of Rights Offering. Without the prior written consent of the Standby Purchaser, the Company may (a) waive irregularities in the manner of exercise of the Rights, and (b) waive conditions relating to the method (but not the timing) of the exercise of the Rights.
Section 24. Most Favored Nation. Except as disclosed or set forth herein, during the period from the date of this Agreement through the Closing Date, neither the Company nor its subsidiaries shall enter into any additional, or modify any existing, agreements with any existing or future investors in the Company or any of its subsidiaries that have the effect of establishing rights, imposing restrictions or otherwise benefiting such investor in a manner more favorable in any material respect to such investor than the rights, restrictions and benefits established with respect to the Standby Purchaser in this Agreement, unless, in any such case, this Agreement has been amended to provide the Standby Purchaser with such additional rights and benefits or reduced restrictions.
Section 25. Miscellaneous.
(a) The obligations of the Company, FLMHC, and Federal Life under this Agreement shall be joint and several.
(b) The Company shall not after the date of this Agreement enter into any agreement with respect to its securities which is inconsistent with or violates the rights granted to the Standby Purchaser in this Agreement.
(c) The headings in this Agreement are for purposes of reference only and shall not limit or otherwise affect the meaning of this Agreement.
(d) This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, but all of which, when taken together, shall constitute one and the same instrument. In the event that any signature is delivered by facsimile transmission, or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile signature page were an original thereof.
[Remainder of this page intentionally left blank.]
36 |
IN WITNESS WHEREOF, the parties have caused this Agreement to be duly executed and delivered as of the date first above written.
FEDERAL LIFE GROUP, INC. |
By: | ||
William S. Austin | ||
President |
FEDERAL LIFE MUTUAL HOLDING COMPANY |
By: | ||
William S. Austin | ||
President |
FEDERAL LIFE INSURANCE COMPANY |
By: | ||
William S. Austin | ||
President |
INSURANCE CAPITAL GROUP, LLC |
By: |
37 |
EXHIBIT A
Proposed Note Terms:
Issuer: FLMHC
Advances: The Note will be structured as a line of credit facility and the Standby Purchaser will make advances to the Issuer within five (5) days after the Issuer has made a written request to the Standby Purchaser for such advance, provided that the outstanding aggregate balance of all advances shall not exceed $2,000,000.
Maturity: 24 months from issuance
Rate: Interest shall accrue on the outstanding principal balance of the Note at a fixed rate of 3.75% per annum for the first 12 months (provided that such 12-month period shall be extended for up to six additional months if the Closing has been delayed in the manner described in the second proviso to Section 16(a)(iv)), and then a fixed rate of 10% per annum thereafter
Default Rate: Fixed rate of 10% per annum
Interest payment: Interest accrued each quarter will be paid on the last day of each quarter
Defaults: Non-payment, bankruptcy, non-compliance with covenants in Standby Purchase Agreement
Other terms: To be assumed by the Company upon closing of the Offerings, and the principal converted into shares of Common Stock on the completion of the Conversion at the Subscription Price.
38 |
EXHIBIT B
1. Definitions.
Capitalized terms used in this Exhibit B that are not defined in this Exhibit B shall have the meaning given to such terms in the Standby Stock Purchase Agreement. As used in this Agreement, the following capitalized defined terms shall have the following meanings:
“1933 Act” shall mean the Securities Act of 1933, as amended from time to time.
“1934 Act” shall mean the Securities Exchange Act of 1934, as amended from time to time.
“Company” shall mean Federal Life Group, Inc. and shall also include the Company’s successors.
“Depositary” shall mean The Depository Trust Company, or any other depositary appointed by the Company, provided, however, that such depositary must have an address in the Borough of Manhattan, in the City of New York.
“Person” shall mean an individual, partnership (general or limited), corporation, limited liability company, trust or unincorporated organization, or a government or agency or political subdivision thereof.
“Prospectus” shall mean the prospectus included in a Registration Statement, including any preliminary prospectus, and any such prospectus as amended or supplemented by any prospectus supplement, including any such prospectus supplement with respect to the terms of the offering of any portion of the Shares covered by a Shelf Registration Statement, and by all other amendments and supplements to a prospectus, including post-effective amendments, and in each case including all material incorporated by reference therein.
“Registration Expenses” shall mean any and all expenses incident to performance of or compliance by the Company with this Agreement, including without limitation: (i) all SEC, stock exchange or Financial Industry Regulatory Authority (“FINRA”) registration and filing fees, (ii) all fees and expenses incurred in connection with compliance with state securities or blue sky laws and compliance with the rules of FINRA (including reasonable fees and disbursements of counsel for any underwriters or the Standby Purchaser in connection with blue sky qualification of any of the Shares and any filings with FINRA), (iii) all expenses of any Persons in preparing or assisting in preparing, word processing, printing and distributing any Registration Statement, any Prospectus, any amendments or supplements thereto, any underwriting agreements, securities sales agreements and other documents relating to the performance of and compliance with this Agreement, (iv) all fees and expenses incurred in connection with the listing, if any, of any of the Shares on any securities exchange or exchanges, (v) the fees and disbursements of counsel for the Company and the fees and expenses of the independent registered public accounting firm of the Company, including the expenses of any special audits or “comfort” letters required by or incident to such performance and compliance, and (vi) any fees and disbursements of the underwriters customarily required to be paid by issuers or sellers of securities and the fees and expenses of any special experts retained by the Company in connection with any Registration Statement, but excluding underwriting discounts and commissions and transfer taxes, if any, relating to the sale or disposition of Shares by the Standby Purchaser.
39 |
“SEC” shall mean the United States Securities and Exchange Commission or any successor agency or government body performing the functions currently performed by the United States Securities and Exchange Commission.
“Shares” shall mean all shares of common stock owned by the Standby Purchaser that were acquired in the Community Offering.
“Shelf Registration” shall mean a registration effected pursuant to Section 2.1 of this Agreement.
“Shelf Registration Statement” shall mean a “shelf” registration statement of the Company pursuant to the provisions of Section 2.1 of this Agreement which covers all of the Shares on an appropriate form under Rule 415 under the 1933 Act, or any similar rule that may be adopted by the SEC, and all amendments and supplements to such registration statement, including post-effective amendments, in each case including the Prospectus contained therein, all exhibits thereto and all material incorporated by reference therein.
2. Registration Under the 1933 Act.
2.1 Registration of Shares. The Company shall, for the benefit of the Standby Purchaser, at the Company’s cost, (A) prepare and file with the SEC a Shelf Registration Statement within 120 days after receipt of a written request of the Standby Purchaser on or after the end of the Solicitation Period, on an appropriate form under the 1933 Act with respect to offers and sales of the Shares, and (B) use all commercially reasonable efforts to cause the Shelf Registration Statement to be declared effective under the 1933 Act within 120 days of the date of filing of the Shelf Registration Statement. The Company will:
(a) Use all commercially reasonable efforts to keep the Shelf Registration Statement continuously effective in order to permit the Prospectus forming part thereof to be usable by the Standby Purchaser for a period of two years from the date the Shelf Registration Statement becomes effective under the 1933 Act, or for such shorter period that will terminate when all Shares covered by the Shelf Registration Statement have been sold pursuant to the Shelf Registration Statement or cease to be owned by the Standby Purchaser (the “Effectiveness Period”); provided, however, that the Effectiveness Period in respect of the Shelf Registration Statement shall be extended to the extent required to permit dealers to comply with the applicable prospectus delivery requirements of Rule 174 under the 1933 Act and as otherwise provided herein.
40 |
(b) Notwithstanding any other provisions hereof, use all commercially reasonable efforts to ensure that (i) any Shelf Registration Statement and any amendment thereto and any Prospectus forming part thereof and any supplement thereto complies in all material respects with the 1933 Act and the rules and regulations thereunder, (ii) any Shelf Registration Statement and any amendment thereto does not, when it becomes effective, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading and (iii) any Prospectus forming part of any Shelf Registration Statement, and any supplement to such Prospectus (as amended or supplemented from time to time), does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements, in light of the circumstances under which they were made, not misleading.
The Company shall not permit any securities other than the Shares to be included in the Shelf Registration Statement. The Company further agrees, if necessary, to supplement or amend the Shelf Registration Statement, as required by Section 3(b) below, and to furnish to the Standby Purchaser copies of any such supplement or amendment promptly after its being used or filed with the SEC.
2.2 Expenses. The Company shall pay all Registration Expenses in connection with the registration pursuant to Section 2.1. The Standby Purchaser shall pay all underwriting discounts and commissions and transfer taxes, if any, relating to the sale or disposition of the Shares pursuant to the Shelf Registration Statement.
2.3 Effectiveness. (a) The Company will be deemed not to have used all commercially reasonable efforts to cause the Shelf Registration Statement to become, or to remain, effective during the requisite period if the Company voluntarily takes any action that would, or omits to take any action which omission would, result in any such Registration Statement not being declared or becoming effective or in the Standby Purchaser not being able to offer and sell the Shares during that period as and to the extent contemplated hereby, unless such action is required by applicable law.
(b) A Shelf Registration Statement pursuant to Section 2.1 hereof will not be deemed to have become effective unless it has been declared effective by the SEC or has otherwise become effective under the 1933 Act; provided, however, that if, after it has been declared or has otherwise become effective, the offering of Shares pursuant to a Shelf Registration Statement is interfered with by any stop order, injunction or other order or requirement of the SEC or any other governmental agency or court, such Registration Statement will be deemed not to have become effective during the period of such interference, until the offering of the Shares pursuant to such Registration Statement may legally resume.
3. Registration Procedures.
In connection with the obligations of the Company pursuant to Section 2.1, the Company shall:
(a) prepare and file with the SEC a Registration Statement on the appropriate form under the 1933 Act, which form (i) shall be selected by the Company, (ii) shall be available for the sale of the Shares by the Standby Purchaser, (iii) shall comply as to form in all material respects with the requirements of the applicable form and include or incorporate by reference all financial statements required by the SEC to be filed therewith or incorporated by reference therein, and (iv) shall comply in all material respects with the requirements of Regulation S-T under the 1933 Act, and use all commercially reasonable efforts to cause such Registration Statement to become effective and remain effective in accordance with Section 2 hereof;
41 |
(b) prepare and file with the SEC such amendments and post-effective amendments to such Registration Statement as may be necessary under applicable law to keep such Registration Statement effective for the applicable period; and cause the Prospectus to be supplemented by any required prospectus supplement, and as so supplemented to be filed pursuant to Rule 424 (or any similar provision then in force) under the 1933 Act and comply with the provisions of the 1933 Act, the 1934 Act and the rules and regulations thereunder applicable to them with respect to the disposition of all Shares covered by such Registration Statement during the applicable period in accordance with the intended method or methods of distribution by the Standby Purchaser;
(c) (i) notify the Standby Purchaser at least ten business days prior to filing, that a Shelf Registration Statement with respect to the Shares is being filed and advising the Standby Purchaser that the distribution of such Shares will be made in accordance with the method selected by Standby Purchaser; (ii) furnish to the Standby Purchaser and to each underwriter of an underwritten offering of such Shares, if any, without charge, as many copies of each Prospectus, including each preliminary Prospectus, and any amendment or supplement thereto and such other documents as the Standby Purchaser or underwriter may reasonably request, including financial statements and schedules and, if the Standby Purchaser so requests, all exhibits in order to facilitate the public sale or other disposition of such Shares; and (iii) hereby consents to the use of the Prospectus or any amendment or supplement thereto by the Standby Purchaser in connection with the offering and sale of the Shares covered by the Prospectus or any amendment or supplement thereto;
(d) use all commercially reasonable efforts to register or qualify the Shares under all applicable state securities or “blue sky” laws of such jurisdictions as the Standby Purchaser and each underwriter of an underwritten offering of Shares shall reasonably request by the time the applicable Registration Statement is declared effective by the SEC, and do any and all other acts and things which may be reasonably necessary or advisable to enable the Standby Purchaser and each underwriter to consummate the disposition in each such jurisdiction of the Shares; provided, however, that the Company shall not be required to (i) qualify as a foreign corporation or as a dealer in securities in any jurisdiction where it would not otherwise be required to qualify but for this Section 3(d), or (ii) take any action which would subject it to general service of process or taxation in any such jurisdiction where it is not then so subject;
42 |
(e) notify promptly the Standby Purchaser and, if requested by the Standby Purchaser, confirm such advice in writing promptly (i) when a Registration Statement has become effective and when any post-effective amendments and supplements thereto become effective, (ii) of any request by the SEC or any state securities authority for post-effective amendments and supplements to a Registration Statement and Prospectus or for additional information after the Registration Statement has become effective, (iii) of the issuance by the SEC or any state securities authority of any stop order suspending the effectiveness of a Registration Statement or the initiation of any proceedings for that purpose, (iv) if, between the effective date of a Registration Statement and the closing of any sale of Shares covered thereby, the representations and warranties of the Company contained in any underwriting agreement, securities sales agreement or other similar agreement, if any, relating to the offering cease to be true and correct in all material respects, (v) of the happening of any event or the discovery of any facts during the period a Registration Statement is effective which makes any statement made in such Registration Statement untrue in any material respect or which requires the making of any changes in such Registration Statement in order to make the statements therein not misleading, (vi) of the happening of any event or the discovery of any facts during the period a Registration Statement is effective which makes any statement in the related Prospectus untrue in any material respect or which requires the making of any changes in such Prospectus in order to make the statements therein, in light of the circumstances under which they were made, not misleading, (vii) of the receipt by the Company of any notification with respect to the suspension of the qualification of the Shares for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose and (viii) of any determination by the Company that a post-effective amendment to such Registration Statement would be appropriate;
(f) use all commercially reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of a Registration Statement at the earliest possible moment;
(g) furnish to the Standby Purchaser, and each underwriter, if any, without charge, at least one conformed copy of each Registration Statement and any post-effective amendment thereto, including financial statements and schedules (without documents incorporated therein by reference and all exhibits thereto, unless requested);
(h) cooperate with the Standby Purchaser to facilitate the timely preparation and delivery of certificates representing such Shares (or statements of Shares owned, if the Company’s shares of common stock are issued in book entry only form) to be sold and not bearing any restrictive legends and registered in such names as the Standby Purchaser or the underwriters, if any, may reasonably request at least three business days prior to the closing of any sale of Shares;
(i) upon the occurrence of any event or the discovery of any facts, each as contemplated by Sections 3(e)(v), 3(e)(vi) and 3(e)(vii) hereof, as promptly as practicable after the occurrence of such an event, use all commercially reasonable efforts to prepare a supplement or post-effective amendment to the Registration Statement or the related Prospectus or any document incorporated therein by reference or file any other required document so that, as thereafter delivered to the purchasers of the Shares, such Prospectus will not contain at the time of such delivery any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading or will remain so qualified. At such time as such public disclosure is otherwise made or the Company determines that such disclosure is not necessary, in each case to correct any misstatement of a material fact or to include any omitted material fact, the Company agrees promptly to notify the Standby Purchaser of such determination and to furnish the Standby Purchaser such number of copies of the Prospectus as amended or supplemented, as the Standby Purchaser may reasonably request;
43 |
(j) a reasonable time prior to the filing of any Registration Statement, any Prospectus, any amendment to a Registration Statement or amendment or supplement to a Prospectus or any document which is to be incorporated by reference into a Registration Statement or a Prospectus after initial filing of a Registration Statement, provide copies of such document to the Standby Purchaser; and make representatives of the Company as shall be reasonably requested by the Standby Purchaser available for discussion of such document;
(k) if not previously received, obtain a CUSIP number for all Shares not later than the effective date of a Registration Statement;
(l) enter into agreements (including underwriting agreements) and take all other customary and appropriate actions in order to expedite or facilitate the disposition of such Shares and in such connection whether or not an underwriting agreement is entered into and whether or not the registration is an underwritten registration:
(i) make such representations and warranties to the Standby Purchaser and the underwriters, if any, in form, substance and scope as are customarily made by issuers to underwriters in similar underwritten offerings as may be reasonably requested by them;
(ii) obtain opinions of counsel to the Company and updates thereof (which counsel and opinions (in form, scope and substance) shall be reasonably satisfactory to the managing underwriters, if any, and the Standby Purchaser) addressed to the Standby Purchaser and the underwriters, if any, covering the matters customarily covered in opinions requested in sales of securities or underwritten offerings and such other matters as may be reasonably requested by the Standby Purchaser and underwriters;
(iii) obtain “comfort” letters and updates thereof from the Company’s independent registered public accounting firm (and, if necessary, any other independent registered public accounting firm of any subsidiary of the Company or of any business acquired by the Company for which financial statements are, or are required to be, included in the Registration Statement) addressed to the underwriters, if any, and use all commercially reasonable efforts to have such letter addressed to the Standby Purchaser (in accordance with AS 6101: Letters for Underwriters and Certain other Requesting Parties of the Public Company Accounting Oversight Board), such letters to be in customary form and covering matters of the type customarily covered in “comfort” letters to underwriters in connection with similar underwritten offerings;
(iv) enter into a securities sales agreement with the Standby Purchaser and an agent of the Standby Purchaser providing for, among other things, the appointment of such agent for the Standby Purchaser for the purpose of soliciting purchases of Shares, which agreement shall be in form, substance and scope customary for similar offerings;
44 |
(v) if an underwriting agreement is entered into, cause the same to set forth indemnification provisions and procedures substantially equivalent to the indemnification provisions and procedures set forth in Section 4 hereof with respect to the underwriters and all other parties to be indemnified pursuant to said Section or, at the request of any underwriters, in the form customarily provided to such underwriters in similar types of transactions; and
(vi) deliver such documents and certificates as may be reasonably requested and as are customarily delivered in similar offerings to the Standby Purchaser and the managing underwriters, if any.
The above shall be done at (i) the effectiveness of such Registration Statement (and each post-effective amendment thereto) and (ii) each closing under any underwriting or similar agreement as and to the extent required thereunder;
(m) make available for inspection by representatives of the Standby Purchaser, any underwriters participating in any disposition pursuant to a Shelf Registration Statement, and any counsel or accountant retained by any of the foregoing, all financial and other records, pertinent corporate documents and properties of the Company reasonably requested by any such persons, and cause the respective officers, directors, employees, and any other agents of the Company to supply all information reasonably requested by any such representative, underwriter, special counsel or accountant in connection with a Registration Statement, and make such representatives of the Company available for discussion of such documents as shall be reasonably requested by any such representative, underwriter, special counsel or accountant; provided that information which the Company determines in good faith, to be confidential and which it notifies such parties is confidential shall not be disclosed by such parties unless (i) such parties reasonably determine that the disclosure of such information is necessary to avoid or correct a material misstatement or omission in the applicable Registration Statement or the related Prospectus, (ii) such party reasonably determines, based on the advice of counsel, that disclosure of such information is required pursuant to a subpoena or other order for a court of competent jurisdiction or any other administrative agency or is otherwise required by applicable law, in which case each such party shall promptly notify, if permitted by applicable law, the Company, or (iii) such information has been made generally available to the public;
(n) a reasonable time prior to filing any Shelf Registration Statement, any Prospectus forming a part thereof, any amendment to such Shelf Registration Statement or amendment or supplement to such Prospectus, provide copies of such document to the Standby Purchaser, to counsel for the Standby Purchaser and to the underwriter or underwriters of an underwritten offering of Shares, if any, make such changes in any such document prior to the filing thereof as the counsel to the Standby Purchaser the underwriter or underwriters reasonably request and not file any such document in a form to which the Standby Purchaser, counsel for the Standby Purchaser or any underwriter shall not have previously been advised and furnished a copy of or to which the Standby Purchaser, counsel to the Standby Purchaser or any underwriter shall reasonably object, and make the representatives of the Company available for discussion of such document as shall be reasonably requested by the Standby Purchaser, counsel for the Standby Purchasers of Purchaser or any underwriter;
45 |
(o) use all commercially reasonable efforts to cause all Shares to be listed on any securities exchange on which shares of common stock of the Company are then listed if requested by the Standby Purchaser, or if requested by the underwriter or underwriters of an underwritten offering of Shares, if any;
(p) otherwise comply with all applicable rules and regulations of the SEC and make available to its security the Standby Purchasers, as soon as reasonably practicable, an earnings statement covering at least 12 months which shall satisfy the provisions of Section 11(a) of the 1933 Act and Rule 158 thereunder;
(q) cooperate and assist in any filings required to be made with FINRA and in the performance of any due diligence investigation by any underwriter and its counsel (including any “qualified independent underwriter” that is required to be retained in accordance with the rules and regulations of FINRA); and
(r) the Company may (as a condition to the Standby Purchaser’s participation in the Shelf Registration) require the Standby Purchaser to furnish to the Company such information regarding the Standby Purchaser and the proposed distribution by the Standby Purchaser of the Shares as the Company may from time to time reasonably request in writing.
The Standby Purchaser agrees that, upon receipt of any notice from the Company of (i) the happening of any event or the discovery of any facts, each of the kind described in Section 3(e)(v) or 3(e)(vi) hereof, or (ii) the good faith determination of the Board of Directors or the Chief Executive Officer and Chief Financial Officer of the Company that the continued effectiveness of the applicable Registration Statement and use of the Prospectus would require disclosure of confidential information related to a material acquisition or divestiture of assets or a material corporate transaction, event or development, the Standby Purchaser will forthwith discontinue disposition of Shares pursuant to a Registration Statement until the Standby Purchaser’s receipt of the copies of the supplemented or amended Prospectus contemplated by Section 3(k) hereof, and, if so directed by the Company, the Standby Purchaser will deliver to the Company (at its expense) all copies in the Standby Purchaser’s possession, other than permanent file copies then in the Standby Purchaser’s possession, of the Prospectus covering Shares current at the time of receipt of such notice; provided that the Company shall not allow the applicable Registration Statement to fail or cease to be effective or allow the Prospectus to be unusable pursuant to the provisions of this paragraph for more than 45 days during any year of effectiveness contemplated by Section 2 hereof. It is understood and agreed that the provisions of this paragraph shall not affect the Company’s obligations under Section 2.5 of this Agreement.
The Standby Purchaser hereby agrees with the Company that the Standby Purchaser of will not participate in any underwritten offering hereunder unless the Standby Purchaser completes and executes all questionnaires, powers of attorney, indemnities, underwriting agreements and other documents required under the terms of such underwriting arrangements.
46 |
4. Indemnification; Contribution.
(a) With respect to the Securities, the Company agrees to indemnify and hold harmless the Standby Purchaser, each Person who participates as an underwriter (any such Person being an “Underwriter”) and each Person, if any, who controls any such Person within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act with respect to the Securities as follows:
(i) against any and all loss, liability, claim, damage and expense whatsoever, as incurred, arising out of any untrue statement or alleged untrue statement of a material fact contained in any Registration Statement (or any amendment or supplement thereto) pursuant to which Shares were registered under the 1933 Act, including all documents incorporated therein by reference, or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements therein not misleading, or arising out of any untrue statement or alleged untrue statement of a material fact contained in any Prospectus (or any amendment or supplement thereto) or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading;
(ii) against any and all loss, liability, claim, damage and expense whatsoever, as incurred, to the extent of the aggregate amount paid in settlement of any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or of any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission; provided that (subject to Section 4(d) below) any such settlement is effected with the written consent of the Company; and
(iii) against any and all expense whatsoever, as incurred (including the reasonable fees and disbursements of counsel chosen by any indemnified party), reasonably incurred in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission, to the extent that any such expense is not paid under subparagraph (i) or (ii) above; provided, however, that this indemnity agreement shall not apply to any loss, liability, claim, damage or expense to the extent arising out of any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with written information furnished to the Company by the Standby Purchaser or Underwriter expressly for use in a Registration Statement (or any amendment thereto) or any Prospectus (or any amendment or supplement thereto).
(b) The Standby Purchaser agrees to indemnify and hold harmless the Company, each Underwriter, and each of their respective directors and officers, and each Person, if any, who controls the Company or any Underwriter within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act, against any and all loss, liability, claim, damage and expense described in the indemnity contained in Section 4(a) hereof, as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in the Shelf Registration Statement (or any amendment thereto) or any Prospectus included therein (or any amendment or supplement thereto) in reliance upon and in conformity with written information with respect to such the Standby Purchaser furnished to the Company by such the Standby Purchaser expressly for use in the Shelf Registration Statement (or any amendment thereto) or such Prospectus (or any amendment or supplement thereto); provided, however, that the Standby Purchaser shall not be liable for any claims hereunder in excess of the amount of net proceeds received by the Standby Purchaser from the sale of Shares pursuant to such Shelf Registration Statement.
47 |
(c) Each indemnified party shall give notice as promptly as reasonably practicable to each indemnifying party of any action or proceeding commenced against it in respect of which indemnity may be sought hereunder, but failure so to notify an indemnifying party shall not relieve such indemnifying party from any liability hereunder to the extent it is not materially prejudiced as a result thereof and in any event shall not relieve it from any liability which it may have otherwise than on account of this indemnity agreement. An indemnifying party may participate at its own expense in the defense of such action; provided, however, that counsel to the indemnifying party shall not (except with the consent of the indemnified party) also be counsel to the indemnified party. No indemnifying party shall, without the prior written consent of the indemnified parties, settle or compromise or consent to the entry of any judgment with respect to any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever in respect of which indemnification or contribution could be sought under this Section 4 (whether or not the indemnified parties are actual or potential parties thereto), unless such settlement, compromise or consent (i) includes an unconditional release of each indemnified party from all liability arising out of such litigation, investigation, proceeding or claim and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party.
(d) If at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated by Section 4(a)(ii) effected without its written consent if (i) such settlement is entered into more than 45 days after receipt by such indemnifying party of the aforesaid request, (ii) such indemnifying party shall have received notice of the terms of such settlement at least 30 days prior to such settlement being entered into and (iii) such indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such settlement.
(e) If the indemnification provided for in this Section 4 is for any reason unavailable to or insufficient to hold harmless an indemnified party in respect of any losses, liabilities, claims, damages or expenses referred to therein, then each indemnifying party shall contribute to the aggregate amount of such losses, liabilities, claims, damages and expenses incurred by such indemnified party, as incurred, in such proportion as is appropriate to reflect the relative fault of the Company on the one hand and the Standby Purchaser, and Underwriters on the other hand in connection with the statements or omissions which resulted in such losses, liabilities, claims, damages or expenses, as well as any other relevant equitable considerations.
48 |
The relative fault of the Company on the one hand and the Standby Purchaser, and Underwriters on the other hand shall be determined by reference to, among other things, whether any such untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company, the Standby Purchasers, or Underwriters and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.
The Company, the Standby Purchasers, and Underwriters agree that it would not be just and equitable if contribution pursuant to this Section 4 were determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to above in this Section 4. The aggregate amount of losses, liabilities, claims, damages and expenses incurred by an indemnified party and referred to above in this Section 4 shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue or alleged untrue statement or omission or alleged omission.
Notwithstanding the provisions of this Section 4, neither the Standby Purchaser nor any Underwriter shall be required to contribute any amount in excess of the amount by which the net proceeds received by the Standby Purchaser from the sale of the Shares exceeds the amount of any damages which the Standby Purchaser or Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission with respect to the Shares from the sale of the Shares.
No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation.
For purposes of this Section 4, each Person, if any, who controls the Standby Purchaser or any Underwriter within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act shall have the same rights to contribution as the Standby Purchaser or Underwriter and each director of the Company, and each Person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act shall have the same rights to contribution as the Company.
5. Miscellaneous.
5.1 Rule 144 and Rule 144A. For so long as the Company is subject to the reporting requirements of Section 13 or 15 of the 1934 Act, the Company covenants that it will file the reports required to be filed by it under the 1933 Act and Section 13(a) or 15(d) of the 1934 Act and the rules and regulations adopted by the SEC thereunder. If the Company ceases to be so required to file such reports, the Company covenants that it will upon the request of the Standby Purchaser (a) make publicly available such information as is necessary to permit sales pursuant to Rule 144 under the 1933 Act, (b) deliver such information to a prospective purchaser as is necessary to permit sales pursuant to Rule 144A under the 1933 Act and it will take such further action as the Standby Purchaser may reasonably request, and (c) take such further action that is reasonable in the circumstances, in each case, to the extent required from time to time to enable the Standby Purchaser to sell its Shares without registration under the 1933 Act within the limitation of the exemptions provided by (i) Rule 144 under the 1933 Act, as such Rule may be amended from time to time, (ii) Rule 144A under the 1933 Act, as such Rule may be amended from time to time, or (iii) any similar rules or regulations hereafter adopted by the SEC. Upon the request of the Standby Purchaser, the Company will deliver to the Standby Purchaser a written statement as to whether it has complied with such requirements.
49 |
5.2 Notices. All notices and other communications provided for or permitted hereunder shall be made in writing by hand delivery, registered first-class mail, email, or any courier guaranteeing overnight delivery (a) if to Standby Purchaser, initially at the Standby Purchaser’s address set forth in the Agreement, and thereafter at the most current address given by Standby Purchaser to the Company by means of a notice given in accordance with the provisions of this Section 5.4; and (b) if to the Company, initially at the Company’s address set forth in the Agreement, and thereafter at such other address of which notice is given in accordance with the provisions of this Section 5.4.
All such notices and communications shall be deemed to have been duly given: at the time delivered by hand, if personally delivered; two business days after being deposited in the mail, postage prepaid, if mailed; when receipt is acknowledged, if emailed; and on the next business day if timely delivered to an air courier guaranteeing overnight delivery.
Copies of all such notices, demands, or other communications shall be concurrently delivered by the person giving the same to the Trustee under the Indenture, at the address specified in such Indenture.
5.3 Specific Enforcement. Without limiting the remedies available to the Standby Purchaser, the Company acknowledges that any failure by the Company to comply with its obligations under Sections 2.1 through 2.4 hereof may result in material irreparable injury to the Standby Purchaser for which there is no adequate remedy at law, that it would not be possible to measure damages for such injuries precisely and that, in the event of any such failure, the Standby Purchaser may obtain such relief as may be required to specifically enforce the Company’s obligations under Sections 2.1 through 2.4 hereof.
50 |
EXHIBIT C
Major Decisions
· | Use of Proceeds – making use of the net proceeds of the Offerings (including the contribution or loan of such net proceeds to Federal Life or FLMHC); other than a contribution of at least $12,500,000 of such net proceeds, which shall be contributed to Federal Life immediately after the Closing. |
· | Merger, Consolidation, Sale of Assets or Sale of a Controlling Stake in the Company – the merger or consolidation of the Company or Federal Life with any Person or the sale, lease or other transfer of all or substantially all of the Company’s or Federal Life’s assets to any Person, or entry into any agreement to do any of the foregoing. |
· | Material Affiliate transactions - the entry into any material transaction with any Affiliate of the Company, FLMHC or Federal Life. |
51 |
Exhibit 10.6
EXECUTIVE AGREEMENT
Agreement made this 3rd day of March 2010 between FEDERAL LIFE INSURANCE COMPANY (MUTUAL), an Illinois mutual life insurance company (hereinafter referred to as the “Company”), and JOSEPH D. AUSTIN (hereinafter sometimes referred to as the “Chairman”).
Joseph D. Austin is presently employed by the Company as its Chairman and Chief Executive Officer.
The Board of Directors of the Company recognizes that his contribution to the growth and success of the Company since his election as Chief Executive Officer of the Company on June 21, 1977 has been most substantial. The Board desires to provide for the continued employment of the Chairman which the Board has determined will be in the best interests of the Company and its policyholders and will enforce and encourage the continued attention and dedication to the Company of the Chairman as its Chief Executive Officer. The Chairman is willing to commit himself to continue to serve the Company on the terms and conditions herein provided.
In order to effect the foregoing, the Company and the Chairman wish to enter into an agreement on the terms and conditions set forth below.
Accordingly, in consideration of the promises and the respective covenants and agreements herein contained, in further consideration of services performed and to be performed by the Chairman and intending to be legally bound, the parties hereto agree as follows:
1. Employment.
A. The Company agrees to employ the Chairman as Chief Executive Officer of the Company and the Chairman agrees to serve as the Chief Executive Officer of the Company during the term of employment as set forth in this Agreement. The Chairman shall report only to the Board of Directors of the Company and his powers and authority shall be superior to those of any officers or employees of the Company or of any subsidiaries thereof. The Chairman agrees to serve as a Director and as Chairman of the Board of Directors of the Company as well as serving as chairman or as a member of various committees of the Board of Directors as provided in the Company's By-Laws.
B. If at any time during the term of employment, the Board of Directors of the Company fails to re-elect the Chairman as the Chief Executive Officer and the policyholders fail to elect him as a Director of the Company, or removes the Chairman from such office or from such directorship, or if at any time during the term of this agreement, the Chairman shall fail to be vested by the Company with the powers and authority of the Chief Executive Officer of the Company, except in connection with a termination for material breach or just cause as hereinafter set forth in this Agreement, or if the ownership or control of the Company, including illustratively the power and right to elect a majority of the Board of Directors of the Company becomes vested directly or indirectly in persons other than persons who currently, as of the effective date hereof, have such power and right, the Chairman shall have the right, by written notice to the Company, to terminate his services hereunder effective as of the last day of the month following the receipt by the Company of any such written notice and the Chairman shall have no other obligations under this Agreement. The Chairman's termination of services under this Paragraph shall be treated as a termination of employment by the Company other than for material breach or just cause on the Chairman's part and, accordingly, shall be governed by the provisions of Paragraph 7A of this Agreement.
1
2. Term of Employment.
The initial term of employment, as this phrase is used throughout this Agreement, shall be for the period beginning on the date of this Agreement and ending three (3) years thereafter consistent with the provisions of Chapter 215 ILCS 5/245, as it exists at the time this Agreement is executed. This agreement is automatically extended each day for an additional day except that a notice of non-extension may be given at any time by the Board of Directors in which case the term of employment will expire at the end of its then current term.
3. Chairman's Duties During Term of Employment.
The Chairman shall devote his full business time (with allowances for vacations and sick leave) and attention and best efforts to the affairs of the Company and its subsidiaries and affiliates during the term of employment; provided, however, that he may serve as a director of other corporations and entities and may engage in other activities to the extent that they do not inhibit the performance of his duties hereof or conflict with the business of the Company or its subsidiaries and affiliates.
4. Compensation.
The Chairman's base salary will be determined each year by the Board of Directors at its annual meeting and will be paid in substantially equal monthly installments plus a bonus determined annually by the Board of Directors based upon the Board of Director's determination as to the Performance of the Chairman.
5. Other Benefits.
In addition to the compensation provided for herein, the Chairman shall be entitled to participate in any and all employee benefit programs of the Company as currently in effect. Further, the Chairman shall be entitled to receive prompt reimbursement for all expenses which he deems reasonably incurred by him in performing services hereunder provided such expenses are incurred and accounted for in accordance with the policies and procedures presently established by the Company.
6. Counsel Fees and Indemnification.
A. In the event that: (1) the Company terminates or seeks to terminate this Agreement alleging as justification for such termination a material breach by the Chairman or causes hereinafter set forth; the Chairman disputes such termination or attempted termination; and/or (2) the Chairman elects to terminate his services hereunder pursuant to Paragraph 1B of this Agreement; the Company disputes its obligations to pay to the Chairman that portion of his compensation as hereinafter provided; the Company shall pay or reimburse to the Chairman all reasonable costs incurred by him in such dispute, including attorney's fees and costs providing the Chairman shall prevail in such action.
2
B. The Company further represents and warrants: (1) that the Chairman is and shall continue to be covered and insured up to the maximum limits provided by all insurance that the Company maintains to indemnify its directors and officers (and to indemnify the Company for any obligations which it incurs as a result of its undertaking to indemnify its officers and directors) and (2) that the Company will exert its best efforts to maintain such insurance at least at its present limits in effect throughout the term of the Chairman's employment.
C. The Company hereby warrants and represents that the undertakings of payment indemnification and maintenance of such insurance coverage for the Chairman set out above are not in conflict with the charter of the Company or its By-Laws or with any validly existing agreement or other proper corporate action of the Company.
7. Termination.
A. Termination by the Company other than for Material or Just Cause.
If the Company shall terminate the Chairman's employment during the term of employment for other than a material breach of this Agreement or “just cause”, as herein defined, the Chairman shall have no obligation to seek other employment in mitigation of damages in respect of any period following the date of such termination and the Chairman shall be entitled to receive from the Company $515,000 per annum which shall be payable to the Chairman in monthly installments without regard to, or reduction because of, any other compensation or income which the Chairman receives or is entitled to receive whether from the Company or otherwise. It is stipulated that any payments made in accordance with the foregoing shall be paid to and received by the Chairman as liquidated damages for the unwarranted termination of his employment and not as penalties and he shall be entitled to receive no further sums under this Agreement except as such that have accrued as of the date of termination or as otherwise specifically provided in this Agreement. In view of the fact that the term of this Agreement is for three (3) years pursuant to the provisions of the aforesaid described Chapter 215 ILCS 5/245, it is contemplated that the payments provided to be made by virtue of this provision shall be completed at the expiration of three (3) years from the date of such termination.
B. Termination by the Company for Material Breach or for Just Cause.
“Just cause” shall mean willful misconduct, dishonesty, conviction of a felony, habitual drunkenness or excessive absenteeism not related to illness. Should the Chairman's employment be terminated for a material breach of this Agreement or for “just cause”, the Company shall be obligated to pay the Chairman his then base salary only through the end of the month during which such termination occurs plus such other sums as are payable to the Chairman under this Agreement and which have accrued as of the end of such month.
3
C. Termination by the Chairman.
Without prejudice to the provisions of Paragraph 1B of this Agreement, it is agreed that if during the term of employment the Chairman concludes because of changes in the composition of the Board of Directors of the Company or of other events or occurrences of material effect that he can no longer properly and effectively discharge his responsibilities as Chief Executive Officer of the Company, he may at any time resign as Director of the Company and from his position as Chairman and Chief Executive Officer of the Company after giving the Company not less than sixty (60) days prior written notice of the effective date of his resignation. Any such resignation shall not be deemed to be a material breach by the Chairman of this Agreement.
It is further agreed that upon such resignation, except for obligations of either party to the other which have accrued as of the date of the Chairman's resignation or as otherwise specifically provided in this Agreement, the Chairman shall be entitled to receive the compensation provided under Paragraph 7A of this Paragraph 7 as if such termination was by the Company other than for material breach or other just cause. It is provided, however, that the Chairman's obligation of non-disclosure as provided in Paragraph 11 of this Agreement shall remain undiminished and in full force and effect and the obligation of the Chairman under Paragraph 8 of this Agreement not to compete shall continue for the period during which payments continue to be made to the Chairman under the provisions of Paragraph 7A.
8. Non-Competition.
A. Except as is otherwise provided in Paragraph 7C, it is agreed that during the term of employment and during any period in which the Chairman is receiving compensation as provided in Paragraphs 4 and 7, the Chairman will not without the prior approval of the Board of Directors of the Company become an officer, employee, agent, partner or director of any business enterprise which is in substantial direct competition (as defined below) with the Company or any subsidiary or affiliate of the Company, as the business of the Company or any subsidiary or affiliate may be constituted during the term of employment or at the termination thereof.
B. If the Chairman's employment by the Company is terminated by the Chairman during the term of employment, the Chairman shall not during the period in which he is compensated under the provisions of Paragraphs 7A and 7C following such termination become an officer, employee, agent, partner or director of any business enterprise in substantial direct competition with the Company or any subsidiaries of the Company as the business of the Company or any said subsidiaries may be constituted at the time of such termination.
C. For the purpose of this Paragraph 8, a business enterprise with which the Chairman becomes associated as an officer, employee, agent, partner or director shall be considered in “substantial direct competition” if during a year when such competition is prohibited its sales of any product or service which is competitive with a product or service furnished by the Company or any subsidiary of the Company amount to more than ten percent (10%) of the Company's and subsidiaries' total combined sales of its product or services. This provision shall be effective during the period in which the Chairman is receiving payments from the Company under the provisions of Paragraphs 7A and 7C.
4
9. Effect of Death and Disability.
A. In the event of death of the Chairman during the period of employment, the legal representative of the Chairman shall be entitled to $515,000 to be paid in twelve (12) equal monthly installments beginning at the end of the month in which death occurs. These payments are in lieu of any other life insurance provided by the Company for the Chairman at the Company's expense. If other life insurance is provided to the Chairman at the Company's expense the payments provided for in this Paragraph will be reduced by the amount of the other life insurance. The period of employment shall be deemed to have ended as of the close of business on the last day of the month in which death shall have occurred but without prejudice to any payments due in respect to the Chairman's death.
B. If, as a result of the Chairman's incapacity due to physical or mental illness, the Chairman shall have been absent from his duties hereunder on a full-time basis for the entire period of nine (9) consecutive months, the period of employment shall be deemed to have ended as of the close of business on the last day of such nine (9) month period but without prejudice to any payments due to the Chairman in respect to disability.
In the event of disability of the Chairman during the period of employment, the Chairman shall be entitled to the base salary provided of in Paragraph 4 above at the rate being paid at the time of the commencement of disability for the first nine (9) month period of such disability. Thereafter, the President shall receive fifty percent (50%) of such rate being paid at the time of the commencement of disability for the remaining term provided for in this Agreement; provided however, that this Agreement after the expiration of the nine (9) month period shall be reduced by any payments to which the Chairman may be entitled for the payment period because of disability under any disability plan of the Company or of any subsidiary or affiliate thereof.
10. Successors or Assigns.
Any successor or assign (whether direct or indirect by purchase, merger, consolidation or change of control) shall absolutely and unconditionally assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no succession or assignment had taken place. The Company agrees that it will require any successor, or assign, under the circumstances herein above set forth, to expressly, absolutely and unconditionally assume and agree to perform this Agreement. Any failure of the Company to obtain such agreement prior to the effectiveness of any such succession or assignment shall be a material breach of this Agreement and shall entitle the Chairman to terminate under the provisions of Paragraph 7A. As used in this Paragraph, Company shall mean the Company as herein before defined and any successor of its business and/or assets as aforesaid which executes and delivers the agreement provided for in this Paragraph or which otherwise becomes bound by the terms and conditions of this Agreement by operation of law.
This Agreement shall inure to the benefit of and be enforceable by the Chairman's legal representative, executors, administrators, successors, heirs, devisees, designees and legatees. If the Chairman should die while any amounts are still payable to him hereunder such amounts unless otherwise provided for herein shall be paid in accordance with the terms of this Agreement to the Chairman's devisees, legatees, or other designees, or, if there be no such designees, to the Chairman's estate.
5
11. Non-Disclosure.
The Chairman agrees that he shall not at any time during or following his employment with the Company disclose or use, except in the course of his employment with the Company in the pursuit of the business of the Company or any of its subsidiaries and affiliates, any confidential information or proprietary data of the Company or any of its subsidiaries and affiliates whether such information or proprietary data is in his memory or embodied in writing or other physical form.
12. Conflicts.
Any paragraph, sentence, phrase or other provision of this Executive Agreement which is in conflict with any applicable statute, rule or other law shall be deemed, if possible, to be modified or altered to conform thereto or, if not possible, to be omitted herefrom. The invalidity of any portion hereof shall not affect the form and effect of the remaining valid portions hereof. Paragraph headings are included herein for convenience and are not intended to affect in any way the interpretation of any remaining paragraphs of this Agreement.
13. Governing Law.
This Executive Agreement is governed by and is to be construed in accordance with the laws of the State of Illinois.
14. Notice.
All notices shall be in writing and shall be deemed effective when delivered in person, or 48 hours after deposit thereof in the U.S. mails, postage pre-paid, for delivery as registered mail, return-receipt requested, addressed in the case of the Chairman to his last known address as carried on the personnel records of the Company and in the case of the Company to the corporate headquarters to the attention of the Secretary or to such other address as the parties to be notified may specify by notice to the other party.
15. Arbitration.
A. Any controversy or claim arising out of or relating to this Agreement or any breach thereof shall be settled by arbitration before three (3) arbitrators, as provided below, and judgment of the award rendered which the arbitrators, or at least a majority of the arbitrators, may be entered in any court having jurisdiction thereof,
B. Each party shall appoint a disinterested and neutral arbitrator and the two thus appointed shall appoint a third disinterested and neutral arbitrator. If the two arbitrators so chosen cannot agree on the appointment of a third arbitrator then such arbitrator shall be appointed by the then Chief Judge of the United States District Court of Illinois,
6
16. Modification.
Wherever necessary this Agreement will be modified to comply with IRS Code Section 409A.
Otherwise, no provision of this Agreement may be modified, waived or discharged unless such modification, waiver or discharge is agreed to in writing signed by the Chairman and the Company. No waiver by either party hereto at any time by any breach of any part hereto of any compliance with any conditions or provisions of this Agreement to be performed by such party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time.
IN WITNESS WHEREOF, the Company, by order of its Board of Directors, has caused this Agreement, consisting of seven (7) pages, to be signed in its corporate name by its duly authorized Director and impressed with its corporate seal, attested by its Secretary and the Director has hereunto set his hand on the day and year first above written.
FEDERAL LIFE INSURANCE COMPANY (MUTUAL) | ||
By: | /s/ James H. Stacke | |
Director - Authorized |
[corporate seal]
ATTEST:
/s/ Judy A. Manning |
Secretary |
7
Exhibit 10.7
EXECUTIVE AGREEMENT
Agreement made this 30th day of November 2017 between FEDERAL LIFE INSURANCE COMPANY, an Illinois stock life insurance company (hereinafter referred to as the “Company”), and WILLIAM S. AUSTIN (hereinafter sometimes referred to as the “President”).
William S. Austin is presently employed by the Company as its President and Chief Operating Officer.
The Board of Directors of the Company desires to provide for the continued employment of the President which the Board has determined will be in the best interests of the Company and its policyholders and will enforce and encourage the continued attention and dedication to the Company of the President. The President is willing to commit himself to continue to serve the Company on the terms and conditions herein provided.
In order to effect the foregoing, the Company and the President wish to enter into an agreement on the terms and conditions set forth below.
Accordingly, in consideration of the promises and the respective covenants and agreements herein contained, in further consideration of services performed and to be performed by the President and intending to be legally bound, the parties hereto agree as follows:
1. Employment.
A. The Company agrees to employ the President as President and Chief Operating Officer of the Company or in a capacity whose functions require an equivalent level of knowledge and responsibility to those now being performed. If at any time Joseph D. Austin retires, or otherwise terminates his employment then William S. Austin will be elected Chairman and Chief Executive Officer of the Company.
B. If at any time William S. Austin is not in employed as an officer as provided in Paragraph 1A, he shall have the right, by written notice to the Company, to terminate his services hereunder effective as of the last day of the month following the receipt by the Company of any such written notice and the he shall have no other obligations under this Agreement. His termination of services under this Paragraph shall be treated as a termination of employment by the Company other than for material breach or just cause on his part and accordingly, shall be governed by the provisions of Paragraph 7A of this Agreement.
2. Term of Employment.
The initial term of employment, as this phrase is used throughout this Agreement, shall be for the period beginning on the date of this Agreement and ending three (3) years thereafter consistent with the provisions of Chapter 215 ILCS 5/245, as it exists at the time this Agreement is executed. This agreement is automatically extended each day for an additional day except that a notice of non-extension may be given at any time by the Board of Directors in which case the term of employment will expire at the end of its then current term.
1
3. President's Duties During Term of Employment.
The President shall devote his full business time (with allowances for vacations and sick leave) and attention and best efforts to the affairs of the Company and its subsidiaries and affiliates during the term of employment; provided, however, that he may serve as a director of other corporations and entities and may engage in other activities to the extent that they do not inhibit the performance of his duties hereof or conflict with the business of the Company or its subsidiaries and affiliates.
4. Compensation.
The President’s base salary will be determined each year by the Board of Directors at its annual meeting and will be paid in substantially equal monthly installments plus a bonus determined annually by the Board of Directors based upon the Board of Directors’ determination as to the performance of the President.
5. Other Benefits.
In addition to the compensation provided for herein, the President shall be entitled to participate in any and all employee benefit programs of the Company as currently in effect. Further, the President shall be entitled to receive prompt reimbursement for all expenses which he deems reasonably incurred by him in performing services hereunder provided such expenses are incurred and accounted for in accordance with the policies and procedures presently established by the Company.
6. Counsel Fees and Indemnification.
A. In the event that: (1) the Company terminates or seeks to terminate this Agreement alleging as justification for such termination a material breach by the President or causes hereinafter set forth; the President disputes such termination or attempted termination; and/or (2) the President elects to terminate his services hereunder pursuant to Paragraph 1B of this Agreement; the Company disputes its obligations to pay to the President that portion of his base salary as hereinafter provided; the Company shall pay or reimburse to the President all reasonable costs incurred by him in such dispute, including attorney's fees and costs providing the President shall prevail in such action.
B. The Company further represents and warrants: (1) that the President is and shall continue to be covered and insured up to the maximum limits provided by all insurance that the Company maintains to indemnify its directors and officers (and to indemnify the Company for any obligations which it incurs as a result of its undertaking to indemnify its officers and directors) and (2) that the Company will exert its best efforts to maintain such insurance at least at its present limits in effect throughout the term of the President's employment.
C. The Company hereby warrants and represents that the undertakings of payment indemnification and maintenance of such insurance coverage for the President set out above are not in conflict with the charter of the Company or its By-Laws or with any validly existing agreement or other proper corporate action of the Company.
2
7. Termination.
A. Termination by the Company other than for Material or Just Cause.
If the Company shall terminate the President's employment during the term of employment for other than a material breach of this Agreement or “just cause”, as herein defined, the President shall have no obligation to seek other employment in mitigation of damages in respect of any period following the date of such termination and the President shall be entitled to receive from the Company the full base salary to which he is then entitled to the end of the term of employment which shall be payable to the President in monthly installments without regard to, or reduction because of, any other compensation or income which the President receives or is entitled to receive whether from the Company or otherwise. It is stipulated that any payments made in accordance with the foregoing shall be paid to and received by the President as liquidated damages for the unwarranted termination of his employment and not as penalties and he shall be entitled to receive no further sums under this Agreement except as such that have accrued as of the date of termination or as otherwise specifically provided in this Agreement. In view of the fact that the term of this Agreement is for three (3) years pursuant to the provisions of the aforesaid described Chapter 215 ILCS 5/245, it is contemplated that the payments provided to be made by virtue of this provision shall be completed at the expiration of three (3) years from the date of such termination.
It is further understood that coverage under the Home Office Employees’ Group Health Plan during the period when payments are being made under this Paragraph or Paragraph 7C will continue at the same price as if employment had continued.
B. Termination by the Company for Material Breach or for Just Cause.
“Just cause” shall mean willful misconduct, dishonesty, conviction of a felony, habitual drunkenness or excessive absenteeism not related to illness. Should the President's employment be terminated for a material breach of this Agreement or for “just cause”, the Company shall be obligated to pay the President his then base salary only through the end of the month during which such termination occurs plus such other sums as are payable to the President under this Agreement and which have accrued as of the end of such month.
C. Termination by the President.
Without prejudice to the provisions of Paragraph 1B of this Agreement, it is agreed that if during the term of employment the President’s duties are materially diminished he may at any time resign from his position as President and Chief Operating Officer of the Company after giving the Chief Executive Officer not less than sixty (60) days prior written notice of the effective date of his resignation. Any such resignation shall not be deemed to be a material breach by the President of this Agreement.
It is further agreed that upon such resignation, except for obligations of either party to the other which have accrued as of the date of the President's resignation or as otherwise specifically provided in this Agreement, the President shall be entitled to receive the compensation provided under Paragraph 7A of this Paragraph 7 as if such termination was by the Company other than for material breach or other just cause. It is provided, however, that the President's obligation of non-disclosure as provided in Paragraph 11 of this Agreement shall remain undiminished and in full force and effect and the obligation of the President under Paragraph 8 of this Agreement not to compete shall continue for the period during which payments continue to be made to the President under the provisions of Paragraph 7A.
3
8. Non-Competition.
A. Except as is otherwise provided in Paragraph 7C, it is agreed that during the term of employment and during any period in which the President is receiving compensation as provided in Paragraphs 4 and 7, the President will not without the prior approval of the Chairman of the Board become an officer, employee, agent, partner or director of any business enterprise which is in substantial direct competition (as defined below) with the Company or any subsidiary or affiliate of the Company, as the business of the Company or any subsidiary or affiliate may be constituted during the term of employment or at the termination thereof.
B. If the President's employment by the Company is terminated by the President during the term of employment, the President shall not during the period in which he is compensated under the provisions of Paragraphs 7A and 7C following such termination become an officer, employee, agent, partner or director of any business enterprise in substantial direct competition with the Company or any subsidiaries of the Company as the business of the Company or any said subsidiaries may be constituted at the time of such termination.
C. For the purpose of this Paragraph 8, a business enterprise with which the President becomes associated as an officer, employee, agent, partner or director shall be considered in “substantial direct competition” if during a year when such competition is prohibited its sales of any product or service which is competitive with a product or service furnished by the Company or any subsidiary of the Company amount to more than ten percent (10%) of the Company's and subsidiaries' total combined sales of its product or services. This provision shall be effective during the period in which the President is receiving payments from the Company under the provisions of Paragraphs 7A and 7C.
9. Effect of Death and Disability.
A. In the event of death of the President during the period of employment, the legal representative of the President shall be entitled to the base salary provided for in Paragraph 4 for the month in which death shall have taken place at the rate being paid at the time of death and the period of employment shall be deemed to have ended as of the close of business on the last day of the month in which death shall have occurred but without prejudice to any payments due in respect to the President's death.
It is further understood that the foregoing shall not foreclose the Board of Directors from voting to continue the compensation of the President to his widow for a reasonable period after his death.
4
B. If, as a result of the President's incapacity due to physical or mental illness, the President shall have been absent from his duties hereunder on a full-time basis for the entire period of nine (9) consecutive months, the period of employment shall be deemed to have ended as of the close of business on the last day of such nine (9) month period but without prejudice to any payments due to the President in respect to disability.
In the event of disability of the President during the period of employment, the President shall be entitled to the base salary provided of in Paragraph 4 above at the rate being paid at the time of the commencement of disability for the first nine (9) month period of such disability. Thereafter, the President shall receive fifty percent (50%) of such rate being paid at the time of the commencement of disability for the remaining term provided for in this Agreement; provided, however, that this Agreement after the expiration of the nine (9) month period shall be reduced by any payments to which the President may be entitled for the payment period because of disability under any disability plan of the Company or of any subsidiary or affiliate thereof.
10. Successors or Assigns.
Any successor or assign (whether direct or indirect by purchase, merger, consolidation or change of control) shall absolutely and unconditionally assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no succession or assignment had taken place. The Company agrees that it will require any successor, or assign, under the circumstances herein above set forth, to expressly, absolutely and unconditionally assume and agree to perform this Agreement. Any failure of the Company to obtain such agreement prior to the effectiveness of any such succession or assignment shall be a material breach of this Agreement and shall entitle the President to terminate under the provisions of Paragraph 7A. As used in this Paragraph, Company shall mean the Company as herein before defined and any successor of its business and/or assets as aforesaid which executes and delivers the agreement provided for in this Paragraph or which otherwise becomes bound by the terms and conditions of this Agreement by operation of law.
This Agreement shall inure to the benefit of and be enforceable by the President's legal representative, executors, administrators, successors, heirs, devisees, designees and legatees. If the President should die while any amounts are still payable to him hereunder such amounts unless otherwise provided for herein shall be paid in accordance with the terms of this Agreement to the President's devisees, legatees, or other designees, or, if there be no such designees, to the President's estate.
11. Non-disclosure.
The President agrees that he shall not at any time while receiving compensation from the Company disclose or use, except in the course of his employment with the Company in the pursuit of the business of the Company or any of its subsidiaries and affiliates, any confidential information or proprietary data of the Company or any of its subsidiaries and affiliates whether such information or proprietary data is in his memory or embodied in writing or other physical form.
5
12. Conflicts.
Any paragraph, sentence, phrase or other provision of this Executive Agreement which is in conflict with any applicable statute, rule or other law shall be deemed, if possible, to be modified or altered to conform thereto or, if not possible, to be omitted here from. The invalidity of any portion hereof shall not affect the form and effect of the remaining valid portions hereof. Paragraph headings are included herein for convenience and are not intended to affect in any way the interpretation of any remaining Paragraphs of this Agreement.
13. Governing Law.
This Executive Agreement is governed by and is to be construed in accordance with the laws of the State of Illinois.
14. Notice.
All notices shall be in writing and shall be deemed effective when delivered in person, or 48 hours after deposit thereof in the U.S. mails, postage pre-paid, for delivery as registered mail, return-receipt requested, addressed in the case of the President to his last known address as carried on the personnel records of the Company and in the case of the Company to the corporate headquarters to the attention of the Chief Executive Officer or to such other address as the parties to be notified may specify by notice to the other party.
15. Arbitration.
A. Any controversy or claim arising out of or relating to this Agreement or any breach thereof shall be settled by arbitration before three (3) arbitrators, as provided below, and judgment of the award rendered which the arbitrators, or at least a majority of the arbitrators, may be entered in any court having jurisdiction thereof.
B. Each party shall appoint a disinterested and neutral arbitrator and the two thus appointed shall appoint a third disinterested and neutral arbitrator. If the two arbitrators so chosen cannot agree on the appointment of a third arbitrator then such arbitrator shall be appointed by the then Chief Judge of the United States District Court of Illinois.
16. Representation and Warranties.
The Company represents and warrants that the execution of this Agreement by the Company has been duly authorized by resolution of its Board of Directors.
17. Modification.
Wherever necessary this Agreement will be modified to comply with IRS Code Section 409A.
Otherwise, no provision of this Agreement may be modified, waived or discharged unless such modification, waiver or discharge is agreed to in writing signed by the President and the Company. No waiver by either party hereto at any time by any breach of any part hereto of any compliance with any conditions or provisions of this Agreement to be performed by such party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time.
6
IN WITNESS WHEREOF, the Company, by order of its Board of Directors, has caused this Agreement, consisting of ten (10) pages, to be signed in its corporate name by its duly authorized Director and impressed with its corporate seal, attested by its Secretary and the Director has hereunto set his hand on the day and year first above written.
FEDERAL LIFE INSURANCE COMPANY (MUTUAL) | ||
By: | ||
Director - Authorized |
[corporate seal]
ATTEST:
Secretary |
7
Exhibit 10.8
EXECUTIVE AGREEMENT
Agreement made this 3rd day of March 2010 between FEDERAL LIFE INSURANCE COMPANY (MUTUAL), an Illinois mutual life insurance company (hereinafter referred to as the “Company”), and MICHAEL AUSTIN (hereinafter sometimes referred to as the “Executive Vice President”).
Michael Austin is presently employed by the Company as its Executive Vice President and Chief Marketing Officer.
The Board of Directors of the Company desires to provide for the continued employment of the Executive Vice President which the Board has determined will be in the best interests of the Company and its policyholders and will enforce and encourage the continued attention and dedication to the Company of the Executive Vice President. The Executive Vice President is willing to commit himself to continue to serve the Company on the terms and conditions herein provided.
In order to effect the foregoing, the Company and the Executive Vice President wish to enter into an agreement on the terms and conditions set forth below.
Accordingly, in consideration of the promises and the respective covenants and agreements herein contained, in further consideration of services performed and to be performed by the Executive Vice President and intending to be legally bound, the parties hereto agree as follows:
1. Employment.
A. The Company agrees to employ the Executive Vice President as Executive Vice President and Chief Marketing Officer of the Company or in a capacity whose functions require an equivalent level of knowledge and responsibility to those now being performed.
B. If at any time during the term of employment, the Board of Directors of the Company fails to re-elect the Executive Vice President, or removes the Executive Vice President from such office at any time during the term of this agreement, the Executive Vice President shall have the right, by written notice to the Company, to terminate his services hereunder effective as of the last day of the month following the receipt by the Company of any such written notice and the Executive Vice President shall have no other obligations under this Agreement. The Executive Vice President's termination of services under this Paragraph shall be treated as a termination of employment by the Company other than for material breach or just cause on the Executive Vice President's part and, accordingly, shall be governed by the provisions of Paragraph 7A of this Agreement.
2. Term of Employment.
The initial term of employment, as this phrase is used throughout this Agreement, shall be for the period beginning on the date of this Agreement and ending three (3) years thereafter consistent with the provisions of Chapter 215 ILCS 5/245, as it exists at the time this Agreement is executed. This agreement is automatically extended each day for an additional day except that a notice of non-extension may be given at any time by the Board of Directors in which case the term of employment will expire at the end of its then current term.
1
3. Executive Vice President's Duties During Term of Employment.
The Executive Vice President shall devote his full business time (with allowances for vacations and sick leave) and attention and best efforts to the affairs of the Company and its subsidiaries and affiliates during the term of employment; provided, however, that he may serve as a director of other corporations and entities and may engage in other activities to the extent that they do not inhibit the performance of his duties hereof or conflict with the business of the Company or its subsidiaries and affiliates.
4. Compensation.
The Executive Vice President's base salary will be determined each year by the Board of Directors at its annual meeting and will be paid in substantially equal monthly installments plus a bonus determined annually by the Board of Directors based upon the Board of Directors' determination as to the performance of the Executive Vice President.
5. Other Benefits.
In addition to the compensation provided for herein, the Executive Vice President shall be entitled to participate in any and all employee benefit programs of the Company as currently in effect. Further, the Executive Vice President shall be entitled to receive prompt reimbursement for all expenses which he deems reasonably incurred by him in performing services hereunder provided such expenses are incurred and accounted for in accordance with the policies and procedures presently established by the Company.
6. Counsel Fees and Indemnification.
A. In the event that: (1) the Company terminates or seeks to terminate this Agreement alleging as justification for such termination a material breach by the Executive Vice President or causes hereinafter set forth; the Executive Vice President disputes such termination or attempted termination; and/or (2) the Executive Vice President elects to terminate his services hereunder pursuant to Paragraph 1B of this Agreement; the Company disputes its obligations to pay to the Executive Vice President that portion of his base salary as hereinafter provided; the Company shall pay or reimburse to the Executive Vice President all reasonable costs incurred by him in such dispute, including attorney's fees and costs providing the Executive Vice President shall prevail in such action.
B. The Company further represents and warrants: (1) that the Executive Vice President is and shall continue to be covered and insured up to the maximum limits provided by all insurance that the Company maintains to indemnify its directors and officers (and to indemnify the Company for any obligations which it incurs as a result of its undertaking to indemnify its officers and directors) and (2) that the Company will exert its best efforts to maintain such insurance at least at its present limits in effect throughout the term of the Executive Vice President's employment.
2
C. The Company hereby warrants and represents that the undertakings of payment indemnification and maintenance of such insurance coverage for the Executive Vice President set out above are not in conflict with the charter of the Company or its By-Laws or with any validly existing agreement or other proper corporate action of the Company.
7. Termination.
A. Termination by the Company other than for Material or Just Cause.
If the Company shall terminate the Executive Vice President's employment during the term of employment for other than a material breach of this Agreement or “just cause”, as herein defined, the Executive Vice President shall have no obligation to seek other employment in mitigation of damages in respect of any period following the date of such termination and the Executive Vice President shall be entitled to receive from the Company the full base salary to which he is then entitled to the end of the term of employment which shall be payable to the Executive Vice President in monthly installments without regard to, or reduction because of, any other compensation or income which the Executive Vice President receives or is entitled to receive whether from the Company or otherwise. It is stipulated that any payments made in accordance with the foregoing shall be paid to and received by the Executive Vice President as liquidated damages for the unwarranted termination of his employment and not as penalties and he shall be entitled to receive no further sums under this Agreement except as such that have accrued as of the date of termination or as otherwise specifically provided in this Agreement. In view of the fact that the term of this Agreement is for three (3) years pursuant to the provisions of the aforesaid described Chapter 215 ILCS 5/245, it is contemplated that the payments provided to be made by virtue of this provision shall be completed at the expiration of three (3) years from the date of such termination.
It is further understood that coverage under the Home Office Employees' Group Health Plan during the period when payments are being made under this Paragraph or Paragraph 7C will continue at the same price as if employment had continued.
B. Termination by the Company for Material Breach or for Just Cause.
“Just cause” shall mean willful misconduct, dishonesty, conviction of a felony, habitual drunkenness or excessive absenteeism not related to illness. Should the Executive Vice President's employment be terminated for a material breach of this Agreement or for “just cause”, the Company shall be obligated to pay the Executive Vice President his then base salary only through the end of the month during which such termination occurs plus such other sums as are payable to the Executive Vice President under this Agreement and which have accrued as of the end of such month.
C. Termination by the Executive Vice President.
Without prejudice to the provisions of Paragraph 1B of this Agreement, it is agreed that if during the term of employment the Executive Vice President's duties are materially diminished he may at any time resign from his position as Executive Vice President -Marketing of the Company after giving the Chief Executive Officer not less than sixty (60) days prior written notice of the effective date of his resignation. Any such resignation shall not be deemed to be a material breach by the Executive Vice President of this Agreement.
3
It is further agreed that upon such resignation, except for obligations of either party to the other which have accrued as of the date of the Executive Vice President's resignation or as otherwise specifically provided in this Agreement, the Executive Vice President shall be entitled to receive the compensation provided under Paragraph 7A of this Paragraph 7 as if such termination was by the Company other than for material breach or other just cause, It is provided, however, that the Executive Vice President's obligation of non-disclosure as provided in Paragraph 11 of this Agreement shall remain undiminished and in full force and effect and the obligation of the Executive Vice President under Paragraph 8 of this Agreement not to compete shall continue for the period during which payments continue to be made to the Executive Vice President under the provisions of Paragraph 7A.
8. Non-Competition.
A. Except as is otherwise provided in Paragraph 7C, it is agreed that during the term of employment and during any period in which the Executive Vice President is receiving compensation as provided in Paragraphs 4 and 7, the Executive Vice President will not without the prior approval of the Chairman of the Board become an officer, employee, agent, partner or director of any business enterprise which is in substantial direct competition (as defined below) with the Company or any subsidiary or affiliate of the Company, as the business of the Company or any subsidiary or affiliate may be constituted during the term of employment or at the termination thereof.
B. If the Executive Vice President's employment by the Company is terminated by the Executive Vice President during the term of employment, the Executive Vice President shall not during the period in which he is compensated under the provisions of Paragraphs 7A and 7C following such termination become an officer, employee, agent, partner or director of any business enterprise in substantial direct competition with the Company or any subsidiaries of the Company as the business of the Company or any said subsidiaries may be constituted at the time of such termination.
C. For the purpose of this Paragraph 8, a business enterprise with which the Executive Vice President becomes associated as an officer, employee, agent, partner or director shall be considered in “substantial direct competition” if during a year when such competition is prohibited its sales of any product or service which is competitive with a product or service furnished by the Company or any subsidiary of the Company amount to more than ten percent (10%) of the Company's and subsidiaries' total combined sales of its product or services. This provision shall be effective during the period in which the Executive Vice President is receiving payments from the Company under the provisions of Paragraphs 7A and 7C.
9. Effect of Death and Disability.
A. In the event of death of the Executive Vice President during the period of employment, the legal representative of the Executive Vice President shall be entitled to the base salary provided for in Paragraph 4 for the month in which death shall have taken place at the rate being paid at the time of death and the period of employment shall be deemed to have ended as of the close of business on the last day of the month in which death shall have occurred but without prejudice to any payments due in respect to the Executive Vice President's death.
4
It is further understood that the foregoing shall not foreclose the Board of Directors from voting to continue the compensation of the Executive Vice President to his widow for a reasonable period after his death.
B. If, as a result of the Executive Vice President's incapacity due to physical or mental illness, the Executive Vice President shall have been absent from his duties hereunder on a full-time basis for the entire period of nine (9) consecutive months, the period of employment shall be deemed to have ended as of the close of business on the last day of such nine (9) month period but without prejudice to any payments due to the Executive Vice President in respect to disability,
In the event of disability of the Executive Vice President during the period of employment, the Executive Vice President shall be entitled to the base salary provided of in Paragraph 4 above at the rate being paid at the time of the commencement of disability for the first nine (9) month period of such disability. Thereafter, the Executive Vice President shall receive fifty percent (50%) of such rate being paid at the time of the commencement of disability for the remaining term provided for in this Agreement; provided, however, that this Agreement after the expiration of the nine (9) month period shall be reduced by any payments to which the Executive Vice President may be entitled for the payment period because of disability under any disability plan of the Company or of any subsidiary or affiliate thereof.
10. Successors or Assigns,
Any successor or assign (whether direct or indirect by purchase, merger, consolidation or change of control) shall absolutely and unconditionally assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no succession or assignment had taken place. The Company agrees that it will require any successor, or assign, under the circumstances herein above set forth, to expressly, absolutely and unconditionally assume and agree to perform this Agreement. Any failure of the Company to obtain such agreement prior to the effectiveness of any such succession or assignment shall be a material breach of this Agreement and shall entitle the Executive Vice President to terminate under the provisions of Paragraph 7A. As used in this Paragraph, Company shall mean the Company as herein before defined and any successor of its business and/or assets as aforesaid which executes and delivers the agreement Page 7 provided for in this Paragraph or which otherwise becomes bound by the terms and conditions of this Agreement by operation of law.
This Agreement shall inure to the benefit of and be enforceable by the Executive Vice President's legal representative, executors, administrators, successors, heirs, devisees, designees and legatees. If the Executive Vice President should die while any amounts are still payable to him hereunder such amounts unless otherwise provided for herein shall be paid in accordance with the terms of this Agreement to the Executive Vice President's devisees, legatees, or other designees, or, if there be no such designees, to the Executive Vice President's estate.
5
11. Non-Disclosure.
The Executive Vice President agrees that he shall not at any time while receiving compensation from the Company disclose or use, except in the course of his employment with the Company in the pursuit of the business of the Company or any of its subsidiaries and affiliates, any confidential information or proprietary data of the Company or any of its subsidiaries and affiliates whether such information or proprietary data is in his memory or embodied in writing or other physical form.
12. Conflicts.
Any paragraph, sentence, phrase or other provision of this Executive Agreement which is in conflict with any applicable statute, rule or other law shall be deemed, if possible, to be modified or altered to conform thereto or, if not possible, to be omitted here from. The invalidity of any portion hereof shall not affect the form and effect of the remaining valid portions hereof. Paragraph headings are included herein for convenience and are not intended to affect in any way the interpretation of any remaining Paragraphs of this Agreement.
13. Governing Law.
This Executive Agreement is governed by and is to be construed in accordance with the laws of the State of Illinois.
14. Notice.
All notices shall be in writing and shall be deemed effective when delivered in person, or 48 hours after deposit thereof in the U.S. mails, postage pre-paid, for delivery as registered mail, return-receipt requested, addressed in the case of the Executive Vice President to his last known address as carried on the personnel records of the Company and in the case of the Company to the corporate headquarters to the attention of the Chief Executive Officer or to such other address as the parties to be notified may specify by notice to the other party.
15. Arbitration.
A. Any controversy or claim arising out of or relating to this Agreement or any breach thereof shall be settled by arbitration before three (3) arbitrators, as provided below, and judgment of the award rendered which the arbitrators, or at least a majority of the arbitrators, may be entered in any court having jurisdiction thereof.
B. Each party shall appoint a disinterested and neutral arbitrator and the two thus appointed shall appoint a third disinterested and neutral arbitrator. If the two arbitrators so chosen cannot agree on the appointment of a third arbitrator then such arbitrator shall be appointed by the then Chief Judge of the United States District Court of Illinois.
16. Representation and Warranties.
The Company represents and warrants that the execution of this Agreement by the Company has been duly authorized by resolution of its Board of Directors.
6
17. Modification.
Wherever necessary this Agreement will be modified to comply with IRS Code Section 409A.
Otherwise, no provision of this Agreement may be modified, waived or discharged unless such modification, waiver or discharge is agreed to in writing signed by the Executive Vice President and the Company. No waiver by either party hereto at any time by any breach of any part hereto of any compliance with any conditions or provisions of this Agreement to be performed by such party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time.
IN WITNESS WHEREOF, the Company, by order of its Board of Directors, has caused this Agreement, consisting of ten (10) pages, to be signed in its corporate name by its duly authorized Director and impressed with its corporate seal, attested by its Secretary and the Director has hereunto set his hand on the day and year first above written.
FEDERAL LIFE INSURANCE COMPANY (MUTUAL) | ||
By: | /s/ James H. Stacke | |
Director - Authorized |
[corporate seal]
ATTEST:
/s/ Judy A. Manning | |
Secretary |
7
Exhibit 21.1
SUBSIDIARIES OF REGISTRANT
Company |
State of Organization |
Percentage
of Equity Owned Directly or Indirectly | ||
Federal Life Insurance Company | Illinois | 100% | ||
Americana Realty Company | Illinois | 100% | ||
FED Mutual Financial Services, Inc. | Illinois | 100% | ||
FEDHO Holding Company | Illinois | 100% |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the inclusion in this Form S-1 Registration Statement of Federal Life Mutual Holding Company and Subsidiaries filed with the Securities and Exchange Commission of our report dated July 20, 2018 on our audits of the financial statements of Federal Life Mutual Holding Company and Subsidiaries (A Mutual Insurance Company) as of and for the years ended December 31, 2017 and 2016. We also consent to the references to our firm under the caption “Experts.”
Kansas City, Missouri
July 23, 2018
EXHIBIT 23.2
CONSENT OF RP FINANCIAL, LC
We hereby consent to the inclusion of our opinion letter dated December 22, 2017 addressed to the Board of Directors of Federal Life Mutual Holding Company (“FLMHC”) as an Exhibit to the Registration Statement on Form S-1 and related amendments thereto (collectively, the “Form S-1”) of Federal Life Group, Inc. as filed with the Securities and Exchange Commission (the “SEC”) and to the references to such opinion and the quotation or summarization of such opinion contained therein. In giving such consent, we do not admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended (the “Act”), or the rules and regulations of the SEC thereunder (the “Regulations”), nor do we admit that we are experts with respect to any part of the Registration Statement within the meaning of the term “experts” as used in the Act or the Regulations.
/s/ RP FINANCIAL, LC |
RP FINANCIAL, LC |
Arlington, VA |
July 17, 2018 |
Exhibit 99.5
PRO FORMA VALUATION APPRAISAL REPORT
Federal Life Group, Inc. │Riverwoods, Illinois
PROPOSED HOLDING COMPANY FOR:
Federal Life Insurance Company
Dated as of December 22, 2017
1100 North Glebe Road Suite 600
Arlington, Virginia 22201
703.528.1700
rpfinancial.com
December 22, 2017
Board of Directors
Federal Life Mutual Holding Company
Federal Life Insurance Company
3750 West Deerfield Road
Riverwoods, Illinois 60015
Members of the Board:
At your request, we have completed and hereby provide an independent appraisal (“Appraisal”) of the estimated pro forma market value of the Common Stock which is to be offered in connection with the conversion transaction described below (hereinafter referred to as the “Conversion”).
This Appraisal is furnished pursuant to the requirements stipulated in Section 59.1 of the Illinois Insurance Code. In accordance with Section 59.1(6)(f) of the Illinois Insurance Code, the aggregate price of the capital stock shall be equal to the estimated pro forma market value of the converted stock company based upon an independent evaluation by a qualified person. Furthermore, as permitted by Section 59.1(6)(f), the pro forma market value may be the value that is estimated to be necessary to attract full subscription for the shares as indicated by the independent evaluation. Pursuant to the requirement in Section 59.1(3)(b)(i)(A), the Appraisal must be filed with the Illinois Department of Insurance (the “Department”).
Description of Conversion and Stock Issuance
We understand that Federal Life Mutual Insurance Holding Company (“FLMHC” or the “MHC”), the mutual insurance holding company for Federal Life Insurance Company (“Federal Life” or the “Company”) will reorganize into a stock insurance holding company. Pursuant to the Plan of Conversion (the “Plan”), upon completion of the Conversion, all of the outstanding shares of common stock of FLMHC will be issued to Federal Life Group (“FLG”). FLG will be the first tier parent of FLMHC which will wholly-own Federal Life. The Conversion will be effected only if subscriptions and orders are received for at least the minimum shares of common stock as indicated by the Valuation Range and the members of the MHC approve the Plan of Conversion. Federal Life Group, Inc. (“FLG”) which will offer its common stock in a subscription offering first to eligible members, and second, to the directors and officers.
The Standby Purchase Agreement
Insurance Capital Group, LLC. (“ICG” or the “Standby Purchaser”), has entered into a Standby Purchase Agreement (the “Agreement”) with FLG, FLMHC and Federal Life. Pursuant to the Agreement, the Standby Purchaser agrees to purchase at least the number of shares equal to (i) the number of shares that would be issued at the minimum of the valuation range minus (ii) the sum of any shares for which subscriptions have been accepted in the Subscription Offering, plus any shares for which orders have been accepted in the Community Offering (such number of shares purchased being the “Purchased Shares”). The Standby Purchaser has also been guaranteed the right but not the obligation to purchase 2,800,000 shares issued in the conversion, subject to other requirements of the Agreement. Any order submitted by Standby Purchaser in the Community Offering may be accepted by FLG prior to accepting any other order received in the Community Offering. In addition, the Company and the Standby Purchaser have agreed to certain other operating and management provisions including board representation by the Standby Purchaser. In addition, the Standby Purchaser has agreed that it will not seek to acquire or otherwise control the Company for a period of least 5 years subject to certain conditions.
Washington Headquarters | |
Three Ballston Plaza | |
1100 North Glebe Road, Suite 600 | Telephone: (703) 528-1700 |
Arlington, VA 22201 | Fax No.: (703) 528-1788 |
E-Mail: mail@rpfinancial.com | Toll-Free No.: (866) 723-0594 |
Board of Directors
December 22, 2017
Page 2
RP Financial, LC.
RP Financial, LC. (“RP Financial”) is a financial consulting firm serving the financial services industry nationwide that, among other things, specializes in financial valuations and analyses of business enterprises and securities, including the pro forma valuation for companies undertaking the demutualization process, including insurance companies and savings institutions. RP Financial is a nationally recognized valuation expert in stock conversion transactions for mutually owned financial services companies. The background and experience of RP Financial is detailed in Exhibit V-1. We believe that, except for the fee we will receive for our appraisal services, we are independent of FLMHC, FLG and Federal Life and the other parties engaged by the Company to assist in the conversion process.
Valuation Methodology
In preparing our appraisal, we have reviewed the Plan of Conversion to be filed with the Department. We have conducted a financial analysis of the Company that has included a review of its financial information for fiscal years ended December 31, 2015 through 2016 and through September 30, 2017, all unaudited but prepared in accordance with generally accepted accounting principles (“GAAP”). We have conducted due diligence related discussions with the Company’s management, Stevens & Lee, the Company’s counsel, and Griffin Financial Group, LLC, the Company’s financial and marketing advisor in connection with the stock offering. All conclusions set forth in the Appraisal were reached independently from such discussions. In addition, where appropriate, we have considered information based on other available published sources that we believe are reliable. While we believe the information and data gathered from all these sources are reliable, we cannot guarantee the accuracy and completeness of such information.
We have investigated the competitive environment within which the Company operates and have assessed the Company’s relative strengths and weaknesses. We have kept abreast of the changing regulatory and legislative environment for insurance companies, including those with broadly similar lines of business, and analyzed the potential impact on the Company and the industry as a whole. We have analyzed the potential effects of the Conversion and stock offering on the Company’s operating characteristics and financial performance as they relate to the pro forma market value. We have reviewed the economy in the Company’s primary market area and have compared the Company’s financial performance and condition with publicly-traded insurance companies sharing similar lines of business. We have reviewed conditions in the securities markets in general and in the market for insurance company stocks in particular, including the market for existing insurance companies, the market for the newly issued stock offered by demutualized insurance companies, and the market for mutual thrift institutions converting to stock form. We have also considered the expected market for FLG including the post-transaction illiquidity of the shares in view of the large insider ownership and shares purchased by ICG.
Board of Directors
December 22, 2017
Page 3
Our Appraisal is based on the Company’s representation that the information contained in the regulatory applications and additional information furnished to us by the Company, its independent auditors and actuaries, legal counsel and other authorized agents are truthful, accurate and complete. We did not independently verify the financial statements and other information provided by the Company, its independent auditors and actuaries, legal counsel and other authorized agents nor did we independently value the assets or liabilities of the Company. The valuation considers the Company only as a going concern and should not be considered as an indication of the Company’s liquidation value.
Our appraised value is predicated on a continuation of the current operating environment for the Company and for all insurance companies and their holding companies. Changes in the local, state and national economy, the legislative and regulatory environment for insurance companies and legal professional liability insurers, the stock market, interest rates, and other external forces (such as natural disasters or significant world events) may occur from time to time, often with great unpredictability, and may materially impact the value of insurers as a whole or FLG’s value alone. To the extent that such factors can be foreseen, they have been factored into our analysis.
Pro forma market value is defined as the price at which FLG’s stock, immediately upon completion of the Offering, would change hands between a willing buyer and a willing seller, neither being under any compulsion to buy or sell and both having reasonable knowledge of relevant facts.
Valuation Conclusion
It is our opinion that, as of December 22, 2017 (the “Valuation Date”), the estimated pro forma market value of the Company was $40,000,000 with a range (the “Valuation Range”) of $34,000,000 to $46,000,000. The Valuation Range was based upon a 15% decrease from the midpoint of $40,000,000 to determine the minimum and a 15% increase from the midpoint to establish the maximum. Based on an assumed offering price of $10.00 per share, the number of shares of common stock offered for sale will range from 3,400,000 shares at the minimum to 4,600,000 shares at the maximum with a midpoint of 4,000,000 shares.
Limiting Factors and Considerations
Our valuation is not intended, and must not be construed, as a recommendation of any kind as to the advisability of purchasing shares of the Common Stock. Moreover, because such valuation is necessarily based upon estimates and projections of a number of matters, all of which are subject to change from time to time, no assurance can be given that persons who purchase shares of common stock in the offering will thereafter be able to buy or sell such shares at prices related to the foregoing valuation of the pro forma market value thereof.
Our valuation conclusion reflects our opinion as to the fair market value of the shares issued in the Offering assuming a full distribution of the shares to eligible subscribers. This valuation conclusion does not express an opinion as to the pro forma impact to the subscribers. Furthermore, this valuation is based on offering and transaction terms set forth in the draft documents which set forth the terms and structure of the offering on a preliminary basis. Changes in the transaction terms and structure could have a material impact on the valuation conclusion set forth herein.
Board of Directors
December 22, 2017
Page 4
RP Financial’s valuation was determined based on the financial condition and operations of the Company as of September 30, 2017.
RP Financial is not a seller of securities within the meaning of any federal and state securities laws and any report prepared by RP Financial shall not be used as an offer or solicitation with respect to the purchase or sale of any securities. RP Financial maintains a policy which prohibits the company, its principals or employees from purchasing stock of its client institutions.
Respectfully submitted, | |
RP FINANCIAL, LC. | |
James P. Hennessey | |
Director |
RP® Financial, LC. | TABLE OF CONTENTS |
i |
TABLE OF CONTENTS
Federal Life Insurance Company
Riverwoods, Illinois
PAGE | ||
DESCRIPTION | NUMBER | |
CHAPTER ONE OVERVIEW AND FINANCIAL ANALYSIS | ||
Company Overview | 1.1 | |
Business Strategies | 1.2 | |
Product Description | 1.4 | |
Marketing and Distribution | 1.8 | |
Underwriting | 1.10 | |
Reinsurance | 1.10 | |
Claims Management | 1.11 | |
Executive Officers | 1.12 | |
Plan of Conversion | 1.13 | |
Financial Overview | 1.14 | |
Income and Expense Trends | 1.19 | |
Potential Off Balance Sheet Value | 1.22 | |
Legal Proceedings | 1.23 | |
CHAPTER TWO EXTERNAL ENVIRONMENT | ||
Introduction | 2.1 | |
National Economic Factors | 2.1 | |
Life Insurance Trends | 2.3 | |
Regulatory Environment | 2.5 | |
Competition | 2.6 | |
CHAPTER THREE PEER GROUP ANALYSIS | ||
Peer Group Selection | 3.1 | |
Financial Condition | 3.8 | |
Income and Expense Components | 3.10 | |
Summary | 3.13 |
RP® Financial, LC. | TABLE OF CONTENTS |
ii |
TABLE OF CONTENTS
Federal Life Insurance Company
Riverwoods, Illinois
(continued)
PAGE | |||||
DESCRIPTION | NUMBER | ||||
CHAPTER FOUR VALUATION ANALYSIS | |||||
Introduction | 4.1 | ||||
Pro Forma Approach to the Valuation | 4.1 | ||||
Valuation Analysis | 4.2 | ||||
1. | Financial Considerations | 4.2 | |||
2. | Operating Considerations | 4.3 | |||
3. | Dividends | 4.4 | |||
4 | Liquidity of the Shares | 4.4 | |||
5. | Marketing of the Issue | 4.5 | |||
A. | The Public Market | 4.5 | |||
B. | The New Issue Market | 4.8 | |||
6. | Organization | 4.11 | |||
7. | Regulatory Environment | 4.11 | |||
Summary of Adjustments | 4.12 | ||||
Valuation Approaches | 4.12 | ||||
1. | Price-to-Earnings ("P/E") | 4.14 | |||
2. | Price-to-Book ("P/B") | 4.16 | |||
3. | P/Revenues | 4.16 | |||
Comparison to Recent Demutualizations | 4.16 | ||||
Valuation Conclusion | 4.17 |
RP® Financial, LC. | LIST OF TABLES |
iii |
LIST OF TABLES
Federal Life Insurance Company
Riverwoods, Illinois
TABLE | ||||
NUMBER | DESCRIPTION | PAGE | ||
1.1 | Direct Premium by Product Type | 1.6 | ||
1.2 | Number of Policies by Type | 1.7 | ||
1.3 | Summary of Life Insurance in Force | 1.7 | ||
1.4 | Geographic Distribution of Premium Income | 1.9 | ||
1.5 | Reinsurance Ceded by Reinsurer | 1.11 | ||
1.6 | Historical Balance Sheets | 1.15 | ||
1.7 | Historical Income Statements as a Percent Average Assets | 1.20 | ||
2.1 | Market Shares | 2.7 | ||
3.1 | Peer Group of Publicly-Traded Insurance Companies | 3.3 | ||
3.2 | Comparative Financial Condition Data | 3.9 | ||
3.3 | Comparative Operating Performance Data | 3.12 | ||
4.1 | Stock Market Pricing Trends | 4.7 | ||
4.2 | Demutualization Transaction – Subscription Rights Offerings | 4.9 | ||
4.3 | Public Market Pricing | 4.15 | ||
4.4 | Valuation Range and Offering Characteristics | 4.17 |
RP Financial, LC.
Page 1.1
I. OVERVIEW AND FINANCIAL ANALYSIS
Company Overview
Federal Life Insurance Company (“Federal Life” or the “Company” is an Illinois chartered stock insurance company whose primary business activity is the marketing and underwriting of quality life insurance and annuity products. The Company was incorporated in 1899 and conducts operations through its headquarters office in Riverwoods, Illinois, a suburb approximately thirty miles north of Chicago. The Company is licensed to do business in all states except: Maine, Massachusetts, New Hampshire, New York, and Vermont. Moreover, the Company markets its products through independent agents located across the United States. Federal Life is focused on the underwriting of various life and annuity products and does not offer property, casualty or health insurance.
For more than 100 years, Federal Life has provided quality whole life and term life insurance products as well as various savings products including annuities. Federal Life’s products and services have evolved over time in keeping with changing consumer needs and preferences. In this regard, Federal Life was a pioneer in the variable annuity business when it formed a relationship with Wellington Management Company. In 1976, Federal Life introduced a Variable Annuity that was unique at that time having Wellington Management Funds as investment option as well as a Fixed Annuity with Federal Life. Other innovative product offerings include the 2015 introduction by Federal Life of Market Shield Plus, an Index-Linked Annuity which offers the opportunity to participate in stock market growth on a tax-deferred basis, with downside protection.
In June 2016, the Company was reorganized into a mutual holding company structure whereby the Company converted to the stock form of ownership and became a wholly-owned subsidiary of FedHo Holding Company, Inc., which is a wholly-owned subsidiary of Federal Life Mutual Holding Company (“FLMHC” or the “MHC”).
Federal Life Group, Inc. (“FLG”) will be a newly created Pennsylvania corporation organized to be the stock holding company for Federal Life following the conversion to the stock form of ownership (the “Conversion”). In the Conversion, FLG will become the sole shareholder of FLMHC which will own 100% of Federal Life. Federal Life is subject to examination and comprehensive regulation by the Illinois Department of Insurance. Federal Life is also a member of the Chicago Federal Home Loan Bank.
RP Financial, LC.
Page 1.2
Business Strategies
Federal Life states that its mission is to offer competitive products that are beneficial to customers, create a culture of service that strives to “do the right thing”, and maintain operations that support long term financial strength to ensure the promises of the Company will be kept.
The Company’s vision is to offer products, service and security that will enable people to achieve their goals now and in the future while providing security for future generations. The Company has trademarked the following tagline with the U.S. Patent and Trademark Office to promote this vision: “Live your dreams. Leave a legacy.”
Federal Life offers a variety of annuity, life insurance and had previously but does not currently offer Medicare supplement plans. Federal Life administers and sells a variety of variable, fixed, index-linked and income annuities designed to address contract holders’ needs for protected wealth accumulation on a tax-deferred basis, wealth transfer and income security. The life segment offers insurance products and services, including term, whole, universal and variable life products designed to address policyholders’ needs for financial security and protected wealth transfer, which may be provided on a tax-advantaged basis. Most of the Company’s offerings are marketed through independent agent relationships but Federal Life is increasingly emphasizing direct marketing through the Internet and social media platforms.
Importantly, Federal Life has reported operating losses for over a decade, which management attributes to serval factors. In this regard, the economic environment following the financial crisis in 2007, has resulted in a long period of falling and or very low interest rates which have had a significant impact on the financial results of the Company in recent years. Despite taking proactive steps to mitigate the interest rate risk by significantly diversifying the investment portfolio, and closely monitoring crediting rates, diminished investment income on the Company’s investment securities portfolio has resulted in lower net income.
Like most of the life insurance industry, the Company also suffered significant capital losses in 2008 and 2009 due to the global financial crisis. Many of the losses were on investment grade bonds which under normal conditions would not be considered high credit risks.
Accordingly, the financial results of the Company over the last 10 years have reflected the effects of the low interest rate environment, the global economic crisis and the limited marketing growth due to the changing niche market. The Company sought to preserve capital through this difficult operating environment while also managing expense levels while maintaining an infrastructure with capacity for future growth.
RP Financial, LC.
Page 1.3
In response to the challenging operating environment, Federal Life has developed a growth oriented business plan designed to reverse the recent operating losses. Management believes that growth in underwriting supported by the capital provided by the conversion and facilitated by relationships and partnerships fostered by the standby investor in the offering (the “Standby Investor”) will facilitate the reversal of the current operating losses and provide a future return for investors in the conversion offering. In view of the foregoing, the management of Federal Life has developed the following key business strategies for achieving its vision and mission.
1. | Undertake growth to expand revenues and achieve economies of scale. The Company will be implementing a marketing plan based on the formation of strategic partnerships to improve the Company’s distribution capabilities which will enable significant growth in products that the Company identifies as having unique market opportunities. A portion of this growth will be achieved through the Standby Investor who has longstanding experience and relationships within the insurance industry. The strategic partnership will leverage national distribution systems with existing relationships with the partner to enhance the current marketing program of the Company. |
2. | Maximize the use of the existing infrastructure capacity in growth plans to create a competitive advantage. The Company has maintained an administrative infrastructure capacity which can be utilized efficiently in the future growth plans. The Company is able to make modest incremental investments in infrastructure to create a companywide digital transformation that will allow it to adapt to the technological demands of the industry with a competitive advantage for service. The digital transformation over the next several years is targeted to result a full suite of digital distribution and service business applications. Existing programs and applications will be improved, which will increase the speed with which new products are released and existing products are updated. This will eliminate time-consuming, manual processes and allows employees and agents to focus on higher priority tasks, increasing efficiency. |
3. | Promote a performance oriented culture within the organization to ensure financial strength. The Company has sought to develop a performance oriented culture which emphasizes execution and accountability. The highest priority goal of the plan will be to maintain operations that support long term financial strength. Areas requiring improvement will be identified and modified as appropriate. Projections and forecasts will be continuously updated, and the strategic plans will be dynamically changed to ensure the operations support this goal. This will include reviewing that expenses and staff levels are appropriate for actual growth rates achieved. |
4. | Identify potential internal opportunities to increase regulatory surplus to support growth and risk levels. The Company is currently exploring internal resources to improve surplus levels separate from operations. The Company owns several assets which currently have market values significantly in excess of the statutory book values, and also has other avenues it is exploring to improve surplus levels. These opportunities include: |
RP Financial, LC.
Page 1.4
· | The Company’s home office building which is located on 10 acres of property in a sought after location in Riverwoods, Illinois. The current market value is estimated to be materially in excess of the current book value under both STAT and GAAP accounting; |
· | The Company owns oil and gas mineral rights leases that are at market values materially above the current book values. The Company will continue to explore additional opportunities to utilize these assets to benefit operations or raise surplus levels. |
· | FHLB – As a member of the Federal Home Loan Bank of Chicago, Federal Life has access to low-cost, flexible advances that can be used for funding, liquidity and yield enhancement. |
· | Reinsurance – The Company has entered into new reinsurance treaties that will stabilize the operations of the Company, and provide surplus relief to assist in growth plans. The increase in capital resulting from the Conversion transaction will facilitate Federal Life’s flexibility with respect to its reinsurance arrangements. |
5. | Complete the conversion to capitalize future growth and provide enhanced access to capital markets in the future to support growth and risk levels. The Company is currently pursuing a plan to raise enough capital to support the future growth plans by offering common stock investments in a full subscription rights demutualization. The current plan is to offer subscription rights to invest in the Company to policyholders, directors, officers, employees and other stakeholders such as agents. The Company will also sell stock to the Standby Investor which will facilitate growth objectives through referrals and industry relationships of the Standby Investor. |
Product Description
Federal life offers a variety of life insurance and annuity/savings.
Life Insurance.
The Company offers a variety of term and whole life policies. Term life policies are offered for terms of up to 30 years and for a minimum benefit amount of $50,000. The Company has policies with the ability to change the coverage based on changing circumstances of the policyholder including the ability to add a spouse as an additional insured to this plan, instead of having to purchase a second plan. Whole life policies offered by the Company include traditional level premium insurance products and single premium plans. The Company’s insurance products include the following:
RP Financial, LC.
Page 1.5
Current Interest Tradition - Interest Sensitive Whole Life. Current Interest Tradition provides whole life coverage, with level premiums and a level death benefit. A variety of optional riders are available for an additional charge.
The Level Term Series – 10, 15, 20 and 30-year periods - Level Premium Term Life. The Level Term Series provides term life coverage for a specific period, with level premiums and a level death benefit. These plans are renewable and convertible, and also feature a variety of optional riders for an additional charge.
Ultra Flex-Life – Universal Life. Ultra Flex-Life provides flexible premiums, a choice of death benefit options (level or increasing), and a variety of optional riders available for an additional charge. This plan also allows an additional insured to be added to the base plan.
The Estate Builder – Single Premium Whole Life. The Estate Builder provides permanent whole life coverage by locking in a guaranteed death benefit purchased with a one-time premium payment. This plan also features a built-in accelerated death benefit, free of charge.
Express Plan – Final Expense Coverage. The Express Plan provides permanent whole life coverage, with level premiums and lower face amounts ($2,500-$25,000), available via simplified underwriting.
Graded Benefit Whole Life – Final Expense Coverage. The Graded Benefit Whole Life plan provides permanent whole life coverage, with level premiums and lower face amounts ($2,500-$25,000), with a graded benefit during the first two policy years. This plan is offered as an alternative for individuals who may not qualify for the Express Plan.
Annuities
The Company offers a variety of annuities that can be used for both primary and supplemental retirement savings, and can provide either an immediate or future stream of guaranteed income. These retirement plans can also be setup as Traditional or Roth IRAs and include the following products:
Market Shield Plus - Single Premium Deferred Annuity with Fixed and Index-Linked Options. Market Shield Plus allows the customer to build long-term savings by earning interest as the market increases, while protecting principal during periods of decline. This product earns interest on a tax-deferred basis and features three allocation options. There are two annual point- to-point index-linked allocation options which earn interest based on the S&P500®, and one fixed allocation option that earns interest based on a current competitive rate. Interest is credited on an annual basis. Additionally, Market Shield Plus features a built-in Nursing Home Rider, which is included free of charge, and an optional Income Benefit Rider (Income Security Shield).
RP Financial, LC.
Page 1.6
Flexi/Saver – Flexible Premium Deferred Annuity. Flexi/Saver features a guaranteed principal, death benefit, and minimum interest rate. Additionally, this product earns interest on a tax-deferred basis, and offers a variety of annuitization payout options.
Maxi/Saver – Single Premium Deferred Annuity. Maxi/Saver features a guaranteed principal, death benefit, and minimum interest rate. Additionally, this product earns interest on a tax-deferred basis and offers a variety of annuitization payout options.
Income Security Shield – Single Premium Immediate Annuity. Income Security Shield requires a one-time initial premium payment. The customer can then choose to begin receiving guaranteed income payments within the first contract year at regularly scheduled intervals (i.e. monthly, quarterly, semi-annually, or annually). A variety of payout options, including Life Income with Cash Refund, are available.
Table 1.1 below shows the gross direct premiums by product type.
Table 1.1
Federal Life Insurance Company
Direct Premium by Product Type
(Dollars In Thousands)
Nine Months | ||||||||||||
Fiscal Year Ended | Ended | |||||||||||
12/31/2015 | 12/31/2016 | 9/30/2017 | ||||||||||
Whole Life Premium | $ | 10,156 | $ | 9,655 | $ | 6,197 | ||||||
Term life Premium | $ | 4,684 | $ | 4,571 | $ | 3,448 | ||||||
FEGLI Premium | $ | 2,926 | $ | 2,908 | $ | 2,181 | ||||||
Total Life Insurance Premiums | $ | 17,766 | $ | 17,134 | $ | 11,827 | ||||||
Fixed Annuity Premium | $ | 3,098 | $ | 7,376 | $ | 9,519 | ||||||
Variable Annuity Premium | 0 | 0 | 0 | |||||||||
Total Annuity Premiums | $ | 3,098 | $ | 7,376 | $ | 9,519 |
Source: Internal Financial Reports
RP Financial, LC.
Page 1.7
Table 1.2 below shows the number of policies by type of policy as of the end of the last two fiscal years and as of September 30, 2017 which reflects the historical focus on writing whole life insurance policies.
Table 1.2
Federal Life Insurance Company
Number of Policies by Type
Nine Months | ||||||||||||
Fiscal Year Ended | Ended | |||||||||||
12/31/2015 | 12/31/2016 | 9/30/2017 | ||||||||||
Whole life | 18,901 | 18,710 | 18,270 | |||||||||
Term life | 9,180 | 9,080 | 9,016 | |||||||||
Group life | 1,146 | 1,079 | 1,034 | |||||||||
FEGLI | 4,929 | 4,422 | 4,422 | |||||||||
Fixed annuities | 1,740 | 1,773 | 1,840 | |||||||||
Variable annuities | 176 | 149 | 142 | |||||||||
Total | 36,072 | 35,213 | 34,724 |
Source: Internal Financial Reports.
Table 1.3 shows the total value of life Insurance in force by type of policy as of the end of the last two fiscal years and as of September 30, 2017.
Table 1.3
Federal Life Insurance Company
Summary of Life Insurance In Force
(Dollars in Thousands)
As of the Fiscal Year Ended | As of | |||||||||||
12/31/2015 | 12/31/2016 | 9/30/2017 | ||||||||||
Whole Life | $ | 721,213 | $ | 719,135 | $ | 705,797 | ||||||
Term Life | 1,026,524 | 1,019,717 | 1,007,992 | |||||||||
FEGLI | 624,615 | 559,752 | 559,752 | |||||||||
Total | $ | 2,372,352 | $ | 2,298,604 | $ | 2,273,541 |
Source: Internal Financial Reports.
RP Financial, LC.
Page 1.8
Marketing and Distribution
The Company historically distributed life, health and annuity products through financial institutions such as banks, mortgage companies and savings and loans. This strategy was highly successful and the Company had significant capital increases for many years creating a heavily capitalized balance sheet. Changes in the regulatory environment and the resulting consolidation of financial institutions led to the elimination of many smaller banks, mortgage companies and savings and loans. These events had the direct effect of significantly reducing new premium production for the Company and limiting balance sheet growth.
The Company made a strategic decision to emphasize the senior market in 2011 with the introduction a new single premium whole life plan. This program enabled the Company to develop relationships with many producers in the senior market who were also major producers of other products which were not being offered by the Company, including index annuities. In an effort to expand further into the senior market the Company developed an index annuity which was introduced in the 4th quarter of 2015.
Federal Life maintains a network of independent agents and agencies for distribution. The Company offers competitive commission schedules and personalized sales training and development programs. The Company is currently upgrading its digital distribution and service system to enhance the sales process for contracted agents. Currently, Federal Life maintains relationships with approximately 1,000 independent agents, with a compensation system structured to encourage production and long-term persistency. Agents receive commissions for new life insurance and annuity sales and renewal commissions on premium payments in subsequent years. Production bonuses are paid based on the premium level of new life business written each quarter and the persistency of the business written by the agent. (Persistency is a commonly used industry benchmark that gauges business quality based on the consistency of premium payments.)
Table 1.4 below reflects that while Federal Life has a concentration of agents and premium income derived from Illinois residents (42.5% of total premiums year-to-date through September 30, 2017), the agent network is widely dispersed and more than one-half of the premium income is derived from out-of-state policyholders.
RP Financial, LC.
Page 1.9
Table 1.4
Geographic Distribution of Premium Income
As of September 30, 2017
(Dollars in Thousands)
Life | Accident & | |||||||||||||||||||
Insurance | Annuity | Health | ||||||||||||||||||
State | Premiums | Considerations | Premiums | Total | ||||||||||||||||
($000) | ($000) | ($000) | ($000) | (%) | ||||||||||||||||
Illinois | $ | 3,436 | $ | 4,752 | $ | 24 | $ | 8,212 | 42.5 | % | ||||||||||
Ohio | 253 | 1,790 | 1 | 2,044 | 10.6 | % | ||||||||||||||
Michigan | 251 | 1,567 | 1 | 1,819 | 9.4 | % | ||||||||||||||
California | 1,468 | 22 | 13 | 1,503 | 7.8 | % | ||||||||||||||
Florida | 755 | 428 | 10 | 1,193 | 6.2 | % | ||||||||||||||
Wisconsin | 494 | 376 | 17 | 887 | 4.6 | % | ||||||||||||||
Texas | 804 | 30 | 3 | 837 | 4.3 | % | ||||||||||||||
New Jersey | 300 | 303 | 3 | 605 | 3.1 | % | ||||||||||||||
Pennsylvania | 263 | 3 | 4 | 270 | 1.4 | % | ||||||||||||||
Georgia | 229 | 9 | 3 | 242 | 1.3 | % | ||||||||||||||
All Other States | 1,470 | 239 | 15 | 1,724 | 8.9 | % | ||||||||||||||
Total | $ | 9,723 | $ | 9,519 | $ | 95 | $ | 19,336 | 100.0 | % |
Source: Internal financial reports.
RP Financial, LC.
Page 1.10
Underwriting
Federal Life follows industry underwriting standards and procedures, designed to assess, qualify, and rate life applicants before issuing the policies. To implement these procedures, the Company employs an experienced underwriting staff.
The underwriting process involves a multi-step review process for each application, which is supported by any required testing and records, including: blood, urine, or oral fluid testing, paramedical/physicians’ examinations, and/or motor vehicle, pharmacological, and medical inspection reports and records. The Company’s non-medical limit is $150,000, which means that blood and urine testing is generally required for face amounts exceeding that amount. Other factors may affect table and premium rates, such as the proposed insured’s tobacco/nicotine use. Tobacco/nicotine use within the 2-year period prior to application may result in a higher mortality charge. Additional underwriting requirements and inspection reports may be required when the face amount of the policy and/or the age of the proposed insured increases. Based on the results of these tests, Federal Life may adjust the mortality charge or decline coverage completely.
Reinsurance
Federal Life reinsures a portion of its life insurance exposure with unaffiliated insurance companies under traditional indemnity reinsurance agreements, which assists in diversifying risk and limiting its maximum loss on risks that exceed the Company’s policy retention limits. The current maximum retention limit on an insured’s life is $250,000. New sales of life products are reinsured above prescribed limits and do not require the reinsurer’s prior approval within certain guidelines.
Reinsurance contracts do not fully discharge Federal Life’s obligation to pay claims on the reinsured business. As the ceding insurer, Federal Life remains responsible for policy claims to the extent the reinsurer fails to pay claims. No reinsurer of business ceded by Federal Life has failed to pay any material policy claims (either individually or in the aggregate) with respect to the ceded business. The management of Federal Life continually evaluates the financial strength of its reinsurers and monitors concentrations of credit risk. If for any reason reinsurance coverages would need to be replaced, Federal Life believes that replacement coverages from financially responsible reinsurers would be available.
Table 1.5 below reflects that the majority of the reinsurance has been placed with Optimum Re, Inc.
RP Financial, LC.
Page 1.11
Table 1.5
Federal Life Insurance Company
Reinsurance Ceded By Reinsurer
9/30/2017 | ||||||||
Amount Ceded | Reserve Ceded | |||||||
($000) | ($000) | |||||||
Swiss RE (Cigna) | $ | 57 | $ | 1 | ||||
Optimum RE (LNL) | 4 | 1 | ||||||
Optimum RE | 645,804 | 2,035 | ||||||
Swiss RE | 238 | 5 | ||||||
Prudential | 799 | 3 | ||||||
SCOR | 37,742 | 448 | ||||||
Total | $ | 684,644 | $ | 2,493 |
Source: Internal Financial Reports.
Claims Management
Federal Life processed approximately $7.9 million and $7.7 million of life insurance benefit claims in the fiscal year ended December 31, 2016 and the nine months ended September 30, 2017, on policies underwritten by the Company. The Company provides a high level of customer service and is committed to paying all valid claims. The claim may be reported by an agent, a beneficiary, an interested party, or in the case of a qualifying disability or terminal illness, the policyholder. Claims may also be initiated by us as a result of a search of the Social Security Death Master File or other database. Through the claims administration system, Federal Life records, processes and pays the appropriate benefit for any reported claim. The claims administrative staff orders medical and investigative reports from third-party providers. The claims administrative staff determines the benefit payable based upon the Cyberlife system, calculations from the Actuarial Department, and other amounts such as post mortem interest. The claims administrative staff reports and recovers reinsurance payments from the appropriate reinsurance providers.
The Company as an Illinois domestic insurer regularly consults the Social Security Administration’s Death Master File (“Death Master File”) in accordance with applicable state requirements. These processes help identify potential deceased insureds for whom claims have not been presented in the normal course of business. If unreported deaths are identified, Federal Life determines the validity of claims, locates beneficiaries, and pays benefits accordingly.
RP Financial, LC.
Page 1.12
Executive Officers
Federal Life is managed by an experienced group of executives led by Joseph D. Austin, Chief Executive Officer and Chairman of the Board and William S. Austin, its President and Chief Operating Officer (“COO”). Current management has longstanding experience both at Federal Life and within the insurance industry. Summary biographies of the Company’s executive officers are included below:
Joseph D. Austin has been employed with the Company since 1972 and a member of the Board of Directors since 1973. He was elected Chairman of the Board, President and Chief Executive Officer in June 1977. Since 2002 he has served as Chairman of the Board and Chief Executive Officer. Mr. Austin holds a B.A. degree from the University of Scranton and is a Fellow of the Society of Actuaries and a Member of the American Academy of Actuaries. Prior to joining Federal Life, Mr. Austin served in actuarial, administrative and marketing positions and on the Board of Directors of several other life insurance companies as well as serving as an expert consultant to the U.S. Post Office Department.
William S. Austin has been employed with the Company since 1990 and a member of the Board of Directors since 1992. He has served as President and Chief Operating Officer since 2002. Mr. Austin is a graduate of Marquette University and has an M.B.A. degree in Finance, Investments and Banking from the University of Wisconsin-Madison. Mr. Austin is a Chartered Life Underwriter and a member of the Society of Financial Services Professionals.
Michael Austin has been employed with the Company since 1982 and a member of the Board of Directors since 1992. He has served as Executive Vice President and Chief Marketing Officer since 2000. Mr. Austin attended Western Illinois University. He holds a FINRA Series 6 and Broker-Dealer Agency license with FED Mutual Financial Services, Inc. (a subsidiary of Federal Life Insurance Company) and also holds a producer's license for life and casualty insurance in the State of Illinois. Mr. Austin is responsible for marketing of the Company.
Anders Raaum has been employed with the Company since 1994 and has served as Chief Financial Officer since 2011. Mr. Raaum has a B.A. degree in Business Administration from the University of Oregon and an M.B.A. degree in Finance, Investments and Banking from the University of Wisconsin-Madison and is a Chartered Financial Analyst and a Chartered Life Underwriter. He is also a registered FINRA Full Registration/General Securities Representative and a General Securities Principal with FED Mutual Financial Services, Inc. (a subsidiary of Federal Life Insurance Company. Mr. Raaum is responsible for overseeing the invested assets of Federal Life and well as all accounting functions and regulatory reporting for the Company.
Paul R. Murphy has been employed with the Company since 2002 as its Actuary. He has a B.S. degree in Mathematics Education and a Master of Science degree in Mathematics from the University of Illinois and is a Fellow of the Society of Actuaries, a Member of the American Academy of Actuaries and a Fellow of the Life Management Institute. Mr. Murphy is responsible for actuarial functions for Federal Life and serves as the Appointed Actuary and Illustration Actuary for the Company.
RP Financial, LC.
Page 1.13
Plan of Conversion
As a mutual insurance holding company, FLMHC does not have shareholders. It has members. The members of the FLMHC are the policyholders of Federal Life. On March 8, 2018, the Board of Directors of the FLMHC unanimously adopted the Plan of Conversion, subject to the approval of the Illinois Department of Insurance and the members of FLMHC.
The Plan of Conversion provides for the conversion of Federal Life Mutual Holding Company, a mutual holding company organized under the laws of Illinois (such entity, both before and after the Conversion, being referred to as “FLMHC”), from a mutual holding company into a stock company, and the issuance by FLMHC of newly-issued shares of common stock of FLMHC to FLG pursuant to the Illinois Insurance Code. The Plan of Conversion provides that FLG will offer shares of its common stock for sale in a subscription offering to eligible members of FLMHC, and the directors, officers, and employees of FLMHC. In addition, the Company may elect to offer the shares of common stock not subscribed for in the subscription offering, if any, for sale in a community offering commencing during or upon completion of the subscription offering and in a subsequent syndicated community offering. An identified standby investor, Insurance Capital Group, LLC. (“ICG”) has entered into a Standby Purchase Agreement (the “Agreement”), to purchase in the community offering all unsold shares in the offering up to at least the minimum of the valuation range subject to certain restrictions on their acquisition, sale, and voting of the common stock.
Upon completion of the Conversion, all of the outstanding shares of common stock of FLMHC will be issued to FLG. FLG will be the first-tier parent of FLMHC which will wholly-own Federal Life. The Conversion will be effected only if the orders received in the subscription and community offerings equal or exceed at least the minimum of the Valuation Range and the members of the MHC approve the Plan of Conversion. The Conversion will be accounted for as a simultaneous reorganization, recapitalization, and share offering that will not change the historical accounting basis of FLMHC’s consolidated financial statements.
After paying its expenses and commissions related to the Conversion, FLG will retain a majority of the proceeds of the Offering after downstreaming $12.5 million of the proceeds to Federal Life. The net proceeds infused into Federal Life will supply additional capital that Federal Life needs to support future premium growth, including the expansion of the Company’s producer networks and the marketing of its products. On a short-term basis, the net proceeds will be invested primarily in U.S. Government securities, other federal agency securities, and other corporate and asset-backed securities consistent with the Company’s investment policy.
RP Financial, LC.
Page 1.14
The principal purpose of the Conversion as articulated in the Plan is to create a stock holding company to enhance its strategic and financial flexibility and to provide the Eligible Members with the right to acquire an equity interest in FLG. The Board has indicated its belief that the additional capital resulting from the Conversion would result in the following:
· | Support further organic growth in life insurance premiums written and annuity deposits; |
· | Provide the capital necessary to permit increased sales of life insurance and annuities by Federal Life; |
· | Enable FLG to attract institutional investors and engage in strategic transactions advantageous to FLG and its subsidiaries; and |
· | The Board further believes that the transaction is fair and equitable, is consistent with the purpose and intent of Section 59.1 and will not prejudice the interests of the Members. |
Financial Overview
This valuation analysis is based on Federal Life’s historical financial statements and operations up through September 30, 2017. The financial data presentation for Federal Life in the tables below and incorporated by reference in Exhibit I-1 is based on United States generally accepted accounting principles (“GAAP”). Statutory financial data for Federal Life is included in Exhibit I-2 to provide a more lengthy presentation of the Company’s operating trends, notwithstanding the significant differences between GAAP and the statutory financial presentation. Table 1.6 presents Federal Life’s balance sheet for the fiscal years ended December 31, 2015 and 2016, and as of September 30, 2017, presented in accordance with GAAP.
Growth Trends
The Company balance sheet has remained relatively stable reflecting limited change in Federal’s Life’s operations as the Company has restricted growth in the face of on-going operating losses. Fixed maturity investment securities, which comprise the majority of the asset base, increased from $173.2 million as of December 31, 2015, to $182.9 million as of September 30, 2017, which was partially offset by a reduction in equity securities from $10.2 million as of December 31, 2015, to $7.5 million as of September 30, 2017. The remaining balance of non- invested assets, consisted of various insurance and non-insurance related accruals, the largest of which were deferred policy acquisition costs and assets held in separate accounts, both of which increased modestly through the one and three-quarter year period ended September 30, 2017.
RP Financial, LC.
Page 1.15
Table 1.6
Federal Life Insurance Company
Historical Balance Sheets
As of the Fiscal Year Ended December 31, | As of | |||||||||||||||||||||||
2015 | 2016 | September 30, 2017 | ||||||||||||||||||||||
% of | % of | % of | ||||||||||||||||||||||
Amount | Assets | Amount | Assets | Amount | Assets | |||||||||||||||||||
($000) | (%) | ($000) | (%) | ($000) | (%) | |||||||||||||||||||
ASSETS | ||||||||||||||||||||||||
INVESTMENTS: | ||||||||||||||||||||||||
Available-for-sale | ||||||||||||||||||||||||
Fixed maturities, at fair value | $ | 173,161 | 71.87 | % | $ | 173,102 | 70.64 | % | $ | 182,937 | 71.01 | % | ||||||||||||
Equity securities, at fair value | 10,199 | 4.23 | % | 7,927 | 3.23 | % | 7,526 | 2.92 | % | |||||||||||||||
Policy loans | 10,129 | 4.20 | % | 10,059 | 4.11 | % | 9,937 | 3.86 | % | |||||||||||||||
Other invested assets | - | 0.00 | % | 2,059 | 0.84 | % | 2,208 | 0.86 | % | |||||||||||||||
Short-term investments | 4,987 | 2.07 | % | 5,548 | 2.26 | % | 4,868 | 1.89 | % | |||||||||||||||
Total investments | $ | 198,476 | 82.37 | % | $ | 198,695 | 81.09 | % | $ | 207,476 | 80.53 | % | ||||||||||||
OTHER ASSETS: | ||||||||||||||||||||||||
Cash | $ | 1,567 | 0.65 | % | $ | 2,719 | 1.11 | % | $ | 1,602 | 0.62 | % | ||||||||||||
Real Estate | 1,882 | 0.78 | % | 1,987 | 0.81 | % | 1,915 | 0.74 | % | |||||||||||||||
Accrued investment income | 1,951 | 0.81 | % | 1,827 | 0.75 | % | 1,905 | 0.74 | % | |||||||||||||||
Accounts receivable | 552 | 0.23 | % | 575 | 0.23 | % | 2,722 | 1.06 | % | |||||||||||||||
Reinsurance recoverable | 411 | 0.17 | % | 3,526 | 1.44 | % | 3,680 | 1.43 | % | |||||||||||||||
Prepaid reinsurance premiums | 103 | 0.04 | % | 924 | 0.38 | % | 1,097 | 0.43 | % | |||||||||||||||
Deferred policy acquisition costs, net | 11,605 | 4.82 | % | 11,938 | 4.87 | % | 12,048 | 4.68 | % | |||||||||||||||
Deferred sales inducement costs | 13 | 0.01 | % | 314 | 0.13 | % | 754 | 0.29 | % | |||||||||||||||
Income taxes recoverable | - | 0.00 | % | - | 0.00 | % | - | 0.00 | % | |||||||||||||||
Deferred tax asset | 487 | 0.20 | % | 457 | 0.19 | % | 460 | 0.18 | % | |||||||||||||||
Property and equipment | 343 | 0.14 | % | 310 | 0.13 | % | 229 | 0.09 | % | |||||||||||||||
Other Assets | 227 | 0.09 | % | 254 | 0.10 | % | 196 | 0.08 | % | |||||||||||||||
Assets held in separate accounts | 23,335 | 9.68 | % | 21,513 | 8.78 | % | 23,554 | 9.14 | % | |||||||||||||||
TOTAL ASSETS | $ | 240,952 | 100.00 | % | $ | 245,039 | 100.00 | % | $ | 257,638 | 100.00 | % | ||||||||||||
LIABILITIES & EQUITY | ||||||||||||||||||||||||
LIABILITIES: | ||||||||||||||||||||||||
Policy liabilities and accruals: | ||||||||||||||||||||||||
Policyholder account balance | $ | 94,691 | 39.30 | % | $ | 99,440 | 40.58 | % | $ | 107,090 | 41.57 | % | ||||||||||||
Future life policy benefits | 72,760 | 30.20 | % | 73,097 | 29.83 | % | 72,155 | 28.01 | % | |||||||||||||||
Future life and accident and health policy benefits | 146 | 0.06 | % | 90 | 0.04 | % | 89 | 0.03 | % | |||||||||||||||
Resrve for deposit type contracts | 10,039 | 4.17 | % | 10,529 | 4.30 | % | 10,726 | 4.16 | % | |||||||||||||||
Other policyholder funds | 1,806 | 0.75 | % | 1,889 | 0.77 | % | 5,243 | 2.04 | % | |||||||||||||||
Unearned premium | 1,234 | 0.51 | % | 1,396 | 0.57 | % | 1,383 | 0.54 | % | |||||||||||||||
Taxes payable | 64 | 0.03 | % | 5 | 0.00 | % | 5 | 0.00 | % | |||||||||||||||
Deferrred tax liability | 5 | 0.00 | % | 6 | 0.00 | % | 7 | 0.00 | % | |||||||||||||||
Other liabilities | 1,380 | 0.57 | % | 1,137 | 0.46 | % | 1,145 | 0.44 | % | |||||||||||||||
Separate accounts | 23,335 | 9.68 | % | 21,513 | 8.78 | % | 23,554 | 9.14 | % | |||||||||||||||
TOTAL LIABILITIES | $ | 205,460 | 85.27 | % | $ | 209,102 | 85.33 | % | $ | 221,397 | 85.93 | % | ||||||||||||
Equity | ||||||||||||||||||||||||
Common stock | $ | 0 | 0.00 | % | $ | 2,500 | 1.02 | % | $ | 2,500 | 0.97 | % | ||||||||||||
Retained earnings | $ | 29,576 | 12.27 | % | $ | 27,924 | 11.40 | % | $ | 26,779 | 10.39 | % | ||||||||||||
Accumulated other comprehensive income | 5,916 | 2.46 | % | 5,513 | 2.25 | % | 6,962 | 2.70 | % | |||||||||||||||
TOTAL EQUITY | $ | 35,492 | 14.73 | % | $ | 35,937 | 14.67 | % | $ | 36,241 | 14.07 | % | ||||||||||||
TOTAL LIABILITIES & EQUITY | $ | 240,952 | 100.00 | % | $ | 245,039 | 100.00 | % | $ | 257,638 | 100.00 | % |
Source: Federal Life's and subsidiaries unaudited GAAP adjusted financial statements.
RP Financial, LC.
Page 1.16
Liabilities have remained between 85% and 86% of assets since the end of fiscal 2015. Policyholder account balances have increased reflecting in part, the normal variances typically observed in the accounts. Other liabilities including reserves for future policy benefits and liabilities related to annuities sold remained relatively stable.
Total equity remained relatively stable since the end of fiscal 2015 as retained earnings diminished because of the ongoing operating losses as well as the mutual holding company restructuring which resulted in the upstreaming of capital to the MHC which was subsequently down streamed to the Company as a credit to common stock. Stability of the capital base in the face of operating losses reported by Federal Life was supported by increases in the value of the investment portfolio, which positively impacted the balance of accumulated other comprehensive income (“AOCI”).
The following discussion addresses the major balance sheet items in terms of characteristics, composition and trends.
Investment Securities
Investment decisions for the fixed income portfolio are made by management. Investment management advisory services are provided by Deutsche Asset Management (“Deutsche”) with respect to structured products such as residential mortgage backed securities, commercial mortgage backed securities, asset backed securities, and non-investment grade corporate bonds. Deutsche Asset Management is a leading global asset manager that offers investment services across all asset classes to a variety of individual and institutional clients, including insurance companies. Investment purchases and sales for the defined sectors are made by Deutsche within the parameters established by the Company’s investment guidelines and with prior notification of the Company’s management team. Other investments, primarily exchange traded stock fund investments (“ETFs”), are managed by the Company’s senior management with the assistance of Alley Company, LLC.
RP Financial, LC.
Page 1.17
Federal Life’s investment policy is conservative and has placed primary emphasis on capital preservation and the maintenance of liquidity appropriate for the current and long-term requirements of the Company. The Company’s primary investment objective is to earn a sustainable positive risk-adjusted, after-tax total rate of return on invested assets. Specifically, the structure and composition of the portfolio will seek to complement all aspects of the insurance operations including, but not limited to, liquidity requirements, cash flow, taxation, risk tolerance, and the applicable regulatory directives governing investment activity. The process of policy implementation is meant to be flexible so that the assets of the Company can be invested in a prudent manner under any normal business cycle or market condition which can be reasonably anticipated.
In conforming with the Company’s investment policy, fixed income securities must be rated BB- or higher by Standard & and Poor’s at the time of purchase, with such securities subject to issuer specific limitations by rating category, and overall limitations on investment amounts by rating category. There are various other requirements with respect to management of the investment portfolio detailed in the investment policy pertaining to issuer diversification, sector limitations, etc.
The composition of the investment portfolio is set forth below as of September 30, 2017. As reflected in the data, more than 80% of the portfolio is comprised of corporate and mortgage-backed securities. The average yield and duration of the portfolio as of September 30, 2017, was 3.11% and 6.24 years, respectively.
Type | Market Value | Market Yield | Duration | Market Value / Book Value | Unrealized Gain / Loss | |||||||||||||||
ABS | $ | 1,026 | 3.46 | % | 3.36 | 0.10 | % | $ | 6 | |||||||||||
MBS-Commercial | 4,914 | 3.43 | % | 7.02 | 0.10 | % | (22 | ) | ||||||||||||
MBS-Residential | 39,107 | 3.25 | % | 9.07 | 0.10 | % | 1,487 | |||||||||||||
Municipal | 16,846 | 3.23 | % | 7.24 | 0.10 | % | 763 | |||||||||||||
Corporate | 109,694 | 3.02 | % | 5.24 | 0.10 | % | 3,565 | |||||||||||||
Government Agy | 8,933 | 3.39 | % | 4.38 | 0.10 | % | (65 | ) | ||||||||||||
U. S. Treasury | 2,417 | 2.03 | % | 6.07 | 0.11 | % | 213 | |||||||||||||
Total Bonds | $ | 182,937 | 3.11 | % | 6.24 | 0.10 | % | $ | 5,946 |
RP Financial, LC.
Page 1.18
Historically, fixed-income investments have accounted for the majority of the Company’s investments portfolio. As of September 30, 2017, the was a small balance of equity securities investments ($7.5 million or 2.92% of assets) which consisted primarily of exchange- traded funds (“ETFs”).
Other Assets
Other assets totaled $50.1 million or 19.46% of assets. The largest component of other assets is investments underlying annuities sold by Federal Life, which are held in separate accounts. Deferred policy acquisition costs are also material and reflect the commissions paid to agents on long term insurance policies which are deferred and expensed over the estimated term of the policies. The remaining balance of other assets include operating and trade related accounts such as cash, reinsurance recoverables, prepaid reinsurance premiums and accounts receivable. These balances fluctuate based on typical fluctuations in the Company’s insurance business and internal operations.
Policyholder Account Balances and Policy Benefits
The majority of the Company’s liabilities are comprised of obligations to policyholders. In this regard, policyholder account balances representing the cash surrender value of the policies, totaled $107.1 million, or 41.57% of assets, as of September 30, 2017. Reserves for future life insurance benefits of policy holders was also material, totaling $72.2 million, equal to 28.01% of total assets.
Other Liabilities
Other liabilities consisted primarily of reserves for deposit-type contracts and liabilities for funds due to annuity holders. The remaining balance of other liabilities include operating and trade related accounts such as liabilities for separate accounts, policyholder funds and various accrued liabilities. These balances fluctuate based on typical fluctuations in the Company’s insurance business and internal operations.
Equity
The balance of GAAP equity has remained relatively stable in a range of $35.5 million to $36.2 million since December 31, 2015. A portion of retained earnings was reallocated as a result of the MHC reorganization to common stock while AOCI has increased to offset the impact of operating losses. The conversion and issuance of stock will substantially bolster the Company’s capital position and provide the capital resources required for the Company to implement a growth oriented business plan. In this regard, the infusion of the conversion proceeds will bolster the Company’s capital resources on both a GAAP and statutory basis.
RP Financial, LC.
Page 1.19
Income and Expense Trends
The Company has been reporting operating losses on a GAAP basis for more than a decade, which management attributes to a high level of competition in the traditional markets for life insurance and annuity products. Specifically, Federal Life’s small size and resulting high cost structure have resulted in operating losses for the last decade. Moreover, the erosion of the statutory surplus has eroded the ability to introduce products and services which, while entailing a significant upfront cost to develop and market, could provide enhanced revenues and earnings over the long term. Additionally, the low interest rate environment has diminished net investment income on investment assets used to provide guaranteed benefits to policyholders.
The Company’s losses are reflected in Table 1.7, which provides historical income statements for fiscal 2016 and for the nine months ended September 30, 2017. The ratios presented reflect revenues and expenses as a percent of both average assets and revenues for the periods depicted, with the ratios expressed as a percent of asset reflecting annualized nine month results for the period ended September 30, 2017.
Overall, the Company reported a loss equal to $2.0 million in fiscal 2016, and $1.1 million for the nine months ended September 30, 2017. The fiscal 2016 loss equaled 0.81 percent of assets and 7.7 percent of revenues. Over the nine months ended September 30, 2017, losses equaled 0.56 percent of assets on an annualized basis and 6.2% of revenues for the corresponding period.
Net Premiums Earned
Premiums on life insurance policies comprise the largest component of revenues, and equaled $14.9 million (58.03% of revenues) in fiscal 2016 and $9.7 million (54.3% of revenues) for the first nine months of fiscal 2017. The substantial majority of the Company’s premium revenues is derived through the sale of Federal Life’s insurance and annuity products.
RP Financial, LC.
Page 1.20
Table 1.7
Federal Life Insurance Company
Historical Income Statements as a Percent of Average Assets
For the Fiscal Year Ended | For the Nine Months Ended | |||||||||||||||||||||||
December 31, 2016 | September 30, 2017 | |||||||||||||||||||||||
% of Avg | % of | % of Avg. | % of | |||||||||||||||||||||
Amount | Assets | Revenues | Amount | Assets (1) | Revenues | |||||||||||||||||||
($000) | (%) | (%) | ($000) | (%) | (%) | |||||||||||||||||||
REVENUES: | ||||||||||||||||||||||||
Premiums | $ | 14,879 | 6.12 | % | 58.03 | % | $ | 9,698 | 4.86 | % | 54.30 | % | ||||||||||||
Net investment income | 8,797 | 3.62 | % | 34.31 | % | 6,326 | 3.17 | % | 35.42 | % | ||||||||||||||
Net realized capital gains | 1,783 | 0.73 | % | 6.95 | % | 1,697 | 0.85 | % | 9.50 | % | ||||||||||||||
Miscellaneous income | 179 | 0.07 | % | 0.70 | % | 138 | 0.07 | % | 0.77 | % | ||||||||||||||
Total revenues | $ | 25,638 | 10.55 | % | 100.00 | % | $ | 17,859 | 8.94 | % | 100.00 | % | ||||||||||||
EXPENSES: | ||||||||||||||||||||||||
Policyholder benefits | $ | 18,645 | 7.67 | % | 72.72 | % | $ | 12,577 | 6.30 | % | 70.42 | % | ||||||||||||
Interest credited to policyholders | 315 | 0.13 | % | 1.23 | % | 330 | 0.17 | % | 1.85 | % | ||||||||||||||
Operating Costs and expenses | 7,809 | 3.21 | % | 30.46 | % | 5,441 | 2.72 | % | 30.47 | % | ||||||||||||||
Taxes, licenses and fees | 722 | 0.30 | % | 2.82 | % | 554 | 0.28 | % | 3.10 | % | ||||||||||||||
Total Benefits and Expenses | 27,491 | 11.31 | % | 107.23 | % | 18,902 | 9.46 | % | 105.84 | % | ||||||||||||||
INCOME (LOSS) BEFORE DIVIDENDS TO POLICY HOLDERS AND INCOME TAXES | $ | (1,853 | ) | -0.76 | % | -7.23 | % | $ | (1,043 | ) | -0.52 | % | -5.84 | % | ||||||||||
DIVIDENDS TO POLICY HOLDERS | 86 | 0.04 | % | 0.34 | % | 49 | 0.02 | % | 0.27 | % | ||||||||||||||
INCOME (LOSS) BEFORE INCOME TAXES | $ | (1,939 | ) | -0.80 | % | -7.56 | % | $ | (1,092 | ) | -0.55 | % | -6.11 | % | ||||||||||
INCOME TAX (BENEFIT) PROVISION: | $ | 32 | 0.01 | % | 0.12 | % | $ | 18 | 0.01 | % | 0.10 | % | ||||||||||||
NET INCOME | $ | (1,971 | ) | -0.81 | % | -7.69 | % | $ | (1,110 | ) | -0.56 | % | -6.22 | % |
(1) Reflects annualized ratio.
Source: Federal Life's and subsidiaries unaudited GAAP adjusted financial statements.
RP Financial, LC.
Page 1.21
Investment Income
Investment income consists of dividends and interest earned on invested assets. As previously noted, investment income has been declining over time as the higher yielding investments have matured with the proceeds reinvested into securities with relatively low interest rates consistent with the prevailing market. Investment income equaled $8.8 million (34.3% of revenues) in fiscal 2016 and $6.3 million (35.4% of revenues) for the first nine months of fiscal 2017.
Other Income
Other income, outside of policies revenues and investment income, has been a relatively minor contributor to the earnings of the Company for the period of time shown in Table 1.7 and primarily consisted of realized capital gains on the sale of investments and other miscellaneous revenue sources.
Policyholder Benefits
Benefit expenses related to policyholder claims represent the largest component of expenses, equaling $12.6 million, or 70.4% of revenues. Life and annuity policy liabilities are developed by actuarial methods and are intended to provide, in the aggregate, reserves that are greater than, or equal to, the minimum or guaranteed policy cash values or the amounts required by law.
Operating Costs and Expenses
Operating and administrative expenses consist of the administrative expenses directly related to underwriting insurance and the ancillary activities of the Company. Federal Life has sought to limit the growth of operating expenses with the objective of stemming the recent operating losses. In this regard, the Company has reduced staffing and sought to minimize other controllable costs without impacting revenues. Additionally, the Company has held off on revenue producing initiatives, such as introducing alternative variable annuity products given their upfront costs. Operating costs and expenses totaled $7.8 million (30.5% of revenues) in fiscal 2016, and $5.4 million (30.5% of revenues) for the nine months ended September 30, 2017.
RP Financial, LC.
Page 1.22
Income Taxes
As of September 30, 2017, Federal Life had net operating loss carryforwards (“NOLs”) available to offset future taxable income totaling $28.6 million with expirations extending out for 15 years through 2032. As of September 30, 2017 the Company had a deferred tax asset (“DTA”) related to the NOL equal to $9.7 million, but only carried a net deferred tax asset of $0.5 million as an admitted asset on its balance sheet. The value of the DTA will be affected by any future changes in the corporate tax rate and could be further limited by IRS rules related to change in ownership. Management has indicated that the ability of the Company to utilize NOL’s to offset taxable income in the future might be subject to an annual “382 limitation” of approximately $0.7 million, depending on the pre-sale value of the Company. Moreover, the ability to utilize the NOLs will be subject to the Company’s plans to implement a growth oriented business plan and generate taxable income.
Potential Off Balance Sheet Value
The Company has several assets that management estimates may have value beyond the historical cost as reflected on the balance sheet. In this regard, Federal Life’s headquarters office in Riverwoods, Illinois had a de minimus net book value as the building was fully depreciated as of September 30, 2017. The tax value is in the range of $5.5 million, and management has indicated that the value could be higher in a market sale transaction. Alternatively, the office could be divided with a portion of the spaced leased to a tenant.
In addition to the foregoing, the Company’s wholly owned subsidiary Americana Realty Company owns mineral rights on land primarily in Texas and Oklahoma that has generated an average of approximately $875,000 in annual bonus and royalty payments over the past five years. These mineral rights have been fully depleted and have a zero book value on Americana’s balance sheet. Management believes that the sale of these mineral rights could yield significant value.
Importantly, management has indicated no current intent to undertake any of the foregoing strategies to monetize the unrealized value in the main office building or the mineral rights it owns. Additionally, some of the benefits of such unrealized values are realized through operations, in terms of the relatively low occupancy costs and revenues from the mineral rights.
RP Financial, LC.
Page 1.23
Legal Proceedings
Other than the routine legal proceedings that occur in the Company’s ordinary course of business, the Company is not involved in litigation that is expected to have a material impact on financial condition or operations.
RP Financial, LC.
Page 2.1
II. EXTERNAL ENVIRONMENT
Introduction
As the U.S. economy continues its steady post-recession recovery, the gap between small and large insurance companies is projected to widen. Many segments of the insurance industry are highly cyclical and subject to intense competition, particularly in Federal Life’s more significant markets in the Midwest and in the life and annuity insurance product segments. While life insurance ownership amongst U.S. households has increased steadily over the years, the mix has shifted towards employer-based plans in recent years, driven by population growth, reductions in unemployment and increased corporate profitability. Going forward, industry analysts expect that many life insurers will see greater demand for simple products, particularly whole life insurance, as individuals flee to greater levels of safety in today’s volatile financial environment. Another important external factor critical to Federal Life’s business is the current low interest rate environment that has caused bond yields to plummet to historical lows and limited investment income for all insurers. Other factors impacting life insurers include the changing regulatory landscape, evolving customer expectations and the looming threat of technology start-ups entering the life insurance market. In summary, the major factors that will influence Federal Life’s business during 2017-2018 include: national economic factors, customer expectations, regulatory matters, and competition. These topics are further discussed below.
National Economic Trends
Profitability for Federal Life and the life insurance industry will be significantly affected by investment returns and the strength and health of the economy, which may impact demand for insurance products. In assessing national economic trends over the past quarter, manufacturing activity decelerated in July 2017, based on readings of 56.3 and 53.9, respectively. The U.S. economy added 209,000 jobs in July and the July unemployment rate fell to 4.3%. Housing starts for July declined 4.8%, while new and existing home sales also fell in July decreasing by 9.4% and 1.3%, respectively. Durable-goods orders declined 6.8% in July, which was driven by a drop in aircraft orders. Excluding aircraft orders, July durable-goods orders were up 0.5%. Economic activity in the manufacturing and service sectors expanded at faster rates in August, based on respective readings of 58.8 and 55.3. The U.S. economy added 156,000 jobs in August and the August unemployment rate ticked up to 4.4%. Housing data for August showed a slight slowdown compared to July, as August housing starts fell 0.8%, existing home sales slipped 1.7% and new home sales decreased 3.4%. Manufacturing activity for September reached a 13-year high, with a reading of 60.8. Similarly, the September service sector activity reading of 59.8 was a 12-year high. The U.S. economy lost 33,000 jobs in September, reflecting the impact of hurricanes Harvey and Irma. The September unemployment rate fell to a post-crisis low of 4.2%. Sales of existing homes edged up 0.7% in September, while new home sales for September surged 18.9%. Indications that the U.S. economy was gaining momentum was provided by a 2.2% increase in September durable- goods orders and GDP increased at a 3.0% annual rate in the third quarter.
RP Financial, LC.
Page 2.2
Manufacturing activity for October 2017 expanded at a slightly lower rate compared to September, with a reading of 58.7. Comparatively, service sector activity accelerated in October to a reading of 60.1, its highest reading since August 2005. The unemployment rate for October declined to a 17-year low of 4.1%, as U.S. employers added 261,000 jobs in October.
The upward trend in long-term Treasury yields continued at the start of the third quarter of 2017, which was followed by a slight decline in long-term Treasury yields in the second half of July. The Federal Reserve elected to hold rates steady following its late-July policy meeting and signaled readiness to begin shrinking its bond holdings as soon as September 2017. Following a period of relatively stable interest rates through most of August, long-term Treasury yields trended lower in late-August through the first part of September. Factors contributing to the rally in Treasury bonds included warnings from Federal Reserve officials regarding low inflation and its impact on further rate increases, as well as a flight to safe-haven investments fueled by escalating tensions between the U.S. and North Korea. Long-term Treasury yields edged higher ahead of the Federal Reserve’s September meeting. The Federal Reserve concluded its September policy meeting leaving interest rates unchanged and indicated that it was on track to raise short-term interest rates later in 2017. The upward trend in long-term Treasury yields continued through the end of the third quarter.
Strong reports for September manufacturing and service sector activity contributed to sustaining the upward trend in long-term Treasury yields at the start of the fourth quarter of 2017. Comparatively, soft inflation data contributed to a rally in Treasury bonds in mid-October. Long-term Treasury yields moved higher during the second half of October, with the 10-year Treasury yield closing above 2.4% for the time in five months. Investors preparing for the Federal Reserve to back away from years of stimulus efforts was a noted factor contributing to the rise in Treasury yields. At the start of November, the Federal Reserve concluded its policy meeting leaving its target rate unchanged as expected. Treasury yields eased lower in early- November, as the nomination of Jerome Powell as the next Federal Reserve chairman eased some investors’ fears. As of November 8, 2017, the bond equivalent yields for U.S. Treasury bonds with terms of one and ten years equaled 1.53% and 2.32%, respectively, versus comparable year ago yields of 0.71% and 1.88%. Exhibit II-2 provides historical interest rate trends.
RP Financial, LC.
Page 2.3
Based on the consensus outlook of economists surveyed by The Wall Street Journal in October 2017, GDP growth was projected to increase to 2.4% in 2018. The unemployment rate was forecasted to equal 4.2% in December 2017 and then decline slightly to equal 4.1% in June 2018. An average of 161,000 jobs were projected to be added per month during 2017. On average, the economists forecasted an increase in the federal funds rate to 1.37% in December 2017 and then increase to 1.72% in June 2018. On average, the economists forecasted that the 10-year Treasury yield would increase to 2.46% in December 2017 and then increase to 2.76% in June 2017. The surveyed economists also forecasted home prices would rise 4.8% in 2018 and housing starts would continue to trend slightly higher in 2018.
Life Insurance Trends
Since 2010, the number of Americans with life insurance coverage has increased by approximately 0.5% to 172 million or approximately 53% the U.S. population. Coverage growth over this period can be attributed to enrollment in employer-based life insurance plans, which increased by 9 million persons from 2010 through 2016 (see chart below)
RP Financial, LC.
Page 2.4
Source: LIMRA
Despite the increase in persons with life insurance coverage, coverage amounts continue to be an issue. The mean life insurance coverage amount is currently $168,000, which translates to 3.4 years of income replacement – falling short of the industry recommended 7 years of income replacement. The observed shortfall in insurance coverage amounts is due in part, to relatively low coverage limits imposed by employer-based insurance plans, and a general lack of education regarding life insurance products. Among the 102 million Americans without life insurance coverage at the end of 2016, the primary reasons for not purchasing coverage include a belief that life insurance products are too expensive, and that other financial priorities such as living expenses, establishing savings, managing debt and/or saving for retirement take precedence. In addition, more than a quarter of Americans believe that they would not qualify for insurance, with almost half of millennial respondents without insurance coverage surveyed by LIMR, stating that they have never been approached by a life insurance agent.
The confluence of the aforementioned findings highlights the market opportunity for life insurers in the U.S. According to studies by LIMRA, a financial services consulting and research organization, a consumer centric approach will be key to growth for successful life insurance underwriters, with an emphasis on education and attentive customer service. With more than half of consumers surveyed by the LIMRA, stating that they would have immediate or near immediate trouble paying living expenses if their primary wage earner died, life insurance agents must seek to counsel consumers on the benefits of life insurance as a source of income to cover final expenses, supplement wages and/or retirement income. As millennials age and establish families, their propensity for life insurance products increase accordingly. Winning the business of persons from this segment of the population, characterized by their prevalent use of smartphones and the internet, desire for transparency and instant gratification, will require higher levels of service that may include product innovation, increased focus on social media, and the use of mobile applications and online platforms.
RP Financial, LC.
Page 2.5
Technology will continue to shape the future of the industry, as innovators seek to develop new applications, thereby driving innovation and efficiencies. Industry advances include the use of artificial intelligence in process automation and underwriting decisions, in turn providing consumers with rapid policy approval. Companies leveraging enterprise data will be better positioned to drive product innovation, as such technologies will allow insurers to optimize product offerings to better suit consumer needs, in addition to generating cross-sales.
Regulatory Environment
The current regulatory environment and pending legislation have the potential to impact the life insurance industry as well as Federal Life on many different levels. The Department of Labor fiduciary rules, issued on April 2016, are changing the way in which insurance companies and their agent networks operate. The rule demands that financial professionals, specifically those recommending or soliciting retirement plans or products (defined-contribution plans, defined-benefit plans and IRAs), work in the best interest of their clients. Importantly, the fiduciary standard outlined in the rule indicates a level of accountability beyond the suitability standard previously required of agents and advisors. The suitability standard of old required that an investment recommendation be made to meet a client’s defined need and objectives. The fiduciary standard however, means that agents and advisors would be legally obligated to find and recommend the best possible investment for their clients based on their overall profile. In addition, agents or advisors seeking to continue working on commission will need to provide clients with a disclosure agreement, known as a Best Interest Contract Exemption (“BICE”), thereby clearly outlining all possible conflicts of interest that may exist, such as higher bonuses and commissions for specific product sales. In addition, all compensation received by agents or advisors must be quantified.
RP Financial, LC.
Page 2.6
The impact of the rule on the insurance industry is twofold, an increase in costs stemming from heightened compliance (the rule stipulates that BICE be supervised by a “Financial Institution”), and investment in due diligence efforts required of fiduciaries, along with a possible elimination of the commission-based compensation structure agents and advisors. Following an initial assessment of the rule, many insurance companies, have already begun moving towards a fee based compensation structure for their agents and advisors. Implementation of the rule however, has been delayed until June 2019 by the Trump Administration, to allow for a legal and economic review.
An increased national focus on cybersecurity, following several high-profile security breaches in recent months, is likely to attract government action at both the state and federal level. Recently proposed cybersecurity regulations from New York State, the Federal Reserve, the Office of the Comptroller of the Currency and the Federal Deposit Insurance Corporation serve as early indicators of the Trump Administration’s regulatory agenda. This will spell higher compliance costs for insurers, stemming from cyber risk audits, enterprise-wide training, and penetration testing, as digital transformation continues to gain hold within the industry, thereby increasing exposure to cybercrime.
Competition
Federal Life faces notable competition, including direct competition with insurers that primarily have a local, regional or national presence. The slow growth/declining population of Federal Life’s primary market area of Illinois, over the last several years has naturally had an effect on the economic and business environment, increasing competition for life insurers in the market.
Importantly the impact of the local market conditions is limited as Federal Life operates nationwide with the exception of the New England states. In addition, Federal Life, like many other life insurers, has a significant focus on annuities, a space in which many asset managers. Table 2.1 lists the largest competitors by market share in Federal Life’s top 5 markets, based on 2016 direct premiums written.
RP Financial, LC.
Page 2.7
Table 2.1
Federal Life
Market Share
2016 | 2016 | |||||||||||
Institution | Rank | State Direct Premiums & Annuity Considerations ($000) | Market Share (%) | |||||||||
Illinois - Total Life | ||||||||||||
Prudential Financial Inc. (SNL Life Group) | 1 | 1,696,732 | 8.0 | |||||||||
Massachusetts Mutl Life Ins Co (SNL Life Group) | 2 | 1,106,999 | 5.3 | |||||||||
Northwestern Mutl Life Ins Co. (SNL Life Group) | 3 | 912,527 | 4.3 | |||||||||
Principal Financial Group Inc. (SNL Life Group) | 4 | 838,287 | 4.0 | |||||||||
Jackson (SNL Life Group) | 5 | 815,382 | 3.9 | |||||||||
John Hancock (SNL Life Group) | 6 | 802,241 | 3.8 | |||||||||
Voya Financial Inc. (SNL Life Group) | 7 | 760,166 | 3.6 | |||||||||
New York Life (SNL Life Group) | 8 | 727,242 | 3.5 | |||||||||
American International Group (SNL Life Group) | 9 | 708,066 | 3.4 | |||||||||
AEGON (SNL Life Group) | 10 | 703,337 | 3.3 | |||||||||
Federal Life Insurance Co. | 94 | 9,906 | 0.1 | |||||||||
Total Life Premiums in Market | 21,100,314 | |||||||||||
Ohio - Total Life | ||||||||||||
Western & Southern Financial (SNL Life Group) | 1 | 3,257,094 | 15.1 | |||||||||
Prudential Financial Inc. (SNL Life Group) | 2 | 1,130,026 | 5.3 | |||||||||
Nationwide Mutual Group (SNL Life Group) | 3 | 1,037,672 | 4.8 | |||||||||
Voya Financial Inc. (SNL Life Group) | 4 | 856,789 | 4.0 | |||||||||
Jackson (SNL Life Group) | 5 | 822,454 | 3.8 | |||||||||
Massachusetts Mutl Life Ins Co (SNL Life Group) | 6 | 729,614 | 3.4 | |||||||||
New York Life (SNL Life Group) | 7 | 707,685 | 3.3 | |||||||||
Lincoln Financial (SNL Life Group) | 8 | 654,177 | 3.0 | |||||||||
John Hancock (SNL Life Group) | 9 | 619,977 | 2.9 | |||||||||
American International Group (SNL Life Group) | 10 | 618,054 | 2.9 | |||||||||
Federal Life Insurance Co. | 118 | 2,370 | 0.0 | |||||||||
Total Life Premiums in Market | 21,522,121 | |||||||||||
California - Total Life | ||||||||||||
Prudential Financial Inc. (SNL Life Group) | 1 | 3,986,735 | 7.8 | |||||||||
AEGON (SNL Life Group) | 2 | 3,060,243 | 6.0 | |||||||||
New York Life (SNL Life Group) | 3 | 2,862,496 | 5.6 | |||||||||
John Hancock (SNL Life Group) | 4 | 2,365,467 | 4.6 | |||||||||
American International Group (SNL Life Group) | 5 | 2,316,407 | 4.5 | |||||||||
Massachusetts Mutl Life Ins Co (SNL Life Group) | 6 | 2,158,317 | 4.2 | |||||||||
Voya Financial Inc. (SNL Life Group) | 7 | 2,011,980 | 3.9 | |||||||||
Jackson (SNL Life Group) | 8 | 1,954,043 | 3.8 | |||||||||
Lincoln Financial (SNL Life Group) | 9 | 1,925,509 | 3.8 | |||||||||
Nationwide Mutual Group (SNL Life Group) | 10 | 1,748,029 | 3.4 | |||||||||
Federal Life Insurance Co. | 132 | 2,003 | 0.0 | |||||||||
Total Life Premiums in Market | 51,315,483 | |||||||||||
Florida - Total Life | ||||||||||||
American International Group (SNL Life Group) | 1 | 2,115,923 | 6.3 | |||||||||
AEGON (SNL Life Group) | 2 | 2,046,986 | 6.1 | |||||||||
Prudential Financial Inc. (SNL Life Group) | 3 | 1,846,866 | 5.5 | |||||||||
Nationwide Mutual Group (SNL Life Group) | 4 | 1,723,117 | 5.1 | |||||||||
Lincoln Financial (SNL Life Group) | 5 | 1,620,467 | 4.8 | |||||||||
New York Life (SNL Life Group) | 6 | 1,370,578 | 4.1 | |||||||||
Massachusetts Mutl Life Ins Co (SNL Life Group) | 7 | 1,305,471 | 3.9 | |||||||||
Jackson (SNL Life Group) | 8 | 1,225,869 | 3.6 | |||||||||
John Hancock (SNL Life Group) | 9 | 1,209,279 | 3.6 | |||||||||
Voya Financial Inc. (SNL Life Group) | 10 | 1,073,527 | 3.2 | |||||||||
Federal Life Insurance Co. | 142 | 1,254 | 0.0 | |||||||||
Total Life Premiums in Market | 33,634,825 | |||||||||||
Texas - Total Life | ||||||||||||
American International Group (SNL Life Group) | 1 | 3,012,599 | 9.0 | |||||||||
New York Life (SNL Life Group) | 2 | 1,642,642 | 4.9 | |||||||||
Prudential Financial Inc. (SNL Life Group) | 3 | 1,368,211 | 4.1 | |||||||||
Voya Financial Inc. (SNL Life Group) | 4 | 1,247,832 | 3.7 | |||||||||
Lincoln Financial (SNL Life Group) | 5 | 1,234,451 | 3.7 | |||||||||
Allianz Group (SNL Life Group) | 6 | 1,189,602 | 3.6 | |||||||||
Jackson (SNL Life Group) | 7 | 1,160,386 | 3.5 | |||||||||
AEGON (SNL Life Group) | 8 | 1,141,780 | 3.4 | |||||||||
John Hancock (SNL Life Group) | 9 | 1,109,000 | 3.3 | |||||||||
Massachusetts Mutl Life Ins Co (SNL Life Group) | 10 | 1,102,403 | 3.3 | |||||||||
Federal Life Insurance Co. | 168 | 1,087 | 0.0 | |||||||||
Total Life Premiums in Market | 33,555,061 |
RP Financial, LC.
Page 3.1
III. PEER GROUP ANALYSIS
The applicable valuation technique is the pro forma market value approach, whereby the pro forma market value of Federal Life is derived from the market pricing of a group of publicly- traded insurance companies sharing reasonably comparable characteristics. This section presents an analysis of Federal Life’s operations versus a group of comparable companies (the “Peer Group”) selected from the universe of all publicly-traded insurance companies which share reasonably comparable characteristics with the Company. Factors affecting the Company’s pro forma market value, such as financial condition and operating performance, and liquidity of the stock, can be assessed in relation to the Peer Group. Current market pricing of the Peer Group, subject to adjustments to account for fundamental differences between Federal Life and the Peer Group, will then be used as a basis for the valuation of Federal Life’s to-be- issued common stock.
Peer Group Selection
We consider the appropriate Peer Group to be of publicly-traded companies with established markets for common stock (NASDAQ, NYSE, AMEX and OTC Bulletin Board/Pink Sheets). We believe companies trading outside of these markets are frequently highly irregular in terms of frequency of trading and/or pricing and as a result, the trading activity may not be a reliable indicator of market value. We have excluded from the Peer Group those companies under acquisition and/or those companies whose market prices appear to be distorted by speculative factors or unusual operating conditions.
Ideally, the Peer Group should be comprised of similarly-sized publicly-traded insurance companies that have reasonably comparable financial characteristics and strategies as the Company. While there are many insurance companies with relatively small asset bases, smaller companies are usually not exchange-listed or are in mutual form. Thus, the peer group of publicly-traded companies selected for this analysis are generally significantly larger and more diversified than Federal Life. We also attempted to select Peer Group members whose business focus was on life insurance and annuity/savings products as these companies are subject to the same general market dynamics and pricing trends as the Company, which influences their stock prices and investor perceptions of value.
RP Financial, LC.
Page 3.2
Of the 24 companies composing the Public Life Insurance Group as of December 22, 2017, there were only seven insurers with a total market capitalization under $1 billion. The median market capitalization of the overall Public Life Insurance Group was $4.3 billion and the average size was even larger at $10.5 billion, skewed by such large and well known life insurers as MetLife, Prudential and AFLAC. We applied the following specific selection criteria and focused principally on companies with market capitalization of less than $1 billion and total assets less than $5 billion, which were thus the most comparable to Federal Life:
· | Publicly traded – stock-form insurance company whose shares are traded on New York Stock Exchange, NYSE MKT, or NASDAQ Stock Market or in one of the over the counter markets. |
· | Market segment – Insurance underwriter whose primary market segment is listed as life insurance by SNL Financial. |
· | Not subject to acquisition |
· | Operations – We sought to include companies with either modest losses or earnings on a trailing 12 month basis; and |
· | Market capitalization – Less than $10 billion. |
Table 3.1 lists certain key characteristics of the Peer Group companies.
RP Financial, LC.
Page 3.3
Table 3.1
General Characteristics
Peer Group of Publicly-Traded Insurance Companies
Corporate | Primarily | |||||||
Ticker | Company | Headquarters | Exchange | Lines of Business | ||||
Federal Life Insurance Company | Riverwoods, IL | NA | Asset Accumulation, Life | |||||
AEL | American Equity Investment Life Holding Company | West Des Moines, IA | NYSE | Asset Accumulation, Life | ||||
CIA | Citizens, Inc. | Austin, TX | NYSE | Health, Life, Multi-Peril, Other P&C | ||||
CNO | CNO Financial Group, Inc. | Carmel, IN | NYSE | Asset Accumulation, Asset Management, Health, Life, Manage | ||||
FFG | FBL Financial Group, Inc. | West Des Moines, IA | NYSE | Asset Accumulation, Asset Management, Health, Life | ||||
IHC | Independence Holding Company | Stamford, CT | NYSE | Asset Accumulation, Health, Life, Managed Care | ||||
KCLI | Kansas City Life Insurance Company | Kansas City, MO | OTCQX | Accident & Health, Asset Accumulation, Life, Managed Care | ||||
NWLI | National Western Life Group, Inc. | Austin, TX | NASDAQ | Asset Accumulation, Life, Other L&H | ||||
SNFCA | Security National Financial Corporation | Salt Lake City, UT | NASDAQ | Asset Accumulation, Health, Life | ||||
UTGN | UTG, Inc. | Springfield, IL | OTC Pink | Asset Accumulation, Health, Life |
Source: S&P Global Market Intelligence and Federal Life's internal financials, as of September 30, 2017 for Federal Life and all other Companies.
RP Financial, LC.
Page 3.4
Table 3.1
General Characteristics
Peer Group of Publicly-Traded Insurance Companies
Trailing | ||||||||||||||||||||||
12 Months | As of 12/22/2017 | |||||||||||||||||||||
Total | Policy | Total | Common | Market | ||||||||||||||||||
Ticker | Company | Assets | Revenues | Revenues | Stock Price | Value | ||||||||||||||||
($Mil) | ($Mil) | ($Mil) | ($) | ($Mil) | ||||||||||||||||||
Federal Life Insurance Company (1) | $ | 258 | $ | 13 | $ | 24 | NA | NA | ||||||||||||||
AEL | American Equity Investment Life Holding Company | $ | 60,380 | $ | 230 | $ | 3,275 | $ | 32.13 | $ | 2,863 | |||||||||||
CIA | Citizens, Inc. | $ | 1,651 | $ | 199 | $ | 253 | $ | 7.48 | $ | 375 | |||||||||||
CNO | CNO Financial Group, Inc. | $ | 32,705 | $ | 2,641 | $ | 4,212 | $ | 24.87 | $ | 4,172 | |||||||||||
FFG | FBL Financial Group, Inc. | $ | 9,892 | $ | 311 | $ | 737 | $ | 71.80 | $ | 1,790 | |||||||||||
IHC | Independence Holding Company | $ | 1,039 | $ | 278 | $ | 317 | $ | 27.95 | $ | 415 | |||||||||||
KCLI | Kansas City Life Insurance Company | $ | 4,511 | $ | 292 | $ | 450 | $ | 45.10 | $ | 437 | |||||||||||
NWLI | National Western Life Group, Inc. | $ | 12,138 | $ | 181 | $ | 811 | $ | 337.03 | $ | 1,158 | |||||||||||
SNFCA | Security National Financial Corporation | $ | 1,008 | $ | 69 | $ | 288 | $ | 5.40 | $ | 82 | |||||||||||
UTGN | UTG, Inc. | $ | 405 | $ | 6 | $ | 21 | $ | 25.00 | $ | 83 |
(1) Revenues are annualized nine month results.
Source: S&P Global Market Intelligence and Federal Life's internal financials, as of September 30, 2017 for Federal Life and all other Companies.
RP Financial, LC.
Page 3.5
American Equity Investment Life Holding Company (“AEL”), based in West Des Moines, IA, issues fixed annuity and life insurance products through its wholly-owned life insurance subsidiaries, American Equity Investment Life Insurance Company, American Equity Investment Life Insurance Company of New York and Eagle Life Insurance Company. AEL has one business segment which represents its core business comprised of the sale of fixed index and fixed rate annuities and AEL business strategy is focused on growing policyholder funds and earning predictable returns by managing investment spreads and investment risk. AEL is licensed to sell its annuity products in 50 states and the District of Columbia, and marketing of the products is undertaken through a variable cost distribution network including, independent agents through national marketing organizations, broker/dealers, banks and registered investment advisors.
· | Citizens, Inc. (“CIA”) is an insurance holding company incorporated in Colorado serving the life insurance needs of individuals in the United States since 1969 and internationally since 1975. Through CIA’s insurance subsidiaries, CIA pursues a strategy of offering traditional insurance products in niche markets where its believes it is able to achieve competitive advantages. CIA’s core insurance operations include issuing and servicing: |
· | U.S. Dollar-denominated ordinary whole life insurance and endowment policies predominantly sold to foreign residents, located principally in Latin America and the Pacific Rim, through independent marketing consultants; |
· | Ordinary whole life insurance policies to middle income households concentrated in the Midwest, Mountain West and southern United States through independent marketing consultants; and |
· | Final expense and limited liability property policies to middle and lower income households in Louisiana, Mississippi and Arkansas through employee and independent agents in our home service distribution channel and funeral homes |
· | CNO Financial Group (“CNO”), based in Carmel, Indiana, is an insurance holding company. CNO’s insurance subsidiaries - principally Bankers Life and Casualty Company, Colonial Penn Life Insurance Company and Washington National Insurance Company - primarily serve middle-income pre-retiree and retired Americans by helping them protect against financial adversity and provide for a more secure retirement. CNO’s insurance subsidiaries develop, market and administer health insurance, annuity, individual life insurance and other insurance products with these products sold through three primary distribution channels: career agents, independent producers (some of whom sell one or more of our product lines exclusively) and direct marketing. CNO’s insurance subsidiaries collectively hold licenses to market our insurance products in all fifty states, the District of Columbia, and certain protectorates of the United States. |
RP Financial, LC.
Page 3.6
· | FBL Financial Group, Inc. (“FFG”) is an insurance holding company whose primary operating subsidiary, Farm Bureau Life Insurance Company, underwrites and markets a broad range of life insurance and annuities to individuals and businesses, which are distributed by multiline exclusive Farm Bureau agents. In addition, FBL Financial Group manages all aspects of two Farm Bureau affiliated property-casualty insurance companies for a management fee. Sales through the principal distribution channels are currently conducted in 15 states. FFG’s target market is Farm Bureau members and "Middle America." FFG has traditionally have been very strong in rural and small-town markets while having a growing presence in small and mid-metro markets. The financial needs of FFG’s target market/customer tend to focus on security, insurance needs and retirement savings. FBL Financial Group, is headquartered in West Des Moines, Iowa. |
· | Independence Holding Company (“IHC”), Stamford, CT is an insurance holding company that is principally engaged in underwriting, administering and/or distributing group and individual specialty benefit products, including disability, supplemental health, pet, and group life insurance through its subsidiaries since 1980. The IHC Group owns three insurance companies (Standard Security Life Insurance Company of New York, Madison National Life Insurance Company, Inc. and Independence American Insurance Company), and IHC Specialty Benefits, Inc., a technology-driven insurance sales and marketing company that creates value for insurance producers, carriers and consumers (both individuals and small businesses) through a suite of proprietary tools and products (including ACA plans and small group medical stop-loss). |
· | Kansas City Life Insurance Company (“KCLI”), was established in 1895 and is based in Kansas City, Missouri. KCLI’s primary business is providing financial protection through the sale of life insurance and annuities. Kansas City Life’s Individual Insurance segment provides financial security to consumers in 48 states. Life insurance products are distributed through two channels: the Company’s field force and through third-party marketing arrangements. The Individual Insurance segment consists of individual insurance products for both Kansas City Life and Sunset Life. Kansas City Life offers several insurance products in the Group Insurance segment, including dental, life, accident, vision, and short and long term disability. These offerings encompass both traditional, employer-funded group insurance, as well as voluntary, employee-paid products. The Group Insurance segment markets products primarily to small and mid-size organizations. Marketing is conducted through through sales representatives who target a nationwide network of independent general agents and group brokers, along with the Company’s career general agents. This sales network is this segment’s core distribution system. The Company also markets insurance products through third party alliances and marketing arrangements. |
· | National Western Life Group, Inc. (“NWLI”) is the insurance holding company of National Western Life Insurance Company (NWLIC). Founded in 1956, NWLIC is a stock life insurance company offering a broad portfolio of individual whole life, universal life and term insurance plans, and annuities, including supplementary riders. Products are offered to meet the financial needs of its customers in 49 states as well as residents of various international countries. NWLIC has 277 employees and approximately 30,100 contracted independent agents, brokers, and consultants. |
RP Financial, LC.
Page 3.7
· | Security National Financial Corporation (“SNFCA”) is based in Salt Lake City, Utah, and operates three main business segments: life insurance, funeral service and mortgage loans. SNFCA is designed and structured so each segment relates to the others, and contributes to the profitability of the whole. For example, the cemetery and mortuary operations enjoy a high level of public awareness, assisting in the sales and marketing of SNFCA’s insurance and preneed cemetery and funeral products. Security National Life Insurance Company in turn invests its assets in high quality mortgage loans. Thus, while each segment is a stand-alone profit center, this horizontal integration is strategically planned to improve profitability. Additionally, SNFCA actively pursues growth through acquisitions of life insurance companies and mortuaries, and through expanding its mortgage operations. |
The majority of domestic sales are SNFCA’s annuities. National Western markets and distributes its domestic products primarily through independent national marketing organizations ("NMOs"). These NMOs assist the company in recruiting, contracting, and managing independent agents. International applications are submitted on behalf of their clients by independent contractors, consultants and broker-agents, many of whom have been submitting policy applications to National Western for twenty or more years.
· | UTG, Inc (“UTGN”), a Delaware corporation, is a life insurance holding UTGN. UTGN’s dominant business is individual life insurance, which includes the servicing of existing insurance policies in force, the acquisition of other companies in the life insurance business and the administration and processing of life insurance business for other entities. UTGN’s product portfolio consists of a limited number of life insurance product offerings. All of the products are individual life insurance products, with design variations from each other to provide choices to the customer. These variations generally center around the length of the premium paying period, length of the coverage period and whether the product accumulates cash value or not. In recent years, UTGN has not placed an emphasis on new business production. Current sales primarily represent sales to existing customers through additional insurance needs or conservation efforts. The UTGN currently encourages policy retention as opposed to new sales in an attempt to maintain or improve current persistency levels. UTGN also performs administrative work as a third-party administrator (“TPA”) for unaffiliated life insurance companies seeking business process outsourcing solutions. |
RP Financial, LC.
Page 3.8
The following sections present a comparison of Federal Life’s financial condition and income and expense trends versus the latest financial data reported data by the Peer Group companies. The conclusions drawn from the comparative analysis are then factored into the valuation analysis discussed in the final chapter.
Financial Condition
Overall, the balance sheet composition of Federal Life and the Peer Group was relatively comparable (see Table 3.2). Federal Life’s financial data reflects financial data as of September 30, 2017. The Peer Group data is as of the latest available date for which information is publicly available, which is generally as of September 30, 2017, as well, and is based on their respective public company financial reports which are solely reported on a GAAP basis.
Cash and investments comprised the bulk of assets for both the Company (80.5% of assets) and the Peer Group (83.0% of assets based on the median). The Company’s and the Peer Group’s cash and investments portfolio is dominated by fixed-income securities (75% of cash and investments for the Company and 78% at the median for the Peer Group). The higher level of cash and investments for Federal Life is reflective of the Company’s focus on insurance underwriting, small size, and lower level of diversification of business into non-insurance activities.
Other assets for the Company consisted primarily of deferred policy acquisition costs and assets held in separate accounts. Likewise, the Peer Group companies had a similar composition in other assets. On balance, while the Company is very small and is much less diversified than the majority of the Peer Group members, the composition of its asset base is relatively similar.
RP Financial, LC.
Page 3.9
Table 3.2
Comparative Financial Condition Data
Federal Life Insurance Company and the Peer Group
Policy | Cash and | |||||||||||||||||||||||||||||||||||
Total | Policy | Total | LTM | Reserves/ | Investments/ | Total Equity/ | Tangible Equity/ | |||||||||||||||||||||||||||||
Company Name | City, State | Ticker | Assets | Reserves | Equity | Asset Growth | Equity | Assets | Assets | Assets | ||||||||||||||||||||||||||
($Mil) | ($Mil) | ($Mil) | (%) | (x) | (%) | (%) | (%) | |||||||||||||||||||||||||||||
Federal Life | ||||||||||||||||||||||||||||||||||||
- As of September 30, 2017 | Riverwoods, IL | NA | $ | 258 | $ | 195 | $ | 36 | 6.86 | % | 5.40 | x | 80.53 | % | 14.07 | % | 14.07 | % | ||||||||||||||||||
All Publicly Traded Life and Health Companies | ||||||||||||||||||||||||||||||||||||
Average | 126,634 | 63,220 | 9,913 | 2.13 | % | 6.16 | x | 65.58 | % | 15.23 | % | 14.37 | % | |||||||||||||||||||||||
Median | 27,849 | 18,522 | 3,822 | 1.52 | % | 5.21 | x | 74.13 | % | 13.81 | % | 13.69 | % | |||||||||||||||||||||||
Peer Group | ||||||||||||||||||||||||||||||||||||
Average | $ | 13,748 | $ | 11,346 | $ | 1,373 | 2.42 | % | 6.02 | x | 78.25 | % | 17.52 | % | 16.93 | % | ||||||||||||||||||||
Median | $ | 4,511 | $ | 3,213 | $ | 704 | 2.17 | % | 4.77 | x | 83.04 | % | 14.93 | % | 14.93 | % | ||||||||||||||||||||
Peer Group Companies | ||||||||||||||||||||||||||||||||||||
American Equity Investment Life Holding | West Des Moines, IA | AEL | $ | 60,380 | $ | 55,220 | $ | 2,763 | 8.11 | % | 19.99 | x | 83.04 | % | 4.58 | % | 4.58 | % | ||||||||||||||||||
Citizens, Inc. | Austin, TX | CIA | $ | 1,651 | $ | 1,276 | $ | 264 | 5.42 | % | 4.83 | x | 80.55 | % | 16.00 | % | 15.06 | % | ||||||||||||||||||
CNO Financial Group, Inc. | Carmel, IN | CNO | $ | 32,705 | $ | 23,270 | $ | 4,882 | 0.88 | % | 4.77 | x | 85.39 | % | 14.93 | % | 14.93 | % | ||||||||||||||||||
FBL Financial Group, Inc. | West Des Moines, IA | FFG | $ | 9,892 | $ | 7,576 | $ | 1,279 | 2.31 | % | 5.93 | x | 87.47 | % | 12.93 | % | 12.84 | % | ||||||||||||||||||
Independence Holding Company | Stamford, CT | IHC | $ | 1,039 | $ | 549 | $ | 423 | -16.92 | % | 1.30 | x | 47.87 | % | 40.69 | % | 36.69 | % | ||||||||||||||||||
Kansas City Life Insurance Company | Kansas City, MO | KCLI | $ | 4,511 | $ | 3,213 | $ | 704 | -0.04 | % | 4.56 | x | 78.20 | % | 15.62 | % | 15.62 | % | ||||||||||||||||||
National Western Life Group, Inc. | Austin, TX | NWLI | $ | 12,138 | $ | 10,129 | $ | 1,803 | 2.17 | % | 5.62 | x | 90.13 | % | 14.85 | % | 14.85 | % | ||||||||||||||||||
Security National Financial Corporation | Salt Lake City, UT | SNFCA | $ | 1,008 | $ | 605 | $ | 139 | 20.34 | % | 4.34 | x | 62.86 | % | 13.83 | % | 13.59 | % | ||||||||||||||||||
UTG, Inc. | Springfield, IL | UTGN | $ | 405 | $ | 280 | $ | 98 | -0.50 | % | 2.85 | x | 88.77 | % | 24.24 | % | 24.24 | % |
Source: S&P Global Market Intelligence and Federal Life's audited and unaudited financial statements as of September 30, 2017.
RP Financial, LC.
Page 3.10
Liabilities
Various types of policyholder-liabilities comprised the majority of liabilities for both the Company and the Peer Group. In this regard, the policy reserves, which primarily consisted of reserves for future policy benefits and the policyholder account balances (i.e., cash surrender value of whole life policies), comprised the largest segment of liabilities and totaled $195 million, or 75.8 percent of assets.
The peer Group’s policy-related reserves were $3.2 billion based on the median equal to 71.2 percent of assets. Based on the average, policy reserves totaled $11.3 billion for the Peer Group, equal to 82.5 percent of the average Peer Group assets of $13.7 billion.
Equity
Federal Life’s pre-offering equity base of 14.07% of assets as measured on a GAAP basis was modestly below the Peer Group’s median equity ratio of 14.93% of assets. Federal Life operates with no intangible assets while the Peer Group possesses a moderate level on intangibles, resulting in similar tangible equity to asset ratios for the Company and Peer Group equal to 14.1% and 14.9% based on the median. As a result of the similarity of the capital levels and the composition of liabilities, the ratios of policy reserves/equity for Federal Life, equal to 5.40x fell within the range of the Peer Group average and median equal to 6.02x and 4.77x, respectively.
As a result of the conversion offering, Federal Life’s GAAP and statutory capital ratios will be substantially bolstered to levels in excess of the Peer Group average and median ratios. The increased capitalization will facilitate the adoption of a growth-oriented business plan designed to restore the Company’s operations to profitability.
Income and Expense Components
Federal Life’s recent operating performance versus the Peer Group is reflected in Table 3.3. The earnings data for Federal Life is based on annualized GAAP financial data for the nine months ended September 30, 2017. The Peer Group’s financial data is as of or for the most recent twelve months for which data is publicly available and is based on their respective public company reports which reflect GAAP financial reporting.
RP Financial, LC.
Page 3.11
As noted in Section One of the valuation, Federal Life has been reporting operating losses in recent years which has eroded capital. Management has attributed the ongoing losses to several factors including a high level of competition in the traditional markets for life insurance and annuity products. Specifically, Federal Life’s small size and resulting high cost structure have resulted in operating losses for the last decade. Moreover, the erosion of the statutory surplus has eroded the ability to introduce products and services which, while entailing a significant upfront cost to develop and market, could provide enhanced revenues and earnings over the long term. Additionally, the low interest rate environment has diminished net investment income on investment assets used to provide guaranteed benefits to policyholders.
The Company’s small size in comparison to the Peer Group is reflected in the revenues data, including both total revenues and policy revenues. In this regard, total revenues equaled $18 million for Federal Life ($24 million on an annualized basis versus the Peer Group median of $450 million). Federal Life’s modest revenues reflect its comparatively more limited line of insurance products in comparison to the Peer Group companies.
Overall, Federal Life reported ongoing losses from operations, with a loss equal to 0.56 percent of assets on an annualized basis and a negative return on equity equal to 4.10%. In contrast, the Peer Group reported positive earnings equal to 0.62 percent of assets based on the median and 5.38 percent of equity.
Revenues
Policy revenues (i.e., net premiums earned) represented the largest revenue source for both the Company and the Peer Group, equal to 54.3% and 42.3% of total revenues, respectively, based on the median for the Peer Group. Given their focus on underwriting long term life insurance policies, investment income is significant for both the Company and the Peer Group, equal to 35.5 percent and 36.3 percent of total revenues, respectively. Accordingly, policy revenues and investment income, both of which are primarily related to the respective insurance operations of the Company and the Peer Group totaled 89.7 percent and 78.5% of revenues, respectively.
RP Financial, LC.
Page 3.12
Table 3.3
Comparative Operating Performance Data
Federal Life Insurance Company and the Peer Group
Policy | ||||||||||||||||||||||||||||||||||||
Total | Policy | Revenues/ | Portfolio Rev./ | Policy Exp. | G&A Exp./ | |||||||||||||||||||||||||||||||
Company Name | City, State | Ticker | Revenue | Revenues | Revenues | Revenues | Revenues | Revenues | ROAA | ROAE | ||||||||||||||||||||||||||
($Mil) | ($Mil) | ($Mil) | (%) | (%) | (%) | (%) | (%) | |||||||||||||||||||||||||||||
Federal Life | ||||||||||||||||||||||||||||||||||||
- Annualized For the Nine Months Ended September 30, 2017 (1) | Riverwoods, IL | NA | $ | 24 | $ | 13 | 54.30 | % | 35.42 | % | 72.29 | % | 30.47 | % | -0.56 | % | -4.10 | % | ||||||||||||||||||
All Publicly Traded Life and Health Companies | ||||||||||||||||||||||||||||||||||||
Average | $ | 9,539 | $ | 6,547 | 58.58 | % | 27.91 | % | 57.75 | % | 39.46 | % | 1.03 | % | 1.61 | % | ||||||||||||||||||||
Median | $ | 3,675 | $ | 1,784 | 63.52 | % | 24.95 | % | 58.78 | % | 28.45 | % | 0.59 | % | 8.35 | % | ||||||||||||||||||||
Peer Group | ||||||||||||||||||||||||||||||||||||
Average | $ | 1,152 | $ | 468 | 46.39 | % | 41.24 | % | 54.27 | % | 36.61 | % | 0.88 | % | 5.65 | % | ||||||||||||||||||||
Median | $ | 450 | $ | 230 | 42.26 | % | 36.27 | % | 58.66 | % | 32.60 | % | 0.62 | % | 5.38 | % | ||||||||||||||||||||
Peer Group Companies | ||||||||||||||||||||||||||||||||||||
American Equity Investment Life Holding Company | West Des Moines, IA | AEL | $ | 3,275 | $ | 230 | 7.03 | % | 59.61 | % | 51.24 | % | 35.29 | % | 0.45 | % | 10.18 | % | ||||||||||||||||||
Citizens, Inc. | Austin, TX | CIA | $ | 253 | $ | 199 | 78.61 | % | 20.85 | % | 65.11 | % | 32.60 | % | 0.39 | % | 2.42 | % | ||||||||||||||||||
CNO Financial Group, Inc. | Carmel, IN | CNO | $ | 4,212 | $ | 2,641 | 62.71 | % | 36.27 | % | 58.66 | % | 25.57 | % | 1.48 | % | 10.36 | % | ||||||||||||||||||
FBL Financial Group, Inc. | West Des Moines, IA | FFG | $ | 737 | $ | 311 | 42.26 | % | 55.67 | % | 58.90 | % | 20.35 | % | 1.16 | % | 9.15 | % | ||||||||||||||||||
Independence Holding Company | Stamford, CT | IHC | $ | 317 | $ | 278 | 87.68 | % | 5.63 | % | 43.83 | % | 47.25 | % | 3.02 | % | 7.69 | % | ||||||||||||||||||
Kansas City Life Insurance Company | Kansas City, MO | KCLI | $ | 450 | $ | 292 | 64.94 | % | 33.57 | % | 62.75 | % | 30.22 | % | 0.51 | % | 3.31 | % | ||||||||||||||||||
National Western Life Group, Inc. | Austin, TX | NWLI | $ | 811 | $ | 181 | 22.34 | % | 75.37 | % | 54.77 | % | 27.21 | % | 0.79 | % | 5.38 | % | ||||||||||||||||||
Security National Financial Corporation | Salt Lake City, UT | SNFCA | $ | 288 | $ | 69 | 24.09 | % | 14.42 | % | 21.08 | % | 73.80 | % | 0.62 | % | 4.39 | % | ||||||||||||||||||
UTG, Inc. | Springfield, IL | UTGN | $ | 21 | $ | 6 | 27.85 | % | 69.77 | % | 72.10 | % | 37.18 | % | -0.49 | % | -2.06 | % |
(1) Reflects annualized 9 month result for Federal Life.
Source: S&P Global Market Intelligence and Federal Life's internal financials, for the nine months ended September 30, 2017 for Federal Life and the twelve months ended September 30, 2017 for Peers.
RP Financial, LC.
Page 3.13
Expenses
The Company operated with a relatively high level of policy expenses reflecting its small size, as policy expenses totaled 72.3 percent of revenues, which was well above the Peer Group median of 58.7 percent. Coupled with a similar level of G&A expense which totaled 30.5 percent of revenues for the Company versus a median of 32.6 percent for the Peer Group, the Company’s overhead and policy expenses totaled 102.8% of revenues, and with the ratio in excess of 100% reflective of Federal Life’s recent operating losses. In comparison, the Peer Group’s median G&A and policy expenses combined to equal 91.3 percent of revenues reflecting their generally profitable operations from underwriting life insurance and other insurance-related operations.
Taxes
As of September 30, 2017, Federal Life had net operating loss carryforwards (“NOLs”) available to offset future taxable income totaling $28.6 million with expirations extending out for 15 years through 2032. As of September 30, 2017, the Company had a deferred tax asset (“DTA”) related to the NOL equal to $9.7 million, but only carried a net deferred tax asset of $0.5 million as an admitted asset on its balance sheet. The value of the DTA will be affected by any future changes in the corporate tax rate and could be further limited by IRS rules related to change in ownership. In contrast, the majority of the Peer Group companies are in a fully taxable position. While the ability to utilize a portion of the tax loss carryforwards may benefit the Company’s future operations, the value of such tax benefits will be subject to Federal Life’s ability to reverse the recent operating losses and generate taxable income.
Summary
Based on the above analysis, RP Financial concluded that the Peer Group forms a reasonable basis for determining the pro forma market value of Federal Life. Areas where substantial differences exist will be further addressed in the valuation section to follow, which will lead to valuation adjustments.
RP Financial, LC.
Page 4.1
IV. VALUATION ANALYSIS
Introduction
This section of the valuation report presents the valuation analysis and methodology used to determine Federal Life’s estimated pro forma market value. The valuation utilizes the market value approach to value incorporating the selection of the Peer Group, fundamental and technical analysis on both the Company and the Peer Group, and determination of the Company’s pro forma market value utilizing the pro forma market value approach.
Pro Forma Approach to the Valuation
Employing the principles embodied in the pro forma market value approach, the valuation incorporates a detailed analysis based on the Peer Group, discussed in Section III, which constitutes a “fundamental analysis”. The valuation also incorporates a “technical analysis”, incorporating recently completed stock offerings of other demutualized insurance companies. It should be noted that these valuation analyses, based on either the Peer Group or recent insurance company demutualizations, cannot possibly fully account for all the market forces which impact trading activity and pricing characteristics of a stock on a given day.
The appraised value determined herein is based on the current market and operating environment for the Company and for all insurance companies. Subsequent changes in the local and national economy, the legislative and regulatory environment, the stock market, interest rates, and other external forces (such as natural disasters or major world events), which may occur from time to time (often with great unpredictability) may materially impact the market value of all insurance company stocks, including Federal Life, the market value of the stocks of life insurers, or Federal Life’s value alone.
The basis of the appraised value determined herein is that of a minority stock issuance in keeping with standard conversion valuation guidelines and the Company’s Plan of Conversion, whereby all of the shares will be issued at the same stock price. We made no valuation adjustment to account for ICG’s ownership position, which could acquire up to 80 percent of the outstanding shares.
RP Financial, LC.
Page 4.2
Valuation Analysis
The following sections summarize the key differences between the Company and the Peer Group addressed in Section III and how those differences affect the pro forma valuation. Emphasis is placed on the specific strengths and weaknesses of the Company relative to the Peer Group in such key areas as financial considerations, operating considerations, risk assessment, primary market and growth, dividends, liquidity of the shares, marketing of the issue, management, and the effect of government regulations and/or regulatory reform. We have also considered the market for insurance company stocks, in particular new issues, in evaluating the impact of the new issue market on the value of Federal Life coming to market at this time. Finally, we have considered the overall market for common stocks generally with particular focus on the market for the common stock of life insurance underwriters.
1. | Financial Considerations |
The financial condition of a company is an important determinant in pro forma market value, because investors typically look to such factors as liquidity, capital and balance sheet composition in assessing investment attractiveness. In assessing comparative strengths and weaknesses, we have considered the Company on a pro forma basis, that is raising the equity capital and infusing the majority of the proceeds into Federal Life. The similarities and differences in the financial condition are noted below:
· | Balance Sheet Composition and Liquidity. Federal Life’s balance sheet composition was broadly similar to the Peer Group company’s balance sheets with a comparable level of invested assets which comprised the majority of assets for both the Company and the Peer Group. Other assets for the Company consisted primarily of deferred policy acquisition costs and assets held in separate accounts. Likewise, the Peer Group companies had a similar composition in other assets which were primarily insurance-related assets. On balance, while the Company is very small and is much less diversified than the majority of the Peer Group members, the composition of its asset base is relatively similar. |
· | Equity Capital. The Company operates with a similar pre-offering tangible equity ratio in comparison to the Peer Group median. The Company capital position will be enhanced with the conversion as up to $12.5 million of the net conversion proceeds are infused into Federal Life to support its insurance underwriting operations. The remaining balance of the proceeds will be retained by FLG for general corporate purposes. On a pro forma basis, the Company’s tangible GAAP equity to assets ratio is projected to be in the range of 23% to 26% based on the valuation set forth herein, which will be well in excess of the Peer Group averages and medians. |
RP Financial, LC.
Page 4.3
· | Potential Unrealized Off Balance Sheet Value. As described in Section One (Overview and Financial Analysis), the Company has several assets with significant value beyond the historical cost as reflected on the balance sheet. These may potentially include Federal Life’s headquarters office and the Company’s ownership of mineral rights on land in Texas and Oklahoma. Importantly, management has indicated no current intent to undertake any of the foregoing strategies to monetize the unrealized value in the main office building or the mineral rights it owns. Additionally, some of the benefits of such unrealized values are realized through operations, in terms of the relatively low occupancy costs and revenues from the mineral rights. It is our belief that the Peer Group companies do not have similar elements of potential unrealized value. |
· | Potential Value of the Deferred Tax Asset (“DTA”). The Company currently has a 100% valuation allowance established against the DTA. To the extent Federal Life can utilize NOLs on a post-conversion basis, a portion of the value of the DTA may be recognized through the reversal of the valuation allowance. The Peer Group companies are generally fully taxable with regard to state and federal income taxes and thus, do not have the potential to realize such tax benefits. At the same time, any benefit which the Company may realize is contingent upon its achieving profitable operations in the future. |
On balance, we believe an upward adjustment is warranted for the Company’s higher pro forma capitalization and potential unrealized value in fixed assets and the ownership of mineral rights.
2. | Operating Considerations |
Earnings are a key factor in determining pro forma market value, as the level and risk characteristics of an insurance company’s earnings stream and the prospects and ability to generate future earnings heavily influence the multiple the investment community will pay for pro forma earnings. The major factors considered in the valuation are described below.
· | Reported Profitability. Federal Life has reported operating losses since fiscal 2002 and losses equaled 0.56% of assets on an annualized basis for the nine months ended September 30, 2017, and a negative return on equity equal to 4.10%. By comparison, eight of the nine Peer Group companies reported positive net income. |
· | Earnings Growth Potential. Several factors were considered in assessing earnings growth potential. In general, we believe that the Company’s earnings growth potential is limited in the near term due to a number of factors. |
Ø | First, it remains a challenging investing environment to reinvest the conversion proceeds as intermediate to longer term interest rates remain near their historical lows. Accordingly, the reinvestment benefit of the proceeds will be modest initially. |
RP Financial, LC.
Page 4.4
Ø | The conversion proceeds will provide substantial additional statutory capital with which Federal Life intends to implement a growth oriented business plan which may include the following: |
- | The Company will be implementing a marketing plan based on the formation of strategic partnerships to improve the Company’s distribution capabilities which will enable significant growth in products that the Company identifies as having unique market opportunities. A portion of the growth is expected to be derived from the marketing of a variable annuity product. |
- | The Standby Investor who has longstanding experience and relationships within the insurance industry is expected to facilitate the expansion. |
- | In addition to the foregoing, the Company may seek to diversify into other financial services businesses and/or seek potential acquisition opportunities as a stock company. |
Overall, primarily in view of the history of operating losses and execution risk in the growth- oriented business plan, we concluded a significant downward valuation adjustment for the foregoing operating considerations was appropriate.
3. | Dividends |
Management has indicated that it will not pay a cash dividend initially. Federal Life’s pro forma capitalization will improve the dividend paying capacity of the Company. At the same time, the post-conversion growth objectives will require earnings retention, to the extent the Company can reverse the operating losses which have eroded the Company’s capital in recent years.
A total of six out of the nine companies in the Peer Group currently pays a cash dividend, with an average dividend yield of 1.3%. On balance, we believe that in view of the stated intent that the Company will not pay a dividend coupled with the recent history of operating losses and the need to retain capital for future growth will limit the Company’s dividend paying capacity.
On balance, we have applied a downward adjustment for this factor.
4. | Liquidity of the Shares |
The Peer Group is by definition composed of companies that are traded in the public markets, and 7 of the nine of the Peer Group members trade on either the New York exchange or the NASDAQ system while two trade in the over the counter market. Typically, the number of shares outstanding and market capitalization provides an indication of how much liquidity there will be in a stock. The market capitalization of the Peer Group companies ranged from $82 million to $4.2 billion as of December 22, 2017, with average and median market values of $436 million and $1.3 billion, respectively. The shares issued and outstanding to shareholders of the Peer Group members ranged from approximately 3.3 to 167.8 million, with average and median shares outstanding of approximately 15.3 million and 42.1 million, respectively. The Company’s stock offering is expected to result in shares outstanding and market capitalization which will be far below the range exhibited by the Peer Group average and median, and the pro forma market capitalization at the midpoint of the offering range will be less than half of the smallest Peer Group companies. In addition, the majority of the stock will be held by the Standby Purchaser and insiders who are long term holders of the stock.
RP Financial, LC.
Page 4.5
At the same time, the Company expects that its shares will be traded on NASDAQ and there will be at least several market makers in the issue. Overall, we concluded that a downward adjustment was warranted for this factor.
5. | Marketing of the Issue |
Two separate markets exist for insurance company stocks: (1) the after-market for public companies in which trading activity is regular and investment decisions are made based upon financial condition, earnings, capital, ROE, dividends and prospects; and (2) the new issue market in which demutualizing insurers are evaluated based on the same factors but on a pro forma basis without the benefit of prior operations as a publicly-held company and stock trading history. Both markets were considered in the valuation of the Company’s to-be-issued stock.
A. | The Public Market |
The value of publicly-traded insurance company stocks, i.e., those which are listed on an exchange or on NASDAQ, is easily measurable, and is tracked by investment firms, related organizations and by electronic means. In general, the stocks of insurance companies react to market stimuli such as interest rates, inflation, perceived industry health, projected rates of economic growth, regulatory issues and stock market conditions in general.
Table 4.1 shows the recent performance of various insurance stock indexes along with broader market indexes. In terms of assessing general stock market conditions, the broad stock market rallied strongly over the last 12 months. The general market for stocks has been supported by strong underlying fundamentals. Consumer confidence hit 122.1 in December, slightly below the 17-year high set in November of 128.6, according to the Conference Board's index. Confidence has been fueled by a few factors including: the strong job market, the stock market rally and Republicans' tax reforms.
RP Financial, LC.
Page 4.6
The U.S. job market is very strong with the national unemployment rate at 4.1%, the lowest level since 2000. Job openings are abundant too as the U.S. economy has gained jobs for 86 consecutive months, the longest streak in history, according to Labor Department figures going back to 1939. Balanced growth in the global economy has also supported some U.S. employment levels in the last several years.
Strong underlying economic fundamentals have supported a surging stock market. The stock market's surge has also been another reflection of consumer confidence. The Dow ended 2017 just below 25,000 points which reflects a nearly 25 percent increase on a year over year basis. Stock market gains have been supported by corporate earnings growth and the passage of tax reform by the Republican congress in late 2017. In addition, while the Federal Reserve has raised the targeted short-term interest rates and indicated that it anticipates three rate increases in 2018, interest rates remain low by historical standards, which has also supported stock prices.
Insurance company stocks have participated in the ongoing bull market with the SNL Insurance Underwriter Index increasing by 21 percent in 2017 and by nearly 47% over the prior three years. While the performance of the Life and Health sector has lagged the broader index for all insurance underwriters, the stocks of the public life and health insurers have nonetheless participated in the broader stock market rally as indicated by appreciation of the SNL U.S. Life and Health Insurance index of 12 percent over the last year and nearly 26% over the prior three years.
RP Financial, LC.
Page 4.7
Table 4.1
Stock Market Pricing Trends
Through January 2, 2018
Index | Percent Change | |||||||||||
Value | 1 Year | 3 Year | ||||||||||
SNL Insurance Indexes | ||||||||||||
SNL U.S. Insurance | 1,032.09 | 20.56 | 45.82 | |||||||||
SNL U.S. Insurance Underwriter | 1,023.03 | 20.73 | 46.67 | |||||||||
S&P 500 Insurance | 397.03 | 12.39 | 29.62 | |||||||||
NASDAQ Insurance | 8,494.84 | 1.69 | 26.49 | |||||||||
S&P 500 Insurance Brokers | 630.39 | 18.96 | 34.57 | |||||||||
S&P 500 Multi-line Insurance | 116.38 | (1.37 | ) | 12.78 | ||||||||
SNL Sector Indexes | ||||||||||||
SNL U.S. Insurance Multiline | 225.51 | 29.87 | 32.69 | |||||||||
SNL U.S. Insurance L&H | 1,027.49 | 11.59 | 25.98 | |||||||||
S&P 500 L&H | 421.66 | 13.47 | 25.78 | |||||||||
SNL U.S. Insurance P&C | 921.77 | 11.31 | 32.83 | |||||||||
S&P 500 P&C | 539.61 | 16.97 | 42.07 | |||||||||
SNL U.S. Reinsurance | 1,103.46 | (3.41 | ) | 24.27 | ||||||||
SNL U.S. Managed Care | 3,296.10 | 43.44 | 103.47 | |||||||||
SNL U.S. Title Insurer | 1,766.97 | 22.77 | 25.65 | |||||||||
SNL U.S. Mortgage & Finl Guaranty | 103.08 | 14.21 | 30.78 | |||||||||
SNL Global Reinsurance | 181.19 | NA | NA | |||||||||
SNL Asset Size Indexes | ||||||||||||
SNL U.S. Insurance < $250M | 1,258.14 | 27.43 | 91.45 | |||||||||
SNL U.S. Insurance $250M-$500M | 641.97 | 10.06 | (9.12 | ) | ||||||||
SNL U.S. Insurance $500M-$1B | 1,072.15 | 20.89 | 43.90 | |||||||||
SNL U.S. Insurance $1B-$2.5B | 2,094.80 | 10.27 | 36.99 | |||||||||
SNL U.S. Insurance $2.5B-$10B | 1,290.02 | 14.79 | 44.69 | |||||||||
SNL U.S. Insurance > $10B | 971.74 | 21.10 | 46.85 | |||||||||
SNL U.S. Insurance > $1B | 1,063.13 | 20.69 | 46.64 | |||||||||
SNL U.S. Insurance < $1B | 1,326.38 | 21.20 | 44.17 | |||||||||
SNL Market Cap Indexes | ||||||||||||
SNL Micro Cap U.S. Insurance | 261.10 | (11.09 | ) | (26.17 | ) | |||||||
SNL Small Cap U.S. Insurance | 970.41 | 8.90 | 20.49 | |||||||||
SNL Mid Cap U.S. Insurance | 717.06 | 9.19 | 30.55 | |||||||||
SNL Large Cap U.S. Insurance | 969.53 | 24.23 | 50.85 | |||||||||
Broad Market Indexes | ||||||||||||
DJIA | 24,824.01 | 25.61 | 39.20 | |||||||||
S&P 500 | 2,695.81 | 20.41 | 30.98 | |||||||||
S&P Mid-Cap | 1,917.36 | 15.46 | 32.11 | |||||||||
S&P Small-Cap | 942.97 | 12.53 | 36.63 | |||||||||
S&P 500 Financials | 463.66 | 19.95 | 39.07 | |||||||||
NASDAQ | 7,006.90 | 30.16 | 48.24 | |||||||||
NASDAQ Financial | 4,500.97 | 12.60 | 43.95 |
Source: S&P Global Market Intelligence.
RP Financial, LC.
Page 4.8
B. | The New Issue Market |
In addition to stock market conditions for insurers in general, the new issue market for demutualizing insurers is also an important consideration in determining the Company’s pro forma market value. The new issue market is separate and distinct from the market for seasoned stock insurers in that the pricing ratios (primarily price/book and price/earnings) for demutualizing issues are computed on a pro forma basis, specifically: (1) the numerator and denominator are both impacted by the stock offering amount, unlike existing stock issues in which price change affects only the numerator; and (2) the pro forma pricing ratio incorporates assumptions regarding source and use of proceeds, effective tax rates, stock plan purchases, etc. which impact pro forma financials, whereas pricing for existing issues are based on reported financials. The distinction between pricing of demutualizing and existing issues is perhaps no clearer than in the case of the price/tangible book (“P/TB”) ratio in that the P/TB ratio of a demutualizing insurer, particularly those employing the thrift subscription method, will typically result in a discount to tangible book value whereas the P/TB in the current market for the Peer Group reflects a premium to tangible book value, on average. Therefore, it is appropriate to also consider the market for new issues, both at the time of the demutualization and in the aftermarket.
The number of demutualized insurance company issues which are publicly traded is relatively limited, and while there were no demutualization transactions completed pursuant to the subscription rights method between 2010 and 2017, there were two such transactions completed in March 2017. Table 4.2 shows the financial and pricing characteristics of selected demutualized insurers completing their demutualization transactions since 1997. The average and median pro forma P/TB ratios for the ten insurance companies completing demutualizations were 63.0% and 58.1%, respectively. The average and median pro forma price/core earnings (“P/Core”) equaled 17.0 times and 15.1 times, respectively.
Perhaps the most comparable of the offerings was by ICC Holdings, which is also based in Illinois, which completed its offering on March 24, 2017, raising gross proceeds of $35 million, which is comparable in size to the Company’s proposed offering. The transaction was completed at a pro forma P/TB ratio of 56.3% while the pro forma P/E multiple was 17.0x. The fact that ICC Holdings was profitable on pre-conversion basis represents a significant difference from Federal Life’s history of operating losses. At the same time, the bull market environment has continued and Federal Life has developed a growth oriented business plan which is dependent on the capital raised in the offering.
RP Financial, LC.
Page 4.9
Table 4.2
Demutualization Transactions: Subscription Rights Offerings
AM | Demutual | Aggregate Value | Shares Issued | |||||||||||||||||||||||||||||||
Best | Deal Structure | Demut | Initial | Shrs. Dist | Exrcs | |||||||||||||||||||||||||||||
Rating | Main | IPO | Closing | Mkt | Gross | To | Offering | Over- | Issue | |||||||||||||||||||||||||
Ticker | Company | @ IPO | Lines | Form | Struct. | Date | Cap | Prcds | Insureds(6) | Shares | allot. | Price | ||||||||||||||||||||||
($Mil) | ($Mil) | (000) | (000) | ($) | ||||||||||||||||||||||||||||||
NODK | NI Holdings Inc. | A | P/C-Mix | MHC/ | Subscr | 03/13/17 | $ | 104 | $ | 104 | - | 103,500 | - | $ | 10.00 | |||||||||||||||||||
Minority | ||||||||||||||||||||||||||||||||||
ICCH | ICC Holdings | B++ | P/C - Mix | Full | Subscr | 03/24/17 | $ | 35 | $ | 35 | - | 3,500 | - | $ | 10.00 | |||||||||||||||||||
PMIC | Penn Millers Holding Corp. | A- | P/C-Mix | Full | Subscr | 10/16/09 | $ | 54 | $ | 54 | - | 5,444 | - | $ | 10.00 | |||||||||||||||||||
EIHI | Eastern Insurance Holdings, Inc. | B++ | Life/Pc | Full | Subscr | 06/19/06 | 114 | (5) | 75 | (5) | - | 7,475 | - | $ | 10.00 | |||||||||||||||||||
FMMH.OB | Fremont Michigan Insuracorp, MI | B++ | P/C-Mix | Full | Subscr | 10/18/04 | $ | 9 | $ | 9 | - | 862 | - | $ | 10.00 | |||||||||||||||||||
MIGP | Mercer Insurance Group, PA | A | P/C-Mix | Full | Subscr | 12/15/03 | $ | 69 | $ | 59 | - | 5,884 | - | $ | 10.00 | |||||||||||||||||||
NCRI | NCRIC Group, Inc., DC(2) | A- | Med Liab | 2nd Step MHC | Subscr | 06/25/03 | $ | 69 | $ | 41 | - | 4,144 | - | $ | 10.00 | |||||||||||||||||||
PFLD.OB | Professionals Direct, MI | B++ | Attny. Liab | Full | Subscr | 07/01/01 | $ | 3 | $ | 3 | - | 334 | - | $ | 10.00 | |||||||||||||||||||
ACAP | AP Capital, Inc., MI (3) | A- | Med Liab | Full | Subscr | 12/08/00 | $ | 155 | $ | 155 | - | 11,450 | Yes | $ | 13.50 | |||||||||||||||||||
OGGI | Old Guard Grp, Inc., PA | A- | P/C-Mix | Full | Subscr | 02/01/97 | N.A. | $ | 40 | - | 3,955 | No | $ | 10.00 |
(1) | Reflects the impact of a simultaneous merger with Eastern Holding Company. |
(2) | Reflects second step offering by NCRIC Group's mutual holding company. NCRIC completed an initial MHC offering prior to the second step conversion. |
(3) | Core earnings and ROA and ROE ratios reflect adjustment to exclude a significant one-time income tax recovery. |
(4) | None for subscription rights transactions. |
(5) | Includes 3.9 million shares issued connection with a merger with Eastern Holding Co. and 7.5 million shares sold in a subscription offering. |
RP Financial, LC.
Page 4.10
Table 4.2 (continued)
Demutualization Transactions: Subscription Rights Offerings
After-Market | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Price Change | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Pro Forma Financial Ratios | Pro Forma Pricing Ratios | Vs. IPO Price | ||||||||||||||||||||||||||||||||||||||||||||||||||
Company | E/A | Tg. E/A | ROA | ROE | P/E | P/CE | P/B | P/TB | P/Rev | P/A | 1 day | 1 wk | 1 mo | |||||||||||||||||||||||||||||||||||||||
(%) | (%) | (%) | (%) | (x) | (x) | (%) | (%) | (%) | (%) | (%) | (%) | (%) | ||||||||||||||||||||||||||||||||||||||||
NI Holdings Inc. (3) | 64.3 | % | 63.8 | % | 2.37 | % | 3.68 | % | 18.1 | x | 18.1 | x | 66.9 | % | 67.3 | % | 141.5 | % | 42.9 | % | 48 | % | 44 | % | 57 | % | ||||||||||||||||||||||||||
ICC Holdings | 21.7 | % | 21.7 | % | 1.24 | % | 2.99 | % | 17.0 | x | 17.0 | x | 56.3 | % | 56.3 | % | 94.8 | % | 22.3 | % | 44 | % | 53 | % | 52 | % | ||||||||||||||||||||||||||
Penn Millers Holding Corp. | 44.5 | % | 44.5 | % | 0.88 | % | 1.98 | % | 27.0 | x | 27.0 | x | 53.5 | % | 53.5 | % | 119.3 | % | 20.0 | % | 8 | % | 2 | % | 2 | % | ||||||||||||||||||||||||||
Eastern Insurance Holdings, Inc. | 47.1 | % | 44.7 | % | 3.46 | % | 7.36 | % | 8.6 | x | 8.6 | x | 66.7 | % | 74.4 | % | 84.9 | % | 31.4 | % | 14 | % | 21 | % | 29 | % | ||||||||||||||||||||||||||
Fremont Michigan Insuracorp, MI | 25.0 | % | 25.0 | % | 1.00 | % | 4.00 | % | 13.4 | x | 13.4 | x | 53.3 | % | 53.3 | % | 44.7 | % | 13.3 | % | N.A. | N.A. | N.A. | |||||||||||||||||||||||||||||
Mercer Insurance Group, PA | 65.3 | % | 62.1 | % | 1.46 | % | 2.24 | % | 31.7 | x | 31.7 | x | 70.9 | % | 74.5 | % | 160.9 | % | 46.3 | % | 22 | % | 24 | % | 34 | % | ||||||||||||||||||||||||||
NCRIC Group, Inc., DC(1) | 35.3 | % | 32.3 | % | 0.63 | % | 1.78 | % | 46.0 | x | 28.9 | x | 82.1 | % | 89.9 | % | 141.0 | % | 25.9 | % | 5 | % | 3 | % | 10 | % | ||||||||||||||||||||||||||
Professionals Direct, MI | 20.4 | % | 19.2 | % | 3.03 | % | 14.99 | % | 3.7 | x | 4.6 | x | 53.7 | % | 57.2 | % | 43.8 | % | 11.0 | % | N.A. | N.A. | N.A. | |||||||||||||||||||||||||||||
AP Capital, Inc., MI (2) | 38.1 | % | 36.3 | % | 1.80 | % | 4.74 | % | 3.6 | x | 8.9 | x | 42.9 | % | 45.0 | % | 69.7 | % | 16.1 | % | 1 | % | 13 | % | 26 | % | ||||||||||||||||||||||||||
Old Guard Grp, Inc., PA | 39.4 | % | 39.4 | % | 1.89 | % | 4.78 | % | N.M. | 12.3 | x | 59.0 | % | 59.0 | % | 61.7 | % | 40.6 | % | 44 | % | 39 | % | 46 | % |
(1) | Reflects second step offering by NCRIC Group's mutual holding company. NCRIC completed an initial MHC offering prior to the second step conversion. |
(2) | Core earnings and ROA and ROE ratios reflect adjustment to exclude a significant one-time income tax recovery. |
(3) | Reflects pricing ratios on a fully converted basis. |
RP Financial, LC.
Page 4.11
* * * * * * * * * * *
In determining the valuation adjustment for marketing of the issue, we considered trends in both the overall market for insurance companies and the new issue market. Taking these factors and trends into account, RP Financial concluded that a downward adjustment was appropriate in the valuation analysis for purposes of marketing of the issue.
6. | Organization |
By its relatively small level of total assets and revenues, Federal Life’s management team is constrained relative to the resources available relative to other larger insurers. At the same time, the Company has indicated that the management infrastructure in place can manage targeted growth with little or no additions at the senior executive level. On balance we have applied a downward adjustment for Organization as Federal Life’s management depth is limited by the smaller size.
7. | Regulatory Environment |
Both Federal Life and the Peer Group companies operate in a regulated industry with oversight typically provided by state insurance regulators, generally within the framework of guidelines established by state law and the National Association of Insurance Commissioners. Federal Life appears to maintain good relations with its regulators and we believe the Peer Group companies are not subject to operating restrictions. On balance, we believe no adjustment is warranted for this factor.
RP Financial, LC.
Page 4.12
Summary of Adjustments
Overall, based on the factors discussed above, we concluded that the Company’s pro forma market value should be discounted relative to the Peer Group as follows:
Key Valuation Parameters | Valuation Adjustment | |
Financial Considerations | Upward Adjustment | |
Operating Considerations | Significant Downward Adj. | |
Dividends | Downward Adjustment | |
Liquidity of the Shares | Downward Adjustment | |
Marketing of the Issue | Downward Adjustment | |
Organization | Downward Adjustment | |
Regulatory Environment | No Adjustment |
Valuation Approaches
In applying the pro forma market value approach, we considered the three key pricing ratios in valuing Federal Life’s to-be-issued stock – price/earnings (“P/E”), price/book value (“P/B” and price/revenue (“P/Rev”) — all performed on a pro forma basis including the effects of the stock offering proceeds. In computing the pro forma impact of the demutualization and the related pricing ratios, we have incorporated the valuation parameters as provided by management on a preliminary basis (see Exhibit IV-2 and IV-3).
Pursuant to the stock offering, we have also incorporated the valuation parameters as estimated by management for offering expenses. The assumptions utilized in the pro forma analysis in calculating the Company’s value pursuant to the conversion is described more fully below.
Ø | Offering Expenses. Total fixed offering expenses were assumed to be fixed at $1,500,00 based on management’s preliminary estimates. In addition, there will be a variable component in the offering costs paid to the marketing agent as follows: |
Ø | A 2.0% commission on all shares sold in the subscription offering and to an identified list of individuals, customers, etc. developed by Federal Life’s management preliminarily estimated to total $10.0 million: and |
Ø | A 6.5% common on all shares sold to the Public and Standby Investor |
Ø | Based on the foregoing, total offering expenses at the midpoint of the offering range are estimated at $3.65 million. |
RP Financial, LC.
Page 4.13
· | Reinvestment Rate. A 3.10 percent reinvestment rate on the net offering proceeds has been assumed, which is consistent with the current weighted average yield on the investment portfolio as of September 30, 2017. Management has indicated that the offering proceeds will be invested in a laddered portfolio of investment securities relatively consistent with the current investment securities portfolio composition. |
· | Effective Tax Rate. Assumes the current non-taxable status continues owing to NOLs. While the conversion transaction is expected to limit the future ability to utilize NOLs, the annual usage limitation is expected to be in the range of range of $700,000 of taxable income annually. Coupled with the recent reduction in the federal corporate tax rate, it appears that the Company will not be taxable for the short to intermediate term. |
In our estimate of value, we assessed the relationship of the pro forma pricing ratios relative to the Peer Group and the recent demutualizations.
RP Financial’s valuation placed an emphasis on the following:
· | P/E Approach. The P/E approach is historically the preferred valuation approach. Important with respect to Federal Life however, the recent history of operating losses renders the P/E approach to valuation less meaningful relative to P/B and P/Revenue approaches. |
· | P/B Approach. P/B ratios have generally served as a useful benchmark in the valuation of the equity securities of financial securities companies in recent years, including insurance companies, particularly in the context of an initial public offering. RP Financial considered the P/B approach to be a reliable indicator of value given current market conditions, particularly the market for recent demutualizations. RP Financial also considered price/tangible book, which adjusts for intangible assets, particularly goodwill. |
It is important to stress that the P/B ratios of the Peer Group companies are not subject to capital raising – the denominator (reported stockholders’ equity) is relatively stable quarter whereas the numerator (stock price) tends to be more volatile based on prevailing market conditions. In comparison, the Company’s P/B ratio must mathematically be discounted to book value as the denominator (pro forma equity) will always be less than the numerator (the price, the offering amount) since the pro forma equity incorporates both pre-offering equity as well as the net proceeds raised in the offering.
· | P/Revenues Approach. P/Revenue ratios have also been considered a benchmark of trading value. A benefit of the revenues approach is that it is not significantly impacted by the offering proceeds, unlike the earnings and book value approaches. In addition, given the lack of a history of core earnings, we have given the Price/Revenues approach more weight in the valuation conclusion. |
RP Financial, LC.
Page 4.14
Based on the application of the pro forma valuation approaches described above, taking into consideration the valuation adjustments discussed above, RP Financial concluded that the pro forma market value of the shares to be offered by Federal Life was $40.0 million at the midpoint of the offering range. Table 4.3 sets forth details regarding the offering range for the Company and the Company’s pro forma pricing relative to the Peer Group based on stock prices as of December 22, 2017.
In developing the pro forma valuation estimate, RP Financial considered the potential for restoration of positive earnings within the first two or three years following the completion of the conversion transaction. In this regard, the major elements of the business plan to reverse the recent operating losses include:
1. | Undertake growth to expand revenues and achieve economies of scale. |
2. | Maximize the use of the existing infrastructure capacity in growth plans to create a competitive advantage. |
3. | Promote a performance oriented culture within the organization to ensure financial strength. |
4. | Identify potential internal opportunities to increase regulatory surplus to support growth and risk levels. |
5. | Complete the conversion to capitalize future growth and provide enhanced access to capital markets in the future to support growth and risk levels. |
6. | The realization of the foregoing elements of the strategic plan is expected to be facilitated by efforts of the Standby Purchaser to assist in the Company in implementing the foregoing elements of the Strategic Plan. |
1. P/E. The application of the P/E valuation method requires calculating the Company’s pro forma market value by applying a valuation P/E multiple to the pro forma earnings base. In applying this technique, we considered both reported earnings and a recurring earnings base, that is, earnings adjusted to exclude any one-time non-operating items, plus the estimated after-tax earnings benefit of the reinvestment of the net proceeds. As discussed in the financial analysis in Section One, Federal Life reported a net loss equal to $1.110 million for the nine months ended September 30, 2017, equal to $1.480 million on an annualized basis. Based on these net losses, the application of the P/E approach was deemed “not meaningful” and no analysis was performed.
RP Financial, LC.
Page 4.15
Table 4.3
Public Market Pricing
Federal Life Insurance Company and the Peer Group
Prices as of December 22, 2017
Financial Data as of September 30, 2017 | Key Pricing Ratios as of December 22, 2017 | |||||||||||||||||||||||||||||||||||||||||||||
Price/ | Price/ | Price/ | ||||||||||||||||||||||||||||||||||||||||||||
Closing | Market | Equity/ | Price/ | Tangible | TTM | TTM | ||||||||||||||||||||||||||||||||||||||||
Company Name | City, State | Ticker | Exchange | Price | Value | Assets | Assets | ROAA | ROAE | Book | Book | Earnings | Revenue | |||||||||||||||||||||||||||||||||
($) | ($Mil) | ($Mil) | (%) | (%) | (%) | (%) | (%) | (x) | (x) | |||||||||||||||||||||||||||||||||||||
Federal Life Insurance Company | Riverwods, IL | |||||||||||||||||||||||||||||||||||||||||||||
Maximum | $ | 10.00 | $ | 46.00 | $ | 300 | 26.10 | % | -0.06 | % | -0.22 | % | 58.8 | % | 58.8 | % | NM | 1.83 | x | |||||||||||||||||||||||||||
Midpoint | $ | 10.00 | $ | 40.00 | $ | 294 | 24.69 | % | -0.12 | % | -0.48 | % | 55.1 | % | 55.1 | % | NM | 1.60 | x | |||||||||||||||||||||||||||
Minimum | $ | 10.00 | $ | 34.00 | $ | 288 | 23.23 | % | -0.18 | % | -0.78 | % | 50.8 | % | 50.8 | % | NM | 1.37 | x | |||||||||||||||||||||||||||
All Public Life Insurance Companies | ||||||||||||||||||||||||||||||||||||||||||||||
Average | $ | 66.40 | $ | 10,482.5 | $ | 130,630 | 12.98 | % | 0.42 | % | 1.29 | % | 112.3 | % | 119.8 | % | 17.51 | x | 1.35 | x | ||||||||||||||||||||||||||
Median | $ | 51.48 | $ | 4,373.7 | $ | 45,699 | 13.36 | % | 0.59 | % | 8.35 | % | 98.6 | % | 117.9 | % | 12.81 | x | 1.16 | x | ||||||||||||||||||||||||||
Peer Group | ||||||||||||||||||||||||||||||||||||||||||||||
Average | $ | 64.08 | $ | 1,264.1 | $ | 13,748 | 17.52 | % | 0.88 | % | 5.65 | % | 93.9 | % | 97.4 | % | 19.56 | x | 1.52 | x | ||||||||||||||||||||||||||
Median | $ | 27.95 | $ | 436.7 | $ | 4,511 | 14.93 | % | 0.62 | % | 5.38 | % | 85.8 | % | 85.8 | % | 14.16 | x | 1.31 | x | ||||||||||||||||||||||||||
Peer Group Companies | ||||||||||||||||||||||||||||||||||||||||||||||
American Equity Investment Life Holding Company | West Des Moines, IA | AEL | NYSE | $ | 32.13 | $ | 2,863.5 | $ | 60,380 | 4.58 | % | 0.45 | % | 10.18 | % | 103.4 | % | 103.4 | % | 11.16 | x | 0.87 | x | |||||||||||||||||||||||
Citizens, Inc. | Austin, TX | CIA | NYSE | $ | 7.48 | $ | 374.6 | $ | 1,651 | 16.00 | % | 0.39 | % | 2.42 | % | 141.8 | % | 152.3 | % | 60.49 | x | 1.48 | x | |||||||||||||||||||||||
CNO Financial Group, Inc. | Carmel, IN | CNO | NYSE | $ | 24.87 | $ | 4,172.2 | $ | 32,705 | 14.93 | % | 1.48 | % | 10.36 | % | 85.5 | % | 85.5 | % | 8.98 | x | 0.99 | x | |||||||||||||||||||||||
FBL Financial Group, Inc. | West Des Moines, IA | FFG | NYSE | $ | 71.80 | $ | 1,790.2 | $ | 9,892 | 12.93 | % | 1.16 | % | 9.15 | % | 140.3 | % | 141.4 | % | 15.99 | x | 2.43 | x | |||||||||||||||||||||||
Independence Holding Company | Stamford, CT | IHC | NYSE | $ | 27.95 | $ | 415.4 | $ | 1,039 | 40.69 | % | 3.02 | % | 7.69 | % | 99.2 | % | 117.6 | % | 14.12 | x | 1.31 | x | |||||||||||||||||||||||
Kansas City Life Insurance Company | Kansas City, MO | KCLI | OTCQX | $ | 45.10 | $ | 436.7 | $ | 4,511 | 15.62 | % | 0.51 | % | 3.31 | % | 62.0 | % | 62.0 | % | 18.95 | x | 0.97 | x | |||||||||||||||||||||||
National Western Life Group, Inc. | Austin, TX | NWLI | NASDAQ | $ | 337.03 | $ | 1,158.1 | $ | 12,138 | 14.85 | % | 0.79 | % | 5.38 | % | 68.0 | % | 68.0 | % | 12.62 | x | 1.43 | x | |||||||||||||||||||||||
Security National Financial Corporation | Salt Lake City, UT | SNFCA | NASDAQ | $ | 5.40 | $ | 82.4 | $ | 1,008 | 13.83 | % | 0.62 | % | 4.39 | % | 59.2 | % | 60.4 | % | 14.21 | x | 0.29 | x | |||||||||||||||||||||||
UTG, Inc. | Springfield, IL | UTGN | OTC Pink | $ | 25.00 | $ | 83.4 | $ | 405 | 24.24 | % | -0.49 | % | -2.06 | % | 85.8 | % | 85.8 | % | NM | 3.88 | x |
(1) Financial information is on a pro forma basis for Federal Life. Peer Group data is as of September 30, 2017.
Source: S&P Global Market Intelligence and Federal Life's internal f inancials, as of September 30, 2017 for Federal Lif e and September 30, 2017 for all other Companies.
RP Financial, LC.
Page 4.16
2. P/B. The application of the P/B valuation method requires calculating the Company’s pro forma market value by applying a valuation P/B ratio to Federal Life’s pro forma book value. In applying the P/B approach, we relied most heavily on tangible book value (i.e., book value net of intangible assets) because historically the market has not generally given credit for intangible assets.
At the estimated midpoint of the offering range, Federal Life exhibited a pro forma reported and tangible P/B ratios equal 55.1% (the ratios are the same for Federal Life because the Company has no intangible assets on its balance sheet). The Peer Group’s median reported and tangible P/B median ratios were both 85.8%. Accordingly, the Company’s pro forma reported and tangible P/B ratios are both discounted by 36%. RP Financial considered these discounts to be appropriate considering the downward adjustments indicated above, including the Company’s history of operating losses and the more limited liquidity of the stock in the aftermarket coupled with Federal Life’s status as a new issue. These discounts were mitigated to an extent by various positive considerations including the potential ability of the Standby Purchaser to assist the Company in restoring profitability through its industry relationships and related ability to facilitate the Company’s implementation of a growth-oriented business plan.
3. P/Revenues. The P/Revenues valuation methodology determines market value by applying a valuation P/Revenue ratio to the Company’s pro forma revenues. At the estimated midpoint value, Federal Life’s value equaled 1.60x pro forma revenues, which is at a premium of 5.3 percent to the Peer Group average of 1.52x and at a premium of 22.1% to the Peer Group median of 1.31x. A benefit of the revenues approach is that it is not significantly impacted by the offering proceeds, unlike the earnings and book value approaches. At the same time, we believe that investors tend to focus more heavily on overall net earnings levels rather than the magnitude of overall revenues.
Comparison to Recent Demutualizations
We also considered the conversion offering by ICC Holdings, an Illinois-domiciled insurance company, which completed its offering on March 24, 2017, raising gross proceeds of $40 million, which is comparable in size to the Company’s proposed offering size. The transaction was completed at a pro forma P/TB ratio of 56.3% while the pro forma P/E multiple was 17.0x. The fact that ICC Holdings was profitable on pre-conversion basis represents a significant difference from Federal Life’s history of operating losses. At the same time, we considered that the bull market environment has continued, both with respect to the broad market and insurance underwriters, and that Federal Life has developed a growth oriented business plan which is dependent on the capital raised in the offering.
RP Financial, LC.
Page 4.17
Valuation Conclusion
Based on the foregoing, it is our opinion that, based on stock prices as of December 22, 2017, and financial statements through September 30, 2017, the estimated aggregate pro forma market value of the shares to be issued immediately following the offering, was $40,000,000 (the “midpoint value”). A range of value will be established based on the midpoint value to be responsive to moderate changes in market conditions. The resulting range of value pursuant to regulatory guidelines, and the corresponding number of shares based on the Board determined $10.00 per share offering price, is set forth below.
Table 4.4
Federal Life Insurance Company
Valuation Range and Offering Characteristics
Aggregate | ||||||||
Shares | Value | Shares (1) | ||||||
Maximum | $ | 46,000,000 | 4,600,000 | |||||
Midpoint | $ | 40,000,000 | 4,000,000 | |||||
Minimum | $ | 34,000,000 | 3,400,000 | |||||
(1) Based on offering price of $10.00 per share. |
EXHIBITS
LIST OF EXHIBITS
Exhibit | ||
Number | Description | |
I-1 | Federal Life’s Unaudited Financial Statements | |
I-2 | Financial Data based on Statutory Accounting Principles | |
IV-1 | Pricing and Financial Characteristics of Public Life Insurance Companies | |
IV-2 | Pro Forma Analysis Sheet | |
IV-3 | Pro Forma Effect of Offering Proceeds | |
V-1 | Firm Qualifications Statement |
EXHIBIT I-1
Federal Life Insurance Company Unaudited
Financial Statements
[Incorporated by Reference]
EXHIBIT I-2
Federal Life Insurance Company
Financial Statements Based on Statutory Accounting Data
Federal Life Insurance Company | Life Balance Sheet
MI STAT ENTITY KEY: C2347
Periods Last Five Years
2012 Y | 2013 Y | 2014 Y | 2015 Y | 2016 Y | ||||||||||||||||
Period Ended | 12/31/2012 | 12/31/2013 | 12/31/2014 | 12/31/2015 | 12/31/2016 | |||||||||||||||
Data displayed in $000 unless otherwise noted | ||||||||||||||||||||
Assets | ||||||||||||||||||||
Investments: | ||||||||||||||||||||
Bonds | 163,926 | 165,160 | 166,181 | 168,725 | 168,634 | |||||||||||||||
Preferred Stocks | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Common Stocks | 12,152 | 13,037 | 11,568 | 10,667 | 8,468 | |||||||||||||||
Mortgage Loans | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Real Estate | 1,966 | 1,873 | 1,826 | 1,882 | 1,987 | |||||||||||||||
Contract Loans | 10,145 | 10,461 | 10,322 | 10,129 | 10,059 | |||||||||||||||
Derivatives | 0 | 0 | 0 | 0 | 60 | |||||||||||||||
Cash & Short Term Investments | 3,228 | 4,348 | 6,293 | 5,687 | 7,080 | |||||||||||||||
Other Investments | 0 | 0 | 0 | 0 | 2,000 | |||||||||||||||
Total Cash & Investments | 191,417 | 194,879 | 196,189 | 197,090 | 198,287 | |||||||||||||||
Premiums and Considerations Due | 4,500 | 4,412 | 4,060 | 4,219 | 4,497 | |||||||||||||||
Reinsurance Recoverable | 2 | 0 | 50 | 0 | 0 | |||||||||||||||
Receivable from Parent, Subsidiary or Affiliates | 34 | 4 | 0 | 0 | 0 | |||||||||||||||
All Other Admitted Assets | 2,654 | 2,874 | 2,744 | 3,045 | 3,223 | |||||||||||||||
Total Assets without Separate Account | 198,607 | 202,169 | 203,044 | 204,355 | 206,006 | |||||||||||||||
Separate Account Assets | 21,536 | 26,068 | 26,651 | 23,335 | 21,513 | |||||||||||||||
Total Assets | 220,144 | 228,237 | 229,695 | 227,690 | 227,519 | |||||||||||||||
Liabilities | ||||||||||||||||||||
Net Policy Reserves - Life | 162,403 | 166,454 | 169,171 | 171,775 | 173,876 | |||||||||||||||
Net Policy Reserves - A&H | 563 | 491 | 491 | 422 | 351 | |||||||||||||||
Liability for Deposit-Type Contracts | 9,679 | 9,379 | 9,603 | 10,039 | 10,529 | |||||||||||||||
Total Policy Reserves plus Deposits | 172,645 | 176,325 | 179,265 | 182,236 | 184,756 | |||||||||||||||
Contract Claims | 1,906 | 2,248 | 1,490 | 1,806 | 1,889 | |||||||||||||||
Interest Maintenance Reserve | 847 | 918 | 733 | 869 | 686 | |||||||||||||||
Asset Valuation Reserve | 2,922 | 3,230 | 2,928 | 2,765 | 2,822 | |||||||||||||||
Reinsurance Liabilities | 0 | 0 | 0 | 0 | 0 |
2012 Y | 2013 Y | 2014 Y | 2015 Y | 2016 Y | ||||||||||||||||
Commissions, expenses, and tax due | 705 | 815 | 673 | 637 | 663 | |||||||||||||||
Payable to Parent, Subs or Affiliates | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Derivatives | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
All Other Liabilities | 173,243 | 176,971 | 179,932 | 182,979 | 185,231 | |||||||||||||||
Total Liabilities without Sep Accounts | 179,623 | 184,182 | 185,757 | 189,056 | 191,290 | |||||||||||||||
From Separate Account Statements | 21,536 | 26,068 | 26,651 | 23,335 | 21,513 | |||||||||||||||
Total Liabilities incl Sep Accounts | 201,160 | 210,250 | 212,408 | 212,392 | 212,803 | |||||||||||||||
Capital and Surplus | ||||||||||||||||||||
Common Capital Stock | 0 | 0 | 0 | 0 | 2,500 | |||||||||||||||
Preferred Capital Stock | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Surplus Notes | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Unassigned Surplus | 18,584 | 17,588 | 16,887 | 14,899 | 14,316 | |||||||||||||||
Other Including Gross Contributed | 400 | 400 | 400 | 400 | (2,100 | ) | ||||||||||||||
Capital & Surplus | 18,984 | 17,988 | 17,287 | 15,299 | 14,716 | |||||||||||||||
Total Liabilities and C&S | 220,144 | 228,237 | 229,695 | 227,690 | 227,519 | |||||||||||||||
Memo: Affiliated Investments | ||||||||||||||||||||
Bonds | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Preferred Stocks | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Common Stocks | 5,195 | 6,186 | 550 | 572 | 578 | |||||||||||||||
Mortgage Loans | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Cash & Short Term Investments | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
All Other Investments | 0 | 0 | 0 | 0 | 2,000 | |||||||||||||||
Total Affiliated Investments | 5,195 | 6,186 | 550 | 572 | 2,578 | |||||||||||||||
Total Cash & Investments, Excl Affiliated | 186,221 | 188,693 | 195,639 | 196,519 | 195,708 |
Site content and design Copyright © 2018, S&P Global Market Intelligence
Usage of this product is governed by the SNL Master Subscription Agreement or separate S&P Agreement, as applicable.
S&P Global Market Intelligence, 55 Water Street, New York, NY 10041,
Federal Life Insurance Company | Life Income Statement
MI STAT ENTITY KEY: C2347
Periods Last Five Years
2012 Y | 2013 Y | 2014 Y | 2015 Y | 2016 Y | ||||||||||||||||
Period Ended | 12/31/2012 | 12/31/2013 | 12/31/2014 | 12/31/2015 | 12/31/2016 | |||||||||||||||
Data displayed in $000 unless otherwise noted | ||||||||||||||||||||
Revenue | ||||||||||||||||||||
Life Insurance Premiums | 20,179 | 19,472 | 18,386 | 17,535 | 15,262 | |||||||||||||||
Annuity Premiums & Deposits | 1,997 | 3,522 | 2,065 | 3,098 | 7,376 | |||||||||||||||
Accident & Health Premiums | 220 | 199 | 176 | 153 | 139 | |||||||||||||||
Credit Life & Credit A&H Premiums | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Other Premiums & Considerations | 0 | 71 | 0 | 40 | 223 | |||||||||||||||
Premiums, Consideration and Deposits | 22,396 | 23,264 | 20,627 | 20,826 | 23,001 | |||||||||||||||
Net Investment Income | 10,431 | 10,629 | 10,281 | 9,747 | 9,586 | |||||||||||||||
Reinsurance Allowance | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Separate Accounts Revenue | 171 | 199 | 218 | 220 | 183 | |||||||||||||||
Other Income | 282 | 326 | 334 | 383 | 410 | |||||||||||||||
Total Revenue | 33,280 | 34,419 | 31,460 | 31,176 | 33,181 | |||||||||||||||
Expense | ||||||||||||||||||||
Life Benefits | 12,198 | 13,725 | 11,685 | 10,424 | 10,386 | |||||||||||||||
Annuity Benefits | 7,061 | 5,895 | 5,938 | 4,176 | 6,481 | |||||||||||||||
Accident & Health Benefits | 168 | 184 | 198 | 118 | 92 | |||||||||||||||
Credit Life & Credit A&H Benefits | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Other Benefits | 248 | 234 | 239 | 215 | 220 | |||||||||||||||
Total Benefits | 19,675 | 20,039 | 18,059 | 14,933 | 17,178 | |||||||||||||||
Life Surrenders | 2,563 | 2,294 | 3,262 | 3,415 | 3,367 | |||||||||||||||
Annuity Surrenders | 0 | 0 | 0 | 2,750 | 3,758 | |||||||||||||||
Accident & Health Surrenders | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Credit Life & Credit A&H Surrenders | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Other Surrenders | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Total Surrenders | 2,563 | 2,294 | 3,262 | 6,165 | 7,125 | |||||||||||||||
Life Inc. in Reserves | 3,495 | 3,438 | 3,048 | 2,707 | (517 | ) |
2012 Y | 2013 Y | 2014 Y | 2015 Y | 2016 Y | ||||||||||||||||
Annuity Inc. in Reserves | (2,504 | ) | 863 | 18 | 1,012 | 2,723 | ||||||||||||||
Accident & Health Inc. in Reserves | (250 | ) | (72 | ) | 0 | (69 | ) | (71 | ) | |||||||||||
Credit Life & Credit A&H Inc. in Reserves | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Other Inc. in Reserves | (56 | ) | 17 | (89 | ) | 31 | 210 | |||||||||||||
Total Inc. in Reserves | 685 | 4,246 | 2,977 | 3,680 | 2,345 | |||||||||||||||
Life Trsfrs. to Sep. Accts | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Annuity Trsfrs. to Sep. Accts | (146 | ) | (779 | ) | (1,840 | ) | (2,714 | ) | (3,733 | ) | ||||||||||
Accident & Health Trsfrs. to Sep. Accts | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Credit Life & Credit A&H Trsfrs. to Sep. Accts | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Other Trsfrs. to Sep. Accts | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Total Trsfrs. to Sep. Accts | (146 | ) | (779 | ) | (1,840 | ) | (2,714 | ) | (3,733 | ) | ||||||||||
Commissions | 1,700 | 1,759 | 1,538 | 1,656 | 1,925 | |||||||||||||||
General & Administrative Expenses | 9,926 | 8,904 | 8,689 | 8,838 | 9,026 | |||||||||||||||
Insurance Taxes, Licenses and Fees | 909 | 863 | 791 | 766 | 722 | |||||||||||||||
Other Expenses | (15 | ) | (67 | ) | (99 | ) | 66 | (99 | ) | |||||||||||
Total Expenses | 35,298 | 37,259 | 33,378 | 33,390 | 34,490 | |||||||||||||||
Net Income | ||||||||||||||||||||
Policyholder Dividends | 287 | 284 | 271 | 253 | 86 | |||||||||||||||
Net Gain from Operations before FIT | (2,305 | ) | (3,124 | ) | (2,189 | ) | (2,467 | ) | (1,395 | ) | ||||||||||
Federal Income Tax | (156 | ) | (424 | ) | (335 | ) | (245 | ) | (310 | ) | ||||||||||
Net Income before Cap Gains | (2,149 | ) | (2,700 | ) | (1,854 | ) | (2,222 | ) | (1,085 | ) | ||||||||||
Net Realized Capital Gains (Losses) | 410 | 299 | 1,234 | (55 | ) | 1,021 | ||||||||||||||
Net Income | (1,739 | ) | (2,402 | ) | (620 | ) | (2,276 | ) | (64 | ) | ||||||||||
Pre-tax Operating Income | (2,305 | ) | (3,124 | ) | (2,189 | ) | (2,467 | ) | (1,395 | ) | ||||||||||
Change In Capital and Surplus | ||||||||||||||||||||
Capital & Surplus, Beginning of Period | 20,462 | 18,984 | 17,988 | 17,287 | 15,299 | |||||||||||||||
Net Income | (1,739 | ) | (2,402 | ) | (620 | ) | (2,276 | ) | (64 | ) | ||||||||||
Net Unrealized Capital Gains (Losses) | 638 | 1,679 | (433 | ) | 252 | (403 | ) | |||||||||||||
Change in Surplus Notes | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Capital Changes & Surplus Adj | 0 | 0 | 0 | 0 | 0 |
2012 Y | 2013 Y | 2014 Y | 2015 Y | 2016 Y | ||||||||||||||||
Dividends to Stockholders | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
All Other Changes in Surplus | (378 | ) | (274 | ) | 352 | 36 | (116 | ) | ||||||||||||
Capital & Surplus, Current Period Ended | 18,984 | 17,988 | 17,287 | 15,299 | 14,716 |
Site content and design Copyright © 2018, S&P Global Market Intelligence
Usage of this product is governed by the SNL Master Subscription Agreement or separate S&P Agreement, as applicable.
S&P Global Market Intelligence, 55 Water Street, New York, NY 10041,
Federal Life Insurance Company | Life Financial Highlights
MI STAT ENTITY KEY: C2347
Periods Last Five Years
2012 Y | 2013 Y | 2014 Y | 2015 Y | 2016 Y | ||||||||||||||||
Period Ended | 12/31/2012 | 12/31/2013 | 12/31/2014 | 12/31/2015 | 12/31/2016 | |||||||||||||||
Data displayed in $000 unless otherwise noted | ||||||||||||||||||||
Balance Sheet | ||||||||||||||||||||
Total Cash and Investments | 191,417 | 194,879 | 196,189 | 197,090 | 198,287 | |||||||||||||||
Separate Account Assets | 21,536 | 26,068 | 26,651 | 23,335 | 21,513 | |||||||||||||||
Total Assets | 220,144 | 228,237 | 229,695 | 227,690 | 227,519 | |||||||||||||||
Affiliated Investments (incl above) | 5,195 | 6,186 | 550 | 572 | 2,578 | |||||||||||||||
Net Policy Reserves - Life | 162,403 | 166,454 | 169,171 | 171,775 | 173,876 | |||||||||||||||
Net Policy Reserves - A&H | 563 | 491 | 491 | 422 | 351 | |||||||||||||||
Total Policy Reserves | 162,966 | 166,946 | 169,662 | 172,197 | 174,227 | |||||||||||||||
Interest Maintenance Reserve | 847 | 918 | 733 | 869 | 686 | |||||||||||||||
Asset Valuation Reserve | 2,922 | 3,230 | 2,928 | 2,765 | 2,822 | |||||||||||||||
Total Liabilities | 201,160 | 210,250 | 212,408 | 212,392 | 212,803 | |||||||||||||||
Surplus Notes | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Capital and Surplus | 18,984 | 17,988 | 17,287 | 15,299 | 14,716 | |||||||||||||||
C&S / Assets (%) | 9.56 | 8.90 | 8.51 | 7.49 | 7.14 | |||||||||||||||
Total Reserves & Deposits / C&S (%) | 909.41 | 980.25 | 1,037.00 | 1,191.19 | 1,255.46 | |||||||||||||||
Income Statement | ||||||||||||||||||||
Premiums, Consideration & Deposits | 22,396 | 23,264 | 20,627 | 20,826 | 23,001 | |||||||||||||||
Net Investment Income | 10,431 | 10,629 | 10,281 | 9,747 | 9,586 | |||||||||||||||
Separate Accounts Revenue | 171 | 199 | 218 | 220 | 183 | |||||||||||||||
Total Revenue | 33,280 | 34,419 | 31,460 | 31,176 | 33,181 | |||||||||||||||
Benefits | 19,675 | 20,039 | 18,059 | 14,933 | 17,178 | |||||||||||||||
Surrenders | 2,563 | 2,294 | 3,262 | 6,165 | 7,125 | |||||||||||||||
Increase in Reserves and Deposits | 685 | 4,246 | 2,977 | 3,680 | 2,345 | |||||||||||||||
Commissions | 1,700 | 1,759 | 1,538 | 1,656 | 1,925 | |||||||||||||||
General & Administrative Expense | 9,926 | 8,904 | 8,689 | 8,838 | 9,026 | |||||||||||||||
Net transfers to Separate Accounts | (146 | ) | (779 | ) | (1,840 | ) | (2,714 | ) | (3,733 | ) | ||||||||||
Policyholder Dividends | 287 | 284 | 271 | 253 | 86 | |||||||||||||||
Income Tax | (156 | ) | (424 | ) | (335 | ) | (245 | ) | (310 | ) | ||||||||||
Net Realized Capital Gains (Losses) | 410 | 299 | 1,234 | (55 | ) | 1,021 | ||||||||||||||
Net Income | (1,739 | ) | (2,402 | ) | (620 | ) | (2,276 | ) | (64 | ) | ||||||||||
Pre-tax Operating Income | (2,305 | ) | (3,124 | ) | (2,189 | ) | (2,467 | ) | (1,395 | ) | ||||||||||
Premiums & Annuity Considerations By Major Segment (%) | ||||||||||||||||||||
Life | 90.10 | 83.70 | 89.13 | 84.20 | 66.35 | |||||||||||||||
Annuities | 8.92 | 15.14 | 10.01 | 14.88 | 32.07 | |||||||||||||||
Accident & Health | 0.98 | 0.86 | 0.85 | 0.73 | 0.61 | |||||||||||||||
Credit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
Other | 0.00 | 0.30 | 0.00 | 0.19 | 0.97 | |||||||||||||||
Operating Ratios (%) | ||||||||||||||||||||
Growth Rate - Direct Premium & Annuity Cnsdrtns | (7.11 | ) | 9.03 | (6.63 | ) | 6.43 | 20.18 | |||||||||||||
Growth Rate - Premium & Annuity Cnsdrtns | (12.75 | ) | 3.88 | (11.34 | ) | 0.97 | 10.44 | |||||||||||||
Growth Rate - Operating Income | NM | NM | NM | NM | NM | |||||||||||||||
Growth Rate - Revenue | (10.08 | ) | 3.42 | (8.60 | ) | (0.90 | ) | 6.43 | ||||||||||||
Benefit Ratio (Premiums) | 87.85 | 86.14 | 87.55 | 71.70 | 74.68 | |||||||||||||||
Commission Ratio | 7.59 | 7.56 | 7.46 | 7.95 | 8.37 | |||||||||||||||
Expense Ratio (Premiums) | 44.32 | 38.27 | 42.12 | 42.44 | 39.24 |
2012 Y | 2013 Y | 2014 Y | 2015 Y | 2016 Y | ||||||||||||||||
Change in Policyholder Dividend | (7.64 | ) | (1.16 | ) | (4.55 | ) | (6.61 | ) | (65.90 | ) | ||||||||||
Effective Tax Rate | NM | NM | NM | NM | NM | |||||||||||||||
Net Yield on Avg. Invested Assets | 5.43 | 5.50 | 5.28 | 4.97 | 4.87 | |||||||||||||||
Pre-Tax Operating Margin | (6.93 | ) | (9.08 | ) | (6.96 | ) | (7.91 | ) | (4.20 | ) | ||||||||||
Return on Average Equity | (8.86 | ) | (13.35 | ) | (3.53 | ) | (14.17 | ) | (0.45 | ) | ||||||||||
Pre-Tax Operating ROAE | (11.74 | ) | (17.36 | ) | (12.47 | ) | (15.35 | ) | (9.84 | ) | ||||||||||
Return on Average Assets | (0.78 | ) | (1.06 | ) | (0.27 | ) | (0.99 | ) | (0.03 | ) | ||||||||||
Capital, Leverage & Liquidity (%) | ||||||||||||||||||||
RBC - Total Adjusted Capital | 22,053 | 21,360 | 20,350 | 18,192 | 17,581 | |||||||||||||||
ACL Risk Based Capital | 3,471 | 3,373 | 3,095 | 3,052 | 2,906 | |||||||||||||||
Risk Based Capital Ratio(TAC/ACL RBC) | 635.32 | 633.27 | 657.47 | 595.98 | 604.91 | |||||||||||||||
Net Premiums Written / C&S | 114.11 | 129.28 | 117.53 | 129.63 | 162.27 | |||||||||||||||
Affiliated Investments / C&S | 27.37 | 34.39 | 3.18 | 3.74 | 17.52 | |||||||||||||||
Dividends to Stockholders ($000) | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Reserve Analysis | ||||||||||||||||||||
Total Reserves including Separate Accounts | 194,181 | 202,393 | 205,916 | 205,571 | 206,270 | |||||||||||||||
Growth Rate Total Reserves incl. SA (%) | 1.46 | 4.23 | 1.74 | (0.17 | ) | 0.34 | ||||||||||||||
Investments (%) | ||||||||||||||||||||
Net Yield on Invested Assets | 5.43 | 5.50 | 5.28 | 4.97 | 4.87 | |||||||||||||||
Unaff. Bonds / Unaff. Investments | 88.03 | 87.53 | 84.94 | 85.86 | 86.17 | |||||||||||||||
Unaff. Preferred Stocks / Unaff. Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
Unaff. Common Stocks / Unaff. Investments | 3.74 | 3.63 | 5.63 | 5.14 | 4.03 | |||||||||||||||
Affiliated Investments / Total Investments | 2.71 | 3.17 | 0.28 | 0.29 | 1.30 | |||||||||||||||
Gross Yield - Bonds (excl affiliates) | 5.44 | 5.16 | 5.04 | 4.77 | 4.63 | |||||||||||||||
Bond Average Asset Quality (1-6) (#) | 1.49 | 1.44 | 1.43 | 1.46 | 1.45 | |||||||||||||||
Bonds Rated 3-6 / Total Bonds | 7.46 | 5.32 | 5.35 | 5.23 | 4.90 | |||||||||||||||
Bonds < 1 Year / Total Bonds | 11.51 | 11.94 | 16.56 | 15.21 | 9.94 | |||||||||||||||
Reinsurance Analysis ($000) | ||||||||||||||||||||
Reinsurance Ceded - Premiums & Annuity Considerations | ||||||||||||||||||||
Life | 218 | 237 | 224 | 230 | 1,872 | |||||||||||||||
Annuities | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Accident and Health | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Reinsurance Ceded - Reserve Credits Taken | ||||||||||||||||||||
Life & Annuities General Accounts | 375 | 378 | 401 | 411 | 2,378 | |||||||||||||||
Life & Annuities Separate Accounts | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Accident & Health (incl Unearned Prem) | 32 | 0 | 0 | 0 | 0 | |||||||||||||||
Reinsurance Ceded - Outstanding Surplus Relief | ||||||||||||||||||||
Life & Annuities General Accounts | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Life & Annuities Separate Accounts | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Accident and Health | 0 | 0 | 0 | 0 | 0 |
Site content and design Copyright © 2018, S&P Global Market Intelligence
Usage of this product is governed by the SNL Master Subscription Agreement or separate S&P Agreement, as applicable.
S&P Global Market Intelligence, 55 Water Street, New York, NY 10041,
EXHIBIT IV-1
Pricing and Financial Characteristics of Public Life Insurance Companies
Exhibit IV-1
Public Life Insurance Market Pricing
As of December 22, 2017
Market Capitalization | Dividends(4) | Financial Characteristics(6) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Price/ | Market | Pricing Ratios(3) | Amount/ | Payout | Total | Equity/ | Tang. Eq./ | Reported | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Share(1) | Value | P/E | P/B | P/TB | P/TTM Rev | Share | Yield | Ratio(5) | Assets | Assets | T. Assets | ROAA | ROAE | |||||||||||||||||||||||||||||||||||||||||||||||
($) | ($Mil) | (x) | (%) | (%) | (x) | ($) | (%) | (%) | ($Mil) | (%) | (%) | (%) | (%) | |||||||||||||||||||||||||||||||||||||||||||||||
Comparable Group | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Averages | $ | 70.29 | $ | 11,360.62 | 16.86 | x | 118.22 | % | 127.07 | % | 1.43 | x | $ | 0.82 | 1.11 | % | 18.09 | % | $ | 137,723 | 13.04 | % | 12.62 | % | 0.43 | % | 1.13 | % | ||||||||||||||||||||||||||||||||
Medians | $ | 53.31 | $ | 5,853.27 | 12.81 | x | 101.30 | % | 118.49 | % | 1.27 | x | $ | 0.48 | 0.79 | % | 16.01 | % | $ | 45,699 | 13.36 | % | 13.21 | % | 0.70 | % | 9.08 | % | ||||||||||||||||||||||||||||||||
Comparable Group | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AFL | Aflac Incorporated | GA | $ | 87.21 | $ | 34,286.58 | 12.64 | x | 156.30 | % | NA | 1.54 | x | $ | 1.80 | 2.06 | % | 26.09 | % | $ | 136,083 | 16.15 | % | NA | 2.06 | % | 13.09 | % | ||||||||||||||||||||||||||||||||
AEL | American Equity Investment Life Holding Compa | IA | $ | 32.13 | $ | 2,863.48 | 11.16 | x | 103.43 | % | 103.43 | % | 0.87 | x | $ | 0.26 | 0.81 | % | 9.03 | % | $ | 60,380 | 4.58 | % | 4.58 | % | 0.45 | % | 10.18 | % | ||||||||||||||||||||||||||||||
ATH | Athene Holding Ltd. | $ | 51.82 | $ | 10,361.74 | NA | 119.53 | % | 119.53 | % | 1.75 | x | $ | 0.00 | 0.00 | % | NA | $ | 96,061 | 9.02 | % | 9.02 | % | 1.49 | % | 17.64 | % | |||||||||||||||||||||||||||||||||
BHF | Brighthouse Financial, Inc. | NC | $ | 59.54 | $ | 7,131.29 | NA | 51.80 | % | 51.80 | % | 1.62 | x | $ | 0.00 | 0.00 | % | NA | $ | 223,279 | 6.19 | % | 6.19 | % | -1.25 | % | -18.01 | % | ||||||||||||||||||||||||||||||||
CIA | Citizens, Inc. | TX | $ | 7.48 | $ | 374.61 | 60.49 | x | 141.78 | % | 152.28 | % | 1.48 | x | $ | 0.00 | 0.00 | % | 0.00 | % | $ | 1,651 | 16.00 | % | 15.06 | % | 0.39 | % | 2.42 | % | ||||||||||||||||||||||||||||||
CNO | CNO Financial Group, Inc. | IN | $ | 24.87 | $ | 4,172.25 | 8.98 | x | 85.47 | % | 85.47 | % | 0.99 | x | $ | 0.36 | 1.45 | % | 13.00 | % | $ | 32,705 | 14.93 | % | 14.93 | % | 1.48 | % | 10.36 | % | ||||||||||||||||||||||||||||||
FFG | FBL Financial Group, Inc. | IA | $ | 71.80 | $ | 1,790.23 | 15.99 | x | 140.34 | % | 141.45 | % | 2.43 | x | $ | 1.76 | 2.45 | % | 39.20 | % | $ | 9,892 | 12.93 | % | 12.84 | % | 1.16 | % | 9.15 | % | ||||||||||||||||||||||||||||||
IHC | Independence Holding Company | CT | $ | 27.95 | $ | 415.40 | 14.12 | x | 99.16 | % | 117.56 | % | 1.31 | x | $ | 0.12 | 0.43 | % | 6.06 | % | $ | 1,039 | 40.69 | % | 36.69 | % | 3.02 | % | 7.69 | % | ||||||||||||||||||||||||||||||
KCLI | Kansas City Life Insurance Company | MO | $ | 45.10 | $ | 436.72 | 18.95 | x | 62.00 | % | 62.00 | % | 0.97 | x | $ | 1.08 | 2.39 | % | 45.38 | % | $ | 4,511 | 15.62 | % | 15.62 | % | 0.51 | % | 3.31 | % | ||||||||||||||||||||||||||||||
LNC | Lincoln National Corporation | PA | $ | 77.75 | $ | 17,013.99 | 12.17 | x | 104.63 | % | 121.57 | % | 1.23 | x | $ | 1.32 | 1.70 | % | 20.66 | % | $ | 276,785 | 5.89 | % | 5.11 | % | 0.54 | % | 9.42 | % | ||||||||||||||||||||||||||||||
MET | MetLife, Inc. | NY | $ | 50.76 | $ | 53,414.71 | NM | 97.99 | % | 118.77 | % | 0.91 | x | $ | 1.60 | 3.15 | % | NA | $ | 720,515 | 7.90 | % | 6.67 | % | -0.05 | % | -0.65 | % | ||||||||||||||||||||||||||||||||
MDWT | Midwest Holding Inc. | NE | $ | 0.06 | $ | 1.39 | NM | 74.52 | % | 118.21 | % | 0.32 | x | $ | 0.00 | 0.00 | % | NA | $ | 48 | 4.92 | % | 3.50 | % | -10.16 | % | -123.48 | % | ||||||||||||||||||||||||||||||||
NWLI | National Western Life Group, Inc. | TX | $ | 337.03 | $ | 1,158.09 | 12.62 | x | 67.98 | % | 67.98 | % | 1.43 | x | $ | 0.36 | 0.11 | % | 1.35 | % | $ | 12,138 | 14.85 | % | 14.85 | % | 0.79 | % | 5.38 | % | ||||||||||||||||||||||||||||||
PRI | Primerica, Inc. | GA | $ | 103.40 | $ | 4,575.25 | 20.12 | x | 358.36 | % | 373.64 | % | 2.79 | x | $ | 0.80 | 0.77 | % | 15.56 | % | $ | 12,207 | 10.49 | % | 10.10 | % | 2.04 | % | 19.14 | % | ||||||||||||||||||||||||||||||
PFG | Principal Financial Group, Inc. | IA | $ | 71.26 | $ | 20,576.66 | 11.68 | x | 171.37 | % | 213.56 | % | 1.43 | x | $ | 1.96 | 2.75 | % | 32.13 | % | $ | 247,934 | 4.87 | % | 3.95 | % | 0.77 | % | 16.66 | % | ||||||||||||||||||||||||||||||
PRU | Prudential Financial, Inc. | NJ | $ | 116.16 | $ | 49,251.84 | 11.67 | x | 97.94 | % | NA | 0.87 | x | $ | 3.00 | 2.58 | % | 30.15 | % | $ | 821,131 | 6.16 | % | NA | 0.55 | % | 9.01 | % | ||||||||||||||||||||||||||||||||
RGA | Reinsurance Group of America, Incorporated | MO | $ | 155.07 | $ | 9,987.14 | 12.76 | x | 123.27 | % | 123.38 | % | 0.81 | x | $ | 2.00 | 1.29 | % | 16.46 | % | $ | 58,694 | 13.80 | % | 13.79 | % | 1.43 | % | 10.42 | % | ||||||||||||||||||||||||||||||
SNFCA | Security National Financial Corporation | UT | $ | 5.40 | $ | 82.43 | 14.21 | x | 59.16 | % | 60.36 | % | 0.29 | x | $ | 0.00 | 0.00 | % | 0.00 | % | $ | 1,008 | 13.83 | % | 13.59 | % | 0.62 | % | 4.39 | % | ||||||||||||||||||||||||||||||
TMK | Torchmark Corporation | TX | $ | 90.69 | $ | 10,469.87 | 19.30 | x | 202.45 | % | 221.36 | % | 2.57 | x | $ | 0.60 | 0.66 | % | 12.77 | % | $ | 22,994 | 22.47 | % | 20.96 | % | 2.54 | % | 11.55 | % | ||||||||||||||||||||||||||||||
UNM | Unum Group | TN | $ | 54.79 | $ | 12,294.28 | 12.86 | x | 130.10 | % | 134.93 | % | 1.09 | x | $ | 0.92 | 1.68 | % | 21.60 | % | $ | 63,806 | 14.81 | % | 14.35 | % | 1.55 | % | 10.60 | % | ||||||||||||||||||||||||||||||
UTGN | UTG, Inc. | IL | $ | 25.00 | $ | 83.44 | NM | 85.84 | % | 85.84 | % | 3.88 | x | $ | 0.00 | 0.00 | % | NA | $ | 405 | 24.24 | % | 24.24 | % | -0.49 | % | -2.06 | % | ||||||||||||||||||||||||||||||||
VOYA | Voya Financial, Inc. | NY | $ | 51.14 | $ | 9,192.25 | NM | 67.33 | % | 68.31 | % | 0.93 | x | $ | 0.04 | 0.08 | % | NA | $ | 226,644 | 6.45 | % | 6.37 | % | -0.09 | % | -1.39 | % | ||||||||||||||||||||||||||||||||
Under Acquisition | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GNW | Genworth Financial, Inc. | VA | $ | 3.20 | $ | 1,597.31 | 4.78 | x | 12.22 | % | 12.52 | % | 0.18 | x | $ | 0.00 | 0.00 | % | NA | $ | 104,629 | 14.42 | % | 14.16 | % | 0.57 | % | 3.99 | % | |||||||||||||||||||||||||||||||
IHRC | Investors Heritage Capital Corporation | KY | $ | 44.00 | $ | 48.88 | 40.64 | x | 82.54 | % | 82.54 | % | 0.77 | x | $ | 0.01 | 0.57 | % | 23.09 | % | $ | 580 | 10.20 | % | 10.20 | % | 0.20 | % | 2.05 | % |
(1) | Core income, on a diluted per-share basis. Core income is net income after taxes and before extraordinary items, less net income attributable to noncontrolling interest, gain on the sale of securities, amortization of intangibles, goodwill and nonrec |
(2) | P/E = Price to earnings; P/B = Price to book; P/A = Price to assets; P/TB = Price to tangible book value; and P/Core = Price to core earnings. P/E and P/Core =NM if the ratio is negative or above 35x. |
(3) | Indicated 12 month dividend, based on last quarterly dividend declared. |
(4) | Indicated 12 month dividend as a percent of trailing 12 month earnings. |
(5) | ROAA (return on average assets) and ROAE (return on average equity) are indicated ratios based on trailing 12 month earnings and average equity and assets balances. |
(6) | Excludes from averages and medians those companies the subject of actual or rumored acquisition activities or unusual operating characteristics. |
Source: S&P Global Market Intelligence and RP Financial, LC. calculations. The information provided in this report has been obtained from sources we believe are reliable, but we cannot guarantee the accuracy or completeness of such information.
Copyright (c) 2017 by RP® Financial, LC.
EXHIBIT IV-2
Pro Forma Analysis Sheet
RP Financial, LC.
Financial Services Industry Consultants
Exhibit IV-2
Pro Forma Analysis Sheet
Federal Life Insurance Company
Peer Group Aggregate | ||||||||||||||||||||||
Valuation Midpoint Pricing Multiples | Symbol | Subject (1) | Mean | Median | ||||||||||||||||||
1. Price-earnings multiple | = | P/E | N.M. | 19.56 | x | 14.16 | x | |||||||||||||||
2. Price-book ratio | = | P/B | 55.10 | % | 93.90 | % | 85.80 | % | ||||||||||||||
3. Price-tangible book ratio | = | P/TB | 55.10 | % | 97.40 | % | 85.80 | % | ||||||||||||||
4. Price-revenue ratio | = | P/Rev. | 1.60 | x | 1.52 | x | 1.31 | x | ||||||||||||||
Valuation Parameters | ||||||||||||||||||||||
Pre-Conversion Reported Earnings (Y) | $ | (1,480,000 | ) | 30-Sep-17 | ESOP Stock Purchases (E) | 0.00 | % | (4) | ||||||||||||||
Pre-Conversion Core Earnings (CE) | $ | (1,480,000 | ) | 30-Sep-17 | Cost of ESOP Borrowings (S) | 0.00 | % | |||||||||||||||
Pre-Conversion Book Value (B) | $ | 36,241,000 | 30-Sep-17 | ESOP Amortization (T) | 0.00 | years | ||||||||||||||||
Pre-Conv. Tang. Book Value (TB) | $ | 36,241,000 | 30-Sep-17 | Stock Programs Amount (M) | 0.00 | % | ||||||||||||||||
Pre-Conversion Assets (A) | $ | 257,638,000 | 30-Sep-17 | Stock Programs Vesting (N) | 5.00 | years (4) | ||||||||||||||||
Pre-Conversion Revenues (Rev.) | $ | 23,812,000 | 30-Sep-17 | Percentage Sold (PCT) | 100.00 | % | ||||||||||||||||
Reinvestment Rate (R)(2) | 3.11 | % | Fixed Expenses | $ | 1,500,000 | |||||||||||||||||
Est. Conversion Expenses (X)(3) | 9.13 | % | Commissions Paid on Sales to Friends and Family | |||||||||||||||||||
Tax Rate (TAX) | 0.00 | % | Insiders, Friends and Family | 2.00 | % | |||||||||||||||||
Price/Share | $ | 10.00 | Insider Purchases | $ | 10,000,000 | |||||||||||||||||
Commissions Paid on Sales to Public/Standby Investor | 6.50 | % | ||||||||||||||||||||
Option (O1) | 0.00 | % | ||||||||||||||||||||
Estimated Option Value (O2) | 0.00 | % | ||||||||||||||||||||
Option vesting (O3) | 0.00 | |||||||||||||||||||||
Option pct taxable (O4) | 25.00 | % |
Calculation of Pro Forma Value After Conversion
1. | V= | P/E * Y | V= | N.M. | |||
(1 - P/E * PCT * ((1-X-E-M)*R - (1-TAX)*E/T - (1-TAX)*M/N) - (1-(TAX*O4))*O1*O2/O3) | |||||||
2. | V= | P/BE * (Y) | V= | N.M. | |||
(1 - P/BE * PCT * ((1-X-E-M)*R - (1-TAX)*E/T - (1-TAX)*M/N) - (1-(TAX*O4))*O1*O2/O3) | |||||||
3. | V= | P/B * B | V= | $40,000,000 | |||
1 - P/B * PCT * (1-X-E-M) | |||||||
4. | V= | P/TB * TB | V= | $40,000,000 | |||
1 - P/TB * PCT * (1-X-E-M) | |||||||
5. | V= | P/Rev. * Rev. | V= | $40,000,000 | |||
1 - P/Rev. * PCT * (1-X-E-M)*R |
Shares | Price/ | Gross | Pro Forma | |||||||||||||
Conclusion and Range of Value | Issued | Share | Proceeds | Market Value | ||||||||||||
Minimum | 3,400,000 | 10.00000 | $ | 34,000,000 | $ | 34,000,000 | ||||||||||
Midpoint | 4,000,000 | 10.00000 | $ | 40,000,000 | $ | 40,000,000 | ||||||||||
Maximum | 4,600,000 | 10.00000 | $ | 46,000,000 | $ | 46,000,000 |
(1) | Pricing ratios shown reflect the Midpoint Value. |
(2) | Net return reflects a reinvestment rate of 2.00%, and a tax rate of 0.0%. |
(3) | Estimated offering expenses at midpoint of the offering. |
(4) | Stock benefit plans amortization expenses tax effected at 0.0%. |
EXHIBIT IV-3
Pro Forma Effects of Offering Proceeds
RP Financial, LC.
Financial Services Industry Consultants
Exhibit IV-3
Pro Forma Effect of Conversion
Federal Life Insurance Company
Demutualization Proceeds | Minimum | Midpoint | Maximum | |||||||||
Shares Issued | 3,400,000 | 4,000,000 | 4,600,000 | |||||||||
Price Per Share | $ | 10.00 | $ | 10.00 | $ | 10.00 | ||||||
Gross Offering Proceeds | $ | 34,000,000 | $ | 40,000,000 | $ | 46,000,000 | ||||||
Less: Estimated Offering Expenses | 3,260,000 | 3,650,000 | 4,040,000 | |||||||||
Net Demutualization Proceeds | $ | 30,740,000 | $ | 36,350,000 | $ | 41,960,000 | ||||||
Estimated Additional Income from Demutualization Proceeds | ||||||||||||
Net Demutualization Proceeds | $ | 30,740,000 | $ | 36,350,000 | $ | 41,960,000 | ||||||
Less: Non-Cash Stock Purchases | - | - | - | |||||||||
Net Proceeds Available for Reinvestment | $ | 30,740,000 | $ | 36,350,000 | $ | 41,960,000 | ||||||
Estimated Net Incremental Rate of Return (1) | 3.11 | % | 3.11 | % | 3.11 | % | ||||||
Reinvestment Income | $ | 956,014 | $ | 1,130,485 | $ | 1,304,956 |
Before | ||||||||||||||||
Earnings Pro Forma Impact | Demutualization | Pro Forma After Demutualization | ||||||||||||||
12 Months ended September 30, 2017 | $ | (1,480,000 | ) | $ | (523,986 | ) | $ | (349,515 | ) | $ | (175,044 | ) | ||||
12 Months ended September 30, 2017 | $ | (1,480,000 | ) | $ | (523,986 | ) | $ | (349,515 | ) | $ | (175,044 | ) | ||||
Net Worth Pro Forma Impact | ||||||||||||||||
September 30, 2017 (GAAP Estimated) | $ | 36,241,000 | $ | 66,981,000 | $ | 72,591,000 | $ | 78,201,000 | ||||||||
September 30, 2017 (Tangible GAAP Estimated) | $ | 36,241,000 | $ | 66,981,000 | $ | 72,591,000 | $ | 78,201,000 | ||||||||
Revenues Pro Forma Impact | ||||||||||||||||
12 Months ended September 30, 2017 | $ | 23,812,000 | $ | 24,768,014 | $ | 24,942,485 | $ | 25,116,956 |
(1) | Based on current portfolio mix and anticipated short term use of proceeds. |
EXHIBIT V-1
RP Financial, LC.
Firm Qualifications Statement
FIRM QUALIFICATION STATEMENT |
RP® Financial (“RP®) provides financial and management consulting, merger advisory and valuation services to the financial services industry nationwide. We offer a broad array of services, high quality and prompt service, hands-on involvement by principals and senior staff, careful structuring of strategic initiatives and sophisticated valuation and other analyses consistent with industry practices and regulatory requirements. Our staff maintains extensive background in financial and management consulting, valuation and investment banking. Our clients include commercial banks, thrifts, credit unions, mortgage companies, insurance companies and other financial services companies.
STRATEGIC PLANNING SERVICES |
RP®’s strategic planning services are designed to provide effective feasible plans with quantifiable results. We analyze strategic options to enhance shareholder value, achieve regulatory approval or realize other objectives. Such services involve conducting situation analyses; establishing mission/vision statements, developing strategic goals and objectives; and identifying strategies to enhance franchise and/or market value, capital management, earnings enhancement, operational matters and organizational issues. Strategic recommendations typically focus on: capital formation and management, asset/liability targets, profitability, return on equity and stock pricing. Our proprietary financial simulation models provide the basis for evaluating the impact of various strategies and assessing their feasibility and compatibility with regulations.
MERGER ADVISORY SERVICES |
RP®’s merger advisory services include targeting potential buyers and sellers, assessing acquisition merit, conducting due diligence, negotiating and structuring merger transactions, preparing merger business plans and financial simulations, rendering fairness opinions, preparing mark-to-market analyses, valuing intangible assets and supporting the implementation of post-acquisition strategies. Our merger advisory services involve transactions of financially healthy companies and failed bank deals. RP® is also expert in de novo charters and shelf charters. Through financial simulations, comprehensive data bases, valuation proficiency and regulatory familiarity, RP®’s merger advisory services center on enhancing shareholder returns.
VALUATION SERVICES |
RP®’s extensive valuation practice includes bank and thrift mergers, thrift mutual-to-stock conversions, goodwill impairment, insurance company demutualizations, ESOPs, subsidiary companies, merger accounting and other purposes. We are highly experienced in performing appraisals which conform to regulatory guidelines and appraisal standards. RP® is the nation’s leading valuation firm for thrift mutual-to-stock conversions, with appraised values ranging up to $4 billion.
OTHER CONSULTING SERVICES |
RP® offers other consulting services including evaluating the impact of regulatory changes (TARP, etc.), branching and diversification strategies, feasibility studies and special research. We assist banks/thrifts in preparing CRA plans and evaluating wealth management activities on a de novo or merger basis. Our other consulting services are facilitated by proprietary valuation and financial simulation models.
KEY PERSONNEL (Years of Relevant Experience & Contact Information) |
Ronald S. Riggins, Managing Director (37) | (703) 647-6543 | rriggins@rpfinancial.com |
William E. Pommerening, Managing Director (33) | (703) 647-6546 | wpommerening@rpfinancial.com |
Marcus Faust, Managing Director (29) | (703) 647-6553 | mfaust@rpfinancial.com |
Gregory E. Dunn, Director (34) | (703) 647-6548 | gdunn@rpfinancial.com |
James P. Hennessey, Director (30) | (703) 647-6544 | jhennessey@rpfinancial.com |
James J. Oren, Director (30) | (703) 647-6549 | joren@rpfinancial.com |
Carla Pollard, Senior Vice President (27) | (703) 647-6556 | cpollard@rpfinancial.com |
Washington Headquarters | |
Three Ballston Plaza | Telephone: (703) 528-1700 |
1100 North Glebe Road, Suite 600 | Fax No.: (703) 528-1788 |
Arlington, VA 22201 | Toll-Free No.: (866) 723-0594 |
www.rpfinancial.com | E-Mail: mail@rpfinancial.com |